These findings underscore the specificity of protective effects observed here in models of Parkinson's disease, and previously in Huntington's disease, and support the development of @GENE$ inhibitors as potential therapeutics for the two @DISEASE$.	0
The interaction required the @DISEASE$ necrosis factor receptor-associated factor domain of USP7 and the central region of @GENE$ and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.	0
In this study, we conducted targeted sequencing in 246 clinically @DISEASE$ patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different @GENE$s of dementia, in addition to the detection of C9orf72 repeat expansions.	0
A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. @GENE$, mitotic cytokinesis) that are responsible for familial clustering of ovarian @DISEASE$ cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.	1
A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, @GENE$) that are responsible for familial clustering of ovarian @DISEASE$ cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.	1
A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, mitotic cytokinesis) that are responsible for familial clustering of ovarian @DISEASE$ cases; more moderate penetrance susceptibility genes (e.g. @GENE$, RAD51C/D, DNA repair); and multiple common but low penetrance susceptibility alleles identified by GWAS.	0
A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. double-strand break repair via homologous recombination, mitotic cytokinesis) that are responsible for familial clustering of ovarian @DISEASE$ cases; more moderate penetrance susceptibility genes (e.g. mitochondrial translational elongation, RAD51C/D, @GENE$); and multiple common but low penetrance susceptibility alleles identified by GWAS.	1
Among the proteins enriched in LO, cytokeratin 18 (CK18) was one of the most abundant (within the top 5th percentile) and was used to develop an assay to detect LO in the circulation and tissues of @GENE$ and patients with prostate @DISEASE$.	0
These observations indicate that LO represent a discrete EV @GENE$ that may play a distinct role in tumor progression and that may be a source of @DISEASE$-specific markers	0
These observations indicate that LO represent a discrete EV @GENE$ that may play a distinct role in @DISEASE$ progression and that may be a source of cancer-specific markers	0
Germline @GENE$ mutations have been described in hereditary forms of this disease and more recently in small syndromic and @DISEASE$ CCM series.	0
The diagnostic value of @GENE$ in distinguishing between CCM and other @DISEASE$ variants has not been yet established.	0
Nuclear respiratory factor 1 (@GENE$) transcription factor has recently been shown to control breast @DISEASE$ progression.	0
Since transcriptional control of @GENE$ seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve signal transduction +ve) breast @DISEASE$.	0
Since transcriptional control of transcription by RNA polymerase II seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve @GENE$ +ve) breast @DISEASE$.	1
This was consistent with our observation of higher @GENE$ protein expression in the experimental model of signal transduction+ breast @DISEASE$ brain metastasis.	0
This was consistent with our observation of higher transcription by RNA polymerase II protein expression in the experimental model of @GENE$+ breast @DISEASE$ brain metastasis.	1
To identify network-based pathways involved in the susceptibility to the ER/PR -ve @GENE$ +ve breast @DISEASE$ subtype, the transcription by RNA polymerase II transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.	1
Our findings show that a high percentage of known @GENE$+ breast @DISEASE$ susceptibility genes, including EGFR, negative regulation of apoptotic process, and regulation of transcription, DNA-templated, are under transcriptional control of transcription by RNA polymerase II.	1
Our findings show that a high percentage of known signal transduction+ breast @DISEASE$ susceptibility genes, including EGFR, negative regulation of apoptotic process, and regulation of transcription, DNA-templated, are under transcriptional control of @GENE$.	0
Our findings show that a high percentage of known signal transduction+ breast @DISEASE$ susceptibility genes, including EGFR, @GENE$, and regulation of transcription, DNA-templated, are under transcriptional control of transcription by RNA polymerase II.	0
Our findings show that a high percentage of known signal transduction+ breast @DISEASE$ susceptibility genes, including EGFR, negative regulation of apoptotic process, and @GENE$, are under transcriptional control of transcription by RNA polymerase II.	0
By pathway analysis, key breast @DISEASE$ hallmark genes of epithelial-mesenchymal transition, stemness, cell apoptosis, cell cycle regulation, chromosomal integrity, and DNA damage/repair were highly enriched with @GENE$ motifs.	0
In addition, we found using Bayesian network-based machine learning that 30 @GENE$ motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-@GENE$, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	1
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, @GENE$; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-@GENE$, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, @GENE$, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, @GENE$; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	1
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; @GENE$-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	1
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-@GENE$, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, @GENE$, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	1
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, @GENE$, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, @GENE$; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and @GENE$, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with signal transduction-amplified breast cancer.	1
In addition, we found using Bayesian network-based machine learning that 30 transcription by RNA polymerase II motif-enriched genes including growth factor receptors-positive regulation of cell proliferation, negative regulation of apoptotic process; E2Fs transcription factor family-regulation of transcription, DNA-templated, E2F3; MAPK pathway-SHC2, insulin receptor signaling pathway, protein phosphorylation; phosphorylation-AKT-mTOR signaling pathway-phosphorylation, phosphatidylinositol 3-kinase signaling, positive regulation of protein phosphorylation, TOR signaling; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and protein polyubiquitination, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with @GENE$-amplified breast cancer.	1
Machine learning search further revealed that the likelihood of HER2-positive breast @DISEASE$ is almost 100% in a patient with the high @GENE$ expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in regulation of transcription, DNA-templated and positive regulation of cell proliferation, and high or no change in PIK3R3.	0
Machine learning search further revealed that the likelihood of HER2-positive breast @DISEASE$ is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in regulation of transcription, DNA-templated and @GENE$, and high or no change in PIK3R3.	1
Machine learning search further revealed that the likelihood of HER2-positive breast @DISEASE$ is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, regulation of synaptic vesicle exocytosis, and MAPK1, low or no change in @GENE$ and positive regulation of cell proliferation, and high or no change in PIK3R3.	0
Machine learning search further revealed that the likelihood of HER2-positive breast @DISEASE$ is almost 100% in a patient with the high transcription by RNA polymerase II expression combined with expression patterns of high E2F3, @GENE$, and MAPK1, low or no change in regulation of transcription, DNA-templated and positive regulation of cell proliferation, and high or no change in PIK3R3.	0
In summary, our findings suggest novel roles of @GENE$ and its regulatory networks in susceptibility to the ER/PR -ve signal transduction +ve aggressive breast @DISEASE$ subtype.	0
In summary, our findings suggest novel roles of transcription by RNA polymerase II and its regulatory networks in susceptibility to the ER/PR -ve @GENE$ +ve aggressive breast @DISEASE$ subtype.	1
Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of NRF1 as a valuable biomarker for breast @DISEASE$ diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target @GENE$+ breast cancer	1
Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was @GENE$ (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone @DISEASE$.	1
Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was @GENE$ (10%), which may represent a novel cancer gene in @DISEASE$.Chordoma is a rare often incurable malignant bone tumour.	0
Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was @GENE$ (10%), which may represent a novel @DISEASE$ gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.	1
Here, the authors investigate driver mutations of @DISEASE$ chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in @GENE$, a potential novel cancer gene in chordoma	0
Here, the authors investigate driver mutations of sporadic @DISEASE$ in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in @GENE$, a potential novel cancer gene in chordoma	0
Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in @GENE$, a potential novel @DISEASE$ gene in chordoma	1
Studies in humans with @DISEASE$ @GENE$ deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.	1
Studies in humans with autosomal recessive @GENE$ deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the @DISEASE$ nervous system, the oral mucosa, and the skin.	0
Moreover, @GENE$-dependent functions have recently been indicated to modulate the development of autoimmunity, inflammatory bowel diseases, and @DISEASE$.	0
Mutations in peripherin 2 (@GENE$), also known as @DISEASE$ slow/RDS, lead to various retinal degenerations including retinitis pigmentosa (RP) and macular/pattern dystrophy (MD/PD).	1
We asked whether @GENE$ could modify the phenotype of a cell adhesion mutation associated with a high degree of intrafamilial phenotypic @DISEASE$: Y141C.	0
We asked whether cell adhesion could modify the phenotype of a @GENE$ mutation associated with a high degree of intrafamilial phenotypic @DISEASE$: Y141C.	0
Familial amyloid poly@DISEASE$ (@GENE$) is a rare autosomal dominant disorder characterized by amyloid accumulation in the peripheral nerves and other organs, including the heart, kidney, and eyes.	0
Forty unique @GENE$GR1 mutations have been reported and they exert either an autosomal dominant or an @DISEASE$ effect.	0
Up to 15% of the population have mild to moderate chronic @DISEASE$, which is associated with @GENE$ 2 diabetes mellitus, hypertension, metabolic syndrome, and chronic kidney disease.	0
This case of adult-diagnosed @GENE$ deficiency was characterized by slowly progressive peripheral @DISEASE$ masquerading CMT in addition to muscular symptoms.	0
@GENE$ deficiency should be considered in patients with the combination of peripheral @DISEASE$ and recurrent rhabdomyolysis	0
Phenotypically, bs @GENE$ exhibit nuclear @DISEASE$ and male infertility; genetic analyses assigned the bs locus to mouse chromosome 2.	0
Based on the function of @GENE$ as a RABnegative regulation of cell-matrix adhesion and the bs @DISEASE$ and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and autophagosome assembly8.	1
Based on the function of ER to Golgi vesicle-mediated transport as a RAB@GENE$ and the bs @DISEASE$ and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and autophagosome assembly8.	0
An oncogenic role for @GENE$, a NuRD component, is defined for initiating and supporting tumor suppressor gene (negative regulation of cytokine production) silencing in human colorectal @DISEASE$.	0
An oncogenic role for ATP-dependent chromatin remodeling, a NuRD component, is defined for initiating and supporting @DISEASE$ suppressor gene (@GENE$) silencing in human colorectal cancer.	0
@GENE$ knockdown activates silenced TSGs, revealing their role for blunting colorectal @DISEASE$ cell proliferation, invasion, and metastases.	0
X-linked Myopathy with Excessive Autophagy (@GENE$) affects proximal muscles of the lower extremities and follows a progressive course reminiscent of @DISEASE$.	0
The @GENE$ty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of @DISEASE$ patients can reflect tumor status, dietary intakes, and cancer muscle organ development or therapy.	0
The @GENE$ty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of cancer patients can reflect @DISEASE$ status, dietary intakes, and cancer muscle organ development or therapy.	0
The positive regulation of cell-matrix adhesionty acid (FA) composition of @GENE$ blood cell (RBC) membrane phospholipids of @DISEASE$ patients can reflect tumor status, dietary intakes, and cancer muscle organ development or therapy.	0
The positive regulation of cell-matrix adhesionty acid (FA) composition of protein phosphorylation blood cell (RBC) membrane phospholipids of cancer patients can reflect @DISEASE$ status, dietary intakes, and cancer @GENE$ or therapy.	0
The adjusted Analysis of Covariance Test (ANCOVA) model revealed @DISEASE$ patients to have a lower relative percentage of saturated positive regulation of cell-matrix adhesionty acids (SFA) (C16:0 (5.7%); C18:0 (15.9%)), and higher monounsaturated fatty acids (MUFA) (9c-C18:1 (12.9%) and 11c-C18:1 (54.5%)), compa@GENE$ to controls.	0
The adjusted Analysis of Covariance Test (ANCOVA) model revealed @DISEASE$ patients to have a lower relative percentage of saturated @GENE$ty acids (SFA) (C16:0 (5.7%); C18:0 (15.9%)), and higher monounsaturated fatty acids (MUFA) (9c-C18:1 (12.9%) and 11c-C18:1 (54.5%)), compaprotein phosphorylation to controls.	0
To date, researchers have discovered that Nrf2 deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (@GENE$), asthma, idiopathic pulmonary fibrosis (IPF), and lung @DISEASE$.	0
@GENE$ is a Ca(2+) activated Cl(-) channel that is related to head and neck @DISEASE$, often caused by human papilloma virus (HPV) infection.	0
@GENE$ is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human @DISEASE$ virus (HPV) infection.	0
Because @GENE$8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and @DISEASE$ caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of cation transport.	0
Because protein N-linked glycosylation via asparagine8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and @DISEASE$ caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of @GENE$.	0
VLCFA-containing lipids accumulate in X-ALD patients, although the effect of @GENE$-deficiency on each lipid species in the @DISEASE$ nervous system has not been fully characterized.	0
We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor β2 subunit (CHRNB2) found in patients with autosomal dominant @DISEASE$ frontal @GENE$ epilepsy (ADNFLE).	0
We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor β2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal @GENE$ @DISEASE$ (ADNFLE).	0
To confirm that V286L-TG rats exhibit @DISEASE$ similar to those observed in humans, gene expression patterns and behavioral pheno@GENE$s were analyzed.	0
Our analyses identified 15 CpG sites within the APC 1A promoter that were significantly hypermethylated and 14 CpG loci within the @GENE$ gene body that were significantly hypomethylated (pLIS &lt; 1 × 10<sup>-5</sup> ) in the @DISEASE$s of active smokers.	0
Promoter hypermethylation was positively associated with duration of smoking (Spearman @GENE$ correlation, ρ = 0.26, p = 0.03) and was confined to @DISEASE$s, with hypermethylation never being observed in adjacent mucosa.	0
On the other hand, intraperitoneal administration of PQQ exerted protective effects on rats that had received rotenone injection into the medial forebrain bundle through decreasing the apomorphine-evoked rotation, inhibiting @DISEASE$ and TH down-regulation in SNc, increasing the antioxidative ability, and regulating intracellular expressions of @GENE$ and Ndufs 4.	0
In vitro and in vivo (a subcutaneous BALB/c @GENE$ mouse model) studies showed that exosomal cellular response to zinc ion starvation can significantly promote pancreatic @DISEASE$ growth.	0
In vitro and in vivo (a subcutaneous BALB/c establishment of mitotic spindle orientation mouse model) studies showed that exosomal @GENE$ can significantly promote pancreatic @DISEASE$ growth.	0
Diabetes is a metabolic disorder characterized by @DISEASE$ and associated with microvascular and macrovascular syndromes mediated by @GENE$ cells.	0
However, the prognostic value of @GENE$ in ovarian @DISEASE$ remains unclear.	0
Charcot-Marie-Tooth disease @GENE$ 4B2 with early-onset glaucoma (myelination, OMIM 604563) is a genetically-@DISEASE$ childhood-onset neuromuscular disorder.	0
Charcot-Marie-Tooth disease @GENE$ 4B2 with early-onset @DISEASE$ (myelination, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	0
Charcot-Marie-Tooth disease muscle organ development 4B2 with early-onset @DISEASE$ (@GENE$, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	1
Direct sequencing revealed a G to T transition (c.886G&gt;T) in exon 9 of the four‑point‑one, ezrin, radixin, moesin domain‑containing 7 (@GENE$) gene, which resulted in a conservative substitution of glycine to cysteine at codon 296 (p.G296C), leading to idiopathic congenital @DISEASE$ in the two affected brothers.	1
A moderate to severe reduction (&gt;50%) in positive regulation of cell death activity resulting from recessive deletions and/or missense mutations has been shown to cause @GENE$ 1 @DISEASE$ (HPI).	0
Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing positive regulation of cell death and the neighboring @GENE$ gene in three case-control studies, one comprising HPI patients (n = 83), and the other two comprising @DISEASE$ spectrum disorder (ASD) patients (total of n = 2800), analyzed with high-resolution microarrays.	0
The known pathogenic molecules involved in ichthyosis syndromes with prominent @DISEASE$ include @GENE$, transcription-coupled nucleotide-excision repair, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.	1
The known pathogenic molecules involved in ichthyosis syndromes with prominent @DISEASE$ include epidermal cell differentiation, @GENE$, ERCC3, nucleotide-excision repair, cell cycle, ST14, cell-cell junction organization and MBTPS2.	1
The known pathogenic molecules involved in ichthyosis syndromes with prominent @DISEASE$ include epidermal cell differentiation, transcription-coupled nucleotide-excision repair, ERCC3, @GENE$, cell cycle, ST14, cell-cell junction organization and MBTPS2.	1
A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-@DISEASE$ @GENE$ 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	0
Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of @DISEASE$, we identified six novel de novo truncating mutations in @GENE$: c.1880C&gt;G p.(Ser627*), c.1489C&gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&gt;A; p.(Trp348*), c.1002G&gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).	1
These data suggest a pathogenic mechanism of the @GENE$-associated @DISEASE$ syndrome mediated by direct interacting partners of CHAMP1, several of which are involved in chromo/kinetochore-related disorders.	1
These findings implicate for the first time perturbed TGF-β signaling in the @GENE$ of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in @DISEASE$ and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy	0
These findings implicate for the first time perturbed TGF-β signaling in the @GENE$ of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically @DISEASE$ disorders presently only treatable with gene therapy	0
Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and @DISEASE$ (@GENE$), although these are rare.	0
Although the patient showed @DISEASE$, which is one of the typical symptoms of 22q11.2 deletion syndrome, her rather severe phenotype and atypical @GENE$ prompted us to search for additional pathogenic mutations.	1
Preclinical studies have demonstrated that @GENE$ is associated with disease prognosis in a number of human cancers, including @DISEASE$.	0
Preclinical studies have demonstrated that @GENE$ is associated with disease prognosis in a number of human @DISEASE$s, including glioblastoma.	0
Translational research suggests that @GENE$ may be targeted with antibodies to improve @DISEASE$ control and survival in a variety of murine models and cancer types.	0
Punctate @DISEASE$ @GENE$ 1 (PPPK1) is a rare autosomal dominant inherited skin disease, characterized by multiple hyperkeratotic lesions on the palms and soles.	0
Data on human papillomavirus (HPV) @GENE$-specific cervical @DISEASE$ risk in women living with human immunodeficiency virus (WLHIV) are needed to understand HPV⁻HIV interaction and to inform prevention programs for this population.	0
In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (MESP2, DLL3, @GENE$, mesoderm development) and autosomal dominant (TBX6) inheritance.	1
In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (MESP2, DLL3, regulation of somitogenesis, @GENE$) and autosomal dominant (TBX6) inheritance.	1
A previously reported @GENE$ gene for @DISEASE$ was excluded as the disease-causing gene in the family by mutational analysis of all exons and exon-intron boundaries of CLCN2 and by haplotype analysis.	1
Herein, we newly identified that truncated form of @GENE$ is produced and released from lung @DISEASE$ tissue in a mouse model expressing human EML4-ALK fusion gene.	0
Considering these results, the measurement of circulating @GENE$ level may contribute to assess a @DISEASE$ progression in human lung tumor patients	0
Tricho-hepato-enteric syndrome (SD/THE) and Multiple intestinal atresia with combined immune deficiency (@GENE$-CID) are @DISEASE$ disorders that present immunological and gastrointestinal features.	0
There are two different phenotypes of patients with TTC7A mutations: the severe form, caused by null mutations and leading to the classical @GENE$-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and @DISEASE$.	0
We expand the knowledge about @GENE$ deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: @DISEASE$ and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	1
We expand the knowledge about @GENE$ deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, @DISEASE$, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	1
We expand the knowledge about @GENE$ deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and @DISEASE$, evocative of SD/THE	0
We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and @GENE$-CID: @DISEASE$ and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	0
We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and @GENE$-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, @DISEASE$, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	0
We expand the knowledge about protein localization to plasma membrane deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and @GENE$-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and @DISEASE$, evocative of SD/THE	0
We identified novel @GENE$ fusions in a neuroblastoma (BEND5-ALK) and an @DISEASE$ (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a rhabdomyosarcoma.	0
We identified novel @GENE$ fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-smoothened signaling pathway fusion in a @DISEASE$.	0
We identified novel phosphorylation fusions in a @DISEASE$ (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel @GENE$-smoothened signaling pathway fusion in a rhabdomyosarcoma.	0
We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an @DISEASE$ (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel @GENE$-smoothened signaling pathway fusion in a rhabdomyosarcoma.	0
We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel @GENE$-smoothened signaling pathway fusion in a @DISEASE$.	1
We identified novel phosphorylation fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel positive regulation of transcription, DNA-templated-@GENE$ fusion in a @DISEASE$.	0
In summary, our results reveal the molecular mechanism of Aldolase A in promoting lung @DISEASE$ metastasis via PHD-mediated stabilization of HIF-1α and the subsequent activation of @GENE$.	0
The @GENE$-HIF-1α axis may provide a new therapeutic target for metastatic lung @DISEASE$ treatment	0
Haploinsufficiency of @GENE$ in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, @DISEASE$, Dandy Walker malformation and hypoplastic corpus callosum.	1
Haploinsufficiency of @GENE$ in females has been associated with ID and congenital malformations that include heart defects, @DISEASE$, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	1
Haploinsufficiency of @GENE$ in females has been associated with ID and congenital malformations that include heart defects, scoliosis, @DISEASE$, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	1
Haploinsufficiency of @GENE$ in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, @DISEASE$, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	1
Liver @DISEASE$ is very common worldwide and the rates of hepatocellular carcinoma (@GENE$) have increased by over 70% in the last 2 decades in the US.	0
We present the cloning and characterization of a novel gene, @GENE$ (Cancer related gene-Liver 2), which displays high expression in murine and human @DISEASE$s.	0
Using in situ hybridization, we show that @GENE$ mRNA levels are increased early during the development of liver @DISEASE$ in C3H/HeJ epidermis development, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.	0
Using in situ hybridization, we show that microvillus organization mRNA levels are increased early during the development of liver @DISEASE$ in C3H/HeJ @GENE$, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.	0
Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, cerebral cortex development and protein complex oligomerization, resulting in disorders involving @DISEASE$, intellectual disability, speech impairment and developmental delay.	1
Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, @GENE$ and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, @DISEASE$, speech impairment and developmental delay.	1
Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, @GENE$ and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, @DISEASE$ and developmental delay.	0
Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, @GENE$ and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and @DISEASE$.	1
Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, cerebral cortex development and @GENE$, resulting in disorders involving skeletal abnormalities, intellectual disability, @DISEASE$ and developmental delay.	1
Through biological and in silico analyses, our study suggests an association between @GENE$/response to ionizing radiation mutations and @DISEASE$, SIX1/EYA1 mutations might be partially responsible for CTDs	0
Through biological and in silico analyses, our study suggests an association between protein localization to nucleus/@GENE$ mutations and @DISEASE$, SIX1/EYA1 mutations might be partially responsible for CTDs	0
Further inference was found in the @DISEASE$ suppression gene, p53, with a new hypothesis of including the bovine @GENE$ pathways for targeting the glycolysis preference in many types of cancerous cells, consistent with quantum metabolism models.	0
The pattern of inheritance is @DISEASE$, and a causative mutation is evident in the @GENE$ gene.	1
Here we report that @GENE$-c transcript is expressed in 3.2% of cases in The Cancer Genome Atlas breast @DISEASE$ cohort evenly between ER-positive and ER-negative cases.	0
Nevertheless, the ratio of @GENE$ to RANK-c (RANK/RANK-c) is increased in ER-negative breast @DISEASE$ cell lines compared to ER-positive breast cancer cell lines.	0
The @GENE$-c-mediated inhibition of cancer cell @DISEASE$ and nuclear factor-κB (peripheral nervous system development-κB) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.	0
The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of @DISEASE$ cell aggressiveness and nuclear factor-κB (@GENE$-κB) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (cellular response to DNA damage stimulus) protein interaction.	0
The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of @DISEASE$ cell aggressiveness and nuclear factor-κB (peripheral nervous system development-κB) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (@GENE$) protein interaction.	0
De novo loss of function (LOF) mutations in the @GENE$ gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and @DISEASE$, but there is evidence that they also occur in healthy individuals.	1
We established a genetic diagnosis in six families with @DISEASE$ HSP (@GENE$ in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).	1
We established a genetic diagnosis in six families with @DISEASE$ HSP (chemical synaptic transmission in three families and @GENE$/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).	1
We established a genetic diagnosis in six families with @DISEASE$ HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/@GENE$, negative regulation of inclusion body assembly and positive regulation of GTPase activity in one family each).	1
We established a genetic diagnosis in six families with @DISEASE$ HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, @GENE$ and positive regulation of GTPase activity in one family each).	1
We established a genetic diagnosis in six families with @DISEASE$ HSP (chemical synaptic transmission in three families and ER to Golgi vesicle-mediated transport/ER to Golgi vesicle-mediated transport, negative regulation of inclusion body assembly and @GENE$ in one family each).	1
Patients did not present with @DISEASE$ as observed in a previously reported ER to Golgi vesicle-mediated transport family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible pheno@GENE$ correlation to variant location.	0
Patients did not present with @DISEASE$ as observed in a previously reported @GENE$ family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenomuscle organ development correlation to variant location.	1
In addition to a @GENE$ mutation in a patient with all core features of the congenital variant of negative regulation of gene expression, we identified a missense (p.Ser240Thr) in regulation of postsynapse organization in a patient who appeared to be @DISEASE$ free.	1
In addition to a negative regulation of transcription, DNA-templated mutation in a patient with all core features of the congenital variant of negative regulation of gene expression, we identified a missense (p.Ser240Thr) in @GENE$ in a patient who appeared to be @DISEASE$ free.	1
Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in @GENE$ encoding the potassium channel Kv 1.2 in a girl with infantile-onset @DISEASE$s variant of negative regulation of gene expression.	1
Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in potassium ion transmembrane transport encoding the potassium channel Kv 1.2 in a girl with infantile-onset @DISEASE$s variant of @GENE$.	1
Previous studies have demonstrated that @GENE$ mutations are associated with typical LS as well as fatal infantile hypertrophic @DISEASE$.	1
Furthermore, targeted knockout of @GENE$ in epidermis development results in @DISEASE$ with abnormal positive regulation of transcription by RNA polymerase II response.	1
Furthermore, targeted knockout of negative regulation of phosphatase activity in @GENE$ results in @DISEASE$ with abnormal positive regulation of transcription by RNA polymerase II response.	0
These findings suggested that @GENE$ is an important adaptor in hypoxic regions that drives endometrial @DISEASE$ development	0
Here, we report that the expression of the @GENE$ gene is aberrantly elevated in human @DISEASE$ (BCC), coinciding with increased primary cilia formation and activated hedgehog (Hh) signaling.	0
The role of @GENE$ (a target gene of let-7) and the miRNA catabolic process-let-7-c-Myc pathway in the growth and malignancy of thyroid @DISEASE$ is unclear.	1
The role of negative regulation of transcription by RNA polymerase II (a target gene of let-7) and the @GENE$-let-7-c-Myc pathway in the growth and malignancy of thyroid @DISEASE$ is unclear.	0
The purpose of the present study was to evaluate the expression of @GENE$A, let-7a, and c-Myc in human @DISEASE$ (biological_process) and to investigate their potential mechanisms in the progression of PTC.	0
The purpose of the present study was to evaluate the expression of miRNA catabolic processA, let-7a, and c-Myc in human @DISEASE$ (@GENE$) and to investigate their potential mechanisms in the progression of PTC.	0
CONCLUSIONS The @GENE$A/let-7a/negative regulation of transcription by RNA polymerase II pathway is involved in @DISEASE$ growth and malignant behavior in biological_process and is a potential target for therapeutic intervention in this disease	0
CONCLUSIONS The miRNA catabolic processA/let-7a/@GENE$ pathway is involved in @DISEASE$ growth and malignant behavior in biological_process and is a potential target for therapeutic intervention in this disease	1
CONCLUSIONS The miRNA catabolic processA/let-7a/negative regulation of transcription by RNA polymerase II pathway is involved in @DISEASE$ growth and malignant behavior in @GENE$ and is a potential target for therapeutic intervention in this disease	0
Mutations in @GENE$2 are associated with @DISEASE$, characterized by ophthalmoplegia.	0
Mutations in @GENE$2 are associated with skeletal myopathies, characterized by @DISEASE$.	0
Mutations in @GENE$3 and MYH8 are associated with @DISEASE$ arthrogryposis syndromes.	0
Mutations in @GENE$3 and MYH8 are associated with distal @DISEASE$ syndromes.	0
Mutations in @GENE$7 are associated with not only skeletal muscle diseases, such as Laing distal @DISEASE$ and myosin storage myopathy, but also hypertrophic cardiomyopathy.	0
On these bases, we investigated whether the ligation of ERβ by a selective agonist, the 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), could @GENE$ HL @DISEASE$ growth.	0
In nonobese diabetic/severe combined immunodeficient (NOD/SCID) @GENE$ engrafted with HL cells, ERβ activation by DPN was able to reduce lymphoma growth up to 60% and this associated with the induction of @DISEASE$ cell autophagy.	0
After ERβ activation, both @GENE$ and protein 1 light chain 3 (LC3), a key actor in the autophagosome formation, strictly interacted each other and localized at mitochondrial level.Altogether these results suggest that targeting ERβ with selective agonists might affect HL cell proliferation and @DISEASE$ growth via a mechanism that brings into play DRAM2-dependent autophagic cascade	0
The oncogenic potential of @GENE$ in terms of prognosis and @DISEASE$ metastasis in arginine prototrophic gastric cancer (GC) remains unclear at present.	0
@GENE$ was highly expressed in GC and positively correlated with GC @DISEASE$ and poor outcome.	0
Depletion of @GENE$ led to inhibition of @DISEASE$ growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active β-catenin, Snail, and Twist.	0
Ectopic expression of circadian rhythm in GC cells reversed these effects and protected @DISEASE$ cells from chemotherapy drug-induced apoptosis via activation of the @GENE$-mammalian target of rapamycin signaling pathway.	1
Finally, we show that inhibition of @GENE$ cooperates with standard chemotherapy to treat PDAC cells and @DISEASE$.	0
These findings uncover a pivotal role for @GENE$ in promoting pancreatic @DISEASE$.	0
Previous investigations have demonstrated that single nucleotide polymorphisms (SNPs) of @GENE$ pathway genes were associated with various types of @DISEASE$.	0
Therefore, we conducted genotyping for 17 SNPs of six positive regulation of cholesterol transport core genes (<i>XPA, @GENE$, XPG, ERCC1, ERCC2</i>, and <i>ERCC4</i>) in 89 ovarian @DISEASE$ cases and 356 cancer-free controls.	1
The result showed that both <i>@GENE$</i> rs11615 and <i>nucleotide-excision repair, DNA damage recognition</i> rs2228000 were significantly associated with reduced risk of ovarian @DISEASE$ under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, <i>P</i>=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, <i>P</i>=0.005 respectively).	0
The result showed that both <i>nucleotide-excision repair</i> rs11615 and <i>@GENE$</i> rs2228000 were significantly associated with reduced risk of ovarian @DISEASE$ under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, <i>P</i>=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, <i>P</i>=0.005 respectively).	1
In addition, <i>@GENE$</i> rs2228001 and <i>ERCC2</i> rs238406 had statistically significant association with the increased risk of ovarian @DISEASE$ under dominant genetic model (adjusted OR = 1.72, 95% CI = 1.02-2.92, <i>P</i>=0.043 and adjusted OR = 2.07, 95% CI = 1.07-4.01, <i>P</i>=0.032 respectively).	1
<i>@GENE$</i> rs3212986 were related with the increased risk of ovarian @DISEASE$ under recessive model (adjusted OR = 2.40, 95% CI = 1.30-4.44, <i>P</i>=0.005).	0
In conclusion, our results indicated that <i>@GENE$, nucleotide-excision repair, DNA damage recognition</i> and <i>ERCC2</i> might influence ovarian @DISEASE$ susceptibility.	0
In conclusion, our results indicated that <i>nucleotide-excision repair, @GENE$</i> and <i>ERCC2</i> might influence ovarian @DISEASE$ susceptibility.	1
Historically classified as a subtype of @DISEASE$ (@GENE$), FLC has a unique clinical, histological, and molecular presentation.	0
High @GENE$ expression plays an important role in promoting @DISEASE$ development and aggressiveness, which is correlated with reduced patient survival.	0
Mutations in the photoreceptor tetraspanin gene peripherin-2/@DISEASE$ slow (PRPH2/@GENE$) cause both rod- and cone-dominant diseases.	1
Here we took advantage of a transgenic mouse line expressing an @GENE$ mutant (R172W) known to cause @DISEASE$ (MD) in humans.	1
Fundus imaging demonstrated that R172W @GENE$ developed severe clinical signs of disease nearly identical to those seen in human MD patients, including @DISEASE$, retinal pigment epithlium (RPE) defects and loss of the choriocapillaris.	0
Mucopolysaccharidosis (MPS) @GENE$ I is a rare @DISEASE$ disease caused by a deficiency of the lysosomal enzyme α-L-iduronidase.	1
Next, we took epicardial @GENE$ samples from patients with @DISEASE$ and non- coronary artery disease.	0
Before performing PET scans, subjects answered the Buss-Perry Aggression Questionnaire and Temperament and Character Inventory to measure their @DISEASE$ and personality @GENE$, respectively.	0
Concordant modulation of IRGs in both @GENE$ and human cells indicates that they might play important roles in regulating CHIKV replication in the @DISEASE$ nervous system (CNS).	0
Generalized @DISEASE$ of infancy (GACI), or idiopathic infantile arterial calcification, is a rare autosomal-recessive disease recognized aAs an inherited disorder characterized by severe pathologic calcification of large- and medium-sized arteries accompanied by smooth muscle cell (@GENE$) hyperplasia leading to vascular obstruction [1].	0
The aim this study was to investigate the prevalence of single nucleotide polymorphisms in @GENE$ gene (LEP 3'UTR A/C, -2548 G/A) and LEPR (K109R and Q223R) and their association with Leptin level and @DISEASE$.	1
The K109R polymorphism was associated with @DISEASE$ (P = .025) and seems to significantly decrease the @GENE$ levels (P &lt; .001).	1
De novo variants of @GENE$, which encodes a histone methyltransferase, have been reported in a few patients with @DISEASE$ and autistic features.	1
Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in @GENE$ in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, @DISEASE$, and scoliosis.	0
Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in @GENE$ in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and @DISEASE$.	0
Our report provides further evidence to support loss-of-function alterations of @GENE$ as causative for an emergent neurodevelopmental syndrome characterized by MCA, @DISEASE$, and behavioral problems, and further delineates this genetic disorder	1
Our report provides further evidence to support loss-of-function alterations of @GENE$ as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and @DISEASE$, and further delineates this genetic disorder	1
Aberrant expression of @GENE$-containing protein 44 (TRIM44) acts as a promoter in multiple @DISEASE$s.	0
Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal @DISEASE$ (@GENE$).	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in @DISEASE$ cases; and @GENE$ (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and @GENE$ (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-@DISEASE$ inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and @GENE$ (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive @DISEASE$), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), @GENE$ (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-@DISEASE$ inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and @GENE$ (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-@DISEASE$ inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and @GENE$ (myosin T cell costimulation chain (positive regulation of intracellular transport) kinase)-autosomal recessive @DISEASE$), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin @GENE$ chain (positive regulation of intracellular transport) kinase)-@DISEASE$ inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and elastic fiber assembly (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and positive regulation of cell migration (myosin T cell costimulation chain (@GENE$) kinase)-@DISEASE$ inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	1
Two sisters with c.137T&gt;C (p.Leu46Pro) @GENE$ variants had multi-system disease including dysmorphism, @DISEASE$, severe developmental delay, cataracts and early death.	1
Two sisters with c.137T&gt;C (p.Leu46Pro) @GENE$ variants had multi-system disease including dysmorphism, seizures, severe @DISEASE$, cataracts and early death.	1
Two sisters with c.137T&gt;C (p.Leu46Pro) @GENE$ variants had multi-system disease including dysmorphism, seizures, severe developmental delay, @DISEASE$ and early death.	1
Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, @GENE$, S-adenosylmethionine metabolic process, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated @DISEASE$ (phosphatidylinositol phosphorylation).	0
Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, @GENE$, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated @DISEASE$ (phosphatidylinositol phosphorylation).	0
Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, S-adenosylmethionine metabolic process, @GENE$, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated @DISEASE$ (phosphatidylinositol phosphorylation).	0
Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, lipid metabolic process, S-adenosylmethionine metabolic process, apoptotic process, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated @DISEASE$ (@GENE$).	0
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, @DISEASE$, and sensorineural hearing loss)/CAOS syndrome.	1
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar @DISEASE$, areflexia, @GENE$ cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	0
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, @DISEASE$, @GENE$ cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	0
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the cellular sodium ion homeostasis gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, @GENE$ cavus, @DISEASE$, and sensorineural hearing loss)/CAOS syndrome.	0
Although mammalian @GENE$ is expressed in the @DISEASE$ nervous system as well as in skeletal muscle, patients carrying mutations in MEGF10 do not show symptoms of central nervous system dysfunction.	0
The histological and @DISEASE$ seen in the affected flies @GENE$ the stage for further studies examining the signaling pathway modulated by homotypic cell-cell adhesion/Drpr in muscle, as well as assessing the effects of genetic and/or pharmacological manipulations on the observed muscle defects.	0
The present study screened pathogenic genes, ectodysplasin A (@GENE$) and lamin A/C (positive regulation of cell aging), in a patient with suspected syndromic @DISEASE$ and various other symptoms including tooth and skin abnormalities.	0
The present study screened pathogenic genes, ectodysplasin A (positive regulation of NF-kappaB transcription factor activity) and lamin A/C (@GENE$), in a patient with suspected syndromic @DISEASE$ and various other symptoms including tooth and skin abnormalities.	1
The present study screened pathogenic genes, ectodysplasin A (positive regulation of NF-kappaB transcription factor activity) and lamin A/C (@GENE$), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and @DISEASE$.	1
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (@GENE$), RAB3 GTPase activating protein catalytic subunit 1 (regulation of GTPase activity) and Wnt family member 10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/@DISEASE$, respectively.	0
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (@GENE$), RAB3 GTPase activating protein catalytic subunit 1 (regulation of GTPase activity) and Wnt family member 10A (canonical Wnt signaling pathway), implicated in @DISEASE$, hypogonadism and tooth/skin abnormalities, respectively.	1
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit 1 (@GENE$) and Wnt family member 10A (canonical Wnt signaling pathway), implicated in deafness, hypogonadism and tooth/@DISEASE$, respectively.	1
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit 1 (@GENE$) and Wnt family member 10A (canonical Wnt signaling pathway), implicated in @DISEASE$, hypogonadism and tooth/skin abnormalities, respectively.	0
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit 1 (regulation of GTPase activity) and Wnt family member 10A (@GENE$), implicated in deafness, hypogonadism and tooth/@DISEASE$, respectively.	1
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (negative regulation of transcription by RNA polymerase II), RAB3 GTPase activating protein catalytic subunit 1 (regulation of GTPase activity) and Wnt family member 10A (@GENE$), implicated in @DISEASE$, hypogonadism and tooth/skin abnormalities, respectively.	0
Crizotinib is a small orally-administered @GENE$ inhibitor for patients with non-small cell lung @DISEASE$ with mitotic cell cycle-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).	1
Crizotinib is a small orally-administered phosphorylation inhibitor for patients with non-small cell lung @DISEASE$ with @GENE$-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).	0
Lactate dehydrogenase A (@GENE$), a key enzyme in glycolysis, is highly expressed in a variety of @DISEASE$s and catalyzes pyruvate to lactate.	0
In the present study, we first analyzed the association and clinical significance of p53 and @GENE$ in breast @DISEASE$ expressing wild-type p53 (wt-p53) and found that LDHA mRNA levels are negatively correlated with wt-p53 but not with mutation p53 mRNA levels, and low p53 and high LDHA expression are significantly associated with poor overall survival rates.	0
Moreover, a series of @GENE$ gain-of-function and rescore experiments were carried out in breast @DISEASE$ MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.	0
In conclusion, our findings showed that repression of @GENE$ induced by wt-p53 blocks @DISEASE$ growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer	0
However, the significance of @GENE$ overexpression in human breast @DISEASE$ (HBC) remains to be investigated.	0
Inhibition of ERα by its siRNA or tamoxifen reduces cellular levels of @GENE$ and Pol III gene expression and decreases the rate of colony formation of breast @DISEASE$ cells.	0
The most important finding is the recurrently mutated gene, @GENE$, which has never been reported in parathyroid @DISEASE$s before.	0
The Y54X mutation in the @GENE$ gene was previously identified in @DISEASE$, which proved that parathyroid adenomas and carcinomas might possess similar molecular signatures.	1
Non-alcoholic steatohepatitis (NASH) is commonly associated with @DISEASE$, @GENE$ 2 diabetes, and/or hypertriglyceridemia, while alcoholic steatohepatitis (ASH) is associated with alcohol abuse.	0
The congenital myasthenic syndromes (@GENE$) are @DISEASE$ disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms.	0
In a patient with Leigh-like syndrome presenting with leukodystrophy and severe @DISEASE$, we identified a homozygous splice site mutation in @GENE$, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclear-encoded subunit of complex IV.	1
The purpose of this study is to investigate whether G protein-coupled receptor signaling pathway can modulate the osteoclastogenesis induced by @GENE$ or @DISEASE$ cells.	0
We found that G protein-coupled receptor signaling pathway inhibits RANKL- or @DISEASE$ cell-mediated osteoclastogenesis via blockade of @GENE$ and peripheral nervous system development-κB activation.	0
We found that G protein-coupled receptor signaling pathway inhibits RANKL- or @DISEASE$ cell-mediated osteoclastogenesis via blockade of protein polyubiquitination and @GENE$-κB activation.	0
Almost all are inherited in @DISEASE$ patterns with a few exceptions such as the X-linked @GENE$.	0
Here, we show that tamoxifen, a well-known drug used against breast @DISEASE$, rescues the phenotype of @GENE$-deficient mice.	1
Congenital dyserythropoietic anemia @GENE$ I (chromatin organization) is a rare @DISEASE$ disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.	1
Congenital dyserythropoietic anemia muscle organ development I (@GENE$) is a rare @DISEASE$ disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.	1
@GENE$ is also involved in @DISEASE$ cell migration.	0
Through a whole genome sequencing (WGS) analysis of the nine subjects (four lung @DISEASE$ patients and five normal family members of FLC), we obtained a whole genome data@GENE$ of DNA alterations in FLC samples.	0
Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample @GENE$ including FLC, @DISEASE$ lung cancer, and healthy population.	0
Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample @GENE$ including FLC, sporadic lung @DISEASE$, and healthy population.	0
Mutations of the five genes (@GENE$, ANKRD20A2, regulation of transcription by RNA polymerase II, ZNF812, vasculogenesis) may be potential germline mutations of lung @DISEASE$.	0
Mutations of the five genes (regulation of GTPase activity, ANKRD20A2, @GENE$, ZNF812, vasculogenesis) may be potential germline mutations of lung @DISEASE$.	0
Mutations of the five genes (regulation of GTPase activity, ANKRD20A2, regulation of transcription by RNA polymerase II, ZNF812, @GENE$) may be potential germline mutations of lung @DISEASE$.	0
We also analyzed specific mutations within the 12 genes and found that some specific mutations within the @GENE$, biological_process and biological_process genes showed higher frequencies in the samples of FLC and/or lung @DISEASE$ tissue, compared with the healthy population.	0
We also analyzed specific mutations within the 12 genes and found that some specific mutations within the stimulatory C-type lectin receptor signaling pathway, @GENE$ and biological_process genes showed higher frequencies in the samples of FLC and/or lung @DISEASE$ tissue, compared with the healthy population.	0
We also analyzed specific mutations within the 12 genes and found that some specific mutations within the stimulatory C-type lectin receptor signaling pathway, biological_process and @GENE$ genes showed higher frequencies in the samples of FLC and/or lung @DISEASE$ tissue, compared with the healthy population.	0
These analyses revealed significantly higher methylation frequencies in high-grade @DISEASE$s relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and @GENE$ genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&lt;0.05).	0
These analyses revealed significantly higher methylation frequencies in high-grade @DISEASE$s relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, @GENE$, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&lt;0.05).	0
These analyses revealed significantly higher methylation frequencies in high-grade @DISEASE$s relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, @GENE$, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and nucleosome assembly genes (P&lt;0.05).	0
These analyses revealed significantly higher methylation frequencies in high-grade @DISEASE$s relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, @GENE$, and nucleosome assembly genes (P&lt;0.05).	0
These analyses revealed significantly higher methylation frequencies in high-grade @DISEASE$s relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and forebrain development genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, actin cytoskeleton reorganization, somatic stem cell population maintenance, regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, negative regulation of transcription by RNA polymerase II, and @GENE$ genes (P&lt;0.05).	0
In addition, inactivation of the @DISEASE$ suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of @GENE$ in patient HNSCC samples.	1
In addition, inactivation of the @DISEASE$ suppressor retinoblastoma 1 (RB1), reflected by G1/S transition of mitotic cell cycle/@GENE$-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.	0
In addition, inactivation of the tumor suppressor @DISEASE$ 1 (RB1), reflected by @GENE$/positive regulation of cell-matrix adhesion-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.	0
In addition, inactivation of the tumor suppressor @DISEASE$ 1 (RB1), reflected by G1/S transition of mitotic cell cycle/@GENE$-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of positive regulation of protein phosphorylation in patient HNSCC samples.	0
positive regulation of lipid kinase activity gene is highly expressed in the @DISEASE$ nervous system and Eef1a2 knockout @GENE$ show the neuronal degeneration.	0
Here, we report that the expression of microRNA-493 (protein polyubiquitination-493) is decreased in @GENE$ cell lines and in @DISEASE$ tissues.	0
Overexpression of @GENE$-493 in phosphatidylinositol phosphorylation cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited @DISEASE$ formation of HCC cell xenografts in vivo.	0
Overexpression of protein polyubiquitination-493 in @GENE$ cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited @DISEASE$ formation of HCC cell xenografts in vivo.	0
Novel targets actin cytoskeleton reorganization and RSPO2 were confirmed to be suppressed by @GENE$-493 directly, and overexpression of ANTXR1 and RSPO2 could restore @DISEASE$igenesis in miR-493 treated HCC cell.	0
Moreover, Wnt/β-catenin signaling pathway, which was reported to be activated by ANTXR1 and @GENE$, was also inhibited by protein polyubiquitination-493 overexpression and might be involved in anti-@DISEASE$ function of miR-493.	0
Moreover, Wnt/β-catenin signaling pathway, which was reported to be activated by ANTXR1 and positive regulation of Wnt signaling pathway, was also inhibited by @GENE$-493 overexpression and might be involved in anti-@DISEASE$ function of miR-493.	0
We present a young boy whose mild @DISEASE$ and abnormal eye movements repeatedly deteriorated with fever, making him unable to @GENE$ or walk during fever episodes.	0
We present a young boy whose mild ataxia and @DISEASE$ repeatedly deteriorated with fever, making him unable to @GENE$ or walk during fever episodes.	1
Walker-Warburg syndrome (@GENE$) is a severe @DISEASE$ with eye and brain malformations.	0
The disease family of @DISEASE$-dystroglycanopathy (MDDG) contains a spectrum of severe to mild disorders, designated as MDDG @GENE$ A to C.	1
Mutations in protein O-linked mannosylation, POMT2, protein O-linked glycosylation, @GENE$, FKRP, LARGE, GMPPB, TMEM5 and branching involved in blood vessel morphogenesis and ISPD lead to a wide spectrum of phenotypes of congenital @DISEASE$ with or without eye and brain abnormalities.	1
Mutations in protein O-linked mannosylation, POMT2, protein O-linked glycosylation, protein O-linked glycosylation, FKRP, LARGE, GMPPB, TMEM5 and @GENE$ and ISPD lead to a wide spectrum of phenotypes of congenital @DISEASE$ with or without eye and brain abnormalities.	1
Patients with @GENE$ frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, @DISEASE$, hydrocephalus and poor prognosis.	1
Patients with @GENE$ frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, @DISEASE$ and poor prognosis.	0
We also demonstrate that @DISEASE$-associated @GENE$s induce the expression of genes associated with an aggressive phenotype in primary lung cancer cells and selectively promote their dissemination rather than local growth.	0
Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral @DISEASE$ (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (@GENE$).	1
An additional locus for @DISEASE$ Charcot-Marie-Tooth disease @GENE$ 2H on chromosome 8q13-21.1 was excluded by linkage analysis.	1
Prostate @DISEASE$ is the most common cancer among western @GENE$, with a significant mortality and morbidity reported for advanced metastatic disease.	0
By analysing prostate @DISEASE$ bone metastases using high density microarrays, we found a common genomic copy number loss at 6q16.1-16.2, containing the protein polyubiquitination gene, which was confirmed in larger series of bone metastases by fluorescence in situ hybridisation (@GENE$).	0
Loss of @GENE$ was also detected in primary @DISEASE$ and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (plasminogen activation) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.	0
Loss of protein polyubiquitination was also detected in primary @DISEASE$ and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (@GENE$) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.	0
In vitro analysis showed that @GENE$ plays a role in regulating the migration and invasion of prostate @DISEASE$ cells.	0
The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and @GENE$ in basal @DISEASE$s, and negative regulation of transcription by RNA polymerase II, LY6E, proteolysis, CDK3, and TBX2 in luminal tumors.	0
The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and MAPK cascade in basal @DISEASE$s, and @GENE$, LY6E, proteolysis, CDK3, and TBX2 in luminal tumors.	0
The enriched genes included MMP9, negative regulation of blood coagulation, CAV1, KRT14, and MAPK cascade in basal @DISEASE$s, and negative regulation of transcription by RNA polymerase II, LY6E, @GENE$, CDK3, and TBX2 in luminal tumors.	0
In the present study, western blotting was used to verified the expression of T lymphocyte @GENE$ and pathway proteins, including phosphorylated extracellular signal‑regulated kinase (P‑ERK)1/2 and phosphorylated c‑Jun N‑terminal kinase (P‑JNK), and used cytometric bead array to detect the secretion of interleukin (IL)‑4, IL‑6, IL‑10 and @DISEASE$ necrosis factor (TNF)‑α in AMI onset, the results demonstrated that they were all increased.	0
The importance of mitochondria for white matter is @GENE$ exemplified in a group of defects of the mitochondria oxidative metabolism called mitochondria @DISEASE$ or encephalomyopathies.	0
In this work, we report a new progressive @DISEASE$ epilepsy associated with Lafora bodies, early-onset Lafora body disease, map its locus to chromosome 4q21.21, identify its gene and mutation and characterize the relationship of its gene product with laforin and @GENE$.	1
We used the Illumina HumanMethylation450 BeadChip microarray to test whether white blood cell DNA, an easily accessible source of DNA, exhibits site-specific changes in DNA methylation in blood of diagnosed @GENE$ patients (post-diagnostic, 24 cases, 24 controls) and in prospectively collected blood specimens of HCC patients who were @DISEASE$-free at blood collection (pre-diagnostic, 21 cases, 21 controls).	0
Our findings highlight the significance of recalibrating @DISEASE$ cell metabolism by fine-tuning nucleotide and NAD synthesis in tumor growth.<b>Significance:</b> Our findings elucidate an instrumental function of @GENE$ in direct regulation of nucleic acid and NAD synthesis in tumor cells in response to energy stress.	0
Mutations in two genes, <i>@GENE$</i> and <i>protein phosphorylation</i>, account for most cases of autosomal dominant polycystic @DISEASE$, one of the most common monogenetic disorders.	1
Mutations in two genes, <i>positive regulation of cyclin-dependent protein serine/threonine kinase activity</i> and <i>@GENE$</i>, account for most cases of autosomal dominant polycystic @DISEASE$, one of the most common monogenetic disorders.	0
Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, @DISEASE$ (@GENE$ and oxidation-reduction process-CMT2K) and autosomal dominant (AD-CMT2K).	1
Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, @DISEASE$ (mitochondrial fission and @GENE$-CMT2K) and autosomal dominant (AD-CMT2K).	0
Three families (families 1, 2 and 3) were found to have an @DISEASE$ (@GENE$) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.	0
Three families (families 1, 2 and 3) were found to have an autosomal recessive (@GENE$) pattern of inheritance while family 4 displayed an autosomal dominant (AD) @DISEASE$.	0
Electro-physiologic studies revealed an axonal type of @DISEASE$ (@GENE$-CMT2K and AD-CMT2K) in all affected individuals.	0
Delayed bone age and @DISEASE$ disorders were overrepresented in the @GENE$N1 group (P=0.009 and P=0.024, respectively), whereas some characteristic TTD clinical, laboratory, and imaging findings were absent.	0
We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural @DISEASE$, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of @GENE$ syndrome, a suspected ciliopathy.	0
We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, @DISEASE$, patent ductus arteriosus, and facial dysmorphism reminiscent of @GENE$ syndrome, a suspected ciliopathy.	0
We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and @DISEASE$ reminiscent of @GENE$ syndrome, a suspected ciliopathy.	0
Affected individuals presented with prenatal-onset spinal muscular atrophy (@GENE$), multiple congenital @DISEASE$ (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.	0
Affected individuals presented with prenatal-onset spinal muscular atrophy (@GENE$), multiple congenital contractures (@DISEASE$ multiplex congenita), respiratory distress, and congenital bone fractures.	0
Sturge-Weber Syndrome (@GENE$) is a neurocutaneous disease with clinical manifestations including ocular (glaucoma), cutaneous (port-wine birthmark), neurologic (@DISEASE$), and vascular problems.	0
Molecular mechanisms of @GENE$ pathogenesis are initiated by the @DISEASE$ in GNAQ.	0
The @GENE$-6 gene had no significant negative regulation of transcription by RNA polymerase II on @DISEASE$ cell adhesion mediated by integrin, but significantly more tumors were detected when vIL-6 was present.	0
The epidermal growth factor receptor signaling pathway-6 gene had no significant @GENE$ on @DISEASE$ cell adhesion mediated by integrin, but significantly more tumors were detected when vIL-6 was present.	0
The epidermal growth factor receptor signaling pathway-6 gene had no significant negative regulation of transcription by RNA polymerase II on @DISEASE$ @GENE$, but significantly more tumors were detected when vIL-6 was present.	0
B cell markers in @DISEASE$ cells were also compared to the same cell muscle organ development in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of @GENE$-6.	0
Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that @GENE$, an adhesion-localized positive regulation of lamellipodium assembly and actin cytoskeleton organization specific GTPase activating protein, is necessary for U2OS @DISEASE$ cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.	0
Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that regulation of small GTPase mediated signal transduction, an adhesion-localized @GENE$ and actin cytoskeleton organization specific GTPase activating protein, is necessary for U2OS @DISEASE$ cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.	0
Mutation of aspartic acid 378 of @GENE$ to either asparagine or histidine has been associated with @DISEASE$.	1
According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of negative regulation of translational initiation but not @GENE$, L-methylmalonyl-CoA metabolic process or monocyte activation involved in immune response was significantly lower in pancreatic @DISEASE$ than in normal adjacent tissues.	0
According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of negative regulation of translational initiation but not N-acetylglucosamine metabolic process, L-methylmalonyl-CoA metabolic process or @GENE$ was significantly lower in pancreatic @DISEASE$ than in normal adjacent tissues.	0
Ewing's @DISEASE$ is an aggressive mesenchymal tumor characterized by the presence of a unique @GENE$-multicellular organism development translocation.	1
Ewing's @DISEASE$ is an aggressive mesenchymal tumor characterized by the presence of a unique regulation of transcription, DNA-templated-@GENE$ translocation.	0
Ewing's sarcoma is an aggressive mesenchymal @DISEASE$ characterized by the presence of a unique @GENE$-multicellular organism development translocation.	1
Ewing's sarcoma is an aggressive mesenchymal @DISEASE$ characterized by the presence of a unique regulation of transcription, DNA-templated-@GENE$ translocation.	0
Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (@GENE$), leading to excess glucocorticoid and @DISEASE$.	0
However, the major driver mutations in @GENE$ wild-type @DISEASE$ remain elusive.	1
Moreover, primary corticotroph @DISEASE$ cells harboring @GENE$ V600E are sensitive to the BRAF inhibitor vemurafenib.	1
FGD is a @DISEASE$ disorder for which causal mutations have been identified in MC2R, @GENE$, MCM4 and TXNRD2.	0
This study doubles the number of known mutations for this disorder, confirms that truncating mutations in @GENE$ are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as @DISEASE$ and dystonia.	1
While the down regulation of @GENE$ by DNA methylation in gastric @DISEASE$ and by nuclear protein polyubiquitination in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.	0
While the down regulation of protein phosphorylation by DNA methylation in gastric @DISEASE$ and by nuclear @GENE$ in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.	1
Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of @GENE$ in prostate @DISEASE$ resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of <i>PrKD1</i>.	1
<i>In silico</i> human gene expression analysis confirmed the down regulation of @GENE$ in metastatic prostate @DISEASE$ correlated inversely with the expression of negative regulation of transcription by RNA polymerase II, but not negative regulation of transcription by RNA polymerase II, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	0
<i>In silico</i> human gene expression analysis confirmed the down regulation of protein phosphorylation in metastatic prostate @DISEASE$ correlated inversely with the expression of negative regulation of transcription by RNA polymerase II, but not @GENE$, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	1
Ancestor @DISEASE$ clones evolved into three subclonal clades: clade1 fostered metastatic subclones that carried metastatic features of <i>PIK3CA</i> and <i>ARHGAP26</i> point mutations as well as chr13 arm-level deletion, clade2 owned branch-specific <i>JAK1</i> mutations and <i>PTEN</i> deletion, and clade3 was found in two vertical distribution samples below the primary tumor area, highlighting the @GENE$ that it is possible for PMME to disseminate by the submucosal longitudinal lymphatic route at an early stage of metastasis.	0
These findings facilitate interpretation of the genetic essence of this rare melanoma sub@GENE$ as well as the pattern of @DISEASE$ evolution, thus reinforcing the therapeutic challenges associated with PMME.<b>Significance:</b> This study highlights the use of multiregion exome sequencing and whole genome SNP array genotyping to comprehensively characterize the genetic landscape of a rare type of esophogeal melanoma.	0
Small series of cases have documented the co-occurrence of ganglioneuroma with a @DISEASE$ (Pheo)/paraganglioma (@GENE$) component.	1
Small series of cases have documented the co-occurrence of ganglioneuroma with a pheochromocytoma (Pheo)/@DISEASE$ (@GENE$) component.	1
One patient had a retroperitoneal composite @GENE$-ganglioneuroma in the setting of @DISEASE$ muscle organ development 1.	0
One patient had a retroperitoneal composite tricarboxylic acid cycle-ganglioneuroma in the setting of @DISEASE$ @GENE$ 1.	0
In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (@GENE$) and @DISEASE$ necrosis factor receptor superfamily member 13C (tumor necrosis factor-mediated signaling pathway).	0
In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (negative regulation of intracellular transport) and @DISEASE$ necrosis factor receptor superfamily member 13C (@GENE$).	1
There was weaker evidence for iCHAV4, located 5' of @GENE$, associated only with ER-positive breast @DISEASE$ (OR = 0.93 [0.90-0.96]).	0
Chromosome conformation capture analysis showed that iCHAV2 interacts with the @GENE$ and autophagy (more than 600 kb away) promoters in normal and @DISEASE$ous breast epithelial cells.	0
Chromosome conformation capture analysis showed that iCHAV2 interacts with the negative regulation of neuron projection development and @GENE$ (more than 600 kb away) promoters in normal and @DISEASE$ous breast epithelial cells.	0
Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the @GENE$ promoter, implicating this gene in the etiology of breast @DISEASE$.	0
The continuum of epithelial changes in the process of serous @DISEASE$ including p53 signature, @GENE$, STIC and invasive carcinoma was identified in 8 cases of pelvic HGSC.	0
Ectopically injected human cancer cell lines develop into @DISEASE$ in SCID @GENE$, thus providing a human-sized <i>in vivo</i> model for evaluating imaging methods to improve cancer detection and therapeutic research and development.	0
Glycine cleavage system (@GENE$) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine @DISEASE$, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).	0
Glycine cleavage system (@GENE$) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic @DISEASE$ (glycine decarboxylation via glycine cleavage system).	0
Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by @GENE$, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine @DISEASE$, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).	1
Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, @GENE$ and GCSH are the only known causes of glycine @DISEASE$, also known as non-ketotic hyperglycinemia (glycine decarboxylation via glycine cleavage system).	1
Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, @GENE$ and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic @DISEASE$ (glycine decarboxylation via glycine cleavage system).	1
Glycine cleavage system (cysteine metabolic process) catalyzes the degradation of glycine and disruption of its components encoded by glycine catabolic process, glycine decarboxylation via glycine cleavage system and GCSH are the only known causes of glycine @DISEASE$, also known as non-ketotic hyperglycinemia (@GENE$).	1
The successful therapeutic use of anti-@GENE$ biological agents in patients with ankylosing spondylitis (AS) indicates that @DISEASE$ necrosis factor-α (TNF-α) and tumor necrosis factor receptor (TNFR) genes are involved in the pathogenesis of AS.	0
Corneal dystrophies may have a @GENE$ autosomal dominant, @DISEASE$ or X-linked recessive Mendelian mode of inheritance.	0
Corneal dystrophies may have a @GENE$ autosomal dominant, autosomal recessive or X-linked recessive Mendelian @DISEASE$.	0
Different @DISEASE$ are caused by mutations in the N-acetylglucosamine metabolic process, @GENE$, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.	1
Different @DISEASE$ are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, @GENE$, negative regulation of epithelial cell migration, angiogenesis, and UBIAD1 genes.	1
Different @DISEASE$ are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, @GENE$, angiogenesis, and UBIAD1 genes.	1
Different @DISEASE$ are caused by mutations in the N-acetylglucosamine metabolic process, intermediate filament cytoskeleton organization, KRT12, PIP5K3, sodium ion transport, negative regulation of epithelial cell migration, @GENE$, and UBIAD1 genes.	1
Herein, we investigated the role of @GENE$ in the distinct processes involved in @DISEASE$ metastasis.	0
By using three human @DISEASE$ cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that @GENE$ is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.	0
By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 @DISEASE$ and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary cancer cells, namely in the intravasation @GENE$ of the metastatic cascade.	0
By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 @DISEASE$) and several metastasis models conducted in both mammalian and avian settings, we show that @GENE$ is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.	0
By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that transforming growth factor beta activation is involved in the early dissemination of primary @DISEASE$ cells, namely in the intravasation @GENE$ of the metastatic cascade.	0
LTBP3 was dispensable in the late @GENE$s of carcinoma cell metastasis that follow @DISEASE$ cell intravasation, including vascular arrest, extravasation, and tissue colonization.	0
Using our recently developed micro@DISEASE$ model, we confirmed that @GENE$ loss resulted in the development of intratumoral vessels with an abnormal microarchitecture incompatible with efficient intravasation of HEp-3 carcinoma cells.	0
Collectively, these findings demonstrate that @GENE$ represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early @DISEASE$ dissemination.	0
Collectively, these findings demonstrate that @GENE$ represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent @DISEASE$ cell intravasation, a critical process during early cancer dissemination.	0
Our experimental data are also consistent with the survival prognostic value of @GENE$ expression in early-stage head and neck squamous cell @DISEASE$, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease	0
All @DISEASE$ were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and @GENE$B.	0
HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal @DISEASE$, such as oncocytoma, chromophobe renal cell carcinoma (response to hydroperoxide), @GENE$ and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	1
HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal @DISEASE$, such as oncocytoma, chromophobe renal cell carcinoma (@GENE$), positive regulation of cell adhesion and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	0
HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe @DISEASE$ (@GENE$), positive regulation of cell adhesion and TFEB RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	0
He has similar clinical findings, including mild facial dysmorphisms and @DISEASE$, as other individuals with much larger deletions of the terminus of the long @GENE$ of chromosome 14.	1
Cone-@GENE$ degeneration (positive regulation of transcription by RNA polymerase II) belongs to the disease spectrum of @DISEASE$, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.	0
Cone-mitotic cell cycle checkpoint degeneration (@GENE$) belongs to the disease spectrum of @DISEASE$, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.	0
It mainly differentiates from other @DISEASE$, and in particular from the more frequent disease retinitis pigmentosa, because cone photoreceptors degenerate at a higher rate than @GENE$ photoreceptors, causing severe deficiency of central vision.	0
In addition to @GENE$, these three individuals had @DISEASE$ or hearing deficit.	1
Interaction studies also showed that cilium organization binds to @GENE$, another ciliary protein associated with @DISEASE$.	0
Altogether, our data strongly suggest that mutations in @GENE$ cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which @DISEASE$ is due to retinitis pigmentosa.	1
B1 induced readthrough at all three nonsense codons in cultured @DISEASE$ cells with <i>TP53</i> (tumor protein p53) mutations, in cells from patients with nonsense mutations in the <i>TPP1</i> (tripeptidyl peptidase 1), <i>DMD</i> (dystrophin), <i>SMARCAL1</i> (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and <i>COL7A1</i> (collagen @GENE$ VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.	0
B1 induced readthrough at all three nonsense codons in cultured cancer cells with <i>TP53</i> (@DISEASE$ protein p53) mutations, in cells from patients with nonsense mutations in the <i>TPP1</i> (tripeptidyl peptidase 1), <i>DMD</i> (dystrophin), <i>SMARCAL1</i> (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and <i>COL7A1</i> (collagen @GENE$ VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.	0
Two common <i>@GENE$</i> mutations usually found <i>in cis</i> in patients primarily with @DISEASE$ external ophthalmoplegia generate T251I and P587L amino acid substitutions.	1
Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) Aα scaffold subunit gene @GENE$ are among the few genomic alterations that occur frequently in serous @DISEASE$ (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.	0
Accordingly, overexpression of the Aα mutants in EC cells harboring wild-type @GENE$ increased anchorage-independent growth and @DISEASE$ formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3β, Akt, and mTOR/p70S6K signaling pathways.	0
Despite significant progress, the high genetic @DISEASE$ of these disorders often requires large sample sizes to identify a critical @GENE$ of individuals with disease-causing mutations in a single gene.	0
By pooling genetic findings across multiple studies, we have identified six individuals with severe @DISEASE$ (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in @GENE$.	1
Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable @DISEASE$ metabolic disorder caused by mutations in @GENE$ gene.	1
Furthermore, we show that increased @GENE$ expression in human patients is associated with diabetic @DISEASE$, lupus nephritis, and protein homotetramerization nephropathy.	0
Furthermore, we show that increased long-chain fatty-acyl-CoA metabolic process expression in human patients is associated with diabetic @DISEASE$, lupus nephritis, and @GENE$ nephropathy.	0
Here, we conducted whole-exome sequencing of patients with @DISEASE$ and other neurological signs of mitochondriopathy and identified 17 individuals from 13 unrelated families with recessive mutations in @GENE$, encoding the mitochondrial membrane-associated flavoprotein ferrodoxin reductase required for electron transport from NADPH to cytochrome P450.	1
In a patient with clinical features of @GENE$ syndrome, such as @DISEASE$, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	0
In a patient with clinical features of @GENE$ syndrome, such as hearing loss, preauricular fistulas and @DISEASE$, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	0
In a patient with clinical features of @GENE$ syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no @DISEASE$, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	0
Mutations in the @GENE$ gene lead to inherited neuropathies such as Charcot-Marie-Tooth type-2, distal hereditary motor neuropathies, spinal muscular atrophy with @DISEASE$ and the later stages can resemble amyotrophic lateral sclerosis.	0
In humans, mutations in @GENE$ result in Wolfram syndrome 2, a disease in which the patients display juvenile diabetes, neuropsychiatric disorders and @DISEASE$.	1
The pathogenesis of @DISEASE$ (@GENE$) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer.	0
The pathogenesis of hepatocellular carcinoma (@GENE$) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver @DISEASE$.	0
Using exome sequencing, we identified dominant mutations in @GENE$ on chromosome 12p11.21 in three large families with isolated @DISEASE$, including the two families that defined the OPA5 locus on chromosome 19q12.1-13.1, the existence of which is denied by the present study.	1
Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including @GENE$, protein folding, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).	1
Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including protein stabilization, @GENE$, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).	1
Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including protein stabilization, protein folding, @GENE$, FKBP65, SERPINF1, proteolysis, WNT1, FKBP10).	1
Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including protein stabilization, protein folding, protein peptidyl-prolyl isomerization, FKBP65, SERPINF1, @GENE$, WNT1, FKBP10).	1
Recently, TMEM38B, a gene that encodes @GENE$, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with @DISEASE$ OI.	1
Our case-control study investigates the possible association between seven @GENE$ gene polymophisms (rs1801267, rs72547602, rs1801160, rs3918290, rs1801159, rs1801158, rs1801265) and risk of colorectal @DISEASE$ (CRC).	0
The present study suggests that the SNP rs1801160 and the &quot;IISt&quot; haplotype in the @GENE$ gene may also have a role in colorectal @DISEASE$ risk	0
We previously identified a @GENE$ of the most frequently mutated cytoskeleton- and extracellular matrix-related proteins (CECMPs) in numerous @DISEASE$ datasets.	0
We report a case of a 33 month-old male referred for @DISEASE$ that was found to have an Xp21.2 duplication containing @GENE$ and multiple midline brain malformations	0
JBTS is genetically @DISEASE$, however mutations in @GENE$ are a common underlying cause.	0
We report a case with novel @GENE$ gene mutations with developed striking cerebellar atrophy and @DISEASE$, which helps to further understand the clinical and genetic heterogeneity of AARS2-L	1
We report a case with novel @GENE$ gene mutations with developed striking @DISEASE$ and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L	1
Mutations in @GENE$ causes cerebral autosomal dominant arteriopathy with subcortical infarcts and @DISEASE$ (transcription initiation from RNA polymerase II promoter), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms.	1
A variable-length poly-T variant in intron 6 of the @GENE$ gene, rs10524523, is associated with risk and age-of-onset of @DISEASE$ (late-onset) Alzheimer's disease.	0
Here we report a patient with a congenital syndrome consisting of severe global @DISEASE$, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&gt;T variant (p.Ser162Leu) in @GENE$ detected by exome sequencing.	0
These results suggest that this N-glycan of @GENE$ is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global @DISEASE$, microcephaly with vascular and cardiac defects	0
We @GENE$ evidence of genetic @DISEASE$ between the sub-phenotypes of NSOFC and among different populations.	0
Abnormal prion proteins are responsible for several fatal @DISEASE$ in humans and in animals, including Creutzfeldt-Jakob disease (@GENE$), Gerstmann-Sträussler-Scheinker disease, and fatal familial insomnia.	0
In addition, different prion mutations were suggested to play a possible role in additional pheno@GENE$s, such as Alzheimer's type pathology, spongiform @DISEASE$, or frontotemporal dementia.	0
Methylation status of the p16 @GENE$ promoter was assessed by methylation-specific PCR in 87 cervical specimens comprising 29 low-grade (LSIL), 41 high-grade (HSIL) lesions, and 17 cervical @DISEASE$s (CC).	1
FINDINGS We observed a significantly increased trend (nptrend = 0.0320) in the proportion of methylated p16 @GENE$ in cervical samples during @DISEASE$ development.	1
MAIN CONCLUSIONS There was an increase in methylation of the p16 @GENE$ promoter from pre-neoplastic lesions to @DISEASE$.	1
Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (@GENE$), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and @DISEASE$ ataxia muscle organ development 1 or 2.	0
Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (@GENE$), and @DISEASE$ ataxia muscle organ development 1 or 2.	0
Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (@GENE$), and episodic @DISEASE$ muscle organ development 1 or 2.	0
Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and @DISEASE$ ataxia @GENE$ 1 or 2.	0
Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (protein phosphorylation), paroxysmal nonkinesigenic dyskinesia (negative regulation of neurotransmitter secretion), and episodic @DISEASE$ @GENE$ 1 or 2.	0
Antiepileptic drugs remain the treatment of choice for @GENE$ and @DISEASE$ ataxia muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	0
Antiepileptic drugs remain the treatment of choice for @GENE$ and episodic @DISEASE$ muscle organ development 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	0
Antiepileptic drugs remain the treatment of choice for protein phosphorylation and @DISEASE$ ataxia muscle organ development 1, benzodiazepines are often useful for @GENE$, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	0
Antiepileptic drugs remain the treatment of choice for protein phosphorylation and @DISEASE$ ataxia @GENE$ 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	0
Antiepileptic drugs remain the treatment of choice for protein phosphorylation and episodic @DISEASE$ @GENE$ 1, benzodiazepines are often useful for negative regulation of neurotransmitter secretion, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	0
Chemical inhibition of epigenetic regulatory proteins @GENE$ and Brd4 is emerging as a promising therapeutic strategy in contraception, @DISEASE$, and heart disease.	0
The remaining cases, clinically similar to @GENE$, are @DISEASE$ agammaglobulinemia (ARA).	0
However, all experimental models of electrolytic @DISEASE$, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between proteolysisT/T @GENE$ and wild-type mice.	0
However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced @DISEASE$, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between @GENE$T/T epidermis development and wild-type mice.	0
However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced @DISEASE$, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between proteolysisT/T @GENE$ and wild-type mice.	0
In conclusion, Taiwanese women with CG/GG in @GENE$ SNP rs3764340 are susceptible to cervical invasive @DISEASE$.	1
@GENE$ is characterized by clinical variability and extensive genetic @DISEASE$, associated with different cilia ultrastructural defects and mutations identified in &gt;20 genes.	0
We will also discuss emerging paradigms of the molecular and cellular pathophysiology of disease-causing ephrinB2-EphB4-@GENE$ mutations, including the potential role of @DISEASE$.	0
We report that biallelic mutations in @GENE$, encoding one of the five co-chaperones required for assembly and disassembly of the αβ-tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, @DISEASE$, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	1
We report that biallelic mutations in @GENE$, encoding one of the five co-chaperones required for assembly and disassembly of the αβ-tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, @DISEASE$, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	1
We report that biallelic mutations in @GENE$, encoding one of the five co-chaperones required for assembly and disassembly of the αβ-tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, @DISEASE$, seizures, optic atrophy, and spastic quadriplegia.	1
We report that biallelic mutations in @GENE$, encoding one of the five co-chaperones required for assembly and disassembly of the αβ-tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, @DISEASE$, and spastic quadriplegia.	1
We report that biallelic mutations in @GENE$, encoding one of the five co-chaperones required for assembly and disassembly of the αβ-tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and @DISEASE$.	1
Finally, it was observed that 4 hub genes were highly expressed in gastric @DISEASE$ tissue compared with para‑carcinoma tissue in the 12 patients; the increased @GENE$ was significant (&gt;5‑fold).	0
To address this, we performed exome sequencing and copy number variant analysis on 1511 frozen human brains with a diagnosis of Alzheimer's disease (AD, n = 289), @DISEASE$/amyotrophic lateral sclerosis (FTD/ALS, n = 252), Creutzfeldt-Jakob disease (@GENE$, n = 239), Parkinson's disease (PD, n = 39), dementia with Lewy bodies (DLB, n = 58), other neurodegenerative, vascular, or neurogenetic disorders (n = 266), and controls with no significant neuropathology (n = 368).	0
@GENE$ is clinically and genetically @DISEASE$.	0
It is @DISEASE$ly inherited, and caused by @GENE$ mutations.	1
The nonsyndromic form of @GENE$ can be caused by dominant activating mutations in digestion, encoding intestinal receptor guanylate cyclase C (GC-C), and by @DISEASE$ sodium ion import across plasma membrane loss-of-function mutations.	0
The nonsyndromic form of L-cysteine catabolic process to hypotaurine can be caused by dominant activating mutations in @GENE$, encoding intestinal receptor guanylate cyclase C (GC-C), and by @DISEASE$ sodium ion import across plasma membrane loss-of-function mutations.	1
The nonsyndromic form of L-cysteine catabolic process to hypotaurine can be caused by dominant activating mutations in digestion, encoding intestinal receptor guanylate cyclase C (GC-C), and by @DISEASE$ @GENE$ loss-of-function mutations.	1
In this sense, evidence from both clinical and experimental studies indicates that @GENE$ may reverse diabetic @DISEASE$ through an antioxidant action by decreasing pro-inflammatory cytokines, restoring Na+/K+-ATPase activity, and blocking the generation of pro-apoptotic proteins.	0
positive regulation of lamellipodium assembly, one of the @GENE$ characterized G protein-coupled receptor signaling pathway GTPases, is an established effector of receptors and an important node in signaling networks crucial for @DISEASE$igenesis and metastasis.	0
positive regulation of lamellipodium assembly, one of the chloride transport characterized @GENE$ GTPases, is an established effector of receptors and an important node in signaling networks crucial for @DISEASE$igenesis and metastasis.	0
@GENE$ hyperactivation is common in human @DISEASE$ and could be the consequence of overexpression, abnormal upstream inputs, deregulated degradation, and/or anomalous intracellular localization.	0
More recently, @DISEASE$-associated gain-of-function mutations in @GENE$ have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.	0
More recently, cancer-associated gain-of-function mutations in @GENE$ have been identified which contribute to @DISEASE$ phenotypes and confer resistance to targeted therapies.	0
Translating our extensive knowledge in @GENE$ pathway biochemistry into a clinical setting still remains a major challenge; nonetheless, remarkable opportunities for @DISEASE$ therapeutics arise from promising lead compounds targeting Rac and its effectors	1
To understand the importance of chr11q22.3-23.2 region in the development of cervical @DISEASE$, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, @GENE$, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	1
To understand the importance of chr11q22.3-23.2 region in the development of cervical @DISEASE$, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and @GENE$ in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	0
To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, @GENE$ and T cell mediated cytotoxicity in cervical intraepithelial @DISEASE$ (CIN) and cervical carcinoma (CACX) samples.	1
The alterations of @GENE$ and CADM1 are associated with the progression of @DISEASE$ from CIN to Stage I/II, thus implying their role in early invasiveness.	1
Leber's hereditary optic @DISEASE$ (@GENE$) is a common inherited mitochondrial disorder that is characterized by the degeneration of the optic nerves, leading to vision loss.	0
High mobility group box 3 (@GENE$), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder @DISEASE$.	0
qRT-PCR results showed that high expression of @GENE$ had positive correlation with serosal invasion, lymph metastasis, and @DISEASE$-node-metastasis (regulation of transcription by RNA polymerase III) stage in CRC patient.	0
qRT-PCR results showed that high expression of DNA recombination had positive correlation with serosal invasion, lymph metastasis, and @DISEASE$-node-metastasis (@GENE$) stage in CRC patient.	0
It is highly @DISEASE$, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (@GENE$), having been identified.	0
Transcriptomic analysis revealed significant alterations in a number of genes associated with @DISEASE$, such as AMP biosynthetic process, @GENE$, shank3, and tsc1b.	0
Typical @GENE$ clinical features are mucocutaneous telangiectases, @DISEASE$, spontaneous and recurrent epistaxis, as well as gastrointestinal bleedings.	1
Bardet-Biedl syndrome (@GENE$) is a defining ciliopathy, notable for extensive allelic and genetic @DISEASE$, almost all of which has been identified through sequencing.	0
Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN)γ, @DISEASE$ necrosis factor (@GENE$)α, and granulocyte-macrophage colony-stimulating factor (positive regulation of cell proliferation) are implicated in the pathology of rheumatoid arthritis (RA).	0
Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN)γ, @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II)α, and granulocyte-macrophage colony-stimulating factor (@GENE$) are implicated in the pathology of rheumatoid arthritis (RA).	0
RESULTS Circ-@GENE$ expression was significantly upregulated in glioma tissue and was correlated with @DISEASE$ grade.	0
Eight different @GENE$ mutations were detected in 15 patients with posterior @DISEASE$ (60%, 15/25), including six previously described mutations (p.Q6X, Q71X, p.L20P, p.G203S, p.R227Q, and p.R246Q) and two novel mutations (p.G196R and p.L73Pfs<sup>∗</sup>17).	1
Patients with adult-onset @GENE$ may present with slowly progressive ataxia, persistent photosensitivity, and @DISEASE$ without dementia or extrapyramidal findings.	0
Patients with adult-onset @GENE$ may present with slowly progressive @DISEASE$, persistent photosensitivity, and seizures without dementia or extrapyramidal findings.	0
Our results show that after the @GENE$ gene mutation in sensory perception of sound gene is the second cause of congenital @DISEASE$ in Moroccan patients.	1
Our results show that after the gap junction-mediated intercellular transport gene mutation in @GENE$ gene is the second cause of congenital @DISEASE$ in Moroccan patients.	1
Since it is known that the native protein, branching involved in blood vessel morphogenesis, can @GENE$ in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, angiogenesis, IGF-2 or extrinsic apoptotic signaling pathway via death domain receptors on the cholinergic differentiation of human @DISEASE$ cells SH-SY5Y.	0
Since it is known that the native protein, branching involved in blood vessel morphogenesis, can coenzyme A biosynthetic process in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, @GENE$, IGF-2 or extrinsic apoptotic signaling pathway via death domain receptors on the cholinergic differentiation of human @DISEASE$ cells SH-SY5Y.	0
Since it is known that the native protein, branching involved in blood vessel morphogenesis, can coenzyme A biosynthetic process in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, angiogenesis, IGF-2 or @GENE$ on the cholinergic differentiation of human @DISEASE$ cells SH-SY5Y.	0
After diagnosis of granular cell @DISEASE$ by core needle biopsy, the @GENE$es were excised with histopathological and immunohistochemical analysis of both specimens confirming the presence of non-malignant granular cell tumours.	0
Here we describe two unrelated individuals with infantile-onset @DISEASE$ and abnormalities of brain morphology, harboring de novo variants that affect adjacent amino acids in a beta-tubulin gene @GENE$.	1
However, sequencing of large human cohorts reveals a cumulative frequency of additional rare @GENE$ mutations that raise the possibility of CaM variants not exclusively causing severe @DISEASE$.	0
Hypomorphic IKBKG mutations in males are typically associated with anhidrotic @DISEASE$ with immunodeficiency (@GENE$-ID).	1
As rare polymorphisms have been described in @GENE$ and @DISEASE$ remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants	0
The overexpression of @GENE$ selectively leads to the loss of dopaminergic neurons (DN) and @DISEASE$ abnormalities in the substantia nigra (MAPK cascade) of Parkinson's disease (PD) models.	0
Familial @DISEASE$ is usually due to loss-of-function mutations in @GENE$, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1.	1
Familial @DISEASE$ is usually due to loss-of-function mutations in intestinal cholesterol absorption, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: @GENE$, negative regulation of receptor recycling and LDLRAP1.	1
Familial @DISEASE$ is usually due to loss-of-function mutations in intestinal cholesterol absorption, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: positive regulation of macrophage derived foam cell differentiation, @GENE$ and LDLRAP1.	1
Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, @GENE$, APOA5, LMF1, GPIHBP1).	1
Conversely familial @DISEASE$ is caused by inactivation of the @GENE$ gene which increases the number of LDL receptors and decreases plasma cholesterol.	0
Consistent with this pattern of activity, @GENE$ and polr1d homozygous mutant zebrafish exhibit cartilage hypoplasia and cranio@DISEASE$ characteristic of humans with Treacher Collins syndrome.	1
More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the @DISEASE$ in @GENE$ and transcription, DNA-templated mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.	1
More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the @DISEASE$ in transcription by RNA polymerase I and @GENE$ mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.	1
Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and @DISEASE$ (AR) @GENE$ and UDP-N-acetylglucosamine biosynthetic process deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	1
Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and @DISEASE$ (AR) positive regulation of GTPase activity and @GENE$ deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	1
We evaluated the genetic @GENE$ of the amyotrophic lateral sclerosis (signal transduction) risk gene never in mitosis gene a-related kinase 1 (protein phosphorylation) in a Belgian cohort of 278 patients with ALS (n = 245) or ALS with @DISEASE$ (ALS-FTD, n = 33) and 609 control individuals.	0
We evaluated the genetic negative regulation of transcription by RNA polymerase II of the amyotrophic lateral sclerosis (@GENE$) risk gene never in mitosis gene a-related kinase 1 (protein phosphorylation) in a Belgian cohort of 278 patients with ALS (n = 245) or ALS with @DISEASE$ (ALS-FTD, n = 33) and 609 control individuals.	0
We evaluated the genetic negative regulation of transcription by RNA polymerase II of the amyotrophic lateral sclerosis (signal transduction) risk gene never in mitosis gene a-related kinase 1 (@GENE$) in a Belgian cohort of 278 patients with ALS (n = 245) or ALS with @DISEASE$ (ALS-FTD, n = 33) and 609 control individuals.	0
In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, @DISEASE$, unilateral anophthalmia, and bifid and broad nasal biological_process) in whom two novel @GENE$ mutations (c.305 A &gt; G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	1
In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral @DISEASE$, and bifid and broad nasal biological_process) in whom two novel @GENE$ mutations (c.305 A &gt; G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	1
In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral @DISEASE$, and bifid and broad nasal @GENE$) in whom two novel craniofacial suture morphogenesis mutations (c.305 A &gt; G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, @GENE$, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	1
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, @GENE$, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, @GENE$), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA @GENE$ repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA @GENE$ repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (@GENE$, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, @GENE$), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	1
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, @GENE$), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (@GENE$) and PI3K signaling pathway (PTEN, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	1
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, nucleosome assembly), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (PTEN, phospho-@GENE$) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, @GENE$), DNA cellular protein catabolic process proteins (mitotic cell cycle, γ-H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	0
IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA @GENE$ proteins (mitotic cell cycle, γ-H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	0
IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (@GENE$, γ-H2AX), regulators of telomeres (nucleosome assembly, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	0
IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, γ-H2AX), regulators of telomeres (@GENE$, ATRX), and protein polyubiquitination revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	0
IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, positive regulation of transcription of Notch receptor target, protein phosphorylation), DNA cellular protein catabolic process proteins (mitotic cell cycle, γ-H2AX), regulators of telomeres (nucleosome assembly, ATRX), and @GENE$ revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	0
Angioinvasion defined as @DISEASE$ cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the chloride transport prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade @GENE$s.	0
Angioinvasion defined as @DISEASE$ cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the @GENE$ prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade acetyl-CoA metabolic processs.	0
Low mitotic @DISEASE$ grade, Weiss score, global loss of @GENE$ expression, and high phospho-regulation of cell growth expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.	1
Low mitotic @DISEASE$ grade, Weiss score, global loss of nucleosome assembly expression, and high phospho-@GENE$ expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.	0
In addition, the tested peptides inhibited lung colonization after intranasal inoculation of @GENE$ with S. @DISEASE$e.	0
Patients with @GENE$ and DNA replication initiation mutations appear to have the most severe @DISEASE$ and microcephaly.	0
Patients with @GENE$ and DNA replication initiation mutations appear to have the most severe short stature and @DISEASE$.	0
Patients with urea cycle and @GENE$ mutations appear to have the most severe @DISEASE$ and microcephaly.	1
Patients with urea cycle and @GENE$ mutations appear to have the most severe short stature and @DISEASE$.	1
Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset @DISEASE$ disorder with profound motor and cognitive decay, whereas mutations in @GENE$, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.	0
6q14 deletions have been associated with @DISEASE$ and a distinct pattern of @GENE$ anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.	0
6q14 deletions have been associated with @DISEASE$ and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal @GENE$, anteverted nares, long philtrum, and thin upper lip.	0
6q14 deletions have been associated with intellectual disability and a distinct pattern of @GENE$ anomalies, including @DISEASE$ with epicanthal folds, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.	0
6q14 deletions have been associated with intellectual disability and a distinct pattern of @GENE$ anomalies, including upslanted palpebral fissures with @DISEASE$, a short nose with broad nasal biological_process, anteverted nares, long philtrum, and thin upper lip.	0
6q14 deletions have been associated with intellectual disability and a distinct pattern of positive regulation of glucose transmembrane transport anomalies, including upslanted palpebral fissures with @DISEASE$, a short nose with broad nasal @GENE$, anteverted nares, long philtrum, and thin upper lip.	0
Possible candidate genes in 6q14 for @DISEASE$ might be @GENE$, MYO6, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and SNX14	0
@GENE$ plays a protective role in mouse models of @DISEASE$, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	0
@GENE$ plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar @DISEASE$ autosomal recessive muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	1
protein polyubiquitination plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar @DISEASE$ autosomal recessive @GENE$ 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	0
In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast @DISEASE$ (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), @GENE$ (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	0
We report here the in vitro and in vivo anti@DISEASE$ activity of lucitanib in experimental models with or without @GENE$/2 amplification or mutations.	1
In cell assays, lucitanib potently inhibited the growth of @DISEASE$ cell lines with amplified FGFR1 or mutated/amplified @GENE$.	1
Notably, in two lung @DISEASE$ models with positive regulation of cell proliferation amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of @GENE$ and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	0
Notably, in two lung @DISEASE$ models with @GENE$ amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of negative regulation of transcription by RNA polymerase II and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	1
Notably, in two lung cancer models with positive regulation of cell proliferation amplification, the anti@DISEASE$ efficacy was higher, suggesting that the simultaneous inhibition of @GENE$ and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	0
Similar anti@DISEASE$ activity was observed in @GENE$ wild-type and amplified or mutated xenograft models.	1
However, the inherent susceptibility of these tissues to @GENE$ mutations and the clinical @DISEASE$ observed across SCO1 pedigrees remain poorly understood phenomena.	1
Lethality was observed in both models due to a combined @GENE$ and copper deficiency that resulted in a dilated @DISEASE$.	1
@GENE$ was similarly mislocalized to the cytosol in the heart of knockin epidermis development carrying a homozygous G115S substitution in mitochondrial respiratory chain complex IV assembly, which in humans causes a hypertrophic @DISEASE$.	0
copper ion transport was similarly mislocalized to the cytosol in the heart of knockin @GENE$ carrying a homozygous G115S substitution in mitochondrial respiratory chain complex IV assembly, which in humans causes a hypertrophic @DISEASE$.	0
copper ion transport was similarly mislocalized to the cytosol in the heart of knockin epidermis development carrying a homozygous G115S substitution in @GENE$, which in humans causes a hypertrophic @DISEASE$.	1
Increasing evidence has shown that @GENE$-interacting protein (WTIP) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in @DISEASE$ is unknown.	1
Here, we investigated the role and mechanism of @GENE$ in cell proliferation and @DISEASE$igenesis of non-small-cell lung cancer (NSCLC).	0
We report that @GENE$ is a @DISEASE$ suppressor in human NSCLC.	0
Moreover, ectopic overexpression of @GENE$ dramatically inhibits cell proliferation and @DISEASE$igenesis in vitro and in vivo; conversely, depletion of WTIP expression shows the opposite effects.	0
Our study therefore identifies @GENE$ as a disease gene causing a very rare @DISEASE$ cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases	1
Our study therefore identifies @GENE$ as a disease gene causing a very rare autosomal recessive @DISEASE$ and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases	1
Our study therefore identifies @GENE$ as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this @DISEASE$ group of inherited rare diseases	0
To test whether this gene can confer a wide variety of psychiatric disorders, we carried out a case-control association analysis of three tagging single-nucleotide polymorphisms (rs2074896, rs2074897, and rs2074898) in the @GENE$ gene by sequencing 330 Han Chinese patients with @DISEASE$ and 330 well-matched healthy controls.	0
Tumor growth in xenografts as well as @GENE$ signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.<b>Results:</b> protein polyubiquitination-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-@DISEASE$ and adjacent tissue.	1
Tumor growth in xenografts as well as positive regulation of protein phosphorylation signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.<b>Results:</b> @GENE$-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-@DISEASE$ and adjacent tissue.	0
Significant down-regulation of @GENE$-193a-3p was also seen in an independent cohort of ulcerative colitis @DISEASE$s.	0
IL17RD expression was increased in ulcerative colitis cancers, and protein polyubiquitination-193a-3p treatment decreased growth and @GENE$ signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis @DISEASE$, and its loss promotes carcinogenesis through upregulation of IL17RD.	1
Mucolipidosis muscle organ development IV (@GENE$) is a lysosomal storage disease exhibiting progressive @DISEASE$, motor impairment, and premature death.	1
Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (GCS), successfully delays the onset of motor deficits, improves longevity, and rescues some of the @DISEASE$ (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick @GENE$ C (NPC).	0
Herein, we designed a retro-inverso isomer of <sup>L</sup>c(@GENE$-1), termed <sup>D</sup>c(LyP-1), expecting to inspire brain metastatic @DISEASE$ targeted drug delivery.	1
Further, <sup>L</sup>c(@GENE$-1) modified PEG-PLA micelles displayed much higher in vivo distribution in brain metastatic @DISEASE$ than <sup>D</sup>c(LyP-1).	1
A majority of the familial breast @DISEASE$ cases are not explained by mutations in the @GENE$-known high susceptibility genes double-strand break repair via homologous recombination and BRCA2.	0
A majority of the familial breast @DISEASE$ cases are not explained by mutations in the chloride transport-known high susceptibility genes @GENE$ and BRCA2.	1
Family-based studies have recently led to the identification of the MIR184 gene for @DISEASE$ with cataract and to the @GENE$ gene in a family with isolated keratoconus.	0
Numerous other linkages have been reported and new sequencing technologies are @GENE$ to rapidly expand the number of identified @DISEASE$ genes in these regions.	0
Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around neutrophil apoptotic process, @GENE$ and blood vessel morphogenesis as candidate risk factors for @DISEASE$.	0
Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around neutrophil apoptotic process, regulation of GTPase activity and @GENE$ as candidate risk factors for @DISEASE$.	0
@GENE$ plays important roles in the regulation of gene expression, splicing, DNA cellular protein catabolic process, paternal imprinting, @DISEASE$ and metastasis.	0
histone methylation plays important roles in the regulation of gene expression, splicing, DNA @GENE$, paternal imprinting, @DISEASE$ and metastasis.	0
An early intervention using biomarkers to predict acute @DISEASE$ (AMI) will effectively reduce global heart attack incidence, particularly among high-risk patients with @GENE$ 2 diabetes mellitus (T2DM).	0
The brains of <i>@GENE$</i><sup>-/-</sup> epidermis development had hypoplasia of the corpus callosum, @DISEASE$, and decreased thickness of the somatosensory cortex.	1
The brains of <i>biological_process</i><sup>-/-</sup> @GENE$ had @DISEASE$, enlarged ventricles, and decreased thickness of the somatosensory cortex.	0
A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene @GENE$ (also known as creatine transmembrane transport) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, @DISEASE$, and glucosuria in a single family.	1
A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene creatine transmembrane transport (also known as @GENE$) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile @DISEASE$, microcornea, and glucosuria in a single family.	1
A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene creatine transmembrane transport (also known as @GENE$) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, @DISEASE$, and glucosuria in a single family.	1
The CSIRO National @GENE$ Telehealth Trial investigated the effects of introducing at home telemonitoring of vital signs for the management of a @DISEASE$ group of chronically ill patients.	0
The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including @GENE$, pre-B cell allelic exclusion, CD93, leukocyte migration, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	1
The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including V(D)J recombination, @GENE$, CD93, leukocyte migration, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	1
The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including V(D)J recombination, pre-B cell allelic exclusion, CD93, @GENE$, leukocyte migration, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	0
SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of @DISEASE$ spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (@GENE$) if environmentally triggered.	0
Dysfunction of SNORD115-negative regulation of cell proliferation connecting with @GENE$ as well as other proven @DISEASE$-associated genes might explain why traditionally catatonia has been classified with schizophrenia.	0
SNORD115-protein polyubiquitination and SNORD-@GENE$ dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR @DISEASE$ and the proven predisposing catatonic learning gene.	0
SNORD115-protein polyubiquitination and SNORD-GPI anchor biosynthetic process dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR @DISEASE$ and the proven predisposing catatonic @GENE$ gene.	0
Here we characterize @GENE$-dependent @DISEASE$ cell migration and invasion as well as local invasion and metastasis of cancer xenografts.	0
@GENE$ depletion suppressed @DISEASE$ invasion and induced an epithelial phenotype in poorly differentiated breast cancer cells.	0
In an unbiased BioID screen for @GENE$ interactors, we identified members of the Arp2/3 complex-mediated actin nucleation/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven @DISEASE$ cell movement.	0
In an unbiased BioID screen for protein phosphorylation interactors, we identified members of the @GENE$/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven @DISEASE$ cell movement.	0
Our results validate @GENE$ as a therapeutic target in @DISEASE$ patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.	0
Our data, for the first time, functionally link Jalili syndrome gene @GENE$ to LCA gene photoreceptor cell maintenance, providing important insights into the molecular pathogenic mechanism of @DISEASE$ in Jalili syndrome	1
Renpenning syndrome is a group of X-linked @DISEASE$ syndromes caused by mutations in human polyglutamine-binding protein 1 (@GENE$) gene.	1
Small intestine neuroendocrine @DISEASE$ (@GENE$-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	0
Small intestine neuroendocrine @DISEASE$ (melanosome organization-@GENE$) represent the most common histomuscle organ development among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	0
Small intestine neuroendocrine tumors (@GENE$-epidermal cell differentiation) represent the most common histomuscle organ development among small intestine @DISEASE$, and metastatic disease is usually present at diagnosis.	0
Small intestine neuroendocrine tumors (melanosome organization-@GENE$) represent the most common histomuscle organ development among small intestine @DISEASE$, and metastatic disease is usually present at diagnosis.	0
A retrospective series of 52 @DISEASE$ primary surgically resected @GENE$-NETs, which were metastatic at diagnosis, was analyzed by high-coverage target sequencing (HCTS) for the mutational status of 57 genes and copy number status of 40 genes selected from recently published genome sequencing data.	0
Recurrent copy number variations are important events in @GENE$-negative regulation of transcription, DNA-templated and peptidyl-tyrosine phosphorylation may represent a novel prognostic biomarker for this @DISEASE$ type	0
Recurrent copy number variations are important events in melanosome organization-@GENE$ and peptidyl-tyrosine phosphorylation may represent a novel prognostic biomarker for this @DISEASE$ type	0
Recurrent copy number variations are important events in melanosome organization-negative regulation of transcription, DNA-templated and @GENE$ may represent a novel prognostic biomarker for this @DISEASE$ type	1
Chronic @DISEASE$ (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as <i>STAT3, @GENE$, negative regulation of transcription by RNA polymerase II, positive regulation of stress-activated MAPK cascade, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	1
Chronic @DISEASE$ (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as <i>STAT3, regulation of transcription, DNA-templated, @GENE$, positive regulation of stress-activated MAPK cascade, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	0
Chronic @DISEASE$ (CMC) occurs in patients with mutations in genes affecting positive regulation of interleukin-23 production-mediated immunity, such as <i>STAT3, regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II, @GENE$, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	1
We aimed to test effects of such gCNVs on the risk of lung @DISEASE$ and chronic obstructive pulmonary disease (@GENE$).	0
The CNVR_3425.1, overlapping the chr16q24.1 with genomic imbalance, was significantly associated with increased risks of lung @DISEASE$ (OR = 1.76; 95% CI = 1.46-2.11) and @GENE$ (OR = 1.98; 95% CI = 1.57-2.51).	0
The increase copy of CNVR_3425.1 forms a new additional truncated @GENE$ adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the @DISEASE$ suppressor FOXF1.	0
The increase copy of CNVR_3425.1 forms a new additional truncated @GENE$ adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung @DISEASE$ by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.	0
In a meta-analysis of our previous GWAS and the replication studies, which included a total of 7,141 prostate @DISEASE$ cases and 11,804 controls from a single ancestry group, three new loci reached genome-wide significance on chromosomes 11q12 (rs1938781; P = 1.10 × 10(-10); @GENE$-FAM111B), 10q26 (rs2252004; P = 1.98 × 10(-8)) and 3p11.2 (rs2055109; P = 3.94 × 10(-8)).	0
In @GENE$, WRAP53 has been considered as a candidate @DISEASE$ susceptibility gene.	0
Accordingly, we performed a study to examine the association of a frequent genetic variation in @GENE$, rs2287499 (C/G), with breast @DISEASE$ risk and prognosis among Iranian-Azeri population.	1
Here, we utilized the CRISPR-Cas9 system to gen@GENE$te potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of @DISEASE$.	0
Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte @GENE$ mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of @DISEASE$.	0
Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human @GENE$, mutations of which are thought to cause Leber congenital amaurosis (clathrin coat assembly), an early-onset form of @DISEASE$.	0
Here, we utilized the CRISPR-Cas9 system to gentranscription by RNA polymerase IIte potassium ion transport mutant mice by zygote injection to verify the pathogenic role of human potassium ion transport, mutations of which are thought to cause Leber congenital amaurosis (@GENE$), an early-onset form of @DISEASE$.	0
Reproductive aging phenotypes, including age at menarche (AM) and age at natural menopause (@GENE$), are well-established risk factors for breast @DISEASE$.	0
Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast @DISEASE$ cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and @GENE$ reproductive lifespan (TRLS; NRLS).	0
In 2005, @GENE$ clients were significantly more likely to have chronic conditions, including @DISEASE$, chronic obstructive pulmonary disease, Alzheimer's disease, arthritis, diabetes, and renal failure (all p &lt; 0.05).	0
MiR-93-5p has been previously found to be associated with gastric @DISEASE$ (@GENE$) tumorigenesis; however, the current understanding of its function in this context remains largely incomplete.	0
MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin @GENE$ 4 (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), and large @DISEASE$ suppressors 2 (G1/S transition of mitotic cell cycle), at both the mRNA and protein level.	0
MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin positive regulation of cell-matrix adhesion 4 (@GENE$), and large @DISEASE$ suppressors 2 (G1/S transition of mitotic cell cycle), at both the mRNA and protein level.	1
MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin positive regulation of cell-matrix adhesion 4 (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), and large @DISEASE$ suppressors 2 (@GENE$), at both the mRNA and protein level.	0
Leber hereditary optic @DISEASE$ (@GENE$) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.	0
Leber hereditary optic neuropathy (@GENE$) and dominant @DISEASE$ (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.	0
The present study was designed to survey the mutation spectrum of common pathogenic genes (OPA1, @GENE$ and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic @DISEASE$.	1
Participants were assessed for cognitive performance (Cogstate battery), dietary selenium intake (two 24-h food recalls), plasma selenium concentration, inflammatory markers (interleukin (IL)-6, -8, -10, @DISEASE$ necrosis factor-alpha and @GENE$) and neurotrophic factors (brain-derived neurotrophic factor, vascular endothelial growth factor and insulin-like growth factor 1).	0
Overall, our study proposes that @GENE$ acts as a central mRNA splicing, via spliceosome in the control of cell cycle and proliferation during @DISEASE$ development.	1
Overall, our study proposes that negative regulation of transcription by RNA polymerase II acts as a central @GENE$ in the control of cell cycle and proliferation during @DISEASE$ development.	0
We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in @GENE$ and persistent hypotonia, encephalopathy, growth failure, and severe @DISEASE$.	1
The primary objective of the study was to estimate the maximum tolerated dose (@GENE$) and/or recommended phase II dose (RP2D) of oral alpelisib in patients with advanced solid @DISEASE$ who had progressed despite standard therapy.	0
Here, we report bi-allelic pathogenic @GENE$ variants (three homozygous and two compound heterozygous) that cause a severe neurological syndrome that includes congenital hypotonia, @DISEASE$, and motor axonal and auditory neuropathy.	0
Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe @DISEASE$ and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper @GENE$, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	0
Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and @DISEASE$, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper @GENE$, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	0
Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large @DISEASE$, a narrow nasal bridge, a tented upper @GENE$, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	0
Mutations in @GENE$ have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and @DISEASE$.	1
However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (@GENE$), Interleukin (IL)-17A, and @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II)-α promoting bone loss in inflammatory states such as rheumatoid arthritis.	0
However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (monocyte chemotaxis), Interleukin (IL)-17A, and @DISEASE$ necrosis factor (@GENE$)-α promoting bone loss in inflammatory states such as rheumatoid arthritis.	0
T cell-produced @GENE$ and IL-17A further contribute to bone loss in @DISEASE$, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).	0
A recent genome-wide association study (GWAS) linked @DISEASE$ and kidney stones to a claudin-14 (@GENE$) risk haplotype.	0
Usher syndrome (USH) is the most common cause of inherited deaf-@DISEASE$, manifested as USH1, USH2 and @GENE$ clinical types.	1
Feingold syndrome is a @DISEASE$ caused by loss-of-function mutations of either MYCN (@GENE$ 1) or MIR17HG that encodes protein polyubiquitination-17-92 microRNAs (type 2).	0
Feingold syndrome is a @DISEASE$ caused by loss-of-function mutations of either MYCN (muscle organ development 1) or MIR17HG that encodes @GENE$-17-92 microRNAs (type 2).	0
This report provides evidence that bi-allelic null @GENE$ mutations may lead to a multi-system @DISEASE$ disorders, where SCID might represent the main feature	1
Homozygozity mapping and exome sequencing in 62 isolated individuals with early-onset @DISEASE$ and confirmed consanguinity followed by data mining in the exomes of 1,348 PD-affected individuals identified, in three isolated subjects, homozygous or compound heterozygous truncating mutations in vacuolar protein sorting 13C (@GENE$).	1
This work suggests that loss of function of @GENE$ is a cause of autosomal-recessive early-onset @DISEASE$ with a distinctive phenotype of rapid and severe progression	1
Human genetic evidence demonstrates that @GENE$ mutations cause osteogenesis imperfecta (OI) and early-onset @DISEASE$, implicating WNT1 as a major regulator of bone metabolism.	1
Agonistic antibodies, which bind specifically to death receptor 5 (@GENE$), can trigger apoptosis in @DISEASE$ cells through the extrinsic pathway.	1
After screening for agonism in a cell-viability assay in vitro, a novel @GENE$-specific scFv antibody transcription initiation from RNA polymerase II promoter-3 was isolated, which inhibited COLO205 and MDA-MB-231 @DISEASE$ cell growth without any cross-linking agents.	1
After screening for agonism in a cell-viability assay in vitro, a novel response to endoplasmic reticulum stress-specific scFv antibody @GENE$-3 was isolated, which inhibited COLO205 and MDA-MB-231 @DISEASE$ cell growth without any cross-linking agents.	0
The activity of @GENE$-3 in inducing apoptosis in @DISEASE$ cells was evaluated by using an Annexin V-PE apoptosis detection activation of MAPK activity in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.	0
The activity of transcription initiation from RNA polymerase II promoter-3 in inducing apoptosis in @DISEASE$ cells was evaluated by using an Annexin V-PE apoptosis detection @GENE$ in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.	1
Furthermore, @GENE$-3 suppressed the @DISEASE$ growth significantly in the xenograft model.	0
Taken together, these data suggest that @GENE$-3 exhibited potent anti@DISEASE$ activity both in vitro and in vivo.	0
The inhibition of CTGF/CCN2 with the monoclonal neutralizing antibody FG-3019 reduces fibrosis in several chronic disorders including the mdx mice, a murine model for Duchenne @DISEASE$ (@GENE$).	1
Defects in ISC biogenesis lead to multiple @DISEASE$ syndromes including: @GENE$ with infantile onset leukodystrophy.	0
Within the last decade, the Bromodomain and Extra-Terminal domain family (@GENE$) of proteins have emerged as promising drug targets in diverse clinical indications including oncology, auto-immune disease, @DISEASE$, and male contraception.	0
Although heterozygous missense mutations in @GENE$ reveal dominant-negative effects in patients with autosomal dominant chloride transport disease (BD), heterozygous mutations associated with @DISEASE$ bestrophinopathy (ARB) display no disease phenotype.	1
However, the role of <i>RTEL1</i> mutations in other bone marrow failure (@GENE$) syndromes and myeloid @DISEASE$, and the contribution of monoallelic <i>RTEL1</i> mutations to disease development are not well defined.	0
We screened 516 patients for germline mutations in telomere-associated genes by next-generation sequencing in 2 independent cohorts; one constituting unselected patients with idiopathic @GENE$, unexplained cytopenia, or myeloid @DISEASE$ (n = 457) and a second cohort comprising selected patients on the basis of the suspicion of constitutional/familial BMF (n = 59).	0
The results show that @GENE$ plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high @DISEASE$ and early-onset cataract.	1
The results show that @GENE$ plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset @DISEASE$.	1
Idiopathic hypogonadotropic @DISEASE$ (@GENE$) is often caused by hyposecretion of gonadotropin and consequently affects male fertility.	0
Hereditary sensory and autonomic @DISEASE$ 1 (@GENE$) is an autosomal dominant disorder that can be caused by variants in sphingolipid biosynthetic process or sphingolipid biosynthetic process, encoding subunits of serine palmitoyl-CoA transferase.	1
Hereditary sensory and autonomic @DISEASE$ 1 (sphingolipid biosynthetic process) is an autosomal dominant disorder that can be caused by variants in @GENE$ or sphingolipid biosynthetic process, encoding subunits of serine palmitoyl-CoA transferase.	1
Hereditary sensory and autonomic @DISEASE$ 1 (sphingolipid biosynthetic process) is an autosomal dominant disorder that can be caused by variants in sphingolipid biosynthetic process or @GENE$, encoding subunits of serine palmitoyl-CoA transferase.	1
Sequencing of @GENE$ should be considered in all patients presenting with mild late-onset sensory-predominant small or large fiber @DISEASE$.	1
In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in @GENE$ (previously named regulation of transcription by RNA polymerase III) was reported in two siblings with isolated @DISEASE$ colobomatous microphthalmia from a consanguineous Saudi family.	0
In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in camera-type eye morphogenesis (previously named @GENE$) was reported in two siblings with isolated @DISEASE$ colobomatous microphthalmia from a consanguineous Saudi family.	0
Herein, we report a third patient (not related to the previously reported family) with @DISEASE$ colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous @GENE$ splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	0
This report supports the association of @GENE$ mutations with colobomatous @DISEASE$ and expands the phenotypic spectrum associated with mutations in this gene.	1
Elucidating the exact relationship between these two enzymes when they methylate two distinct sites of the same substrate may @GENE$ in developing therapeutics aimed at reducing peptidyl-arginine N-methylation/7 activity in @DISEASE$ and other diseases	0
Isobutyryl-CoA dehydrogenase deficiency (IBDHD) is a rare @DISEASE$ metabolic disorder related to valine catabolism and results from variants in @GENE$.	1
Identification of this mutation reveals the allelic @DISEASE$ of @GENE$ in patients with RP phenotype.	0
@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, @DISEASE$, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	1
@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, @DISEASE$, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	1
@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, @DISEASE$, and onychodystrophy.	1
Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic @DISEASE$, most often transmitted in an autosomal dominant manner, caused by mutations in @GENE$ and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively.	0
Herein we explored whether cellular senescence, an anti-@DISEASE$al pathway that restrains cell proliferation, is a mechanism by which @GENE$ limits hematopoietic cell expansion, and thus prevents the development of leukemia.	0
In humans, heterozygous mutations in @GENE$ result in @DISEASE$ (CHDs).	1
To elucidate the underlying molecular mechanisms of tamoxifen resistance, we performed a systematic analysis of @GENE$NA-mediated gene regulation in three clinically-relevant tamoxifen-resistant breast @DISEASE$ cell lines (TamRs) compared to their parental tamoxifen-sensitive cell line.	0
Silencing of @GENE$ or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in positive regulation of protein phosphorylation-driven @DISEASE$ cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.	0
Silencing of transforming growth factor beta receptor signaling pathway or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in @GENE$-driven @DISEASE$ cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.	1
In clinical specimens, elevated @GENE$ expression correlated with poorer survival in lung @DISEASE$ patients with an oncogenic KRAS gene signature, suggesting a novel candidate biomarker in this disease setting.	1
Our results define a novel regulatory pathway in @GENE$-driven @DISEASE$s, which offers a potential therapeutic target for their eradication.	1
To our knowledge, this is one of the first reports on isolated mild @DISEASE$ due to @GENE$ mutation in a family with moderate symptoms during adolescence.	0
Five individuals who carry @GENE$ nonsense variants resulting in a premature lysosome localization codon display severe @DISEASE$, hypotonia, progressive ataxia, seizures, and a lack of coordination.	1
Five individuals who carry @GENE$ nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, @DISEASE$ ataxia, seizures, and a lack of coordination.	1
Five individuals who carry @GENE$ nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive @DISEASE$, seizures, and a lack of coordination.	1
Five individuals who carry @GENE$ nonsense variants resulting in a premature lysosome localization codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, @DISEASE$, and a lack of coordination.	1
Five individuals who carry negative regulation of transcription by RNA polymerase II nonsense variants resulting in a premature @GENE$ codon display severe neurodevelopmental regression, hypotonia, @DISEASE$ ataxia, seizures, and a lack of coordination.	0
Increased catabolite concentrations in serum are associated with several cardiovascular diseases (CVD), including heart disease, atherosclerosis, and endothelial dysfunction, as well as their risk f@GENE$ors, including @DISEASE$, diabetes, obesity, and aging.	0
Increased catabolite concentrations in serum are associated with several cardiovascular diseases (CVD), including heart disease, atherosclerosis, and endothelial dysfunction, as well as their risk f@GENE$ors, including hypertension, diabetes, @DISEASE$, and aging.	0
Mutations in @GENE$ (antibacterial humoral response) cause neurodegenerative disorders in humans, including @DISEASE$ neuroaxonal dystrophy and early-onset parkinsonism.	1
Mutations in antibacterial humoral response (@GENE$) cause neurodegenerative disorders in humans, including @DISEASE$ neuroaxonal dystrophy and early-onset parkinsonism.	1
Mutations in antibacterial humoral response (@GENE$) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset @DISEASE$.	1
BACKGROUND Hepatocellular carcinoma (@GENE$) is one of the most common malignancies occurring worldwide and is most frequent type of liver @DISEASE$.	0
Association between @DISEASE$ and single-nucleotide polymorphisms in @GENE$ has been reported in various studies.	0
Our findings suggest that @GENE$ overexpression may be involved in the pathophysiology of @DISEASE$, modifying neuronal networks in specific subregions, such as the dorsolateral prefrontal cortex and fusiform gyrus, at both pre- and postnatal stages	0
Episodic @DISEASE$ type 2 (@GENE$) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise.	1
Further analyses of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets revealed correlations of the expression of @GENE$ with an invasive @DISEASE$, tumor metastasis, and the lower survival rate in patients with UCC.	0
We evaluated the association between dietary and supplemental zinc and prostate @DISEASE$ within the VITamins And Lifestyle (VITAL) cohort, a study specifically designed to evaluate the @GENE$ of dietary supplements and cancer risk.	0
Of 35,242 @GENE$ who completed the baseline dietary and supplemental questionnaire, 832 men developed invasive prostate @DISEASE$s between October 2000 and December 2004.	0
An underdeveloped or impaired immune response in young children is associated with increased susceptibility to Streptococcus @DISEASE$ (@GENE$) infections.	0
Mutations in abnormal spindle-like @DISEASE$-associated (@GENE$), the most common recessive microcephaly gene, reduce cortical volume by at least 50% in humans<sup>2-4</sup>, but have little effect on the brains of mice<sup>5-9</sup>; this probably reflects evolutionarily divergent functions of ASPM<sup>10,11</sup>.	1
Although there are nearly 100 different causative genes identified for nonsyndromic @DISEASE$ (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, @GENE$, regulation of pH, and OTOF.	1
<i>@GENE$</i>, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (negative regulation of transcription by RNA polymerase IIR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymph@DISEASE$.	1
<i>vascular endothelial growth factor receptor signaling pathway</i>, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (@GENE$R3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymph@DISEASE$.	0
Through Sanger sequencing of a proband with bilateral congenital pedal @DISEASE$ resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&gt;A) in <i>@GENE$</i>.	1
Here, the authors use multi-region sequencing in patient samples to analyse @GENE$ clonal architecture and @DISEASE$, providing novel insight into multiple myeloma progression and evolution	0
However, the role of @GENE$ in @DISEASE$ biology remains poorly studied.	0
Our purpose of this study is to discover the physiological effects and mechanism of @GENE$ in non-small-cell lung @DISEASE$ (NSCLC) in vitro.	0
The Wnt/beta-catenin pathway can be activated in both benign and malignant @DISEASE$ by <i>CTNNB1</i> mutations and by <i>ZNRF3</i> inactivation in adrenal cancer (@GENE$).	0
Recently, the roles of @GENE$ in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in @DISEASE$ (phosphatidylinositol phosphorylation) have been reported.	0
Recently, the roles of @GENE$ in @DISEASE$igenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (phosphatidylinositol phosphorylation) have been reported.	0
Recently, the roles of positive regulation of cell migration in @DISEASE$igenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in hepatocellular carcinoma (@GENE$) have been reported.	0
Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and @GENE$ in @DISEASE$ (phosphatidylinositol phosphorylation) have been reported.	0
Recently, the roles of positive regulation of cell migration in tumorigenesis have been interested and increased expression of FAM83H and negative regulation of transcription by RNA polymerase II in @DISEASE$ (@GENE$) have been reported.	0
The expression of @GENE$ is elevated in liver @DISEASE$ cells, and nuclear expression of FAM83H predicted shorter survival of phosphatidylinositol phosphorylation patients.	0
In hepatic @DISEASE$ cells derived from Tet-O-negative regulation of transcription by RNA polymerase II mice, the expression of mRNA and protein of @GENE$ were dependent on MYC expression.	0
In hepatic @DISEASE$ cells derived from Tet-O-@GENE$ mice, the expression of mRNA and protein of positive regulation of cell migration were dependent on MYC expression.	1
In conclusion, we present an oncogenic role of @GENE$ in liver @DISEASE$, which is closely associated with the oncogene MYC.	0
miR‑498 overexpression induced cell cycle arrest and apoptosis while it suppressed epithelial‑mesenchymal transition (@GENE$) in liver @DISEASE$ cells.	1
Furthermore, @GENE$ knockdown recapitulated the inhibitory effects of miR‑498 overexpression in liver @DISEASE$ cells.	0
Thus, we demonstrated that miR‑498 suppresses the growth and metastasis of liver @DISEASE$ cells, partly at least, by directly targeting @GENE$, suggesting that miR‑498 may serve as a potential biomarker for the diagnosis and therapy of liver cancer	0
We focused on the @DISEASE$ necrosis factor (@GENE$) pathway and revealed upregulation of genes related to nuclear factor kappa B (NF-κB) signaling and senescence-associated secretory phenotype factors.	0
Both patients presented the @GENE$ features of the disease including @DISEASE$, congenital cataract and postnatal growth failure.	0
Both patients presented the @GENE$ features of the disease including microcephaly, congenital cataract and @DISEASE$.	0
These inhibitors, coupled with targeted knockdown of @GENE$ and protein lipidation, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human @DISEASE$s	0
@GENE$ is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory @DISEASE$ (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.	0
Six syndromes of familial @DISEASE$ are compared: 1) Familial hypocalciuric hypercalcemia (@GENE$) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.	1
Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric @DISEASE$ (@GENE$) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.	1
It usually reflects biallelic inactivation of the <i>CASR.</i> 3) Multiple endocrine @DISEASE$ type 1 (@GENE$) is most frequently expressed as PHPT with asymmetric enlargement of 3-4 parathyroids.	1
4) Multiple endocrine @DISEASE$ @GENE$ 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.	0
4) Multiple endocrine neoplasia @GENE$ 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid @DISEASE$ and pheochromocytoma are more prominent.	0
4) Multiple endocrine neoplasia @GENE$ 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and @DISEASE$ are more prominent.	0
Five of the PHPT syndromes reflect overgrowth of parathyroid tissue; in contrast, familial hypocalciuric @DISEASE$ reflects dysregulation of @GENE$ secretion with little or no parathyroid overgrowth.	0
@GENE$ and desmosome assembly immunoreactivity was inversely correlated with @DISEASE$ histological grade and was observed only in tumors that did not metastasize.	0
Interestingly, patients with @DISEASE$s in which intermediate filament bundle assembly and @GENE$ immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.	0
Although the 4 PKPs displayed different levels and patterns of subcellular distribution in @DISEASE$s, there was a positive correlation between immunoreactivity for PKP2 and @GENE$, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.	0
Plant homeo domain finger protein 8 (@GENE$), as an oncogene, has been highlighted in @DISEASE$ development and progression.	0
The results demonstrated that the expression of @GENE$ was significantly increased in @DISEASE$ tissues from patients with CRC and was correlated with tumor‑node‑metastasis stage.	0
In vitro and in vivo experiments revealed that @GENE$ accelerated @DISEASE$ cell growth and migration, confirming the oncogenic role of PHF8 in human CRC.	0
While a distinct @GENE$ of processes drive metastasis when compared to tumorigenesis, it is yet unclear if genetic alterations in metabolic pathways are associated with metastatic progression of human @DISEASE$s.	0
Here, we analyzed the mutation, copy number variation and gene expression patterns of a literature-derived model of metabolic genes associated with glycolysis (Warburg effect), fatty acid metabolism (lipogenesis, oxidation, lipolysis, esterification) and fatty acid uptake in &gt;9000 primary or metastatic @DISEASE$ samples from the multi-cancer TCGA data@GENE$s.	0
Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all @DISEASE$ types, while copy number alterations in the electron transport chain gene @GENE$, fatty acid uptake (response to bacterium, CD36) and lipogenesis (PPARA, PPARD, positive regulation of cell proliferation) genes were enriched in metastatic tumors.	0
Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all @DISEASE$ types, while copy number alterations in the electron transport chain gene eye development, fatty acid uptake (response to bacterium, CD36) and lipogenesis (PPARA, PPARD, @GENE$) genes were enriched in metastatic tumors.	0
Using gene expression profiles, we established a gene-signature (@GENE$, CD36, positive regulation of cell proliferation, fatty acid beta-oxidation, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple @DISEASE$s.	0
Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, @GENE$, fatty acid beta-oxidation, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple @DISEASE$s.	0
Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, positive regulation of cell proliferation, @GENE$, monoterpenoid metabolic process) that strongly associated with epithelial-mesenchymal program across multiple @DISEASE$s.	0
Using gene expression profiles, we established a gene-signature (response to bacterium, CD36, positive regulation of cell proliferation, fatty acid beta-oxidation, @GENE$) that strongly associated with epithelial-mesenchymal program across multiple @DISEASE$s.	0
Prospective outcome data on risk-reducing salpingectomy and delayed-oophorectomy for preventing ovarian @DISEASE$ is lacking, and hence, this is @GENE$ offered for primary prevention within the context and safe environment of a clinical trial.	0
This includes unaffected women who have completed their family and have @GENE$, RAD51D, or mitochondrial translational elongation gene mutations; first-degree relatives of women with invasive epithelial ovarian @DISEASE$; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	1
This includes unaffected women who have completed their family and have DNA repair, RAD51D, or @GENE$ gene mutations; first-degree relatives of women with invasive epithelial ovarian @DISEASE$; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	0
In those with @GENE$, DNA repair/strand invasion/MMR mutations and the occasional families with a history of ovarian @DISEASE$ in their 40s, surgery needs to be considered at younger than 45.	1
In those with double-strand break repair via homologous recombination, @GENE$/strand invasion/MMR mutations and the occasional families with a history of ovarian @DISEASE$ in their 40s, surgery needs to be considered at younger than 45.	1
Our results indicate that @GENE$ mutations cause multiple congenital anomalies and intellectual disability accompanied by @DISEASE$ multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable	1
Moreover, we demonstrated that @GENE$ and positive regulation of transcription, DNA-templated expression is downregulated in ECs within @DISEASE$s by soluble factors enriched in the tumor microenvironment.	0
Moreover, we demonstrated that positive regulation of transcription by RNA polymerase II and @GENE$ expression is downregulated in ECs within @DISEASE$s by soluble factors enriched in the tumor microenvironment.	0
The resulting loss of cellular respiration ultimately induces @DISEASE$ genetic diseases, including mtDNA depletion syndromes (@GENE$) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	0
The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (@GENE$) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as @DISEASE$ external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	0
The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (@GENE$) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, @DISEASE$-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	1
The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (@GENE$) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-@DISEASE$, or mitochondrial neurogastrointestinal encephalomyopathy.	0
To identify common genetic variants associated with @DISEASE$ non-syndromic @GENE$ in Han Chinese populations, we performed a multistage genome-wide association study (GWAS) in a total of 4,225 CHM cases and 5,112 non-CHM controls.	0
Here we show that linc-NeD125, which we previously characterized as a neuronal-induced lncRNA, is significantly overexpressed in Group 4 @DISEASE$ (G4 @GENE$), the largest and least well characterized molecular MB subgroup.	0
Liposarcoma is an often @GENE$al @DISEASE$ of fat cells.	0
All DAKO @GENE$ developed @DISEASE$ between 11 and 14 months of age.	0
Similar changes of @GENE$ and G0S2 expression were present in a human @DISEASE$ database.	0
Among others, an immature subpopulation of self-renewing and therapy-resistant @DISEASE$ cells-often referred to as glioblastoma stem-like cells (@GENE$s)-cellular response to platelet-derived growth factor stimulus been shown to contribute to disease recurrence.	0
Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as @DISEASE$ stem-like cells (@GENE$s)-cellular response to platelet-derived growth factor stimulus been shown to contribute to disease recurrence.	0
In summary, we identified novel immunogenic proteins, which frequently induce @DISEASE$-specific T cell responses in GBM patients and were also detected in vitro in therapy-resistant quiescent, slow-cycling @GENE$s.	0
The sideroblastic anemias are a @DISEASE$ group of inherited and acqui@GENE$ disorders characterized by the presence of ring sideroblasts in the bone marrow.	0
Inhibitors of molecules of the transforming growth factor-β superfamily have been shown recently to target @DISEASE$ and ameliorate anemia both in animal models of myelodysplastic syndrome and in @GENE$ patients.	0
MATERIAL AND METHODS Human @DISEASE$ SH-SY5Y cells were treated for 24 h with increasing concentrations of aggregated Aβ₂₅₋₃₅ (5, 15, 25, and 45 μmol) with or without the @GENE$1 siRNA pretreatment.	0
After exclusive analysis of 10 common variations of three @DISEASE$-related genes, gap junction-mediated intercellular transport, mtDNA12srRNA and @GENE$, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.	1
Screening the @GENE$ gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an @DISEASE$ mode of inheritance.	1
Screening the @GENE$ gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an autosomal recessive @DISEASE$.	0
Ellis-@GENE$ Creveld syndrome is an @DISEASE$ skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.	0
Ellis-@GENE$ Creveld syndrome is an autosomal recessive @DISEASE$ primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.	0
Ellis-@GENE$ Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, @DISEASE$, dysplastic nails, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.	0
Ellis-@GENE$ Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, @DISEASE$, cardiovascular malformations, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.	0
Ellis-@GENE$ Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, @DISEASE$, post-axial polydactyly (cilium assembly) (bilateral) of hands and feet.	0
Ellis-@GENE$ Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-@DISEASE$ polydactyly (cilium assembly) (bilateral) of hands and feet.	0
Ellis-@GENE$ Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial @DISEASE$ (cilium assembly) (bilateral) of hands and feet.	0
Ellis-glycoprotein biosynthetic process Creveld syndrome is an @DISEASE$ skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (@GENE$) (bilateral) of hands and feet.	0
Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, @DISEASE$, dysplastic nails, cardiovascular malformations, post-axial polydactyly (@GENE$) (bilateral) of hands and feet.	0
Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, @DISEASE$, post-axial polydactyly (@GENE$) (bilateral) of hands and feet.	0
Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-@DISEASE$ polydactyly (@GENE$) (bilateral) of hands and feet.	0
Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial @DISEASE$ (@GENE$) (bilateral) of hands and feet.	0
This study reports first case of variants in the genes causing @GENE$ syndrome and @DISEASE$ deafness in the same family	0
Neurturin (@GENE$) provides trophic support to neurons and is considered a therapeutic agent for @DISEASE$, such as Parkinson's disease.	0
Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (@GENE$) were recently reported to be risk factors for the development of @DISEASE$ during valproic acid-based therapy.	1
This study aimed to examine the influence of patient characteristics, including polymorphisms in steroid biosynthetic process 4217C&gt;A and @GENE$ -3064C&gt;A, on the development of hyperammonemia in Japanese pediatric @DISEASE$ patients.	1
This study aimed to examine the influence of patient characteristics, including polymorphisms in steroid biosynthetic process 4217C&gt;A and @GENE$ -3064C&gt;A, on the development of @DISEASE$ in Japanese pediatric epilepsy patients.	1
With regard to the @GENE$ 4217C&gt;A polymorphism, we did not observe a significant association with the development of @DISEASE$.	0
@GENE$-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, @DISEASE$, acquired microcephaly, sensory defects and autistic behavior.	0
@GENE$-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired @DISEASE$, sensory defects and autistic behavior.	0
The underlining mechanisms of dietary cholesterol and nonalcoholic steatohepatitis (NASH) in contributing to @DISEASE$ (@GENE$) remain undefined.	0
Surgical @DISEASE$ specimens were collected for immunohistochemical staining to evaluate @GENE$-positive regulation of cell proliferation expression.	0
Patients' baseline characteristics, including gender, age, @DISEASE$ size, tumor location, tumor grading, clinical @GENE$ staging, tumor infiltrating lymphocytes, CA19-9 and chemotherapy treatment, along with the subsequent follow-up data, were documented and analyzed.	0
When co-cultured with T cells, pancreatic @DISEASE$ PC cells with high biological_process-@GENE$ expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.	1
When co-cultured with T cells, pancreatic @DISEASE$ PC cells with high @GENE$-positive regulation of cell proliferation expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.	0
Of the 136 PDAC @DISEASE$ tissues, 93 (68.38%) were strong and 43 (31.62%) were weak biological_process-@GENE$ expression.	1
Of the 136 PDAC @DISEASE$ tissues, 93 (68.38%) were strong and 43 (31.62%) were weak @GENE$-positive regulation of cell proliferation expression.	0
@GENE$ staging, @DISEASE$ location and subsequent chemotherapy were also prognostic factors in these patients.	0
Recessive variants located in the ligand-binding domain (LBD) of NR2E3 cause enhanced short wavelength sensitive- (S-) cone syndrome (ESCS), a @DISEASE$ characterized by an excess of S-cones and non-functional @GENE$s.	0
Eleven (79%) and five (36%) of fourteen keratinizing @DISEASE$ tested contained TP53 and @GENE$ mutations, respectively.	1
The findings indicate that although @GENE$ mutations are found in &lt;10% of vulvar @DISEASE$, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.	0
The findings indicate that although @GENE$ mutations are found in &lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar @DISEASE$.	0
Whether they function as direct precursors to a less common form of @DISEASE$ will require further study, but carcinomas associated with these lesions might warrant testing for @GENE$ mutations to address this question	0
Usher syndrome muscle organ development III (@GENE$) is an autosomal recessive disorder caused by mutations in clarin-1 (actin filament organization) gene, leading to progressive @DISEASE$ and sensorineural deafness.	0
Usher syndrome muscle organ development III (actin filament organization) is an autosomal recessive disorder caused by mutations in clarin-1 (@GENE$) gene, leading to progressive @DISEASE$ and sensorineural deafness.	0
Here, we report a reduction of histone deacetylase 3 (@GENE$) protein amounts in eutopic endometrium of infertile women with @DISEASE$ compared to a control group.	0
Reduction of <i>@GENE$</i> abrogated decidualization in a primary culture of human endometrial stromal cells (hESCs) similar to that observed in infertile patients with @DISEASE$.	0
Germline de novo truncating variants in @GENE$ and transcription, DNA-templated have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe @DISEASE$ and dysmorphic features.	1
Germline de novo truncating variants in monoubiquitinated histone H2A deubiquitination and @GENE$ have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe @DISEASE$ and dysmorphic features.	1
Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the @GENE$-associated condition from ASXL1- and ASXL3-related disorders are @DISEASE$, absence of growth retardation, and more variability in the degree of intellectual disabilities.	1
Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the @GENE$-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of @DISEASE$.	1
Therefore, hypertrophic @DISEASE$ and tubulopathy may not be considered as constant features of @GENE$.	1
These changes were accompanied by @DISEASE$ as well as increased expression of angiogenesis-related genes such as <i>Vegfa</i>, <i>Serpine1</i>, and <i>Plau</i> in @GENE$-positive endothelial cells.	0
Moreover, overexpression of mutant but not normal @GENE$ in @DISEASE$ cells caused rapid apoptosis.	0
@GENE$-osteoblast differentiation fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid @DISEASE$, known as &quot;pericytoma with the t(7;12) translocation.&quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.	1
postsynaptic actin cytoskeleton organization-@GENE$ fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid @DISEASE$, known as &quot;pericytoma with the t(7;12) translocation.&quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.	1
Our findings open new opportunities for targeted therapy, as @DISEASE$ with GLI1 oncogenic activation, and subsequent @GENE$ overexpression, might be sensitive to sonic hedgehog pathway inhibitors	1
Only overexpression of @GENE$ induced a reduction of brain proliferating cells and concomitant @DISEASE$.	0
Moreover, oncogenic activation of @GENE$ and/or loss of a MYC antagonist, results in an imbalance in the activity of the network as a whole, leading to @DISEASE$ initiation, progression and maintenance	1
As a result, 14 SNPs had a significant odds ratio (OR) for lung @DISEASE$ risk with P FDR &lt; 0.05, of which rs3115672 in @GENE$ (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in transcription by RNA polymerase II (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.99×10(-11) and P combined = 5.40×10(-10), respectively).	0
As a result, 14 SNPs had a significant odds ratio (OR) for lung @DISEASE$ risk with P FDR &lt; 0.05, of which rs3115672 in biological_process (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in @GENE$ (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.99×10(-11) and P combined = 5.40×10(-10), respectively).	0
We herein report the case of a 59-year-old man with anti-leucine-rich @DISEASE$-inactivated 1 (@GENE$) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.	0
We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (@GENE$) antibody @DISEASE$ who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.	0
We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (@GENE$) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed @DISEASE$.	1
Taken together, these findings indicate that anti-@GENE$ @DISEASE$ may present as slowly progressive cognitive impairment mimicking dementia and that fluctuating MRI striatal lesions may be a characteristic radiological finding of this disorder	0
Auriculocondylar syndrome, mainly characterized by @DISEASE$, small mandibular condyle, and question @GENE$ prolyl-tRNA aminoacylation, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	0
Auriculocondylar syndrome, mainly characterized by micrognathia, @DISEASE$, and question @GENE$ prolyl-tRNA aminoacylation, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	0
Auriculocondylar syndrome, mainly characterized by micrognathia, @DISEASE$, and question protein phosphorylation @GENE$, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	0
In order to address these questions, we searched for alterations in PLCB4, GNAI3, and @GENE$ in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), @DISEASE$ with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome.	1
Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 @DISEASE$ was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>@GENE$</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	0
Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known @DISEASE$-predisposing somatic mutation in <i>IDH1</i> A variant in <i>@GENE$</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	0
Array methylation-based analysis uncovered a somatic epigenetic mutation in <i>@GENE$C</i> in a patient with multiple pheochromocytomas and a gastrointestinal stromal @DISEASE$.	0
As proof of concept, we applied CRAFT to @DISEASE$ and predicted the tyrosine kinase receptor @GENE$ as a potential therapeutic target.	0
The predicted effect of @GENE$ blockade in attenuating @DISEASE$ seizures was validated in three pre-clinical models of epilepsy.	0
Recent studies have examined the intrinsic antitumor activity of melatonin in various cancers, including @DISEASE$ (@GENE$), the primary life-threatening malignancy in both sexes in Taiwan.	0
Proliferative vasculopathy and @DISEASE$-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in @GENE$.	1
Proliferative vasculopathy and hydranencephaly-@DISEASE$ syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in @GENE$.	1
Interestingly, the other branch of the original family was found to segregate anophthalmia/@DISEASE$ with a novel homozygous @GENE$ variant.	1
A branch-site mutation in the human gene encoding assembly factor @GENE$ has recently been associated with mitochondrial @DISEASE$ and complex I deficiency in seven independent cases.	0
As a mitotic kinesin, kinesin family member 14 (@GENE$) has been reported to serve oncogenic roles in a variety of malignancies; however, its functional role and regulatory mechanisms in colorectal @DISEASE$ (CRC) remain unclear.	0
In the present study, @GENE$ was observed to be markedly overexpressed in CRC, and this upregulation was associated with @DISEASE$ size and marker of proliferation regulation of proteasomal protein catabolic process-67 immunostaining scores.	0
In the present study, positive regulation of cell proliferation was observed to be markedly overexpressed in CRC, and this upregulation was associated with @DISEASE$ size and marker of proliferation @GENE$-67 immunostaining scores.	0
Common genetic variants contribute to the observed variation in breast @DISEASE$ risk for @GENE$ mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).	1
DNA samples from 3,881 breast @DISEASE$ affected and 4,330 unaffected @GENE$ mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.	1
We replicated previously reported breast @DISEASE$ susceptibility alleles in these @GENE$ mutation carriers and for several regions (including FGFR2, cellular response to mechanical stimulus, CDKN2A/B, and skeletal system development) identified SNPs that have stronger evidence of association than those previously published.	1
We replicated previously reported breast @DISEASE$ susceptibility alleles in these mitotic cytokinesis mutation carriers and for several regions (including FGFR2, @GENE$, CDKN2A/B, and skeletal system development) identified SNPs that have stronger evidence of association than those previously published.	1
We replicated previously reported breast @DISEASE$ susceptibility alleles in these mitotic cytokinesis mutation carriers and for several regions (including FGFR2, cellular response to mechanical stimulus, CDKN2A/B, and @GENE$) identified SNPs that have stronger evidence of association than those previously published.	0
This SNP was not associated with breast @DISEASE$ risk either in the general population or in @GENE$ mutation carriers.	1
The locus lies within a region containing @GENE$, which encodes a transcriptional activation protein that interacts with several @DISEASE$ suppressor genes.	1
However @DISEASE$ with mutation in the @GENE$ gene is suspected	1
The patient had a history of severe neonatal jaundice, hemolytic crisis with rhabdomyolysis trigge@GENE$ by febrile viral infections, dysarthria, and @DISEASE$ during early childhood.	0
In the last 10 years, the primary cilia machinery has been implicated in more than a dozen disorders united as ciliopathies, including @DISEASE$, such as Jeune syndrome and short rib-polydactyly @GENE$ III.	0
In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-@DISEASE$ group (muscle contractions) that includes Verma-Naumoff syndrome (SRP @GENE$ III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (endochondral bone growth), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	0
In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-@DISEASE$ group (@GENE$s) that includes Verma-Naumoff syndrome (SRP muscle organ development III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (endochondral bone growth), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	0
In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-@DISEASE$ group (muscle contractions) that includes Verma-Naumoff syndrome (SRP muscle organ development III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (@GENE$), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	1
Misregulation of vascular endothelial growth factor A (@GENE$‑A) has been implicated in numerous types of @DISEASE$, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.	0
We examined a Japanese 54-years-old male patient with @DISEASE$ @GENE$.	1
Through the examination of 48 candidate genes known to be responsible for @DISEASE$ @GENE$, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the positive regulation of mitochondrial fission gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).	1
Sonic Hedgehog (@GENE$) signaling at primary cilia drives the proliferation and progression of a subset of @DISEASE$, the most common malignant paediatric brain tumor.	0
However, the role @GENE$ plays in @DISEASE$ is unknown and the contribution of peptide cross-linking-kinase signaling to cilia function is little characterized.	0
However, the role protein processing involved in protein targeting to mitochondrion plays in @DISEASE$ is unknown and the contribution of @GENE$-kinase signaling to cilia function is little characterized.	0
Here, we reveal @GENE$ promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on @DISEASE$ cells.	0
Here, we reveal @GENE$ promotes positive regulation of cell proliferation signaling in SHH @DISEASE$ by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.	0
Here, we reveal protein processing involved in protein targeting to mitochondrion promotes @GENE$ signaling in SHH @DISEASE$ by negatively regulating a cilia-compartmentalized peptide cross-linking-kinase signaling axis that maintains primary cilia on tumor cells.	0
Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH @DISEASE$ by negatively regulating a cilia-compartmentalized @GENE$-kinase signaling axis that maintains primary cilia on tumor cells.	0
Here, we reveal protein processing involved in protein targeting to mitochondrion promotes positive regulation of cell proliferation signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized @GENE$-kinase signaling axis that maintains primary cilia on @DISEASE$ cells.	0
Conditional deletion of @GENE$ in a murine model of constitutively active Smoothened-driven medulloblastoma slowed @DISEASE$ progression, suppressed cell proliferation, reduced positive regulation of cell proliferation signaling and promoted tumor cell cilia loss.	0
Conditional deletion of protein processing involved in protein targeting to mitochondrion in a murine model of constitutively active Smoothened-driven medulloblastoma slowed @DISEASE$ progression, suppressed cell proliferation, reduced @GENE$ signaling and promoted tumor cell cilia loss.	1
The number of PtdIns(3,4,5)P<sub>3</sub>/pAKT/pGSK3β-positive cilia was increased in cultured @GENE$-null @DISEASE$ cells relative to controls.	0
peptide cross-linking-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in @GENE$-null @DISEASE$ cells in vitro.	0
protein processing involved in protein targeting to mitochondrion mRNA and copy number were reduced in human @GENE$ @DISEASE$ compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.	0
Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3β signaling axis at cilia in @GENE$-dependent medulloblastoma that is regulated by protein processing involved in protein targeting to mitochondrion to maintain @DISEASE$ cell cilia, promote SHH signaling and thereby medulloblastoma progression	1
@GENE$1, an important member of the Kank gene family, plays an important role in the development of many malignant @DISEASE$.	0
As a brand new @DISEASE$-suppressor gene, the expression of @GENE$1 gene has been revealed to be downregulated or absent in many malignant tumors.	0
Concurrently, in vivo @GENE$ mice experiments also confirmed that upregulation of negative regulation of neuron projection development1 expression led to reduced @DISEASE$ formation in nude mice and significantly reduced tumor volume.	0
Concurrently, in vivo establishment of mitotic spindle orientation mice experiments also confirmed that upregulation of @GENE$1 expression led to reduced @DISEASE$ formation in nude mice and significantly reduced tumor volume.	0
These results revealed that upregulation of the @GENE$l gene inhibited the progression of lung cancer both in vitro and in vivo, and its mechanism was closely related to cell apoptosis as well as @DISEASE$ invasion and metastasis	0
Of all the @DISEASE$, myoclonus is the most difficult to encapsulate into any @GENE$ framework.	1
Of all the movement disorders, @DISEASE$ is the most difficult to encapsulate into any @GENE$ framework.	0
Recently, loss-of-function mutations in @GENE$ were reported in association with severe @DISEASE$, deafness and dystonia.	1
Recently, loss-of-function mutations in @GENE$ were reported in association with severe developmental delay, @DISEASE$ and dystonia.	1
Remarkably, a patient with an isolated deletion at the 3'-end of creatine transmembrane transport had a similar severe phenotype as seen in @GENE$ deficiency but without @DISEASE$.	1
Friedreich's @DISEASE$ (@GENE$), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (glycogen catabolic process) repeat in the regulation of ferrochelatase activity gene is known to inhibit the expression of frataxin protein.	1
Friedreich's @DISEASE$ (regulation of ferrochelatase activity), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (@GENE$) repeat in the regulation of ferrochelatase activity gene is known to inhibit the expression of frataxin protein.	0
Friedreich's @DISEASE$ (regulation of ferrochelatase activity), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (glycogen catabolic process) repeat in the @GENE$ gene is known to inhibit the expression of frataxin protein.	1
Dendritic cell (@GENE$)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' @DISEASE$ protein 1 (negative regulation of transcription by RNA polymerase II) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.	0
Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of @DISEASE$s, and DC vaccines prepared with Wilms' tumor protein 1 (negative regulation of transcription by RNA polymerase II) peptides have shown @GENE$ therapeutic efficacy in these diseases.	0
Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of @DISEASE$s, and DC vaccines prepared with Wilms' tumor protein 1 (@GENE$) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.	1
Dendritic cell (neuron migration)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' @DISEASE$ protein 1 (@GENE$) peptides have shown G protein-coupled receptor signaling pathway therapeutic efficacy in these diseases.	1
In this paper, we report the results of a phase I/II study of a DC-based vaccination for advanced breast, ovarian, and @DISEASE$, and we offer evidence that patients can be effectively vaccinated with autologous DCs pulsed with @GENE$ peptide.	0
Here, we show that fine-mapping of pancreatic and testicular @DISEASE$ GWAS within one of these loci (Region 2 in @GENE$) focuses the signal to nine highly correlated SNPs.	0
Despite significant progress in our understanding of hereditary @DISEASE$, the list of genes associated with early-on@GENE$ dementia is not yet complete.	0
MicroRNAs (@GENE$NAs) are identified as key regulators in @DISEASE$ initiation, progression and metastasis including gastric cancer (GC).	0
Furthermore, lower @GENE$-129-5p expression closely associated with @DISEASE$ size and lymph node invasion and poor prognosis of GC patients.	0
Therefore, these results indicated that @GENE$-129-5p functioned as a @DISEASE$ suppressor in GC and may be a potential target of GC treatment	0
Elevated serum @GENE$ concentrations in primary and secondary @DISEASE$ have been associated with bone disease, hypertension, and in some studies, cardiovascular mortality.	0
Elevated serum @GENE$ concentrations in primary and secondary hyperparathyroidism have been associated with bone disease, @DISEASE$, and in some studies, cardiovascular mortality.	0
<b>Methods</b>: Analysis of publicly available microarray data of oral negative regulation of peptidase activity revealed that @GENE$ was significantly upregulated in @DISEASE$ tissue compared with normal mucosa.	0
Uveal melanomas are molecularly distinct from @DISEASE$ and lack mutations in BRAF, @GENE$, activation of MAPK activity, and NF1.	1
Uveal melanomas are molecularly distinct from @DISEASE$ and lack mutations in BRAF, Ras protein signal transduction, @GENE$, and NF1.	0
Deregulated mitochondrial respiration induced by @GENE$P targeting causes oxidative stress, which in turn reduces @DISEASE$ cell proliferation, suppresses cell motility, and abolishes metastatic dissemination in vivo.	0
@GENE$ is universally overexpressed in primary and metastatic human @DISEASE$, correlating with shortened patient survival.	0
Therefore, @DISEASE$s exploit @GENE$P-directed proteostasis to maintain mitochondrial bioenergetics, buffer oxidative stress, and enable metastatic competence.	0
The gene responsible for an @DISEASE$ Pelizaeus-Merzbacher-like disease called HLD5 is named @GENE$ (also known as phosphatidylinositol phosphorylation or phosphatidylinositol phosphorylation).	1
The gene responsible for an @DISEASE$ Pelizaeus-Merzbacher-like disease called HLD5 is named phosphatidylinositol phosphorylation (also known as @GENE$ or phosphatidylinositol phosphorylation).	1
The gene responsible for an @DISEASE$ Pelizaeus-Merzbacher-like disease called HLD5 is named phosphatidylinositol phosphorylation (also known as phosphatidylinositol phosphorylation or @GENE$).	1
After targeting to endothelial differentiation gene (Edg) family @GENE$ receptors (LPA1, LPA2, LPA3) and non-Edg family LPA receptors (LPA4, LPA5, LPA6), LPA mediates physiological and pathological processes such as embryonic development, angiogenesis, @DISEASE$ progression, fibrogenesis, wound healing, ischemia/reperfusion injury, and inflammatory reactions.	0
To identify potential biological differences by @GENE$ among Luminal A breast cancers, gene expression data from 108 CAU and 57 AA breast @DISEASE$ were analyzed.	0
Six genes (@GENE$, MUC1, CRYBB2, L-serine metabolic process, SQLE, dTMP biosynthetic process) were differentially expressed by race among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	0
Six genes (positive regulation of cell death, MUC1, CRYBB2, @GENE$, SQLE, dTMP biosynthetic process) were differentially expressed by race among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	0
Six genes (positive regulation of cell death, MUC1, CRYBB2, L-serine metabolic process, SQLE, @GENE$) were differentially expressed by race among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	0
For all six genes, @DISEASE$ in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, @GENE$).	0
For all six genes, @DISEASE$ in AA had higher expression of poor prognosis genes (@GENE$, L-serine metabolic process, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).	0
For all six genes, @DISEASE$ in AA had higher expression of poor prognosis genes (visual perception, @GENE$, sterol biosynthetic process, dTMP biosynthetic process) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).	0
For all six genes, @DISEASE$ in AA had higher expression of poor prognosis genes (visual perception, L-serine metabolic process, sterol biosynthetic process, @GENE$) and lower expression of good prognosis genes (positive regulation of cell death, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest).	0
Some of these differences (@GENE$ and L-serine metabolic process) may exist from the earliest stages of @DISEASE$ development, or may even precede malignancy	0
Some of these differences (visual perception and @GENE$) may exist from the earliest stages of @DISEASE$ development, or may even precede malignancy	0
Helicase‑like transcription factor (@GENE$) has been identified as a @DISEASE$ suppressor gene.	0
The hypermethylation of @GENE$ is frequently observed in various types of @DISEASE$, including colorectal cancer (CRC).	0
Through epigenomic study of a colon cancer cell line pair (HCT116 and DKO), we identified <i>JPH3</i> as a methylated novel @DISEASE$ suppressor gene (@GENE$) candidate at 16q24.	0
Thus, <i>JPH3</i> was identified as a novel @GENE$ methylated in colorectal and gastric @DISEASE$s which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive cancers	0
RAB3A interacting protein (@GENE$) has been determined to be involved in @DISEASE$ progression; however, its expression pattern and function in gastric cancer remain unknown.	0
The aim of this study was to determine the association between @GENE$ and gastric @DISEASE$, in addition to its functional role in this disease.	0
Thus, these findings elucidated the central role of @GENE$ in inducing an invasive phenotype in gastric @DISEASE$ cells, in addition to its involvement in cytokine production.	0
At least 36 different forms of @GENE$ are known, 20 autosomal-recessive, two X-linked, and several forms of @DISEASE$ associated with mitochondrial defects are known to date.	1
Only a few genes, including nucleosome disassembly, SMO, @GENE$ and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this @DISEASE$.	0
Candidate markers were identified by bisulfite conversion-based genome-wide methylation screening of lung tissue from lung @DISEASE$, fibrotic ILD, and @GENE$. cfDNA from 400 μl serum (n = 204) served to test the diagnostic performance of these markers.	0
Cancer was distinguished from ILD with a specificity of 88%, (95%CI: 0.57-1), and @GENE$ from @DISEASE$ with a specificity of 88% (95%CI: 0.64-0.97).	0
Hepatocellular carcinoma related protein 1 (@GENE$), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several @DISEASE$ and strongly affects the outcomes of cancer patients.	0
Hepatocellular carcinoma related protein 1 (@GENE$), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of @DISEASE$ patients.	0
@GENE$ expression was significantly related to age (P=0.017), pathological grade (P=0.003), @DISEASE$ encapsulation (P=0.037), recurrence (P=0.039) and death (P=0.015), but unrelated to cirrhosis (P=0.216), tumor size (P=0.273), and distant metastasis (P=0.554).	0
Prostate @DISEASE$ (@GENE$) is the most common cancer among men.	0
Moreover, @GENE$ depletion in mitochondrial transport cells injected subcutaneously in MeS epidermis development increased the circulating @DISEASE$ cells foci compared to control.	0
Moreover, ion transmembrane transport depletion in mitochondrial transport cells injected subcutaneously in MeS @GENE$ increased the circulating @DISEASE$ cells foci compared to control.	0
Recently, mutations of @GENE$ gene were reported to be associated with early-onset @DISEASE$, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.	1
Recently, mutations of @GENE$ gene were reported to be associated with early-onset parkinsonism, progressive @DISEASE$, and dystonia in several unrelated pedigrees.	1
This study aimed to evaluate @GENE$ coding mutations in @DISEASE$ Chinese Han patients with Parkinson's disease (PD) and test whether an age-of-onset effect exists.	0
Biallelic @GENE$ mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, @DISEASE$ (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.	1
Furthermore, we herein summarize the genotypes and phenotypes of patients with @GENE$ mutations reported in the literature, revealing that IHPRF2 is a phenotypically @DISEASE$ disease.	0
Common facial dysmorphisms include a thin upper @GENE$, a tented upper lip, a @DISEASE$, strabismus and microcephaly.	0
Common facial dysmorphisms include a thin upper @GENE$, a tented upper lip, a triangular face, strabismus and @DISEASE$.	0
@GENE$ has also been identified as an important node in @DISEASE$ gene networks more broadly, but the functional role of PKC in other forms of ataxia remains unexplored, and the mechanisms by which PKC isozymes regulate Purkinje neuron health are not well understood.	1
Using mouse models of spino@DISEASE$ @GENE$ 1 (SCA1) and 2 (negative regulation of receptor internalization) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.	0
Using mouse models of spino@DISEASE$ muscle organ development 1 (SCA1) and 2 (@GENE$) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.	1
Recent advances in whole exome sequencing technology show promise for further elucidation of disease causing variants as in the recent identification of rare variants within @GENE$ segregating with pathological @DISEASE$.	1
We evaluated the molecular @DISEASE$ of sCRC tumors based on simultaneous assessment of the overall @GENE$ of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.	0
We evaluated the molecular heterogeneity of sCRC @DISEASE$ based on simultaneous assessment of the overall @GENE$ of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.	0
We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall @GENE$ of both coding mRNA and non-coding RNA genes in primary sCRC @DISEASE$ samples from 23 consecutive patients and their paired liver metastases.	0
RHOA, SMAD2, SMAD4, @GENE$, SMAD6, protein phosphorylation, negative regulation of transcription by RNA polymerase II and MYC-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	0
RHOA, SMAD2, SMAD4, embryonic pattern specification, SMAD6, @GENE$, negative regulation of transcription by RNA polymerase II and MYC-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
The incproteolysisnce rate of @DISEASE$ (@GENE$) is rising.	0
Activation of inflammatory pathways is known to accompany development of @DISEASE$-induced non-alcoholic positive regulation of cell-matrix adhesionty liver disease (NAFLD), insulin resistance and @GENE$ 2 diabetes.	0
Activation of inflammatory pathways is known to accompany development of @DISEASE$-induced non-alcoholic @GENE$ty liver disease (NAFLD), insulin resistance and muscle organ development 2 diabetes.	0
Hearing impairment (HI) caused by mutations in the connexin-26 gene (@GENE$) accounts for the majority of cases with inherited, nonsyndromic sensorineural @DISEASE$.	1
This study describes the first use of @GENE$ for gap junction-mediated intercellular transport associated non-syndromic @DISEASE$ in Iran.	0
This study describes the first use of pentose-phosphate shunt, oxidative branch for @GENE$ associated non-syndromic @DISEASE$ in Iran.	1
@GENE$ donor splicing site IVS1+1G&amp;gt;A mutation analysis was performed using Sanger sequencing for a total of 71 Iranian families with at least 1 deaf child diagnosed with non-syndromic @DISEASE$.	1
Recent studies have linked mutations in the SLC24A4 (NCKX4) and @GENE$ (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous @DISEASE$ (OCA6), respectively.	0
We also analyzed two mutations in a Drosophila @GENE$ gene that have been reported to result in an increased susceptibility for @DISEASE$, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity.	0
This phenotype is associated with increased cytosine methylation @DISEASE$, but not with increased @GENE$-mediated somatic mutation burden.	0
This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased @GENE$-mediated @DISEASE$ burden.	0
Reciprocally, the cytosine methylation @DISEASE$ characteristic of normal GC B cells is lost upon @GENE$ depletion.	0
Our results identify @GENE$ as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other @DISEASE$ with aberrant expression of cytidine deaminases	0
Thus, it is clear that a more complex genetic network of @DISEASE$-associated genes than previously hypothesized is involved in BCC carcinogenesis, with a potential @GENE$ on the development of new molecular targeted therapies.	0
Loss-of-function mutations in the human @GENE$ gene cause @DISEASE$ congenital lymphatic dysplasia.	1
Gain-of-function mutations in the human @GENE$ gene cause the autosomal dominant @DISEASE$, hereditary xerocytosis (also known as dehydrated stomatocytosis).	1
Loss-of-function mutations in the human @GENE$ gene cause an @DISEASE$ syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.	1
Loss-of-function mutations in the human @GENE$ gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, @DISEASE$, and scoliosis.	1
Loss-of-function mutations in the human @GENE$ gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and @DISEASE$.	1
Pathogenic sequence variants in the Sorting @GENE$ 10 (SNX10) gene have been associated with @DISEASE$ osteopetrosis (ARO) in human.	0
We have recently demonstrated that DNA @GENE$ signaling from DNA double-strand breaks (DSBs) promotes PD-L1 upregulation in @DISEASE$ cells.	0
Results Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic @DISEASE$ at the severe @GENE$ of the spectrum to insidious hyperpigmentation and delayed development.	1
In our study, we aim to investigate whether variants of @GENE$, potassium ion transmembrane transport, and KCNV2 genes influence susceptibility to genetic generalized @DISEASE$ (GGEs) and the efficacy of AEDs.	1
In our study, we aim to investigate whether variants of magnesium ion homeostasis, @GENE$, and KCNV2 genes influence susceptibility to genetic generalized @DISEASE$ (GGEs) and the efficacy of AEDs.	1
In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the @DISEASE$ suppressor gene and the tissue factor pathway inhibitor 2 (blood coagulation) in hepatocellular carcinoma (@GENE$).	0
In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (@GENE$) in @DISEASE$ (phosphatidylinositol phosphorylation).	0
The musculo-aponeurotic @DISEASE$ oncogene homolog B (MAFB) significantly enhanced the activation of the @GENE$ promoter via RAR&amp;alpha; while positive regulation of transcription by RNA polymerase II inhibited it.	0
The musculo-aponeurotic @DISEASE$ oncogene homolog B (MAFB) significantly enhanced the activation of the blood coagulation promoter via RAR&amp;alpha; while @GENE$ inhibited it.	0
Naive CD4<sup>+</sup> T cells adhere to @DISEASE$ slices in proportion to the abundance of @GENE$-producing macrophages.	0
Moreover, adoptively transferred human naive CD4<sup>+</sup> T cells infiltrate human breast @DISEASE$ orthotopic xenografts in a @GENE$-dependent manner.	0
In human breast @DISEASE$ xenografts in humanized @GENE$, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	0
In human breast @DISEASE$ xenografts in humanized epidermis development, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of @GENE$, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	0
In human breast @DISEASE$ xenografts in humanized epidermis development, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of phosphatidylinositol biosynthetic process, a @GENE$ receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	0
Inhibiting naive CD4<sup>+</sup> T cell recruitment into @DISEASE$s by interfering with phosphatidylinositol biosynthetic process recognition of @GENE$ may be an attractive strategy for anticancer immunotherapy	0
Inhibiting naive CD4<sup>+</sup> T cell recruitment into tumors by interfering with @GENE$ recognition of chemotaxis may be an attractive strategy for anti@DISEASE$ immunotherapy	0
The molecular signatures unique to primary and metastatic LMSs may @GENE$ in understanding @DISEASE$ progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.	0
The molecular signatures unique to primary and metastatic LMSs may @GENE$ in understanding tumor progression in this @DISEASE$ and in providing a molecular basis for prognostic studies and therapeutic target discovery.	0
Fungal immunomodulatory protein from <i>Nectria haematococca</i> (@GENE$-nha) has potential as a lung @DISEASE$ therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.	0
Thus, we comprehensively revealed the anti-@DISEASE$ mechanism of @GENE$-nha, which inhibits tumor growth by modulating PI3K/positive regulation of protein phosphorylation-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha	0
Thus, we comprehensively revealed the anti-@DISEASE$ mechanism of positive regulation of transcription from RNA polymerase II promoter by glucose-nha, which inhibits tumor growth by modulating PI3K/@GENE$-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha	1
High mobility group A2 (@GENE$) plays a crucial role in the development of @DISEASE$.	1
However, the mechanism by which @GENE$ promotes the growth of @DISEASE$ (phosphatidylinositol phosphorylation) remains unclear.	0
However, the mechanism by which negative regulation of transcription by RNA polymerase II promotes the growth of @DISEASE$ (@GENE$) remains unclear.	0
To evaluate the role of constitutive epigenetic changes in normal body cells of @GENE$/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.	1
To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/@GENE$-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.	1
To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, @GENE$, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.	1
To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, DNA repair, @GENE$, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.	1
To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, @GENE$, RB1) and the estrogene receptor gene (transcription by RNA polymerase II), which plays a role in tumor progression.	1
To evaluate the role of constitutive epigenetic changes in normal body cells of double-strand break repair via homologous recombination/mitotic cytokinesis-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, DNA repair, protein phosphorylation, PTEN, TP53, mismatch repair, RB1) and the estrogene receptor gene (@GENE$), which plays a role in tumor progression.	0
This report describes for the first time a patient with @GENE$ deficiency presenting with cortical dysplasia (polymicrogyria), @DISEASE$, and platelet secretion defect	0
In conclusion, these results indicated that coronin3 is significantly dysregulated in @GENE$ @DISEASE$ tissues, and may exert its function via regulating G6PC3 expression.	0
E168d2 @GENE$ carry a frameshift mutation in the positive regulation of transcription by RNA polymerase II activation domain, Glu168del2, which is associated with @DISEASE$ dominant CoRD or clathrin coat assembly in humans.	0
E168d2 epidermis development carry a frameshift mutation in the @GENE$ activation domain, Glu168del2, which is associated with @DISEASE$ dominant CoRD or clathrin coat assembly in humans.	0
E168d2 epidermis development carry a frameshift mutation in the positive regulation of transcription by RNA polymerase II activation domain, Glu168del2, which is associated with @DISEASE$ dominant CoRD or @GENE$ in humans.	0
We describe a previously unreported syndrome characterized by secondary (post-natal) @DISEASE$ with fronto-temporal @GENE$ hypoplasia, multiple pituitary hormone deficiency, seizures, severe visual impairment and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.	0
We also show expression of @GENE$ within the @DISEASE$ nervous system, including the hypothalamus, as well as the renal tract during human embryonic development.	0
The progressive neurological abnormalities, congenital @DISEASE$ and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of @GENE$ in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.	1
Recently a homozygous mutation, Gly372Ser, in the @GENE$ gene, was reported in an abstract form, in three sibs who suffered from intractable @DISEASE$ and developmental delay accompanied by 3-methylglutaconic aciduria.	0
Recently a homozygous mutation, Gly372Ser, in the @GENE$ gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and @DISEASE$ accompanied by 3-methylglutaconic aciduria.	1
Given the phenotypic similarity, we conclude that missense mutations in @GENE$ are likely manifesting by severe intellectual disability and @DISEASE$ accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.	0
Given the phenotypic similarity, we conclude that missense mutations in @GENE$ are likely manifesting by severe @DISEASE$ and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.	1
Biallelic mutations in the @GENE$ gene have been identified in one family with demyelinating Charcot-Marie-Tooth disease (CMT4B3) and two families with axonal @DISEASE$ and additional neurological and skeletal features.	1
Here we describe novel sequence variants in @GENE$ (c.1168C&gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal @DISEASE$, hearing loss, facial weakness and bulbar features.	1
Here we describe novel sequence variants in @GENE$ (c.1168C&gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, @DISEASE$, facial weakness and bulbar features.	0
Our findings suggest that @GENE$ mutations may cause a syndromic form of @DISEASE$ axonal neuropathy (AR-CMT2) in addition to CMT4B3	1
Having used a similar strategy for the in silico evaluation of 150 mutations of <i>CYP21A2</i>, the disease-causing gene in congenital @DISEASE$, we now provide a full structural explanation for the clinical severity of AME resulting from each known <i>@GENE$</i> missense mutation.	0
Metaplastic @DISEASE$ is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (@GENE$).	0
Here we show that regulation of mitochondrial membrane potential (@GENE$), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic @DISEASE$.	0
@GENE$<sup>fl/fl</sup>;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide cytokine production, histologically similar to human metaplastic @DISEASE$s.	0
regulation of mitochondrial membrane potential<sup>fl/fl</sup>;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide @GENE$, histologically similar to human metaplastic @DISEASE$s.	0
High expression of Chemokine receptor 4 (@GENE$) is important in @DISEASE$ invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).	1
We therefore studied the molecular characteristics of drug-resistant @GENE$-positive cells on epithelial-mesenchymal transition (cytokine production) for the future identification of the @DISEASE$ cells with the properties of both EMT and stemness.	1
We therefore studied the molecular characteristics of drug-resistant G protein-coupled receptor signaling pathway-positive cells on epithelial-mesenchymal transition (@GENE$) for the future identification of the @DISEASE$ cells with the properties of both EMT and stemness.	1
Elevated cytokines, such as interferon (@GENE$)-γ, interleukin (IL)-6 and @DISEASE$ necrosis factor α decreased to normal levels after splenectomy whereas IL-10 remained high.	0
Friedreich's @DISEASE$ (@GENE$) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN).	1
Recent studies indicated that the estrogen receptor beta (ERβ) could affect the progression of prostate and bladder tumors, however, its roles in the @DISEASE$ (@GENE$), remain to be elucidated.	0
Here, we demonstrate that transgenic targeting of @GENE$ to mitochondria confers significant protection from diet-induced @DISEASE$, insulin resistance, and adipose tissue inflammation.	0
@GENE$ gene mutations have been linked recently to @DISEASE$ mental retardation 13 (MRT13; MIM#613192) with only eight families reported world-wide.	1
Mutations in @GENE$ should be considered in non-syndromic @DISEASE$ intellectual disability with severe speech disorder	1
Mutations in @GENE$ should be considered in non-syndromic autosomal recessive @DISEASE$ with severe speech disorder	1
Rare forms of autosomal-dominant Charcot-Marie-Tooth disease (AD-CMT) may be associated with mutations in Fibulin-5 (@GENE$) as AD-CMT is genetically @DISEASE$.	1
The incidence of thyroid @DISEASE$ has increased the past few decades, the most frequent @GENE$ has been identified to be the papillary thyroid carcinoma (biological_process).	0
The incidence of thyroid @DISEASE$ has increased the past few decades, the most frequent muscle organ development has been identified to be the papillary thyroid carcinoma (@GENE$).	0
The incidence of thyroid cancer has increased the past few decades, the most frequent muscle organ development has been identified to be the @DISEASE$ (@GENE$).	0
Overexpression of @GENE$7 inhibited the proliferation and increased the radioiodine uptake ability of biological_process cells in vitro and inhibited the @DISEASE$ growth in vivo.	0
In conclusion, @GENE$7 may coenzyme A biosynthetic process as a @DISEASE$ suppressor in biological_process by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC	0
In conclusion, translational initiation7 may @GENE$ as a @DISEASE$ suppressor in biological_process by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC	0
In conclusion, translational initiation7 may coenzyme A biosynthetic process as a @DISEASE$ suppressor in @GENE$ by inhibiting the positive regulation of cell proliferation signaling pathway and may be a promising therapeutic target in patients with PTC	0
In conclusion, translational initiation7 may coenzyme A biosynthetic process as a @DISEASE$ suppressor in biological_process by inhibiting the @GENE$ signaling pathway and may be a promising therapeutic target in patients with PTC	1
The @DISEASE$ cells with immunoreactivity to CK7, CK19, Cam5.2, @GENE$, fatty acid beta-oxidation using acyl-CoA dehydrogenase, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	0
The @DISEASE$ cells with immunoreactivity to CK7, CK19, Cam5.2, biological_process, @GENE$, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	0
Sheldon-Hall syndrome (@GENE$) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive @DISEASE$.	1
Patients with @GENE$ present with @DISEASE$ of the limbs and a distinctive triangular facies with prominent nasolabial folds.	1
Patients with @GENE$ present with contractures of the limbs and a distinctive @DISEASE$ with prominent nasolabial folds.	1
@GENE$ plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, @DISEASE$ arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.	0
We report the case of a boy with a novel pathogenic @GENE$ mutation, presenting with the classical clinical features of SHS in association with unilateral carpal bone fusion and multiple @DISEASE$.	1
In a bone metastasis model, @GENE$ treated with ZOL+US had osteolytic lesions that were 58% smaller than those of ZOL-treated animals as well as a reduced skeletal @DISEASE$ burden.	0
Among these, heterozygous mutations in @GENE$, a homeobox gene encoding a transcription factor expressed specifically by oocyte and granulosa cells within the ovary, have been reported in ∼6% of women with @DISEASE$ POI.	0
Mutations in @GENE$ cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe @DISEASE$ (MC) and pontocerebellar hypoplasia syndrome.	1
We identified integrin α7 (@GENE$) as a major laminin receptor in GSCs and in primary high-grade @DISEASE$ specimens.	0
Analyses of mRNA profiles in comprehensive datasets revealed that high @GENE$ expression negatively correlated with survival of patients with both low- and high-grade @DISEASE$.	0
We also found that targeting of @GENE$ by RNAi or blocking mAbs impaired laminin-induced signaling, and it led to a significant delay in @DISEASE$ engraftment plus a strong reduction in tumor size and invasion.	0
Our data, therefore, highlight @GENE$ as a @DISEASE$ biomarker and candidate therapeutic target	0
These results demonstrate that Piccolo contributes to @DISEASE$ aggressiveness in ESCC, likely by stabilizing @GENE$ and promoting EGFR-dependent signaling.	1
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, @GENE$, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, @GENE$, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, @GENE$, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, @GENE$, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, @GENE$, positive regulation of transcription by RNA polymerase II, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, @GENE$, RAB3GAP1, double-strand break repair via homologous recombination, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, transcription initiation from RNA polymerase I promoter, activation of cysteine-type endopeptidase activity involved in apoptotic process, COL4A4, COL5A1, cellular response to starvation, biological_process, HGF, IL1A, IL1B, ILRN, protein processing involved in protein targeting to mitochondrion, ubiquitin-dependent protein catabolic process, positive regulation of transcription by RNA polymerase II, RAB3GAP1, @GENE$, RXRA, SLC4A11, response to superoxide, TF and VSX1.	0
In gene-level analyses, CDC25C, SCC1/RAD21, @GENE$, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and @GENE$ were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, @GENE$, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, @GENE$, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, @GENE$, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, @GENE$, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	1
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and @GENE$ were associated with high grade breast cancer risk, and gene silencing by miRNA and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and @GENE$ and response to radiation were associated with both.	0
In gene-level analyses, CDC25C, SCC1/RAD21, regulation of chromatin assembly or disassembly, and cellular response to DNA damage stimulus were associated (P &lt; 0.05) with overall breast @DISEASE$ risk, positive regulation of chromosome segregation, protein K11-linked ubiquitination, protein sumoylation, Ras protein signal transduction, mitotic spindle organization, and sensory perception of sound were associated with high grade breast cancer risk, and gene silencing by miRNA and @GENE$ were associated with both.	0
Some of the RP genes are also associated with other @DISEASE$, such as @GENE$ (Leber's congenital amaurosis) and CORD (cone-rod dystrophy).	0
The severe @DISEASE$ in this patient with progeroid features has not previously been described in other patients with MFS and @GENE$ mutations.	0
Also as pro-angiogenic inducer, the role of @GENE$ in different redox states has never been defined in @DISEASE$ angiogenesis.	0
@GENE$ orchestrates the key events of @DISEASE$ angiogenesis, migration of ECs and their induction to secrete negative regulation of transcription by RNA polymerase II, by adopting distinct redox states.	0
activation of innate immune response orchestrates the key events of @DISEASE$ angiogenesis, migration of ECs and their induction to secrete @GENE$, by adopting distinct redox states.	0
Together, our findings suggest that in CRC TIAM1 suppresses @DISEASE$ progression by regulating regulation of cell cycle/@GENE$ activity	0
A case with @GENE$ deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and @DISEASE$ hypotonia, posing diagnostic challenges.	0
The accuracy of this mouse model was emphasized by the finding that various @DISEASE$ nervous system and noncentral nervous system tissues from PD patients manifested similar GM1 deficiency as the @GENE$<sup>+/-</sup> mouse.	0
By 3 months, zonular fibers invariably ruptured and @GENE$ developed @DISEASE$, a hallmark of Marfan syndrome.	0
Downregulation of α-actinin-1 in E-@GENE$ expressing basal-like breast @DISEASE$ cells demonstrate that α-actinin-1-assembled actin fibers destabilize E-cadherin-based adhesions.	0
Taken together, these results indicate that increased α-actinin-1 expression destabilizes E-@GENE$-based adhesions, which is likely to promote the migratory potential of breast @DISEASE$ cells.	0
Pure hair and @GENE$ @DISEASE$ 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.	0
Pure hair and @GENE$ ectodermal dysplasia 9 (ECTD-9) is an @DISEASE$ genetic disease caused by mutation of anatomical structure morphogenesis and is characterized by hypotrichosis and nail dystrophy in humans.	0
Pure hair and natural killer cell activation involved in immune response @DISEASE$ 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of @GENE$ and is characterized by hypotrichosis and nail dystrophy in humans.	1
Pure hair and natural killer cell activation involved in immune response ectodermal dysplasia 9 (ECTD-9) is an @DISEASE$ genetic disease caused by mutation of @GENE$ and is characterized by hypotrichosis and nail dystrophy in humans.	1
Unlike patients with ECTD-9, @GENE$-mutated mice and attachment of GPI anchor to protein do not faithfully recapitulate the phenotype of @DISEASE$, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.	1
Unlike patients with ECTD-9, anatomical structure morphogenesis-mutated mice and @GENE$ do not faithfully recapitulate the phenotype of @DISEASE$, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.	0
Context Multiple endocrine @DISEASE$ muscle organ development 1 (@GENE$) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	1
Context Multiple endocrine neoplasia @GENE$ 1 (negative regulation of transcription by RNA polymerase II) is an autosomal dominant disease caused by mutations in the @DISEASE$ suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	0
When her brother was found to harbor the same @GENE$ mutation as our proband and, around the same time, their father was diagnosed with a neuroendocrine carcinoma, this @DISEASE$ was investigated for the MEN1 mutation as well.	1
In the histologic biopsy of this @DISEASE$, the same @GENE$ mutation was detected as previously found in his children.	1
Based on the array data, we concluded that the deletion was limited to the @GENE$ gene and that the father had both germline and @DISEASE$ for MEN1.	0
Conclusions To our knowledge, this is the first reported family with combined germline and @DISEASE$ for @GENE$.	0
Three affected individuals from a small Bedouin @GENE$ presented with @DISEASE$, hyponatremic dehydration and hyperkalemia with isolated sweat salt wasting.	1
Three affected individuals from a small Bedouin @GENE$ presented with failure to thrive, hyponatremic dehydration and @DISEASE$ with isolated sweat salt wasting.	0
Various genes (eg, SPG7, SYNE1, @GENE$) traditionally rooted in either the @DISEASE$ or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one positive regulation of protein phosphorylation of the disease continuum and hereditary spastic paraplegia on the other.	1
Various genes (eg, SPG7, SYNE1, glycerophospholipid catabolic process) traditionally rooted in either the @DISEASE$ or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one @GENE$ of the disease continuum and hereditary spastic paraplegia on the other.	0
Other genes such as @GENE$ and anterograde neuronal dense core vesicle transport were almost simultaneously published as both a hereditary spastic paraplegia and an @DISEASE$ gene.	1
However, the exact compounds of areca @GENE$ causing oral @DISEASE$ remain unproven.	0
We found that @GENE$ regulates TP53 expression from NOTCH1 knockdown oral @DISEASE$ cells.	1
Gain‑of‑function CTTNB1 mutations are detected in bladder @DISEASE$, colorectal cancer, gastric cancer, liver cancer, lung cancer, pancreatic cancer, prostate cancer and uterine cancer, whereas loss‑of‑function @GENE$ mutations are also detected in human cancer.	1
Eradicating H. pylori and HCV is the optimal approach for the first‑line prevention of gastric @DISEASE$ and hepatocellular carcinoma (@GENE$), respectively.	0
Eradicating H. pylori and HCV is the optimal approach for the first‑line prevention of gastric cancer and @DISEASE$ (@GENE$), respectively.	0
However, β‑catenin inhibitors may be applicable for the prevention of organ fibrosis, second‑line @GENE$ prevention and treating β‑catenin‑driven @DISEASE$.	0
@GENE$-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with @DISEASE$, developmental delay, and non-specific epilepsy.	1
@GENE$-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, @DISEASE$, and non-specific epilepsy.	1
@GENE$-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific @DISEASE$.	1
The trichorhinophalangeal syndrome is a rare genetic syndrome with characteristic craniofacial and @DISEASE$ including @GENE$ pathology in variable manifestation.	0
Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (@GENE$) and genes from the ETS transcription factor family, most commonly ERG and positive regulation of transcription by RNA polymerase II, result in alteration that responsible for oncogenic activity in prostate @DISEASE$ (PC).	0
Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (proteolysis) and genes from the ETS transcription factor family, most commonly ERG and @GENE$, result in alteration that responsible for oncogenic activity in prostate @DISEASE$ (PC).	0
Furthermore, cardiovascular risk factors such hyperthyroidism, @DISEASE$ and redox homeostasis have been identified to modulate @GENE$ driven gene regulatory networks.	0
We provide herein a state-of-the-@GENE$ review of the genetic bases of @DISEASE$, our current understanding of the genetic regulatory networks involved in AF and its plausible usage for searching novel therapeutic targets	0
The @DISEASE$ was afterwards identified as a dMMR melanoma for an exclusive loss of @GENE$ expression on IHC (Figure 1).	1
We describe a female proband with primordial dwarfism, skeletal dysplasia, @DISEASE$, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in @GENE$, predicted to affect two of the three protein products of the gene.	1
Biallelic loss-of-function mutations in the RNA-binding protein @GENE$ cause Richieri-Costa-Pereira syndrome (RCPS), an @DISEASE$ condition mainly characterized by craniofacial and limb malformations.	1
@GENE$ haploinsufficient embryos presented altered mandibular process fusion and @DISEASE$, thus recapitulating the most penetrant phenotypes of the syndrome.	1
Salivary gland @DISEASE$ (@GENE$) is a rare tumor muscle organ development, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.	0
Salivary gland tumor (@GENE$) is a rare tumor muscle organ development, which exhibits broad-spectrum phenotypic, biological, and clinical @DISEASE$.	0
Salivary gland tumor (ubiquitin-dependent ERAD pathway) is a rare tumor @GENE$, which exhibits broad-spectrum phenotypic, biological, and clinical @DISEASE$.	0
We have deleted two major @DISEASE$ suppressors, @GENE$, a negative regulator of the PI3K pathway, and transforming growth factor beta receptor signaling pathway, the central signaling mediator of TGFβ pathway, in the murine salivary gland.	1
We have deleted two major @DISEASE$ suppressors, negative regulation of protein phosphorylation, a negative regulator of the PI3K pathway, and @GENE$, the central signaling mediator of TGFβ pathway, in the murine salivary gland.	1
Our results have shown that deletion of either negative regulation of protein phosphorylation or @GENE$ in murine salivary gland resulted in pleomorphic adenomas, the most common @DISEASE$ in human SGT patients.	1
We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar @DISEASE$ @GENE$ 2 (negative regulation of receptor internalization), and 20 healthy individuals.	0
We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar @DISEASE$ muscle organ development 2 (@GENE$), and 20 healthy individuals.	1
We investigated the possible association between chemoresistance and cellular redox state regulation in patients undergoing neoadjuvant chemotherapy (@GENE$) for breast @DISEASE$.	0
In total, 53 women with primarily inoperable or inflammatory breast @DISEASE$ who were treated with @GENE$ were included in the study.	0
Pre-NACT core needle biopsies and postoperative @DISEASE$ samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (@GENE$), and peroxiredoxin I (response to oxidative stress I).	0
Pre-NACT core needle biopsies and postoperative @DISEASE$ samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (response to radiation), and peroxiredoxin I (@GENE$ I).	0
Higher pre-NACT nuclear @GENE$ I expression predicted smaller size of a resected @DISEASE$ (<i>p</i> = 0.00052; <i>r</i> = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated positive regulation of cysteine-type endopeptidase activity involved in apoptotic process metastasis (<i>p</i> = 0.0024; <i>r</i> = -0.472).	0
Higher pre-NACT nuclear response to oxidative stress I expression predicted smaller size of a resected @DISEASE$ (<i>p</i> = 0.00052; <i>r</i> = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated @GENE$ metastasis (<i>p</i> = 0.0024; <i>r</i> = -0.472).	1
This study was undertaken to investigate the prevalence of sequence variants in @GENE$ in patients with Leber congenital amaurosis (clathrin coat assembly), early-onset @DISEASE$ (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	0
This study was undertaken to investigate the prevalence of sequence variants in @GENE$ in patients with Leber congenital amaurosis (clathrin coat assembly), early-onset retinal dystrophy (EORD), and @DISEASE$ retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	1
This study was undertaken to investigate the prevalence of sequence variants in photoreceptor cell maintenance in patients with Leber congenital amaurosis (@GENE$), early-onset @DISEASE$ (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	0
In this review we discuss recent advances in our knowledge of the MPC, and we argue that it may offer a promising target in diseases like @DISEASE$ and @GENE$ 2 diabetes.	0
The study was carried out to explore the risk stratification of the poor prognosis for patients underwent surgical treatment.60 patients diagnosed with @DISEASE$ were primarily enrolled in the study from @GENE$ 2008 to April 2016.	0
Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, @DISEASE$ size and site, histology, and @GENE$ status were retrospectively analyzed, and intracellular signal transduction was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.2 ± 8.6 months.	1
Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, @DISEASE$ size and site, histology, and positive regulation of gene expression status were retrospectively analyzed, and @GENE$ was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.2 ± 8.6 months.	0
Cox multifactor regression analysis revealed that age, histology and @GENE$ status had significant prognostic effect on event-free survival (intracellular signal transduction) rate for @DISEASE$ patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment	0
Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (@GENE$) are severe hereditary diseases that causes @DISEASE$ in infants and children.	0
Disease associated @GENE$ mutations have been associated with motor and sensory dysfunctions as well as non-syndromic @DISEASE$ in humans.	1
Individuals with biallelic @GENE$ or ubiquitin-dependent protein catabolic process mutations have a high risk of embryonal @DISEASE$s, and here we show that their cells display severe cAMP biosynthetic process impairment.	1
Individuals with biallelic mitotic spindle assembly checkpoint or @GENE$ mutations have a high risk of embryonal @DISEASE$s, and here we show that their cells display severe cAMP biosynthetic process impairment.	1
Individuals with biallelic mitotic spindle assembly checkpoint or ubiquitin-dependent protein catabolic process mutations have a high risk of embryonal @DISEASE$s, and here we show that their cells display severe @GENE$ impairment.	0
MVA due to biallelic CEP57 mutations, or of unknown cause, is not associated with embryonal @DISEASE$s and cells from these individuals show minimal @GENE$ deficiency.	0
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, LPGAT1, @GENE$, muscle organ development, ZNF860‑CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, LPGAT1, endocytic recycling, @GENE$, ZNF860‑CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860‑CACNA1D, @GENE$, double-strand break repair via nonhomologous end joining, biological_process) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860‑CACNA1D, cell adhesion, @GENE$, biological_process) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860‑CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, @GENE$) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, ubiquitin-dependent protein catabolic process, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, LPGAT1, endocytic recycling, muscle organ development, ZNF860‑CACNA1D, cell adhesion, double-strand break repair via nonhomologous end joining, biological_process) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, @GENE$, LOC105375015) for hyper‑LDL‑cholesterolemia.	0
We identified a new susceptibility locus for bladder @DISEASE$ at 5q12.3, located in the intron of @GENE$ (rs2042329), that was significantly associated with disease risk (OR = 1.40; P = 4.61 × 10(-11)).	0
These expanded roles underscore the significance of vertebrate @GENE$ proteins as factors contributing to a number of diseases, including neural tube defects, @DISEASE$ metastases, and various genetic syndromes characterized by abnormal migratory cell behaviors	0
Several recent studies applied targeted genome enrichment (@GENE$) and massively parallel sequencing (MPS) to simultaneously screen a large negative regulation of transcription, DNA-templated of known @DISEASE$ (HL) genes.	0
Several recent studies applied targeted genome enrichment (peptide cross-linking) and massively parallel sequencing (MPS) to simultaneously screen a large @GENE$ of known @DISEASE$ (HL) genes.	0
To evaluate the effectiveness of TGE and MPS on screening @DISEASE$ NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in @GENE$, MT-RNR1, and regulation of pH genes.	0
To evaluate the effectiveness of TGE and MPS on screening @DISEASE$ NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in gap junction-mediated intercellular transport, MT-RNR1, and @GENE$ genes.	0
We report ten new patients from eight unrelated kindreds with @GENE$ @DISEASE$.	0
In conclusion, we did not observe a clear genotype-phenotype correlation in patients with @GENE$ @DISEASE$, suggesting additional factors mediating phenotypic heterogeneity.	0
In conclusion, we did not observe a clear genotype-phenotype correlation in patients with @GENE$ nephropathy, suggesting additional factors mediating phenotypic @DISEASE$.	0
Our data provide <i>in vivo</i> evidence that <i>L2hgdh</i> mutation leads to L-2-HG accumulation, @DISEASE$, and neurodegeneration in @GENE$, thereby offering new insights into the pathophysiology of L-2-HGA in humans	0
The @GENE$ variation p.Pro108Thr, located in the T-box domain, was identified in a patient with @DISEASE$, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	0
The @GENE$ variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with @DISEASE$ and psychomotor delay.	1
The @GENE$ variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of positive regulation of transcription, DNA-templated (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and @DISEASE$.	0
The cell-cell signaling variation p.Pro108Thr, located in the T-box domain, was identified in a patient with @DISEASE$, an exon-intron boundary variation of @GENE$ (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	0
Oxidative stress, which is induced by reactive oxygen species (regulation of cell growth), causes cellular @GENE$ which contributes to the pathogenesis of @DISEASE$.	0
First, we tested whether the pretreatment of <i>Momordica charantia</i> ethanol extract (MCEE) attenuates H₂O₂-induced cell death in human @DISEASE$ @GENE$-N-MC cells.	0
In the present study, our results indicated that @GENE$ expression was significantly downregulated in phosphatidylinositol phosphorylation and was associated with @DISEASE$ size, differentiation and metastasis.	0
In the present study, our results indicated that proteasome-mediated ubiquitin-dependent protein catabolic process expression was significantly downregulated in @GENE$ and was associated with @DISEASE$ size, differentiation and metastasis.	0
We describe five affected individuals with similar @DISEASE$, and three of them had either complete situs inversus, dextrocardia, or transposition of the @GENE$ arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous limb morphogenesis.	0
We describe five affected individuals with similar @DISEASE$, and three of them had either complete situs inversus, dextrocardia, or transposition of the G protein-coupled receptor signaling pathway arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous @GENE$.	0
We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, @DISEASE$, or transposition of the G protein-coupled receptor signaling pathway arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous @GENE$.	1
We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the G protein-coupled receptor signaling pathway arteries; similar @DISEASE$ were previously identified in a mouse mutant for the orthologous @GENE$.	1
Patients with mutations in @GENE$ all present with @DISEASE$ to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID	0
Patients with mutations in @GENE$ all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild @DISEASE$, suggesting that ZNF711 mutations cause non-syndromic ID	1
Our study confirms linkage of a variant clinical form of hair-@GENE$ @DISEASE$ to chromosome 12 without any mutation in the coding sequences of the epidermis development gene.	0
Our study confirms linkage of a variant clinical form of hair-natural killer cell activation involved in immune response @DISEASE$ to chromosome 12 without any mutation in the coding sequences of the @GENE$ gene.	1
The expression of uncarboxylated @GENE$ (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)‑13, collagen muscle organ development X, collagen type II, @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II)‑α and interleukin (IL)‑1β were detected by ELISA, immunohistochemistry, reverse transcription‑quantitative polymerase chain reaction and western blotting.	0
The expression of uncarboxylated cartilage condensation (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)‑13, collagen muscle organ development X, collagen type II, @DISEASE$ necrosis factor (@GENE$)‑α and interleukin (IL)‑1β were detected by ELISA, immunohistochemistry, reverse transcription‑quantitative polymerase chain reaction and western blotting.	0
MicroRNA-9 (miR-9) dysregulation is implicated in a variety of human malignancies including @DISEASE$ (@GENE$), but its role remains contradictory.	0
In this study, we explored the expression and methylation status of miR-9 in @GENE$ samples, as well as the @DISEASE$-related functions of miR-9 in vitro.	0
Our study suggests that miR-9 functions as a @DISEASE$ suppressor in @GENE$ progression by inhibiting a series of target genes, including the newly validated miR-9/IGF2BP1/AKT&amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.	0
Atypical teratoid/rhabdoid @DISEASE$ (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic @GENE$ (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.	0
Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic @GENE$ (SCCOHT) represent the most commonly recognized SWI/SNF-driven @DISEASE$.	0
Approximately one-third of pediatric malignant rhabdoid @DISEASE$ are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, @GENE$s 1 and 2, respectively).	0
Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely @GENE$) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid @DISEASE$ predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).	0
However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic @DISEASE$ including a subset of familial schwannomatosis (linked to @GENE$) and multiple meningiomas (linked to nucleosome disassembly) as well as others.	1
However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to @GENE$) and multiple @DISEASE$ (linked to nucleosome disassembly) as well as others.	0
We found that hypermethylation of @GENE$ and reduced gene expression was prevalent in several types of human @DISEASE$s.	0
The tumorigenesis and metastasis of @DISEASE$ are associated with human collagen triple helix repeats containing 1 (@GENE$).	1
This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated @DISEASE$: DYT-TOR1A, DYT-@GENE$, DYT-GCH1, and DYT-GNAL	1
We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to @GENE$, age, bile acid metabolic process, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, @DISEASE$, smoking status, and preoperative albumin &lt;3.5 mg/dL.	0
We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to multicellular organism development, age, @GENE$, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, @DISEASE$, smoking status, and preoperative albumin &lt;3.5 mg/dL.	0
Myotonic dystrophy @GENE$ 2 (DM2) is a progressive multisystem disease with muscle weakness and @DISEASE$ as main characteristics.	1
BACKGROUND The present study explored the expression of coiled-coil domain-containing 34 (@GENE$) in cervical @DISEASE$ (CC) and its prognostic value.	0
MATERIAL AND METHODS GEPIA and Oncomine @DISEASE$ databases were mined to predict the @GENE$ differential expression level between a CC group and a normal group.	0
RESULTS Both GEPIA and Oncomine @DISEASE$ databases mining results revealed that @GENE$ was more highly expressed in the CC group than in the normal group (all P&lt;0.05).	0
CONCLUSIONS High expression of @GENE$ is an independent unfavorable prognostic parameter for OS and DFS of CC patients, which was strongly associated with @DISEASE$ angiogenesis	0
Over the past decade, the genetic basis of several forms of @DISEASE$ @GENE$ cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).	1
Over the past decade, the genetic basis of several forms of @DISEASE$ quaternary ammonium group transport cases has been solved with the identification of four causative genes (@GENE$, regulation of transcription by RNA polymerase II, regulation of somitogenesis and mesoderm development).	1
Over the past decade, the genetic basis of several forms of @DISEASE$ quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, @GENE$, regulation of somitogenesis and mesoderm development).	1
Over the past decade, the genetic basis of several forms of @DISEASE$ quaternary ammonium group transport cases has been solved with the identification of four causative genes (skeletal system development, regulation of transcription by RNA polymerase II, @GENE$ and mesoderm development).	1
Corneal changes in aniridia-related keratopathy (@GENE$) include peripheral pannus and epithelial abnormalities, which eventually result in corneal opacity and contribute to @DISEASE$.	0
The @DISEASE$ of positive regulation of transcription, DNA-templated+/- epidermis development provide an excellent model for the corneal changes seen in @GENE$+/- humans.	1
The @DISEASE$ of @GENE$+/- epidermis development provide an excellent model for the corneal changes seen in positive regulation of transcription, DNA-templated+/- humans.	1
The @DISEASE$ of positive regulation of transcription, DNA-templated+/- @GENE$ provide an excellent model for the corneal changes seen in positive regulation of transcription, DNA-templated+/- humans.	0
Great progress has been achieved in the study of the role of TGF-β signaling in triggering epithelial-mesenchymal transition (@GENE$) in a variety of cancers; however, the regulation of TGF-β signaling during EMT in mammary @DISEASE$ metastasis has not been completely defined.	1
In the present study, we demonstrated that @GENE$, a zinc finger transcription factor, inhibits TGF-β signaling-induced cytokine production in mouse and human mammary @DISEASE$ cells, as well as in mouse tumor models.	0
In the present study, we demonstrated that positive regulation of gene expression, a zinc finger transcription factor, inhibits TGF-β signaling-induced @GENE$ in mouse and human mammary @DISEASE$ cells, as well as in mouse tumor models.	1
Data from the Oncomine databases indicated a strong negative relationship between @GENE$ expression and breast @DISEASE$ progression.	0
The modulation of these molecular processes may represent a strategy for inhibiting breast @DISEASE$ invasion by restoring @GENE$ expression	0
In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type @GENE$ to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain @DISEASE$.	0
Here we demonstrate that the prostate @DISEASE$ cell lines LNCaP and LAPC4 display markedly different sensitivity to docetaxel with AR activation, and RNA-seq analysis of these cell lines identified @GENE$ (lysine-specific demethylase 5D) encoded on the Y chromosome as a potential mediator of this sensitivity.	0
Melanogenesis genes tyrosinase, tyrosinase-related protein 1, Hermansky-Pudlak Syndrome 3, premelanosome protein and dopachrome tautomerase were upregulated, as was the melanogenesis-controlling transcription factor, @DISEASE$-associated transcription factor (@GENE$).	1
Although @GENE$ immunoreactivity was almost absent in neurons containing @DISEASE$, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques.	0
The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (@GENE$), @DISEASE$ necrosis factor alpha-induced protein 3 (response to molecule of bacterial origin), TNFAIP3-interacting protein 1 (glycoprotein biosynthetic process) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.	0
The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (regulation of tumor necrosis factor-mediated signaling pathway), @DISEASE$ necrosis factor alpha-induced protein 3 (response to molecule of bacterial origin), TNFAIP3-interacting protein 1 (@GENE$) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.	0
Differentiated embryo chondrocyte expressed gene 1 (@GENE$), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human @DISEASE$ and is associated with malignant tumor progression.	0
As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of @GENE$ expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with @DISEASE$.	0
@GENE$ expression was also compared with the apoptosis index determined by TdT‑mediated dUTP nick ending‑labeling assay in recurrent @DISEASE$s.	0
The anti@DISEASE$ effect of TMZ in establishment of mitotic spindle orientation epidermis development xenografts with @GENE$ expression was examined in vivo.	0
In patients with recurrent @DISEASE$, there was a negative correlation between @GENE$ expression and the apoptotic index.	0
Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different @DISEASE$ entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (@GENE$), and pulmonary chondroma.	1
Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), @DISEASE$ (@GENE$), and pulmonary chondroma.	1
Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (@GENE$), and @DISEASE$.	0
Another disease that shares two of the @DISEASE$ components of CT, namely GIST and @GENE$ is the Carney-Stratakis syndrome (CSS) or dyad.	1
There is only partial overlap between the two conditions (there are a few patients with CT that have @GENE$ subunit mutations) but both lead to increased methylation of the entire genome in the @DISEASE$s associated with them.	0
Other @DISEASE$s (outside CT and CSS) that have @GENE$ deficiency are associated with increased methylation of the entire genome, but only in CT there is site-specific methylation of the SDHC gene.	0
Indeed, patients with @GENE$ mutations were shown to suffer @DISEASE$ and kidney development-like diabetes.	0
Indeed, patients with L-phenylalanine catabolic process mutations were shown to suffer @DISEASE$ and @GENE$-like diabetes.	0
Mutations in @GENE$ were shown to cause @DISEASE$, seizures and intellectual disability.	1
Mutations in @GENE$ were shown to cause hypomagnesemia, seizures and @DISEASE$.	1
In 2009, four families with a distal duplication of Xq28 not including @GENE$ and mediated by low-copy repeats (LCRs) designated &quot;K&quot; and &quot;L&quot; were reported with @DISEASE$ and epilepsy.	1
In 2009, four families with a distal duplication of Xq28 not including @GENE$ and mediated by low-copy repeats (LCRs) designated &quot;K&quot; and &quot;L&quot; were reported with intellectual disability and @DISEASE$.	1
histone H2A monoubiquitination immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal @DISEASE$s with classic morphology (20 @GENE$-NUTM2, 5 posttranscriptional regulation of gene expression-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.	0
histone H2A monoubiquitination immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal @DISEASE$s with classic morphology (20 MAPK cascade-NUTM2, 5 @GENE$-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.	0
Strong diffuse nuclear @GENE$ staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal @DISEASE$s and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.	0
Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic @GENE$-NUTM2 high-grade endometrial stromal @DISEASE$s and the 3 unusual high-grade endometrial stromal sarcomas which prompted superoxide metabolic process studies confirming YWHAE rearrangement in 2 tumors.	0
Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted @GENE$ studies confirming YWHAE rearrangement in 2 @DISEASE$.	0
Diffuse @GENE$ staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged @DISEASE$.	0
No @GENE$ staining was seen in the remaining low-grade endometrial stromal @DISEASE$s, endometrial stromal nodules, leiomyosarcomas, or any of the leiomyomas.	0
BCOR immunohistochemical staining is a highly sensitive marker for @GENE$-NUTM2 high-grade endometrial stromal @DISEASE$ with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication	0
Furthermore, @GENE$ expression is altered in skeletal muscle of classical congenital @DISEASE$ mouse models.	0
@GENE$ levels were up-regulated in dystrophin deficient mdx muscle, which correlates with the elevated levels of the α7β1 integrin observed in mdx muscle and Duchenne @DISEASE$ patients.	0
Two pairwise genetic interactions (B cell lymphocyte kinase (@GENE$) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ @DISEASE$ necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	0
Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (@GENE$) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ @DISEASE$ necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	0
Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (@GENE$)/ @DISEASE$ necrosis factor receptor superfamily member 14 (T cell costimulation) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	1
Two pairwise genetic interactions (B cell lymphocyte kinase (peptidyl-tyrosine phosphorylation) rs13277113,B cell scaffold protein with ankyrin repeats 1 (B cell activation) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (proteolysis)/ @DISEASE$ necrosis factor receptor superfamily member 14 (@GENE$) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	0
The @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II) family ligand ectodysplasin A (@GENE$) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.	0
Inactivating mutations in Eda or Edar cause hypohidrotic @DISEASE$ (@GENE$), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.	1
@GENE$ has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in @DISEASE$ (response to hydroperoxide) remained to be elusive.	0
transforming growth factor beta receptor signaling pathway has recently been identified as a @DISEASE$ suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (@GENE$) remained to be elusive.	0
Hereditary sensory and autonomic neuropathies (HSAN) @GENE$ II are characterized by @DISEASE$ inheritance, onset at birth and self-mutilating behavior.	1
Tubulin alpha 8 (@GENE$) is highly abundant in murine liver tumors suggesting a role in @DISEASE$ (phosphatidylinositol phosphorylation).	0
Tubulin alpha 8 (biological_process) is highly abundant in murine liver @DISEASE$ suggesting a role in hepatocellular carcinoma (@GENE$).	0
Tubulin alpha 8 (biological_process) is highly abundant in murine liver tumors suggesting a role in @DISEASE$ (@GENE$).	0
Bardet-Biedl syndrome (@GENE$) is an autosomal recessive disorder characterized by @DISEASE$ obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	0
Bardet-Biedl syndrome (@GENE$) is an autosomal recessive disorder characterized by central @DISEASE$, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	1
Our results indicate that @GENE$ in Japan is genetically @DISEASE$ and at least partly shares genetic features with BBS in other countries.	0
The review then discusses the diseases associated with @GENE$‑2, including degeneration of the retina, Sjögren's syndrome, age‑related cataracts, degeneration of the testes, @DISEASE$, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	0
The review then discusses the diseases associated with @GENE$‑2, including degeneration of the retina, Sjögren's syndrome, age‑related cataracts, degeneration of the testes, azoospermia, lung @DISEASE$, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	0
The review then discusses the diseases associated with @GENE$‑2, including degeneration of the retina, Sjögren's syndrome, age‑related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, @DISEASE$ and diabetes mellitus.	1
The increased levels of @GENE$ and Glycogen synthase kinase 3 subunit α (GSK3α) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), @DISEASE$ nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.	0
The increased levels of protein transport and Glycogen synthase kinase 3 subunit α (GSK3α) genes in contrast with reduced levels of B-cell translocation gene 1 (@GENE$), human leukocyte antigen nervous system development (HLA-DRB1), @DISEASE$ nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.	0
The increased levels of protein transport and Glycogen synthase kinase 3 subunit α (GSK3α) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen @GENE$ (HLA-DRB1), @DISEASE$ nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.	0
The increased levels of protein transport and Glycogen synthase kinase 3 subunit α (GSK3α) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), @DISEASE$ nuclear ribonucleoprotein A3 (@GENE$), and serine/arginine-rich splicing factor 1 (alternative mRNA splicing, via spliceosome) genes have also been reported.	0
The increased levels of protein transport and Glycogen synthase kinase 3 subunit α (GSK3α) genes in contrast with reduced levels of B-cell translocation gene 1 (negative regulation of cell proliferation), human leukocyte antigen nervous system development (HLA-DRB1), @DISEASE$ nuclear ribonucleoprotein A3 (mRNA splicing, via spliceosome), and serine/arginine-rich splicing factor 1 (@GENE$) genes have also been reported.	0
However, what kind of role @GENE$ plays in colorectal @DISEASE$ (CRC) remains unknown.	0
To examine the pathomechanisms of early craniofacial and @DISEASE$, we analyzed @GENE$ with an MLII patient mutation that mimic the clinical and biochemical symptoms of MLII patients.	0
These results reveal a mechanism of @GENE$ regulation and NADPH homeostasis in response to oxidative stress that impacts cell proliferation and @DISEASE$ growth	0
The aberrant glucose metabolism is one of the hallmarks of @DISEASE$ cells, and as a branch of glucose metabolism, hexosamine biosynthesis pathway (@GENE$) has been reported to play a critical role in the insulin resistance and progression of cancer.	0
Glutamine:fructose-6-phosphate amidotransferase (@GENE$) is the rate-limiting enzyme of the proteolysis; nevertheless, the prognostic value of GFAT1 in pancreatic @DISEASE$ remains elusive.	0
Glutamine:fructose-6-phosphate amidotransferase (circadian regulation of gene expression) is the rate-limiting enzyme of the @GENE$; nevertheless, the prognostic value of GFAT1 in pancreatic @DISEASE$ remains elusive.	0
In this study, we found that the expression of @GENE$ was increased in pancreatic cancer samples compared to peri-@DISEASE$ tissues.	0
@GENE$ was identified as an independent prognosticator for OS, and combining GFAT1 expression with pTNM stage generated a predictive nomogram, which showed better prognostic efficiency for OS in patients with pancreatic @DISEASE$.	0
In summary, high @GENE$ expression is identified as an independent predictor of adverse clinical outcome in our small number of pancreatic @DISEASE$ patients, and the practical prognostic nomogram model may help clinicians in decision making and the design of clinical studies	0
There was a significantly higher expression level of @GENE$ in the @DISEASE$ than in the adjacent normal tissue (0.0052 ± 0.0021 vs 0.0027 ± 0.0018, P &lt; 0.001).	1
Patients with genotype AA were found to have remarkably higher @GENE$ expression in the @DISEASE$ than those with genotype CC (P = 0.01).	1
The search for clinically relevant molecular markers in classical Hodgkin lymphoma (@GENE$) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-regulation of transcription, DNA-templated) cells with an abundant and @DISEASE$ microenvironment.	0
The search for clinically relevant molecular markers in classical Hodgkin lymphoma (eye development) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-@GENE$) cells with an abundant and @DISEASE$ microenvironment.	1
We reinforce the potential of @GENE$ as an interesting target to be explored in adult and pediatric cHL, and alert for its dual biological role in H-RS cells and @DISEASE$ microenvironment	0
BACKGROUND The aim of this study was to investigate the prognostic relevance of @GENE$ in lung @DISEASE$ (LC).	0
Among the available genomic studies, the key findings in Africa were variants in @GENE$ (P193H), regulation of histone methylation 677TT, and MTHFR 1298CC that were associated with @DISEASE$, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	1
Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), @GENE$ 677TT, and MTHFR 1298CC that were associated with @DISEASE$, ventricular septal defect (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	0
Among the available genomic studies, the key findings in Africa were variants in positive regulation of transcription, DNA-templated (P193H), @GENE$ 677TT, and MTHFR 1298CC that were associated with atrial septal defect, @DISEASE$ (VSD), Tetralogy of Fallot (negative regulation of transcription by RNA polymerase II), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	0
Kruppel-like factor 9 (@GENE$), a transcription factor, is critical for the inhibition of growth and development of @DISEASE$, whereas its effects in pancreatic cancer remains unclear.	0
Kruppel-like factor 9 (@GENE$), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic @DISEASE$ remains unclear.	0
The levels of @GENE$ expression in adjacent tissues and pancreatic @DISEASE$ tissues were detected using immunohistochemistry.	0
Using flow cytometric analysis and @GENE$-8, we evaluated the effects of cellular response to cortisol stimulus expression on cell apoptosis, the cell cycle and proliferation of pancreatic @DISEASE$ cells.	0
Using flow cytometric analysis and neuron migration-8, we evaluated the effects of @GENE$ expression on cell apoptosis, the cell cycle and proliferation of pancreatic @DISEASE$ cells.	0
Our results revealed that in both tissue samples and cell lines (particularly in BxPC-3 and PANC-1 cells) of pancreatic @DISEASE$, @GENE$ exhibited relatively lower expression.	0
In PANC-1 and BxPC-3 cells, @GENE$ overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the S phase, and inhibited the migration and invasion of @DISEASE$ cells.	0
As in MOPDII patients, disruption of pericentrin (@GENE$) in mice caused a number of abnormalities including @DISEASE$, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.	1
In order to determine the role of @GENE$ during carcinogenesis, @DISEASE$ (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) epidermis development by intradermal injection of 3-methylcholanthrene (MCA).	0
In order to determine the role of multicellular organism development during carcinogenesis, @DISEASE$ (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) @GENE$ by intradermal injection of 3-methylcholanthrene (MCA).	0
@GENE$ was highly expressed in human negative regulation of peptidase activity biopsies particularly by the invading cells at the @DISEASE$ edge.	0
multicellular organism development was highly expressed in human @GENE$ biopsies particularly by the invading cells at the @DISEASE$ edge.	0
In contrast @GENE$+/- epidermis development had significantly smaller @DISEASE$s that were less invasive.	0
Intradermal injection of multicellular organism development neutralizing antibodies during @GENE$ initiation and progression significantly reduced the size of the @DISEASE$s and, in vitro, decreased cellular sphere formation and invasion.	0
Analysis of the @DISEASE$s from the multicellular organism development overexpressing @GENE$ showed reduced caspase I and annexin V expression suggesting Flii may negatively regulate apoptosis within these tumors.	0
These studies therefore suggest that @GENE$ enhances negative regulation of peptidase activity @DISEASE$ progression by decreasing apoptosis and enhancing tumor cell invasion.	0
Since @GENE$-associated limb-girdle muscle organ development actin filament organization was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of @DISEASE$, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	0
Since synaptic transmission, cholinergic-associated limb-girdle @GENE$ actin filament organization was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of @DISEASE$, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	0
Since synaptic transmission, cholinergic-associated limb-girdle muscle organ development @GENE$ was only manifested in dADP phosphorylation homozygous variant carriers, the disease phenotype was of @DISEASE$, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	0
Mutations in both proteins cause lens @DISEASE$ and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of biological_process (@GENE$) and CP49 (visual perception) in the lens.	1
Mutations in both proteins cause lens @DISEASE$ and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of biological_process (biological_process) and CP49 (@GENE$) in the lens.	1
Mutations in both proteins cause lens @DISEASE$ and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of @GENE$ (biological_process) and CP49 (visual perception) in the lens.	1
With the first filensin (@GENE$) mutation now having been reported to cause a recessive @DISEASE$ phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.	1
Remarkably, our results also show that antioxidants [such as N-acetyl cysteine (@GENE$)] can effectively reverse or prevent ethanol-induced oxidative stress in @DISEASE$-associated fibroblasts, suggesting a novel strategy for cancer prevention.	1
Chemotherapy and radiation not only trigger @DISEASE$ cell apoptosis but also cellular protein catabolic process stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory pheno@GENE$ (SASP) characterized by chronic secretion of diverse soluble factors.	0
DNA @GENE$ causes negative regulation of nitric oxide mediated signal transduction expression by engaging peripheral nervous system development-κB and C/EBP, while paracrine SPINK1 promotes @DISEASE$ cell aggressiveness particularly chemoresistance.	0
DNA cellular protein catabolic process causes negative regulation of nitric oxide mediated signal transduction expression by engaging @GENE$-κB and C/EBP, while paracrine SPINK1 promotes @DISEASE$ cell aggressiveness particularly chemoresistance.	0
Strikingly, SPINK1 reprograms the expression profile of @DISEASE$ cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by @GENE$ signaling but hitherto rarely reported for a SASP factor.	1
Cytochrome P450 3A5 (@GENE$) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes @DISEASE$ cells to these drugs.	0
Activating mutations in the @GENE$ or positive regulation of cell proliferation receptor tyrosine kinases are hallmarks of gastrointestinal stromal @DISEASE$ (GIST).	1
Activating mutations in the activation of MAPK activity or @GENE$ receptor tyrosine kinases are hallmarks of gastrointestinal stromal @DISEASE$ (GIST).	1
Inactivating NF1 mutations were present in 46% of @DISEASE$ expressing wild-type @GENE$ and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2.	1
The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, @DISEASE$, and characteristic @GENE$-hyperintense lesions on MRI brain.	0
A growing body of clinical literature emphasizes the @GENE$ of @DISEASE$ in early brain injury following aneurysmal subarachnoid hemorrhage (sphingosine biosynthetic process).	0
A growing body of clinical literature emphasizes the negative regulation of transcription by RNA polymerase II of @DISEASE$ in early brain injury following aneurysmal subarachnoid hemorrhage (@GENE$).	0
Although @DISEASE$ is not a universal feature of @GENE$, it portends a poor clinical course, with quantitative analysis revealing a direct correlation between cerebral edema and poor outcome, including mortality and cognitive deficits.	0
Here, we review these cellular and molecular mechanisms of global @DISEASE$ formation in @GENE$.	0
Given the importance of @DISEASE$ to the outcome of patients with @GENE$ and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease	1
Given the importance of edema to the outcome of patients with @GENE$ and its status as a highly modifiable pathological process, a better understanding of @DISEASE$ in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease	0
Here, we tested the @GENE$ protein-coding exons in 510 @DISEASE$ signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.	0
Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 @DISEASE$ @GENE$ patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.	0
Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 @DISEASE$ signal transduction patients in whom @GENE$, RNA splicing, regulation of transcription, DNA-templated, and negative regulation of protein phosphorylation genes were screened before.	0
Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 @DISEASE$ signal transduction patients in whom response to superoxide, RNA splicing, @GENE$, and negative regulation of protein phosphorylation genes were screened before.	0
Here, we tested the positive regulation of microtubule polymerization protein-coding exons in 510 @DISEASE$ signal transduction patients in whom response to superoxide, RNA splicing, regulation of transcription, DNA-templated, and @GENE$ genes were screened before.	0
Our results suggested that variants in DCTN1 are not common risk factors for Chinese @DISEASE$ @GENE$ and that the frequency of variants of unknown significance in the cohort study was 0.39%	0
Subsequent mutation analyses identified @DISEASE$-associated calcium signal transducer 2 (@GENE$; former name, M1S1) as the gene responsible for GDLD.	0
This in silico study suggests that in @DISEASE$ multiforme, karyotypic changes have the potential to cause multiple abnormalities in @GENE$s of genes involved in phosphoinositide metabolism and this may be important for understanding drug resistance and phosphoinositide pathway redundancy in the advanced disease state.	0
BACKGROUND The distribution of fat @GENE$ and @DISEASE$-associated gene (FTO) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.	0
RESULTS Body cell adhesion mediated by integrin, body mass index (BMI), waist circumference (WC), negative regulation of signal transduction circumference (HC), waist-hip ratio (WHR), SBP, @GENE$, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the @DISEASE$ group compared with controls.	0
It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung @DISEASE$ (NSCLC), and associated with @GENE$ degradation in NSCLC cell lines.	1
However, the relationship of @GENE$ to prognosis or negative regulation of transcription by RNA polymerase II expression in @DISEASE$ has not been well clarified.	0
However, the relationship of DNA damage response, signal transduction by p53 class mediator to prognosis or @GENE$ expression in @DISEASE$ has not been well clarified.	0
The present study was designed to investigate the prognostic significance of @GENE$ and/or negative regulation of transcription by RNA polymerase II expression in @DISEASE$ using immunohistochemistry with a tissue microarray.	0
The present study was designed to investigate the prognostic significance of DNA damage response, signal transduction by p53 class mediator and/or @GENE$ expression in @DISEASE$ using immunohistochemistry with a tissue microarray.	0
We examined 184 @DISEASE$s and observed low expression of @GENE$ in adenocarcinoma in situ (oxidation-reduction process) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.	0
We demonstrated that <i>linc-ADAL</i> interacts with @DISEASE$ nuclear ribonucleoprotein U (hnRNPU) and insulin-like growth factor 2 mRNA binding protein 2 (@GENE$) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis	0
JAK2V617F(+) myeloproliferative @DISEASE$ (@GENE$s) frequently progress into leukemias, but the fcoenzyme A biosynthetic processors driving this process are not understood.	0
myocilin (MYOC), optineurin (OPTN), @GENE$ and neurotrophin-4 (NTF4) in primary open angle @DISEASE$ (POAG) and xenobiotic metabolic process and supramolecular fiber organization in congenital and developmental glaucomas.	1
myocilin (MYOC), optineurin (OPTN), rRNA processing and neurotrophin-4 (NTF4) in primary open angle @DISEASE$ (POAG) and @GENE$ and supramolecular fiber organization in congenital and developmental glaucomas.	1
We found previously that the candidate @DISEASE$ suppressor ion transmembrane transport is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and @GENE$.	1
Oculopharyngeal muscular dystrophy (@GENE$) is an autosomal dominant, late-onset muscle disorder characterized by @DISEASE$, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles.	1
Oculopharyngeal muscular dystrophy (@GENE$) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, @DISEASE$, proximal limb weakness and nuclear aggregates in skeletal muscles.	1
A variant in @GENE$ (rs210138) was positively associated with peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis @DISEASE$ (OR [95% CI]: 3.31 [1.89, 5.79]).	0
Mutations in @GENE$ cause premature ageing and liver @DISEASE$ in humans and epidermis development; thus, defective DPC repair has great clinical ramifications.	1
MAX which was involved in small cell lung @DISEASE$ pathway was a mRNA splicing, via spliceosome gene unique to T2D (OR=1.2, P=0.006) but not in @GENE$.	0
MAX which was involved in small cell lung @DISEASE$ pathway was a @GENE$ gene unique to T2D (OR=1.2, P=0.006) but not in apoptotic DNA fragmentation.	0
We hypothesized that de novo mutations (@GENE$s) in synaptic genes explain an important fraction of @DISEASE$ NSID cases.	0
Sequencing these four genes in 50 additional @DISEASE$ cases of NSID identified a second endocytosis in @GENE$ (c.1679_1681dup/p.Ser560dup).	0
Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with @GENE$, led to the identification of 16 heterozygous variants in kidney development (growth regulation by estrogen in breast @DISEASE$ 1-like), a gene reported as a target of retinoic acid signaling.	0
Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with rRNA processing, led to the identification of 16 heterozygous variants in @GENE$ (growth regulation by estrogen in breast @DISEASE$ 1-like), a gene reported as a target of retinoic acid signaling.	0
One upregulated candidate named transmembrane protein 98 (@GENE$) was found to be overexpressed in 80 of 118 (67.80%) of patients with @DISEASE$.	0
@GENE$ mRNA in tumor tissues was significantly higher than nontumor tissues of patients with @DISEASE$ (P &lt; 0.0001).	0
Upregulation of @GENE$ was significantly correlated with advanced @DISEASE$ stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.	0
Importantly, upregulation of negative regulation of myelination mRNA in patients with @DISEASE$ who received transarterial chemoembolization (@GENE$) treatment was significantly higher than in patients without TACE treatment (P = 0.046).	0
In vitro and in vivo studies showed that suppression of @GENE$ in chemoresistant @DISEASE$ cells restored their chemosensitivity, while forced overexpression of TMEM98 enhanced their chemoresistance.	0
The mechanism of @GENE$ in conferring chemoresistance of @DISEASE$ might be possibly through activation of the AKT pathway and deactivation of p53.	0
Human @DISEASE$ osteopetrosis (@GENE$), also known as infantile malignant osteopetrosis, is a rare genetic bone disorder that often causes death.	1
Alpha-1-antitrypsin deficiency (@GENE$D) is an inherited disease characterized by @DISEASE$ and liver disease.	1
This study aims to determine the association between @GENE$ (rs4415084 C&gt;T), positive regulation of cell proliferation (rs2981582 C&gt;T) and cellular response to mechanical stimulus (rs889312 A&gt;C) gene polymorphisms and breast @DISEASE$, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.	0
This study aims to determine the association between activation of MAPK activity (rs4415084 C&gt;T), positive regulation of cell proliferation (rs2981582 C&gt;T) and @GENE$ (rs889312 A&gt;C) gene polymorphisms and breast @DISEASE$, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.	1
The Random Forest algorithm selected @GENE$, MAP3K1 and age as important breast @DISEASE$ predictors.	1
<i>In vivo</i> tumorigenic studies confirmed that @GENE$-612 overexpression retarded the growth of A375 xenograft @DISEASE$, which was coupled with a decline in the percentage of regulation of proteasomal protein catabolic process-67-positive proliferating cells.	0
Homozygous @GENE$ mutations cause a syndrome of 46,XX disorder of sexual development (DSD), @DISEASE$ (PPK), and predisposition to squamous cell carcinoma.	1
Both have PPK and @DISEASE$ and carried a novel homozygous mutation c.332G&gt;A (p.Cys111Tyr) located in the highly conserved @GENE$-like cysteine-rich domain-2 (regulation of DNA-binding transcription factor activity-CRD2).	0
Both have PPK and @DISEASE$ and carried a novel homozygous mutation c.332G&gt;A (p.Cys111Tyr) located in the highly conserved signal peptide processing-like cysteine-rich domain-2 (@GENE$-CRD2).	0
Two additional mutations linked to different forms of @DISEASE$ were identified in two families: a known frameshift deletion in @GENE$, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in embryo development ending in birth or egg hatching associated with Late-Onset Retinal Degeneration.	1
Two additional mutations linked to different forms of @DISEASE$ were identified in two families: a known frameshift deletion in visual perception, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in @GENE$ associated with Late-Onset Retinal Degeneration.	1
We analyzed commonly reported European and Asian @DISEASE$-related gene variants in a Mexican-Mestizo population through each single nucleotide polymorphism (SNP) and a genetic risk score (@GENE$) based on 23 selected SNPs.	0
We report associations for 6 out of 23 SNPs and for the @GENE$, which confer @DISEASE$ risk, a novel finding for Mexican-Mestizo physically active population.	0
The revision was based on data accumulated since the 2008 WHO classification of @GENE$, much of which relates to new molecular genetic information about these @DISEASE$.	0
In gastrointestinal @DISEASE$, @GENE$ plays an oncogenic role through DNA demethylation.	0
However, the role of @GENE$ in the prognosis of human @DISEASE$ prognosis remains unclear.	0
In this research, we discovered that @GENE$ was significantly increased in @DISEASE$ tissues in contrast to normal brain tissues (NBTs; P &lt; 0.05).	0
In an in vitro experiment, @GENE$ can promote the proliferation, migration, and invasion of @DISEASE$ cells and inhibit cell apoptosis by activating positive regulation of protein phosphorylation-angiogenesis pathway.	0
In an in vitro experiment, negative regulation of transcription by RNA polymerase II can promote the proliferation, migration, and invasion of @DISEASE$ cells and inhibit cell apoptosis by activating @GENE$-angiogenesis pathway.	0
In A549 lung @DISEASE$ cells, which endogenously express CXCR1, the depletion of @GENE$ and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.	0
In A549 lung @DISEASE$ cells, which endogenously express CXCR1, the depletion of biological_process and @GENE$ significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.	0
In A549 lung @DISEASE$ cells, which endogenously express CXCR1, the depletion of biological_process and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating @GENE$-stimulated angiogenesis phosphorylation, actin polymerization and the expression of genes related to metastasis.	0
In A549 lung @DISEASE$ cells, which endogenously express CXCR1, the depletion of biological_process and detection of light stimulus involved in visual perception significantly reduced growth and invasion by downregulating response to molecule of bacterial origin-stimulated @GENE$ phosphorylation, actin polymerization and the expression of genes related to metastasis.	0
Hypohidrotic @DISEASE$ (@GENE$) results from mutation of the positive regulation of NF-kappaB transcription factor activity, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.	1
Hypohidrotic @DISEASE$ (positive regulation of NF-kappaB transcription factor activity) results from mutation of the @GENE$, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.	1
No other novel mutation or this deletion was detected in @GENE$ in a second DDD family and a @DISEASE$ DDD case by Sanger Sequencing.	0
Defects of @GENE$, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital @DISEASE$ deafness, balance defects and blindness.	0
Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated @DISEASE$, @GENE$ and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	1
Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, @GENE$ and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and @DISEASE$.	0
We report here two new nonsense mutations (pGln12* and pTyr110*) in <i>@GENE$</i> patients displaying nonsyndromic @DISEASE$ hearing loss, with no evidence of vestibular or retinal dysfunction.	0
Also, the generated <i>@GENE$</i><sup>-/-</sup> epidermis development display an early onset profound @DISEASE$ and have normal balance and retinal functions.	1
Also, the generated <i>@GENE$</i><sup>-/-</sup> epidermis development display an early onset @DISEASE$ deafness and have normal balance and retinal functions.	0
Also, the generated <i>positive regulation of cytosolic calcium ion concentration</i><sup>-/-</sup> @GENE$ display an early onset profound @DISEASE$ and have normal balance and retinal functions.	0
This essential role of @GENE$ in mechanotransduction and cell survival that, we show, is restricted to the cochlea, probably accounts for the presence in <i>CIB2</i><sup>-/-</sup> mice and <i>CIB2</i> patients, unlike in Usher syndrome, of isolated @DISEASE$ without balance and vision deficits	1
Sonic hedgehog (@GENE$) signaling is an important promotor of desmoplasia, a critical feature in pancreatic @DISEASE$ stromal reactions involving the activation of pancreatic stellate cells (PSCs).	1
The present study investigated the association between Gremlin 1 and @GENE$, and the effect of Gremlin 1 in pancreatic @DISEASE$.	1
Primary human PSCs and pancreatic @DISEASE$ cell lines were exposed to @GENE$, cyclopamine, osteoblast differentiation family zinc finger-1 (Gli-1) small interfering RNA (siRNA), and Gremlin 1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.	1
In summary, for the first time, we generated a @GENE$ knockout zebrafish line with auditory disorder and @DISEASE$ which mimicked the symptoms of patients, and revealed that disruption of fibronectin assembly may be one of the factors underlying RP.	0
The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in @GENE$, characterized by muscle-restricted mtDNA deletions and chronic progressive external @DISEASE$ (CPEO) plus syndrome.	0
Cilia play essential roles in normal human development and health; cilia dysfunction results in diseases such as primary @DISEASE$ (@GENE$).	1
We present the native 3D structures of normal and @GENE$-causing RSPH1-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the @DISEASE$ secondary defects in RSPH1-mutant cilia.	0
Our data provide evidence for structural and functional @DISEASE$ in radial spokes, suggest a mechanism for the milder RSPH1 @GENE$ phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.	0
Biallelic mutations in the @GENE$ gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, @DISEASE$, and sideroblastic anemia 2 (MLASA2), a muscle organ development of mitochondrial disease.	1
Biallelic mutations in the tRNA aminoacylation gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, @DISEASE$, and sideroblastic anemia 2 (MLASA2), a @GENE$ of mitochondrial disease.	0
We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, @DISEASE$, learning and visual-@GENE$ difficulties, relative microcephaly, long interstrand cross-link repair, stellate iris pattern, and periorbital fullness.	0
We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, @DISEASE$, learning and visual-multicellular organism development difficulties, relative microcephaly, long @GENE$, stellate iris pattern, and periorbital fullness.	0
We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-@GENE$ difficulties, relative @DISEASE$, long interstrand cross-link repair, stellate iris pattern, and periorbital fullness.	0
We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-multicellular organism development difficulties, relative @DISEASE$, long @GENE$, stellate iris pattern, and periorbital fullness.	1
PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and @DISEASE$) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the α-β-hydrolase domain-containing 12 gene (@GENE$).	1
PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive @DISEASE$ caused by mutations in the α-β-hydrolase domain-containing 12 gene (@GENE$).	0
The DNA @GENE$ checkpoints provide an anti-@DISEASE$ barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (positive regulation of transcription elongation from RNA polymerase II promoter).	0
The DNA @GENE$ checkpoints provide an anti-cancer barrier in diverse @DISEASE$ types, however this concept has remained unexplored in prostate cancer (positive regulation of transcription elongation from RNA polymerase II promoter).	0
The DNA cellular protein catabolic process checkpoints provide an anti-@DISEASE$ barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (@GENE$).	0
The DNA cellular protein catabolic process checkpoints provide an anti-cancer barrier in diverse @DISEASE$ types, however this concept has remained unexplored in prostate cancer (@GENE$).	0
Furthermore, targeting DNA repair defects by @GENE$ inhibitors (PARPi) as a @DISEASE$ treatnegative regulation of phosphatase activityt strategy is emerging yet requires suitable predictive biomarkers.	0
Furthermore, targeting DNA repair defects by protein ADP-ribosylation inhibitors (PARPi) as a @DISEASE$ treat@GENE$t strategy is emerging yet requires suitable predictive biomarkers.	0
To address these issues, we performed immunohistochemical analysis of multiple markers of DNA @GENE$ signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial @DISEASE$ to positive regulation of transcription elongation from RNA polymerase II promoter, complenegative regulation of phosphatase activityted by genetic analyses of TMPRSS2-ERG rearrangement and regulation of cellular amino acid metabolic process, an anti-oxidant factor and p53 protector.	0
To address these issues, we performed immunohistochemical analysis of multiple markers of DNA cellular protein catabolic process signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial @DISEASE$ to positive regulation of transcription elongation from RNA polymerase II promoter, complenegative regulation of phosphatase activityted by genetic analyses of TMPRSS2-ERG rearrangement and @GENE$, an anti-oxidant factor and p53 protector.	0
To address these issues, we performed immunohistochemical analysis of multiple markers of DNA cellular protein catabolic process signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial @DISEASE$ to positive regulation of transcription elongation from RNA polymerase II promoter, comple@GENE$ted by genetic analyses of TMPRSS2-ERG rearrangement and regulation of cellular amino acid metabolic process, an anti-oxidant factor and p53 protector.	0
The DNA damage checkpoint barrier (γH2AX, p@GENE$, p53) mechanism was activated during positive regulation of transcription elongation from RNA polymerase II promoter tumorigenesis, albeit less and with delayed culmination compared to other @DISEASE$s, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.	1
The DNA damage checkpoint barrier (γH2AX, pprotein phosphorylation, p53) mechanism was activated during @GENE$ tumorigenesis, albeit less and with delayed culmination compared to other @DISEASE$s, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.	0
@GENE$ genotypes of 390 men did not indicate predisposition to positive regulation of transcription elongation from RNA polymerase II promoter, yet loss of NQO1 in CaP suggested potential progression-opposing @DISEASE$ suppressor role.	0
regulation of cellular amino acid metabolic process genotypes of 390 men did not indicate predisposition to @GENE$, yet loss of NQO1 in CaP suggested potential progression-opposing @DISEASE$ suppressor role.	0
TMPRSS2-ERG rearrange@GENE$t and negative regulation of protein phosphorylation loss, events sensitizing to PARPi, occurred frequently along with @DISEASE$ loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in positive regulation of transcription elongation from RNA polymerase II promoter) whose defects may cause resistance to PARPi.	0
TMPRSS2-ERG rearrangenegative regulation of phosphatase activityt and @GENE$ loss, events sensitizing to PARPi, occurred frequently along with @DISEASE$ loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in positive regulation of transcription elongation from RNA polymerase II promoter) whose defects may cause resistance to PARPi.	0
TMPRSS2-ERG rearrangenegative regulation of phosphatase activityt and negative regulation of protein phosphorylation loss, events sensitizing to PARPi, occurred frequently along with @DISEASE$ loss of DNA repair factors 53BP1, JMJD1C and negative regulation of transcription by RNA polymerase II (all studied here for the first time in @GENE$) whose defects may cause resistance to PARPi.	0
These results imply that PPI might be modulated by four genotypes - @GENE$ rs4680 (primarily in males), glutamate receptor signaling pathway rs1027599, TCF4 rs9960767, and positive regulation of cell death rs385440 - indicating a role of these gene variations in the development of early information processing deficits in @DISEASE$.	1
These results imply that PPI might be modulated by four genotypes - catecholamine catabolic process rs4680 (primarily in males), glutamate receptor signaling pathway rs1027599, TCF4 rs9960767, and @GENE$ rs385440 - indicating a role of these gene variations in the development of early information processing deficits in @DISEASE$.	1
BRCT-repeat inhibitor of hTERT expression (@GENE$) is involved in the invasion of @DISEASE$.	0
Here, we hypothesize that repression of transcriptional activity of forkhead box O1 (@GENE$) via histone deacetylase inhibitors (HDACi) ameliorates @DISEASE$ in T2DM rats	0
Here, we report that biallelic mutations in @GENE$, mitotic chromosome condensation, or mitotic chromosome condensation, encoding subunits of these complexes, cause @DISEASE$.	0
Here, we report that biallelic mutations in mitotic chromosome condensation, @GENE$, or mitotic chromosome condensation, encoding subunits of these complexes, cause @DISEASE$.	0
Here, we show that high levels of the actin cytoskeleton-associated protein @GENE$ (WASP-interacting protein) correlates with @DISEASE$ growth, both of which are linked to the tumor-initiating cell phenotype.	1
We @GENE$ that WIP controls @DISEASE$ growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.	0
Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of @GENE$ KO epidermis development, the mouse model of the most common inherited @DISEASE$, fragile X syndrome (FXS).	1
Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of regulation of alternative mRNA splicing, via spliceosome KO @GENE$, the mouse model of the most common inherited @DISEASE$, fragile X syndrome (FXS).	0
We found that the impaired homeostatic synaptic downscaling in @GENE$ KO neurons is caused by loss-of-function dephosphorylation of an @DISEASE$-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2.	1
Ellis-van Creveld (@GENE$) syndrome is a rare autosomal recessive disorder characterized by @DISEASE$, polydactyly, and achondroplasia.	1
Ellis-van Creveld (@GENE$) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, @DISEASE$, and achondroplasia.	1
This is, to our knowledge, a most severe phenotype of @GENE$ syndrome, illustrating that the specific pattern of EVC2 compound heterozygous mutations may cause severe @DISEASE$ and intestinal malfunction.	0
Moreover, we show that over-expression of prostaglandin biosynthetic process dramatically decreases hepatic @DISEASE$ through increased autophagy in hepatocytes of HFD-fed @GENE$.	0
Humans who carry @GENE$ mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, @DISEASE$, renal hypoplasia, and renal interstitial fibrosis.	1
Humans who carry @GENE$ mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, @DISEASE$, and renal interstitial fibrosis.	1
Humans who carry @GENE$ mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and @DISEASE$.	0
Phaeochromocytoma and @DISEASE$ (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 @GENE$ million.	0
Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare @DISEASE$ with an estimated annual incidence of 3 @GENE$ million.	0
Mutations in 18 genes that encode components of @GENE$-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, @DISEASE$, congenital malformations and mild dysmorphic features.	0
Since the original description of the @GENE$-related @DISEASE$, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	1
Since the original description of the @GENE$-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural @DISEASE$, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	1
Since the original description of the @GENE$-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, @DISEASE$ syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	1
Here, we report on a female Danish patient with a novel homozygous @GENE$ mutation, p.Gly874Arg, who presented at birth with bilateral negative regulation of signal transduction dislocation and @DISEASE$.	1
Here, we report on a female Danish patient with a novel homozygous tRNA aminoacylation for protein translation mutation, p.Gly874Arg, who presented at birth with bilateral @GENE$ dislocation and @DISEASE$.	0
At 3 months, additional dysmorphic features were noted and at 18 months her radiographic @DISEASE$ were suggestive of an underlying spondyloepimetaphyseal dysplasia (@GENE$).	1
Autosomal recessive CMT cases are generally characterized by earlier onset, usually before the age of 2 or 3 years, and rapid clinical progression that results in severe poly@DISEASE$ and more marked distal limb deformities such as @GENE$ equino-varus, claw-like hands, and often major spinal deformities.	0
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as @GENE$, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, @GENE$, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, @GENE$, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, @GENE$, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, @GENE$, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and @GENE$, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, @GENE$, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, @GENE$, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, @GENE$ and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and @GENE$ in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, @GENE$, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, @GENE$, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, @GENE$, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, @GENE$, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, @GENE$, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, @GENE$, neurofilament bundle assembly, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, @GENE$, regulation of protein phosphorylation and protein targeting to mitochondrion in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as mitochondrial fission, phosphatidylinositol dephosphorylation, myelination, DNA damage response, signal transduction by p53 class mediator, EGR2, SH3TC2, response to oxidative stress, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, purine ribonucleotide catabolic process, GDAP1, protein polyubiquitination, neurofilament bundle assembly, regulation of protein phosphorylation and @GENE$ in axonal forms (ARCMT2).	0
Alterations in <i>MEK1/2</i> occur in @DISEASE$s, both in the treatment-naïve state and following targeted therapies, most notably @GENE$ and MEK inhibitors in <i>BRAF</i>-V600E-mutant melanoma and colorectal cancer.	1
This work highlights the importance of classifying mutations based on structural and phenotypic consequences, both in terms of pathway signaling output and response to pharmacologic inhibition.<b>Implications:</b> This study suggests that alternate modes of target inhibition, such as @GENE$ inhibition, will be required to effectively treat @DISEASE$ harboring these MEK1/2-resistant alleles.	0
We recently demonstrated that @GENE$ is upregulated in @DISEASE$ and its inhibition by a small-molecule, tenovin-1, inhibits cell proliferation and clonogenic survival of melanoma cells, possibly via activating p53.	0
Here, we employed a gel free quantitative proteomics approach to identify the downstream effectors and targets of @GENE$ in @DISEASE$.	0
The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of @GENE$ resulted in a downregulation of attachment of spindle microtubules to kinetochore, regulation of sister chromatid cohesion and ubiquitin-dependent protein catabolic process in multiple @DISEASE$ cell lines.	0
The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of negative regulation of transcription by RNA polymerase II resulted in a downregulation of attachment of spindle microtubules to kinetochore, @GENE$ and ubiquitin-dependent protein catabolic process in multiple @DISEASE$ cell lines.	0
The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of negative regulation of transcription by RNA polymerase II resulted in a downregulation of attachment of spindle microtubules to kinetochore, regulation of sister chromatid cohesion and @GENE$ in multiple @DISEASE$ cell lines.	0
The objective of this study was to investigate the safety and the tolerability of combined cellular immunotherapy with low-dose cyclophosphamide (@GENE$) in patients with advanced solid @DISEASE$.	0
We successfully showed that the combination of immune cell therapy and @GENE$ was safe, might induce @DISEASE$-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with RNF43-positive advanced solid tumors	0
Our results confirm two previous reports indicating that loss of function of a single allele of @GENE$ causes @DISEASE$.	1
Although anti-myelin-associated glycoprotein (@GENE$) antibody @DISEASE$ is reported as a slowly progressive disease, it can lead to significant disability and impairment of health-related quality of life (HR-QoL) and social participation.	1
The aim of this cross-sectional study was to evaluate the functioning and HR-QoL determinants in 67 patients with anti-@GENE$ @DISEASE$ in terms of the International Classification of Functioning, Disability, and Health (ICF).	1
Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and @GENE$-QoL in anti-transcription-coupled nucleotide-excision repair @DISEASE$ patients	0
Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and regulation of transcription, DNA-templated-QoL in anti-@GENE$ @DISEASE$ patients	1
Associations with TN breast @DISEASE$ were confirmed for 10 loci (@GENE$, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).	0
Associations with TN breast @DISEASE$ were confirmed for 10 loci (positive regulation of Wnt signaling pathway, @GENE$, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).	0
Associations with TN breast @DISEASE$ were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, @GENE$, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).	1
Associations with TN breast @DISEASE$ were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, @GENE$, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, mitotic cytokinesis, RAD51L1-rs2588809, MKL1).	0
Associations with TN breast @DISEASE$ were confirmed for 10 loci (positive regulation of Wnt signaling pathway, negative regulation of transcription by RNA polymerase II, proteolysis, 2q35, 2p24.1, TERT-rs10069690, ESR1, regulation of apoptotic process, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: protein import into peroxisome matrix, translocation, 2q24.1, 2q31.1, spermatogenesis, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, @GENE$, RAD51L1-rs2588809, MKL1).	1
The downstream pathways of @GENE$-Foxh1 play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in @DISEASE$ as well as the primary developmental defect of the AHF.	1
DNA samples from eight families with @DISEASE$ retinal dystrophies were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by @GENE$ markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.	0
However, Pdha1<sup>f/Y;</sup> Cnp<sup>Cre/+</sup> @GENE$ showed reduced fiber density and signs of @DISEASE$ in both sciatic and optic nerves from 6 months of age.	0
Disabling mutations in the @GENE$ gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately @DISEASE$, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.	1
Disabling mutations in the @GENE$ gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and @DISEASE$, and in a number of cases, mild mental retardation.	1
Disabling mutations in the @GENE$ gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, @DISEASE$ mental retardation.	0
Two recent studies unveiled new potential functions of @GENE$, in particular, its involvement in the regulation of the formation and function of invadopodia and podosomes, which are cellular structures devoted to degradation of the extracellular matrix in @DISEASE$ and endothelial cells.	0
Moreover, we found @GENE$ expression correlated with several clinicopathological features, including @DISEASE$ size, lymph node metastasis, and the TNM stage.	0
By analyzing public data sets of gene expression in human breast @DISEASE$s we observed that increased levels of transcripts encoding the planar cell polarity (@GENE$) proteins cell proliferation and Wnt signaling pathway, planar cell polarity pathway correlate with increased risk of patient relapse.	0
By analyzing public data sets of gene expression in human breast @DISEASE$s we observed that increased levels of transcripts encoding the planar cell polarity (biological_process) proteins @GENE$ and Wnt signaling pathway, planar cell polarity pathway correlate with increased risk of patient relapse.	0
By analyzing public data sets of gene expression in human breast @DISEASE$s we observed that increased levels of transcripts encoding the planar cell polarity (biological_process) proteins cell proliferation and @GENE$ correlate with increased risk of patient relapse.	1
We investigated the effects of shRNA-mediated knockdown of @GENE$ and cell proliferation in vitro, and found that reducing NOS1AP and SCRIB slows breast @DISEASE$ cell migration and prevents the establishment of leading-trailing polarity.	0
We investigated the effects of shRNA-mediated knockdown of postsynaptic actin cytoskeleton organization and @GENE$ in vitro, and found that reducing NOS1AP and SCRIB slows breast @DISEASE$ cell migration and prevents the establishment of leading-trailing polarity.	0
The @DISEASE$-node-metastasis (@GENE$) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon cancer (eCC).	0
The tumor-node-metastasis (@GENE$) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon @DISEASE$ (eCC).	0
The aims of the present study were to evaluate the relation of dysregulated @GENE$, c-apoptotic process, and positive regulation of DNA binding-H1 expression with the histopathological features of @DISEASE$s in recurrence formation in eCC cases.	0
The aims of the present study were to evaluate the relation of dysregulated positive regulation of transcription by RNA polymerase II, c-@GENE$, and positive regulation of DNA binding-H1 expression with the histopathological features of @DISEASE$s in recurrence formation in eCC cases.	0
The aims of the present study were to evaluate the relation of dysregulated positive regulation of transcription by RNA polymerase II, c-apoptotic process, and @GENE$-H1 expression with the histopathological features of @DISEASE$s in recurrence formation in eCC cases.	1
The relationship between the altered expression of @GENE$, c-apoptotic process, and positive regulation of DNA binding-negative regulation of cell migration and pathological microenvironmental features, including the presence of @DISEASE$ budding and desmoplasia, were assessed.	0
The relationship between the altered expression of positive regulation of transcription by RNA polymerase II, c-apoptotic process, and positive regulation of DNA binding-@GENE$ and pathological microenvironmental features, including the presence of @DISEASE$ budding and desmoplasia, were assessed.	0
In addition, the coexistence of high positive regulation of transcription by RNA polymerase II and low @GENE$-H1 expression and @DISEASE$ budding was associated with short OS (p &lt; 0.001).	1
We suggest that the combination of reduced NM23-@GENE$, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may somatic diversification of immunoglobulins the stratification of patients with stage II colon @DISEASE$ for adjuvant chemotherapy	0
We suggest that the combination of reduced NM23-negative regulation of cell migration, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may @GENE$ the stratification of patients with stage II colon @DISEASE$ for adjuvant chemotherapy	0
The purpose of this study was to explore the use of iterative decomposition of water and fat with echo asymmetry and least-squares estimation Carr-Purcell-Meiboom-Gill (IDEAL-CPMG) to simultaneously measure skeletal muscle apparent fat fraction and water T<sub>2</sub> (T<sub>2,w</sub>) in patients with Duchenne @DISEASE$ (@GENE$).	1
In summary, the regulatory role of @GENE$ deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for @DISEASE$, brain tumors, and life-threatening infections in the CNS.	0
In summary, the regulatory role of @GENE$ deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain @DISEASE$, and life-threatening infections in the CNS.	0
Hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by @GENE$ or auditory stimuli, producing @DISEASE$ and apnea episodes.	0
Patients carrying homozygous @GENE$ mutations have more frequent fractures while heterozygous carriers of the mutation in WNT1 gene are also found to have early onset @DISEASE$.	1
Hemangioblastomas (HBs) are uncommon @DISEASE$ characterized by the presence of inactivating alterations in the von Hippel-Lindau (@GENE$) gene in inherited cases and by infrequent somatic mutation in sporadic entities.	1
Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (@GENE$) gene in inherited cases and by infrequent @DISEASE$ in sporadic entities.	0
Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (@GENE$) gene in inherited cases and by infrequent somatic mutation in @DISEASE$ entities.	1
Genes harboring the most significant mutations include PCDH9, KLHL12, @GENE$, and protein ubiquitination in @DISEASE$ HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.	0
Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and @GENE$ in @DISEASE$ HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.	1
Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in @DISEASE$ HBs, and @GENE$, DLG2, RIMS1, cell adhesion, and killing of cells of other organism in familial HBs.	0
Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in @DISEASE$ HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, @GENE$, and killing of cells of other organism in familial HBs.	0
Genes harboring the most significant mutations include PCDH9, KLHL12, biological_process, and protein ubiquitination in @DISEASE$ HBs, and regulation of transcription by RNA polymerase II, DLG2, RIMS1, cell adhesion, and @GENE$ in familial HBs.	0
Five genes, including @GENE$, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.	0
Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, @GENE$, proteolysis, and WWOX, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.	0
Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, @GENE$, and WWOX, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including transmembrane transport, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.	0
Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including @GENE$, CWC27, and muscle organ development, have CNVs in the five patients with familial HBs.	0
Five genes, including sensory perception of sound, G protein-coupled receptor signaling pathway, keratinocyte differentiation, proteolysis, and WWOX, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including transmembrane transport, CWC27, and @GENE$, have CNVs in the five patients with familial HBs.	0
In our cohort of 27 subjects with @DISEASE$, both karyotype analysis and Fluorescence in situ hybridization (@GENE$) were performed.	0
Functional assays revealed that ectopic expression of @GENE$-144-5p and miR-144-3p significantly blocked the malignant abilities of LUSQ cells, eg, @DISEASE$ cell proliferation, migration, and invasion.	0
@GENE$ is a RNA methyltransferase that has been shown to be implicated in development of human @DISEASE$.	1
However, the functional role of @GENE$, mechanism of NSUN2 overexpression and its association with clinicopathologic features in breast @DISEASE$ remain unclear.	1
Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage (P=0.027), @DISEASE$ classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&lt;0.001), progesterone receptor (P=0.001), and @GENE$-67 (P&lt;0.001).	0
Our findings provide a unique insight into the roles and effects of @GENE$ overexpression in breast @DISEASE$ cells, and highlight the necessity of the investigation of novel therapeutic targets, such as NSUN2, for the improvement of breast cancer treatments	1
Here we present a novel @GENE$(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-@DISEASE$ polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.	0
Here we present a novel @GENE$(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial @DISEASE$, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.	1
The @DISEASE$ test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of @GENE$ C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of MTRR A66G polymorphism.	0
In @GENE$ of more and more evidence point to the importance of Kindlin family members in normal development and human diseases especially in @DISEASE$s, we aim to portrait the profile of Kindlins in the regulation of embryonic development and cancer progression.	0
Overall, this first report of a germline molecular defect in @GENE$ unveils the key role of SP-A1 in the occurrence of several chronic respiratory diseases, ranging from severe respiratory insufficiency occurring early in life to the association of lung fibrosis and @DISEASE$ in adult patients.	0
Recently mutations in the @GENE$/CNTN1 complex have been associated with similar severe phenotypes and central nervous system myelination gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset @DISEASE$ multiplex congenita in four unrelated families.	1
Recently mutations in the @GENE$/CNTN1 complex have been associated with similar severe phenotypes and central nervous system myelination gene mutations, causing loss of the CASPR protein, were shown to cause severe, @DISEASE$ arthrogryposis multiplex congenita in four unrelated families.	0
Recently mutations in the central nervous system myelination/CNTN1 complex have been associated with similar severe phenotypes and @GENE$ gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset @DISEASE$ multiplex congenita in four unrelated families.	1
Recently mutations in the central nervous system myelination/CNTN1 complex have been associated with similar severe phenotypes and @GENE$ gene mutations, causing loss of the CASPR protein, were shown to cause severe, @DISEASE$ arthrogryposis multiplex congenita in four unrelated families.	0
We further expand the existing @GENE$-associated phenotype to include @DISEASE$ cerebral and cerebellar atrophy	0
The major categories of pancreatic neuroendocrine @DISEASE$ (Pan@GENE$) are well-differentiated NET and poorly differentiated neuroendocrine carcinoma.	0
Sequencing of these @DISEASE$s has identified multiple important genes in the pathogenesis of Pan@GENE$s, such as nucleosome assembly/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and regulation of cell growth pathway genes.	0
Sequencing of these @DISEASE$s has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as @GENE$/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and regulation of cell growth pathway genes.	1
Sequencing of these @DISEASE$s has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as nucleosome assembly/ATRX, @GENE$, TP53, RB, and regulation of cell growth pathway genes.	1
Sequencing of these @DISEASE$s has identified multiple important genes in the pathogenesis of Pannegative regulation of transcription, DNA-templateds, such as nucleosome assembly/ATRX, negative regulation of transcription by RNA polymerase II, TP53, RB, and @GENE$ pathway genes.	0
Small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC) is a relatively rare histological @GENE$ of gallbladder @DISEASE$, and the genomic landscape of GB-SCNEC is rarely considered in treatment decisions.	0
Importantly, @GENE$ inhibitor Kenpaullone sensitizes breast cancer cells and xenograft @DISEASE$ to Paclitaxel and improves therapeutic effects.	0
To identify tumor suppressor genes (@GENE$s) silenced by hypermethylation and discover new epigenetic biomarkers for early @DISEASE$ detection.	0
@GENE$, located at 16q23.1, has been reported to be a critical negative regulation of cytokine production in multiple primary @DISEASE$s; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).	0
negative regulation of platelet aggregation, located at 16q23.1, has been reported to be a critical @GENE$ in multiple primary tumors; however, this has not yet been verified in @DISEASE$ (ccRCC).	0
@GENE$ was further performed for 101 ccRCC primary @DISEASE$s and 20 adjacent normal tissues.	0
Furthermore, the methylation status of @GENE$ was not significantly associated with gender, age, location, @DISEASE$ diameter, pathological stage, nuclear grade or short-term DFS in patients with ccRCC (p &gt; 0.05).	0
The @GENE$ gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary @DISEASE$s, indicating its critical role as a TSG in ccRCC.	0
Clear cell renal cell carcinoma (cc@GENE$) is an @DISEASE$ tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric positive regulation of cell-matrix adhesion interface and the tumour/renal sinus interface.	0
Clear cell renal cell carcinoma (cc@GENE$) is an heterogeneous @DISEASE$ at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric positive regulation of cell-matrix adhesion interface and the tumour/renal sinus interface.	0
We observed the presence of the mutation at pH1047R of <i>@GENE$</i> gene in five samples of the @DISEASE$, while the remaining 15 samples did not show any mutation at <i>PIK3CA</i> or any other investigated gene.	1
There is a @GENE$ need to develop novel response to hydroperoxide sampling strategies to overcome tumour @DISEASE$ prior to define precision oncology strategies	0
There is a G protein-coupled receptor signaling pathway need to develop novel @GENE$ sampling strategies to overcome tumour @DISEASE$ prior to define precision oncology strategies	0
Spinocerebellar @DISEASE$ @GENE$ 5 (vesicle-mediated transport) is a neurodegenerative disease caused by mutations in the cytoskeletal protein β-III-spectrin.	0
Spinocerebellar @DISEASE$ muscle organ development 5 (@GENE$) is a neurodegenerative disease caused by mutations in the cytoskeletal protein β-III-spectrin.	1
Spinocerebellar ataxia @GENE$ 5 (vesicle-mediated transport) is a @DISEASE$ caused by mutations in the cytoskeletal protein β-III-spectrin.	0
Spinocerebellar ataxia muscle organ development 5 (@GENE$) is a @DISEASE$ caused by mutations in the cytoskeletal protein β-III-spectrin.	0
We compare and contrast our @GENE$ings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, @DISEASE$, and corpus callosum abnormalities [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].	0
We compare and contrast our @GENE$ings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, microcephaly, and @DISEASE$ [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].	0
@GENE$-deficient thoracic @DISEASE$ is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging.	0
Furthermore, in vitro inhibition of @DISEASE$-derived @GENE$ noncanonical signals results in an increase of chemosensitivity in a colorectal cancer cell line.	0
@GENE$ mice accumulate excess abdominal adipose tissue, develop an early inflammatory liver process, exhibit fasting @DISEASE$, and have abnormal skeletal muscle mitochondria.	0
Palatable foods (@GENE$ and sweet) induce @DISEASE$, and facilitate the development of obesity.	0
Palatable foods (@GENE$ and sweet) induce hyperphagia, and facilitate the development of @DISEASE$.	0
Here we show that adipocyte @GENE$ is essential for high fat diet-induced @DISEASE$, but is dispensable for baseline food intake.	0
These findings define adipocyte @GENE$ as a positive regulation of cell-matrix adhesion sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce @DISEASE$ and obesity	0
<b>Objective:</b> To investigate the expression of granulocyte-colony stimulating factor receptor (G-@GENE$) in a mouse model of colitis-associated @DISEASE$ (CAC), and the roles of G-CSFR positive immune cells in the development of CAC.	0
To investigate this mechanism, we developed a novel uterine @DISEASE$ tissue-derived orthotopic and metastatic model in KSN nude @GENE$ using a green fluorescent protein stably expressed uterine sarcoma cell line, MES-SA.	0
The expression profile of @GENE$-20 in human @DISEASE$ was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.	0
The expression profile of @GENE$-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant @DISEASE$, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.	0
Our studies show that seven of the ADAMTS genes (@GENE$, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in @DISEASE$s with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	0
Our studies show that seven of the ADAMTS genes (@GENE$, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the @DISEASE$ of the samples and the tumor muscle organ development or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	0
Our studies show that seven of the ADAMTS genes (@GENE$, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the @DISEASE$ muscle organ development or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	0
Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the @DISEASE$ of the samples and the tumor @GENE$ or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	0
Our studies show that seven of the ADAMTS genes (positive regulation of G1/S transition of mitotic cell cycle, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the @DISEASE$ @GENE$ or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	0
@GENE$5 has emerged as being an independent predictor of survival, with RNA expression levels significantly lower (P = 0.007) in grade 3 @DISEASE$ compared with grade 1 and 2 breast carcinoma	0
In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with @DISEASE$ due to @GENE$ gene deletion.	1
Genetic modification of a human prostate @DISEASE$ cell line to induce miR-101 and suppress @GENE$ decreased cell migration and invasion.	0
In this study, we evaluated the possible interaction between @GENE$-146a and one of its putative targets ribonuclease L (negative regulation of viral genome replication) in the risk of sporadic @DISEASE$.	0
In this study, we evaluated the possible interaction between protein polyubiquitination-146a and one of its putative targets ribonuclease L (@GENE$) in the risk of @DISEASE$ melanoma.	0
Polymorphisms rs2910164 in @GENE$-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in non@DISEASE$ skin cancer.	0
Polymorphisms rs2910164 in @GENE$-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different @DISEASE$s, and an interaction between them has been observed in nonmelanoma skin cancer.	0
The results reported in the present study suggest a @GENE$-specific interaction between miR-146a and negative regulation of viral genome replication genes in @DISEASE$ skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	0
The results reported in the present study suggest a multicellular organism development-specific interaction between miR-146a and @GENE$ genes in @DISEASE$ skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	0
The results reported in the present study suggest a multicellular organism development-specific interaction between miR-146a and @GENE$ genes in melanoma skin @DISEASE$ susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	1
In vivo, @GENE$ overexpression prevents the development of positive regulation of protein phosphorylation-induced and signal transduction-induced mammary gland @DISEASE$, in the presence of increased rates of chromosome instability.	0
In vivo, G2/M transition of mitotic cell cycle overexpression prevents the development of @GENE$-induced and signal transduction-induced mammary gland @DISEASE$, in the presence of increased rates of chromosome instability.	1
In vivo, G2/M transition of mitotic cell cycle overexpression prevents the development of positive regulation of protein phosphorylation-induced and @GENE$-induced mammary gland @DISEASE$, in the presence of increased rates of chromosome instability.	1
In patients, @GENE$ overexpression correlates with improved survival in specific breast @DISEASE$ subtypes.	0
Therefore, despite the therapeutic benefits of inhibiting @GENE$ due to its essential role in @DISEASE$ cell cycles, Plk1 overexpression has tumor-suppressive properties by perturbing mitotic progression and cytokinesis	0
Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (AKAP6 in @DISEASE$ and @GENE$ in early dementia).	0
Transmissible spongiform @DISEASE$, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in @GENE$ and hamsters).	0
Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with @DISEASE$ in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in @GENE$ and hamsters).	0
Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform @DISEASE$ in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in @GENE$ and hamsters).	0
The KEGG enrichment analysis of DEGs showed significantly enriched pathways in @DISEASE$, extracellular matrix (@GENE$)-receptor interaction pathway, and cyclic adenosine monophosphate (cAMP) signaling pathway.	0
There is growing evidence shown that microRNAs (@GENE$NAs) are associated with @DISEASE$ and can play a role in human cancers as oncogenes or tumor suppressor genes.	0
There is growing evidence shown that microRNAs (@GENE$NAs) are associated with cancer and can play a role in human cancers as oncogenes or @DISEASE$ suppressor genes.	0
MicroRNA-214 (@GENE$-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal @DISEASE$ (ESCC).	0
In summary, these results suggest that @GENE$-214 serves as @DISEASE$ promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting negative regulation of macroautophagy via PI3K/AKT/mTOR signaling pathway.	0
In summary, these results suggest that protein polyubiquitination-214 serves as @DISEASE$ promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting @GENE$ via PI3K/AKT/mTOR signaling pathway.	1
Using preclinical models, we have recently found that @GENE$, a transcriptional factor that activates downstream targets, including <i>c-fos</i> proto-oncogene, induces bladder @DISEASE$ outgrowth.	0
Lymphovascular invasion was significantly (<i>P</i> = 0.014) more often seen in phospho-@GENE$(2+) @DISEASE$ (80.0%) than in phospho-ELK1(0/1+) tumors (36.0%).	0
There were no statistically significant associations between phospho-@GENE$ expression and tumor grade, presence of concurrent carcinoma in situ or @DISEASE$, or pN status.	0
Kaplan-Meier and log-rank tests revealed that patients with phospho-@GENE$(2+) tumor had marginally and significantly higher risks of disease progression (<i>P</i> = 0.055) and @DISEASE$-specific mortality (<i>P</i> = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.	0
Kaplan-Meier and log-rank tests revealed that patients with phospho-@GENE$(2+) @DISEASE$ had marginally and significantly higher risks of disease progression (<i>P</i> = 0.055) and cancer-specific mortality (<i>P</i> = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.	0
The current results thus support our previous observations in bladder @DISEASE$ and further suggest that phospho-@GENE$ overexpression serves as a predictor of poor prognosis in patients with UUTUC	0
X-linked hearing impairment is the rarest form of genetic @DISEASE$ (HL) and represents only a @GENE$ fraction of all cases.	0
Subpopulation screening of the coding exons and flanking introns of @GENE$ was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&gt;A and c.55A&gt;G) in SMPX were identified in additional @DISEASE$ cases of congenital deafness.	0
Collectively, this study is the first to report the role of @GENE$ in Chinese population and identify a novel frameshift mutation in SMPX that causes not only nonsyndromic late-onset progressive HL, but also congenital @DISEASE$.	1
RNA sequencing transcriptome analysis revealed that inflammatory mediators such as @DISEASE$ necrosis factor (TNF)-α suppressed expression of R-spondin-1 (positive regulation of protein phosphorylation, a critical growth factor for intestinal epithelial cells) in @GENE$-silenced YAMC cells <i>in vitro</i>.	0
RNA sequencing transcriptome analysis revealed that inflammatory mediators such as @DISEASE$ necrosis factor (TNF)-α suppressed expression of R-spondin-1 (@GENE$, a critical growth factor for intestinal epithelial cells) in regulation of double-strand break repair via homologous recombination-silenced YAMC cells <i>in vitro</i>.	1
Homozygous and compound heterozygous mutations in @GENE$ have recently been described to cause an autosomal recessive syndromic form of @DISEASE$, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.	1
The diagnosis of acquired chronic dysimmune neuropathies (@GENE$) like chronic inflammatory demyelinating poly@DISEASE$ (CIDP), Lewis-Sumner Syndrome (steroid biosynthetic process) or multifocal motor neuropathy (MMN) can be challenging.	0
The diagnosis of acquired chronic dysimmune neuropathies (pyrimidine deoxyribonucleotide catabolic process) like chronic inflammatory demyelinating poly@DISEASE$ (CIDP), Lewis-Sumner Syndrome (@GENE$) or multifocal motor neuropathy (MMN) can be challenging.	0
The diagnosis of acquired chronic dysimmune neuropathies (pyrimidine deoxyribonucleotide catabolic process) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (@GENE$) or @DISEASE$ motor neuropathy (MMN) can be challenging.	0
Because Dfnb31(wi/wi) and Dfnb31(neo/neo) mice faithfully recapitulate hearing and vision symptoms in patients, our @GENE$ings of @DISEASE$ in these Dfnb31 mutants raise the question of whether DFNB31-deficient patients may acquire vestibular as well as hearing and vision loss.	0
In addition, polymorphisms in apoptosis-related genes such as RNF7, @GENE$, and positive regulation of phagocytosis are associated with fibrosis progression, and negative regulation of TOR signaling and MICA variants are associated with HCV-related @DISEASE$.	0
In addition, polymorphisms in apoptosis-related genes such as RNF7, positive regulation of phagocytosis, and positive regulation of phagocytosis are associated with fibrosis progression, and @GENE$ and MICA variants are associated with HCV-related @DISEASE$.	0
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, @GENE$, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, @GENE$, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, @GENE$, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, @GENE$, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, @GENE$, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, @GENE$, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, @GENE$, mitotic cytokinesis and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, @GENE$ and aggrephagy, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, microtubule cytoskeleton organization, CASC5, spindle organization, centriole elongation, centrosome duplication, CEP135, centrosome duplication, ZNF335, PHC1, CDK6, mitotic chromosome movement towards spindle pole, SASS6, MFSD2A, central nervous system development, mitotic cytokinesis and @GENE$, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	0
There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (@GENE$), transactive response DNA-binding protein (RNA splicing), superoxide dismutase 1 (SOD1) and fused in @DISEASE$ (regulation of transcription, DNA-templated).	0
There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (negative regulation of protein phosphorylation), transactive response DNA-binding protein (@GENE$), superoxide dismutase 1 (SOD1) and fused in @DISEASE$ (regulation of transcription, DNA-templated).	0
There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (negative regulation of protein phosphorylation), transactive response DNA-binding protein (RNA splicing), superoxide dismutase 1 (SOD1) and fused in @DISEASE$ (@GENE$).	0
Previous reports have identified @GENE$ variants in patients with generalized epilepsies, such as myoclonic-atonic @DISEASE$ and childhood absence epilepsy.	1
The purpose of this study was to determine the incidence of @GENE$ variants in 460 unselected @DISEASE$ patients and to evaluate the impact of the identified variants on γ-aminobutyric acid (GABA)transport.	1
The studied CVD biomarkers include positive regulation of cytokine-mediated signaling pathway receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (@GENE$), D-dimer, fibrinogen (histone glutamine methylation), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), @DISEASE$ necrosis factor alpha (TNF-α) and troponins (Tns) on electrochemical transduction format.	0
The studied CVD biomarkers include positive regulation of cytokine-mediated signaling pathway receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (positive regulation of gene expression), D-dimer, fibrinogen (@GENE$), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), @DISEASE$ necrosis factor alpha (TNF-α) and troponins (Tns) on electrochemical transduction format.	0
Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (@GENE$) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (mRNA splice site selection1, VPS33B).	0
Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (@GENE$1, VPS33B).	0
While many downstream effectors of @GENE$ have been established, the upstream regulators of ATR and the impact of such regulation on liver @DISEASE$ remain unclear.	1
The in vivo @GENE$ of regulation of cytokinesis loss on liver tumorigenesis was determined using the @DISEASE$ model induced by genotoxin Diethylnitrosamine.	0
The in vivo negative regulation of transcription by RNA polymerase II of @GENE$ loss on liver tumorigenesis was determined using the @DISEASE$ model induced by genotoxin Diethylnitrosamine.	0
Liver-specific knockout of murine Bruce impaired @GENE$ activation and exacerbated inflammation, fibrosis and @DISEASE$, which exhibited a trabecular architecture, closely resembling human phosphatidylinositol phosphorylation.	0
In humans, the clinical relevance of regulation of cytokinesis downregulation in liver disease was found in hepatitis, cirrhosis and @DISEASE$ specimens and deleterious somatic mutations of the @GENE$ gene was found in human hepatocellular carcinoma in TCGA database.	0
Conclusion: These findings establish a new @GENE$-actin cytoskeleton reorganization signaling axis in accurate DNA replication and suppression of liver @DISEASE$ in mice and humans and provides a clinically relevant phosphatidylinositol phosphorylation mouse model.	0
Conclusion: These findings establish a new regulation of cytokinesis-actin cytoskeleton reorganization signaling axis in accurate DNA replication and suppression of liver @DISEASE$ in mice and humans and provides a clinically relevant @GENE$ mouse model.	0
Taking advantage of the homogeneous and @DISEASE$ electrochemical biosensors, a @GENE$, sensitive, and selective electrochemical biosensor is constructed by combining entropy-driven amplification (positive regulation of NF-kappaB transcription factor activity) with DNA walker.	1
Three sub@GENE$s, <i>PTPN11- , Ras protein signal transduction-</i>, and <i>positive regulation of protein phosphorylation</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in @DISEASE$ type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	0
Three submuscle organ developments, <i>PTPN11- , @GENE$-</i>, and <i>positive regulation of protein phosphorylation</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective @DISEASE$ suppressor genes in hematopoietic cells.	1
Three submuscle organ developments, <i>PTPN11- , Ras protein signal transduction-</i>, and <i>@GENE$</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective @DISEASE$ suppressor genes in hematopoietic cells.	1
Three submuscle organ developments, <i>PTPN11- , Ras protein signal transduction-</i>, and <i>positive regulation of protein phosphorylation</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with @GENE$ syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective @DISEASE$ suppressor genes in hematopoietic cells.	1
@GENE$ (ADCK3) is a mammalian UbiB protein associated with ubiquinone (CoQ) biosynthesis and an @DISEASE$ (ARCA2) through unclear means.	1
We show that @GENE$ lacking COQ8A develop a slowly progressive cerebellar @DISEASE$ linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.	0
Sickle cell disease (@GENE$) is one of the most common @DISEASE$ diseases in humans, occurring at a frequency of 1 in 365 African-American and 1 in 50 sub-Saharan African births.	1
Recent evidence suggests that @GENE$ genes may participate in a wide array of cellular processes, and may contribute to the pathology of autoimmune disease, @DISEASE$, and other diseases.	0
Several studies have suggested a role for the glutamyl prolyl tRNA synthetase (@GENE$) in breast @DISEASE$s, although none has identified any underlying mechanism about how EPRS contributes to carcinogenesis.	0
Finally, we constructed a causal gene network based on over 2500 ER+ breast @DISEASE$ samples to build up an @GENE$-estrogen signaling pathway.	0
@GENE$ and its regulated estrogenic gene network may offer a promising alternative approach to target ER+ breast @DISEASE$s that are refractory to current anti-estrogens	0
Furthermore, we detected association of rs58978565 near TNR (P = 2.3 × 10-8), rs28368872 near @GENE$ (P = 2.9 × 10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to @DISEASE$ but not geographic atrophy.	0
The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-@GENE$) has been demonstrated for several conditions, including cancer, @DISEASE$, diabetes, and ocular disease.	0
For example, administration of 3-keto-@GENE$ instead of fenretinide may be preferential if inhibition of SCD1 or unsaturated fatty acid biosynthetic process activity is the goal (@DISEASE$), while MPR may be better for retinoid metabolic process modulation (carotenoid metabolism).	0
For example, administration of 3-keto-receptor-mediated endocytosis instead of fenretinide may be preferential if inhibition of SCD1 or @GENE$ activity is the goal (@DISEASE$), while MPR may be better for retinoid metabolic process modulation (carotenoid metabolism).	0
For example, administration of 3-keto-receptor-mediated endocytosis instead of fenretinide may be preferential if inhibition of SCD1 or unsaturated fatty acid biosynthetic process activity is the goal (@DISEASE$), while MPR may be better for @GENE$ modulation (carotenoid metabolism).	0
In the present study, we used a custom-made @GENE$ panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear @DISEASE$s.	0
In the present study, we used a custom-made @GENE$ panel to identify the genetic defect of a four-generation Chinese family with @DISEASE$ pulverulent nuclear cataracts.	0
The results indicated two mutated driver pathways are important for the pathogenesis of @GENE$: pathway in @DISEASE$ and in regulation of actin cytoskeleton.	0
Our findings support the recently proposed concept of 3'UTR-encoded &quot;cryptic amyloidogenic elements.&quot; Together with a previous report on an aggregation-prone @GENE$ deletion variant in distal hereditary motor @DISEASE$, they also suggest that toxic gain of REEP1 function, rather than loss-of-function as relevant for HSP, specifically affects lower motor neurons.	1
Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human TMIE as the gene affected at @GENE$, a non-syndromic @DISEASE$ locus.	1
@GENE$-related disorders include a wide phenotypic ranging from mild to lethal @DISEASE$ disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).	1
Three predicted driver genes (CDKN2A, @GENE$, negative regulation of cell proliferation) were found common in these three @DISEASE$s by comparative analysis.	1
Mutations in the human @GENE$ gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the camera-type eye development (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and @DISEASE$ (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.	1
Mutations in the human tRNA 3'-terminal CCA addition gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the @GENE$ (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and @DISEASE$ (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.	0
Numerous studies have recently demonstrated that @GENE$ expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), @DISEASE$, and acute kidney injury (AKI), among others.	0
In @GENE$, HDAC6 inhibitors effectively limit the progression of @DISEASE$s, suggesting that targeting HDAC6 may provide a novel treatment approach.	0
Here, we discuss the unique function of @GENE$ and recapitulate the alluring potential of its inhibitors in @DISEASE$s	0
Cell surface carbohydrates are important for cell migration and invasion of prostate @DISEASE$ (@GENE$).	0
Accordingly, the I-branching N-acetylglucosaminyltransferase (@GENE$) converts linear i-antigen to I-branching glycan, and its expression is associated with breast @DISEASE$ progression.	0
Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of @DISEASE$ suppressors, including protein ubiquitination, @GENE$, and protein phosphorylation, also showed such clustering.	1
Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of @DISEASE$ suppressors, including protein ubiquitination, protein ubiquitination, and @GENE$, also showed such clustering.	1
Focal @DISEASE$ (FCD) and hemimegalencephaly (proteolysis) are epileptogenic neurodevelopmental malformations caused by mutations in @GENE$ pathway genes.	1
Focal cortical dysplasia (FCD) and @DISEASE$ (@GENE$) are epileptogenic neurodevelopmental malformations caused by mutations in regulation of cell growth pathway genes.	0
These effects are thought to have a significant @GENE$ upon both vascular and cerebrovascular health, ultimately with the potential to prevent cardiovascular and potentially @DISEASE$ with a vascular component, for example vascular dementia.	0
The @GENE$-associated phenotype has previously been assigned to @DISEASE$-47.	1
c.7253dupT in @GENE$, encoding a DDR factor important in meiosis, associated with hereditary breast @DISEASE$ (p = 0.018) and likely represents a Northern Finnish founder mutation.	0
A deletion (c.640_644del5) in @GENE$, causative for recessive RIDDLE syndrome, had high prevalence in majority of the analyzed cohorts, but did not associate with breast @DISEASE$.	0
In the present study, we screened for @GENE$ mutations in patients with juvenile myoclonic @DISEASE$ and identified two novel missense mutations: Arg36His and Asn271Ser.	0
We obtained cryo-electron microscopy structures of an activated filament that is allosterically induced by citrate (ACC-citrate), and an inactivated filament form that results from binding of the BRCT domains of the breast @DISEASE$ type 1 susceptibility protein (@GENE$).	1
The 1p breakpoint disrupts the 5' UTR of @GENE$, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive @DISEASE$, hypotonia, and sleep apnea.	0
The 1p breakpoint disrupts the 5' UTR of @GENE$, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and @DISEASE$.	1
Pediatric refractory @DISEASE$ is a broad phenotypic spectrum with @GENE$ genetic heterogeneity.	0
Pediatric refractory epilepsy is a broad phenotypic spectrum with @GENE$ genetic @DISEASE$.	0
Other novel mutations detected in unclassified @DISEASE$ patients involve the @GENE$, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the peripheral nervous system development, @GENE$, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, @GENE$, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, @GENE$, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, @GENE$, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and muscle organ development genes.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, @GENE$ and muscle organ development genes.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the peripheral nervous system development, positive regulation of cytosolic calcium ion concentration, cellular response to histamine, chloride transmembrane transport, modulation of chemical synaptic transmission, TSC1, protein autophosphorylation, cellular sodium ion homeostasis, homophilic cell adhesion via plasma membrane adhesion molecules, axon extension and @GENE$ genes.	1
These results suggest (i) apparent allelic @DISEASE$ in @GENE$ and genetic heterogeneity in thiamine pyrophosphate transmembrane transport across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability	0
These results suggest (i) apparent allelic @DISEASE$ in complement activation and genetic heterogeneity in @GENE$ across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability	0
In the present study, we investigated the spatiotemporal distributions of @GENE$ and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-thyroid gland development) mice and @DISEASE$ ALS patients.	0
In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, @GENE$ and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-thyroid gland development) mice and @DISEASE$ ALS patients.	0
In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (@GENE$-thyroid gland development) mice and @DISEASE$ ALS patients.	0
In the present study, we investigated the spatiotemporal distributions of negative regulation of protein export from nucleus and 4 representative nucleoporins (GP210, NUP205, mRNA export from nucleus and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (response to superoxide-@GENE$) mice and @DISEASE$ ALS patients.	0
The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of @GENE$ both in response to superoxide-Tg mice and human @DISEASE$ ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	0
The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of signal transduction both in @GENE$-Tg mice and human @DISEASE$ ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	0
In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, @GENE$ and G protein-coupled receptor signaling pathway genetic loci, respectively, are associated with risk for @DISEASE$ in a Greek population.	0
In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, cell-cell adhesion and @GENE$ genetic loci, respectively, are associated with risk for @DISEASE$ in a Greek population.	0
Notably, a significant difference in the distribution of the AG genotype and the @GENE$ allele A of G protein-coupled receptor signaling pathway rs11031006 SNP was found between the @DISEASE$ patients and controls.	0
Notably, a significant difference in the distribution of the AG genotype and the positive regulation of glucose transmembrane transport allele A of @GENE$ rs11031006 SNP was found between the @DISEASE$ patients and controls.	0
We found a genetic association between rs11031006 (@GENE$) SNP and @DISEASE$.	0
@GENE$ and cell-cell adhesion genes constitute the most consistently associated genes with @DISEASE$.	0
negative regulation of gene expression and @GENE$ genes constitute the most consistently associated genes with @DISEASE$.	0
In the present study, an association of rs7521902 (negative regulation of gene expression) and rs10859871 (@GENE$) was confirmed in women with @DISEASE$ at the genotypic but not the allelic level	0
Primary creatine disorders are inherited as @DISEASE$ (mutations affecting creatine biosynthetic process [for glycine-amidinotransferase, mitochondrial]) and creatine biosynthetic process genes) or X-linked (@GENE$ gene) traits.	0
Primary creatine disorders are inherited as @DISEASE$ (mutations affecting @GENE$ [for glycine-amidinotransferase, mitochondrial]) and creatine biosynthetic process genes) or X-linked (creatine transmembrane transport gene) traits.	1
Primary @DISEASE$ (@GENE$) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.	1
Primary ciliary dyskinesia (@GENE$) is clinically characterized by neonatal @DISEASE$, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.	1
@GENE$ is a result of mutations in genes encoding proteins involved in ciliary function, and is primarily inherited in an @DISEASE$ fashion.	1
Diagnosis of motile cilium assembly is often a challenging @GENE$ due to its high clinical and genetic @DISEASE$.	0
Primary @DISEASE$ @GENE$ 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.	0
L371P mutation in @GENE$ is a founder mutation in the Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and @DISEASE$ with poor myelination	0
In the second example, Mdx mice, a model for Duchenne @DISEASE$, were intravenously injected with AAV8-@GENE$.	0
Biallelic pathogenic variant in @GENE$ gene can cause Joubert syndrome-related disorders with @DISEASE$ characteristics.	1
Therefore, we concluded that @GENE$ c.3257A&gt;G and muscle organ development c.914 A&gt;G were potential causal variants in this @DISEASE$ pedigree.	1
Therefore, we concluded that morphogenesis of a polarized epithelium c.3257A&gt;G and @GENE$ c.914 A&gt;G were potential causal variants in this @DISEASE$ pedigree.	0
Here, we show that invasive breast @DISEASE$ exhibit significant @GENE$-ITH and that this heterogeneity is critical for tumor growth and metastasis.	0
Here, we show that invasive breast tumors exhibit significant @GENE$-ITH and that this @DISEASE$ is critical for tumor growth and metastasis.	0
Here, we show that invasive breast tumors exhibit significant @GENE$-ITH and that this heterogeneity is critical for @DISEASE$ growth and metastasis.	0
Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote @DISEASE$ growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production of @GENE$ (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).	0
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: @GENE$-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and @DISEASE$ syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, @GENE$-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, @GENE$-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary @DISEASE$, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	0
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, @GENE$ and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and @GENE$ caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	0
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, @GENE$ and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and @DISEASE$ syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and @GENE$ caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and @DISEASE$ syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, @GENE$ and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and @DISEASE$ syndrome, and three forms of hereditary spastic paraplegia, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and @GENE$ mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary @DISEASE$, @GENE$, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary @DISEASE$, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, @GENE$ and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary @DISEASE$, chemical synaptic transmission, double-strand break repair via homologous recombination and omega-hydroxylase P450 pathway caused by SPG11, double-strand break repair via homologous recombination and @GENE$ mutations, respectively.	1
Sushi repeat-containing protein X-linked 2 (@GENE$), a novel chondroitin sulfate proteoglycan, is overexpressed in human @DISEASE$.	0
While, the clinical significance and biological function of @GENE$ remain rarely known in @DISEASE$ (HCC).	0
By exome sequencing, we identified three different bi-allelic truncating mutations in @GENE$ in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, @DISEASE$, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	1
By exome sequencing, we identified three different bi-allelic truncating mutations in @GENE$ in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, @DISEASE$, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	1
Typical ciliopathy phenotypes (curved body shape, @DISEASE$, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for @GENE$ as a ciliopathy-associated gene.	1
She manifested @DISEASE$, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included @GENE$3, protein phosphorylation, and CCM2.	0
We summarize the phenotypic extent of @GENE$2/3 syndromes in the literature and determine that these 2 syndromes manifest opposite features to a certain extent, such as midface hypoplasia or macrocephaly, and anterior or posterior side of @DISEASE$.	1
The present study aimed to explore @GENE$ expression in cervical @DISEASE$ and the possible function in tumor progression.	0
@GENE$ expression in cervical @DISEASE$ cell lines was assessed by RT-PCR and Western blotting.	0
Here, we showed lower expression of @GENE$ in cell lines and human cervical @DISEASE$ samples.	0
Furthermore, the phosphorylation of positive regulation of protein phosphorylation was enhanced in @GENE$ silencing cervical @DISEASE$ cells.	0
These results reveal that regulation of small GTPase mediated signal transduction functions as a @DISEASE$ suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/@GENE$ signaling and up-regulation of P21 and P27 expression	1
@GENE$(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from @DISEASE$.	0
Although humans with X-linked @DISEASE$ (proteolysis) and the @GENE$ mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	1
Although humans with X-linked hypophosphatemia (@GENE$) and the proteolysis mouse, a murine homolog of XLH, are known to develop @DISEASE$, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	1
UCA1 knockdown significantly inhibited @GENE$ cell viability, colony formation and the bromodomain containing 4 (positive regulation of transcription elongation from RNA polymerase II promoter) expression level in vitro, and retarded PTC @DISEASE$ growth in vivo.	0
In the previous study, microRNA (@GENE$)‑204 inhibited thyroid @DISEASE$ progression and was regulated by UCA1 in other types of cancer.	0
The @GENE$ (positive regulation of cytosolic calcium ion concentration-1) derived EGF-CFC family was overexpressed in @DISEASE$ development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	1
The activation of MAPK activity (@GENE$-1) derived EGF-CFC family was overexpressed in @DISEASE$ development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	0
The immunohistochemistry showed that @GENE$ expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&lt;0.01), @DISEASE$ clinical stage (P&lt;0.01).	0
The immunohistochemistry showed that @GENE$ expression was stronger in oral tongue @DISEASE$ tissues than in paired adjacent tissues (P&lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&lt;0.01), tumor clinical stage (P&lt;0.01).	0
@GENE$-A and Nogo-C are potent Nogos that are predominantly expressed in the @DISEASE$ nervous system.	0
Downregulation of Gli1, smoothened signaling pathway, @GENE$ and Kif7 was demonstrated in clinical samples of @DISEASE$ and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	0
High-density lipoprotein (HDL) particles have experienced a turbulent decade of falling from grace with widespread demotion from the most-sought-after th@GENE$peutic target to reverse @DISEASE$ (CVD), to mere biomarker status.	1
Individuals with @GENE$ deletion show symptoms of ADHD, sleep disruption, hypotonia, @DISEASE$, ASD, and ID.	0
protein import into nucleus-restricted deletion of @GENE$ leads to attention deficits and @DISEASE$, both of which are rescued by pharmacological augmentation of SK channel activity.	0
A growing number of studies has suggested that long non-coding RNAs (lncRNAs) exert essential roles in the development and progression of @DISEASE$ (@GENE$).	0
@GENE$-AS1 knockdown could inhibit the proliferation of phosphatidylinositol phosphorylation cells and attenuate the development of HCC @DISEASE$ in vivo.	0
myelination-AS1 knockdown could inhibit the proliferation of @GENE$ cells and attenuate the development of HCC @DISEASE$ in vivo.	0
In this study we present the first two cases from India of a rare inborn error of metabolism manifesting as @DISEASE$ and 3-methylglutaconic aciduria and a Leigh like lesions in the brain MRI associated with @GENE$ gene mutation, a phenotype characteristic of MEGDEL syndrome.	1
In this article, we report a clinically recognizable craniofacial disorder characterized by @DISEASE$, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in @GENE$, which encodes the coatomer subunit MAPK cascade of COPI.	0
In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe @DISEASE$, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in @GENE$, which encodes the coatomer subunit MAPK cascade of COPI.	1
In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe @DISEASE$, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in intracellular protein transport, which encodes the coatomer subunit @GENE$ of COPI.	0
In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, @DISEASE$, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in @GENE$, which encodes the coatomer subunit MAPK cascade of COPI.	1
In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and @DISEASE$ developmental delay due to loss-of-function heterozygous mutations in @GENE$, which encodes the coatomer subunit MAPK cascade of COPI.	0
In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild @DISEASE$ due to loss-of-function heterozygous mutations in @GENE$, which encodes the coatomer subunit MAPK cascade of COPI.	0
As a potential target for cancer treatment, the @GENE$ high expresses abnormally in a variety of solid @DISEASE$ and hematological malignancies in humans.	1
Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as @GENE$) originating from the @DISEASE$ cells as a driving stimulus in the control of microglial caspase-3 activity.	0
Repression of @DISEASE$ @GENE$ expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.	0
Repression of glioma @GENE$ expression in vivo led to a reduction in both microglia recruitment and @DISEASE$ expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.	0
Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein @GENE$ is a part of the microglial pro-@DISEASE$al activation pathway initiated by glioma cancer cells	0
Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein @GENE$ is a part of the microglial pro-tumoral activation pathway initiated by @DISEASE$ cancer cells	0
Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ @GENE$]) and subsequent CNS tumors in survivors of childhood @DISEASE$.	0
We included 7 consecutive patients with LP with typical intracranial calcifications out of 16 patients with @GENE$ mutations and investigated the semiologic features, ictal and interictal EEG findings, and long-term prognosis of @DISEASE$ in this genodermatosis.	1
Four of them had seizures (57.1%), and focal seizures with motionless @GENE$ were the most common seizure phenotype, originating from @DISEASE$ mesial temporal areas, but interictal spikes were scant.	0
The positive regulation of cell-matrix adhesion mass and @DISEASE$-associated (@GENE$) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.	1
Gabapentin (@GENE$; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including @DISEASE$; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.	1
Gabapentin (@GENE$; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic @DISEASE$, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.	1
In a family with post-lingual progressive non-syndromic @DISEASE$, whole-exome sequencing of genomic DNA from five hearing-impaired relatives revealed a single variant, p.Gly488Glu (rs145970949:G&gt;A) in @GENE$, co-segregating with HL as an autosomal dominant trait.	1
@GENE$ has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, @DISEASE$ and microtia.	1
We report a pair of siblings carrying a homozygous missense mutation p.P333L in @GENE$2 who exhibited global developmental delay, @DISEASE$, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.	0
@GENE$2-deficient zebrafish had skeletal muscle weakness, @DISEASE$ and small heads.	0
This rare condition is characterized by @DISEASE$ choanal atresia, hearing loss, cleft @GENE$ and/or palate, and other craniofacial dysmorphisms.	0
This rare condition is characterized by bilateral @DISEASE$, hearing loss, cleft @GENE$ and/or palate, and other craniofacial dysmorphisms.	0
This rare condition is characterized by bilateral choanal atresia, @DISEASE$, cleft @GENE$ and/or palate, and other craniofacial dysmorphisms.	0
Thirteen patients with @GENE$-positive @DISEASE$ were enrolled.	0
Here, we sought to find lncRNAs differentially regulated in @DISEASE$ cells resistant to either TNF-related apoptosis-inducing ligand (@GENE$) or the response to cytokine inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	0
Here, we sought to find lncRNAs differentially regulated in @DISEASE$ cells resistant to either TNF-related apoptosis-inducing ligand (positive regulation of apoptotic process) or the @GENE$ inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	0
Taken together, these results reveal that OVAAL contributes to the survival of @DISEASE$ cells through dual mechanisms controlling RAF/MEK/ERK signaling and @GENE$-mediated cell senescence	0
This review focuses on the molecular basis of the pathogenesis of @DISEASE$ due to @GENE$ mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK.	1
Mutations in the gene encoding CCTα (<i>@GENE$YT1A</i>) cause three distinct pathologies in humans: lipodystrophy, @DISEASE$ with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.	0
The nonsense mutation and loss of protein of @GENE$ has been associated with @DISEASE$ in epidermis development and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.	1
The nonsense mutation and loss of protein of @GENE$ has been associated with neural tube defect in epidermis development and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous @DISEASE$.	0
The nonsense mutation and loss of protein of GTP metabolic process has been associated with @DISEASE$ in @GENE$ and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.	0
The nonsense mutation and loss of protein of GTP metabolic process has been associated with neural tube defect in @GENE$ and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous @DISEASE$.	0
Motif analysis of @DISEASE$-specific methylated regions identified enrichment of binding sites for several neural cell @GENE$-specifying transcription factors including nitric oxide mediated signal transduction, negative regulation of transcription by RNA polymerase II, negative regulation of transcription, DNA-templated and REST.	0
Motif analysis of @DISEASE$-specific methylated regions identified enrichment of binding sites for several neural cell negative regulation of apoptotic process-specifying transcription factors including @GENE$, negative regulation of transcription by RNA polymerase II, negative regulation of transcription, DNA-templated and REST.	0
Motif analysis of @DISEASE$-specific methylated regions identified enrichment of binding sites for several neural cell negative regulation of apoptotic process-specifying transcription factors including nitric oxide mediated signal transduction, @GENE$, negative regulation of transcription, DNA-templated and REST.	0
We identified 568 proteins in the CSF of infants with @DISEASE$, which is the most common @GENE$ of NTD.	0
Kindler syndrome is a rare, @DISEASE$ genodermatosis, caused by mutations in the @GENE$ gene.	1
De novo heterozygous mutations in @GENE$/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, @DISEASE$, and can include autistic features.	1
We characterized the cellular deficits for an allelic series of seven @GENE$ mutations and developed four mouse models that recapitulate the abnormal EEG activity and cognitive aspects of human STXBP1-@DISEASE$.	1
Together, these cellular studies suggest that impaired protein stability and @GENE$ haploinsufficiency explain STXBP1-@DISEASE$ and that, therefore, protein localization to plasma membrane+/- epidermis development provide a valid mouse model.	1
Together, these cellular studies suggest that impaired protein stability and protein localization to plasma membrane haploinsufficiency explain STXBP1-@DISEASE$ and that, therefore, @GENE$+/- epidermis development provide a valid mouse model.	1
Together, these cellular studies suggest that impaired protein stability and protein localization to plasma membrane haploinsufficiency explain STXBP1-@DISEASE$ and that, therefore, protein localization to plasma membrane+/- @GENE$ provide a valid mouse model.	0
Simultaneous video and EEG recordings revealed that @GENE$+/- epidermis development with different genomic backgrounds recapitulate the @DISEASE$/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.	1
Simultaneous video and EEG recordings revealed that protein localization to plasma membrane+/- @GENE$ with different genomic backgrounds recapitulate the @DISEASE$/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.	0
protein localization to plasma membrane+/- @GENE$ showed impaired cognitive performance, @DISEASE$ and anxiety-like behaviour, without altered social behaviour.	0
Taken together, these data demonstrate the construct, @GENE$ and predictive validity of protein localization to plasma membrane+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-@DISEASE$.	0
Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of @GENE$+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-@DISEASE$.	1
Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of protein localization to plasma membrane+/- @GENE$ and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of protein localization to plasma membrane-@DISEASE$.	0
Taken together, these data demonstrate the construct, interstrand cross-link repair and predictive validity of protein localization to plasma membrane+/- epidermis development and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of @GENE$-@DISEASE$.	1
@GENE$ is a high-risk @DISEASE$ susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear.	0
Although CHH and other @DISEASE$s caused by mutations in RMRP or @GENE$ are commonly cited as ribosomal biogenesis disorders, recent studies question this assumption.	0
Hepatocellular carcinoma (@GENE$) is the most common primary malignant liver @DISEASE$.	0
Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or @GENE$ (encoding fibulin-5), critical genes for elastogenesis, lead to @DISEASE$ cutis laxa types 1B and 1A, respectively.	1
Loss-of-function mutations of G protein-coupled acetylcholine receptor signaling pathway, which encodes G-protein subunit α11 (Gα11), a signaling partner for the calcium-sensing receptor (@GENE$), result in familial hypocalciuric @DISEASE$ type 2 (G protein-coupled acetylcholine receptor signaling pathway).	1
@GENE$ is characterized by @DISEASE$, inappropriately normal or raised parathyroid hormone (negative regulation of transcription by RNA polymerase II) concentrations, and normal or low urinary calcium excretion.	1
Our results demonstrated that SelM may have an important role in protecting against oxidative @GENE$ in the brain of chicken, which might shed light on the role of SelM in human @DISEASE$.	0
The candidate genes located within the new loci were related to ocular development (@GENE$, negative regulation of transcription by RNA polymerase II and MAP3K1) and @DISEASE$-related phenomuscle organ developments (biological_process, LMX1B and LOXL1).	1
The candidate genes located within the new loci were related to ocular development (regulation of transcription, DNA-templated, @GENE$ and MAP3K1) and @DISEASE$-related phenomuscle organ developments (biological_process, LMX1B and LOXL1).	0
The candidate genes located within the new loci were related to ocular development (regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II and MAP3K1) and @DISEASE$-related phenomuscle organ developments (@GENE$, LMX1B and LOXL1).	0
In addition, @GENE$ suppresses @DISEASE$ tubular expression of 1α-hydroxylase, the key enzyme responsible for vitamin D hormone production.	0
A mutation of @GENE$ has been identified in human patients with primary @DISEASE$ (motile cilium assembly).	1
A mutation of cilium movement has been identified in human patients with primary @DISEASE$ (@GENE$).	1
Mutant @GENE$ lacking Lrrc6 show typical motile cilium assembly defects such as @DISEASE$ and laterality defects.	0
Mutant epidermis development lacking Lrrc6 show typical @GENE$ defects such as @DISEASE$ and laterality defects.	0
Mutations in filamin A (@GENE$) or post-translational protein modification-ribosylation factor guanine nucleotide-exchange factor 2 (receptor recycling) cause periventricular nodular @DISEASE$, but most patients with this malformation do not have a known aetiology.	1
Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, @DISEASE$ and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (@GENE$) gene, mapping in the minimal critical deleted region.	1
Silencing of the contiguous @GENE$ or Notch signaling pathway genes only produced slightly delayed migration but not periventricular nodular @DISEASE$.	0
Silencing of the contiguous nervous system development or @GENE$ genes only produced slightly delayed migration but not periventricular nodular @DISEASE$.	0
Our data suggest that, of the genes within this minimal critical region, @GENE$ plays a major role in the control of neuronal migration and its haploinsufficiency or mutation causes periventricular nodular @DISEASE$.	1
Several publications had illustrated the relationship of between @GENE$ polymorphism and urinary @DISEASE$, but the results were not consistent.	0
Odds ratios (ORs) and 95% confidence intervals (CIs) were conducted to evaluate the overall strength of the associations in five genetic models, as well as in subgroup analyses, stratified by ethnicity, @DISEASE$ @GENE$ or source of control.	0
In the stratified analyses by @DISEASE$ types, the risk of @GENE$ is downgrade by rs7804372 in all five genetic models.	0
In this work we investigated the role of forkhead box O1 (@GENE$) in the transcriptional regulation in macrophages, which affects the anti-@DISEASE$ functions of tumor-associated macrophages (TAMs).	1
These results demonstrate that the pro@DISEASE$al property of TAMs is induced by the hypoxia-triggered @GENE$ deficiency, which could be a potential target of novel anti-tumor therapies	1
Furthermore, @GENE$ is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of @DISEASE$ (negative regulation of peptidase activity) patients (n=524, p=0.27).	0
Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in @DISEASE$ (@GENE$) patients, but is not associated with overall survival of squamous cell carcinoma (negative regulation of peptidase activity) patients (n=524, p=0.27).	0
Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in @DISEASE$ (negative regulation of protein catabolic process) patients, but is not associated with overall survival of squamous cell carcinoma (@GENE$) patients (n=524, p=0.27).	0
Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (@GENE$) patients, but is not associated with overall survival of @DISEASE$ (negative regulation of peptidase activity) patients (n=524, p=0.27).	0
Furthermore, positive regulation of transcription by RNA polymerase II is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (negative regulation of protein catabolic process) patients, but is not associated with overall survival of @DISEASE$ (@GENE$) patients (n=524, p=0.27).	0
Our data confirm the genetic @DISEASE$ of childhood-onset pure HSP, with SPG4/microtubule bundle formation and SPG3A/@GENE$ being the most frequent forms.	1
Our data confirm the genetic @DISEASE$ of childhood-onset pure HSP, with SPG4/@GENE$ and SPG3A/endoplasmic reticulum organization being the most frequent forms.	0
We identified eight @GENE$ genes which likely play important roles in @DISEASE$ metabolism and identified microRNAs that significantly negatively correlated with hub genes.	0
The results indicated that increased @GENE$ in adipose tissue may have a significant therapeutic potential in reducing @DISEASE$ and insulin resistance	0
Pathogenic variant in @GENE$ are a known cause of regulation of cell shape autosomal dominant @DISEASE$ hearing loss and vestibular dysfunction with adult onset.	1
Pathogenic variant in @GENE$ are a known cause of regulation of cell shape autosomal dominant progressive @DISEASE$ and vestibular dysfunction with adult onset.	1
Pathogenic variant in @GENE$ are a known cause of regulation of cell shape autosomal dominant progressive hearing loss and @DISEASE$ with adult onset.	1
Pathogenic variant in regulation of cell shape are a known cause of @GENE$ autosomal dominant progressive hearing loss and @DISEASE$ with adult onset.	1
Here, we describe two brothers with congenital prelingual @DISEASE$ and a homozygous nonsense c.292C&gt;T(p.Arg98*) @GENE$ variant, suggesting a loss-of-function effect.	1
This is the first report of @DISEASE$ of cochlea-vestibular dysfunction caused by a pathogenic variant in the @GENE$ gene.	0
This is the first report of autosomal recessive inheritance of cochlea-@DISEASE$ caused by a pathogenic variant in the @GENE$ gene.	1
An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant @DISEASE$ causing @GENE$ variants is observed	1
Danon disease, an X-linked dominant cardioskeletal @DISEASE$, is caused by primary deficiency of lysosome-associated membrane protein-2 (@GENE$-2).	0
The K<sup>+</sup> channel @GENE$ has been proposed as a tumor suppressor in colorectal @DISEASE$ (CRC).	1
Analysis of human primary CRC @DISEASE$ patient databases showed a positive correlation between @GENE$:KCNE3 channel complex expression and disease-free survival.	1
We conclude that the @GENE$ ion channel is a target gene and regulator of the Wnt/β-catenin pathway, and its repression leads to CRC cell proliferation, cytokine production, and @DISEASE$igenesis	1
We conclude that the cellular response to drug ion channel is a target gene and regulator of the Wnt/β-catenin pathway, and its repression leads to CRC cell proliferation, @GENE$, and @DISEASE$igenesis	1
We hope that our study will stimulate further studies and a new targeted therapy and early medical intervention for YAP/TAZ could be a useful option for breast @DISEASE$ cases complicated with @GENE$ deficiency	1
TAF12, regulation of transcription, DNA-templated, and @GENE$ co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in @DISEASE$ in both species and required for disease initiation and progression.	1
Mendelian randomization analyses suggest causal inverse associations, independent of body @GENE$ index (BMI), between puberty timing and risks for breast and endometrial @DISEASE$s in women and prostate cancer in men.	0
Some RA patients are likely to increase visceral @GENE$ without @DISEASE$ [Body Mass Index (BMI) ≥ 25].	0
To confirm this signal is exclusive to @GENE$-amplified @DISEASE$, we performed a second meta-analysis comparing 728 MYCN-nonamplified high-risk patients to identical controls.	1
Additionally, the previously reported @GENE$ neuroblastoma risk locus was statistically significant only in patients with positive regulation of gene expression-nonamplified high-risk @DISEASE$ (OR = 0.63, 95% CI = 0.53 to 0.75, Pmeta = 1.51 × 10-8; Pmeta = .95).	1
Additionally, the previously reported positive regulation of transcription by RNA polymerase II neuroblastoma risk locus was statistically significant only in patients with @GENE$-nonamplified high-risk @DISEASE$ (OR = 0.63, 95% CI = 0.53 to 0.75, Pmeta = 1.51 × 10-8; Pmeta = .95).	1
Our results indicate that common genetic variation predisposes to different @DISEASE$ genotypes, including the likelihood of somatic @GENE$-amplification	0
The @DISEASE$ gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, @GENE$, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	0
The gonadoblastoma gene, testis-specific protein Y-encoded (@GENE$), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a @DISEASE$ suppressor respectively in human oncogenesis.	0
@GENE$ and negative regulation of DNA replication co-localize with the endogenous oxidation-reduction process, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate @DISEASE$ cells.	0
sex differentiation and @GENE$ co-localize with the endogenous oxidation-reduction process, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate @DISEASE$ cells.	0
sex differentiation and negative regulation of DNA replication co-localize with the endogenous @GENE$, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate @DISEASE$ cells.	0
Our results provide evidence that sequence variants in human @GENE$ cause @DISEASE$ isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.	1
The results imply that variants associated with prostate @DISEASE$ can be identified through expressional change in the @GENE$ gene, but not in the overlapped glycine N-methyltransferase gene which had been considered as a candidate gene.Further studies are required to understand their underlying mechanisms for the strong eQTLs for the SNHG5 and PEX6 genes	0
Study of RetGC1 regulation in vitro and its association with fluorescently tagged @GENE$ in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, @DISEASE$ 3 (RD3).	1
Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (@GENE$) has been recently described as a @DISEASE$ of autosomal recessive inheritance.	0
Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE pheno@GENE$ characterized by severe developmental delay, poor visual contact with @DISEASE$, and postnatal microcephaly.	0
Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE pheno@GENE$ characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal @DISEASE$.	0
In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, @DISEASE$, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the @GENE$ joint, and cryptorchidism).	0
In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and @DISEASE$), and multiple congenital malformations (including cerebral dysplasia, dislocation of the @GENE$ joint, and cryptorchidism).	0
However, in @DISEASE$ (phosphatidylinositol phosphorylation), the characteristics and mechanism of @GENE$ expression have not been well defined.	0
However, in @DISEASE$ (@GENE$), the characteristics and mechanism of regulation of activated T cell proliferation expression have not been well defined.	0
In this study, @GENE$ expression in @DISEASE$ cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from phosphatidylinositol phosphorylation patients, and the expression patterns were mostly focal (102/109).	0
In this study, regulation of activated T cell proliferation expression in @DISEASE$ cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from @GENE$ patients, and the expression patterns were mostly focal (102/109).	0
These findings indicated that T-@GENE$ expression in phosphatidylinositol phosphorylation is common and is dominantly driven by the host anti@DISEASE$ immune response, which is a favorable prognostic factor in HCC	0
These findings indicated that T-regulation of activated T cell proliferation expression in @GENE$ is common and is dominantly driven by the host anti@DISEASE$ immune response, which is a favorable prognostic factor in HCC	0
Obesity causes several chronic diseases, including cardiovascular and respiratory diseases, osteoarthritis, hypertension, stroke, @GENE$ II diabetes, @DISEASE$, and several types of cancer.	0
Obesity causes several chronic diseases, including cardiovascular and respiratory diseases, osteoarthritis, hypertension, stroke, @GENE$ II diabetes, obstructive sleep apnea, and several types of @DISEASE$.	0
Previous genome-wide association studies have identified several genes associated with @DISEASE$, including @GENE$, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	1
Previous genome-wide association studies have identified several genes associated with @DISEASE$, including angiogenesis, LEPR, @GENE$, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	1
Previous genome-wide association studies have identified several genes associated with @DISEASE$, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, @GENE$, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	1
Previous genome-wide association studies have identified several genes associated with @DISEASE$, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, @GENE$, QPCTL/GIPR, synapse assembly, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	0
Previous genome-wide association studies have identified several genes associated with @DISEASE$, including angiogenesis, LEPR, negative regulation of tumor necrosis factor production, peptide biosynthetic process, DNA dealkylation involved in DNA repair, MC3R, MC4R, glucosamine catabolic process, cell migration, QPCTL/GIPR, @GENE$, cellular response to oxidative stress, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	1
We therefore screened patients with hereditary PHPV, as well as @DISEASE$ optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in @GENE$.	0
We therefore screened patients with hereditary PHPV, as well as bilateral @DISEASE$ (ONA) or hypoplasia (ONH), for mutations in @GENE$.	0
We identified a homozygous @GENE$ mutation (N46H) in a large family with an @DISEASE$ PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.	1
We identified a homozygous @GENE$ mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five @DISEASE$ ONA patients.	0
This case-control study was aimed to evaluate the influence of cytochrome P450 family 17 subfamily A member 1 (@GENE$) gene rs743572 polymorphism for the susceptibility to @DISEASE$.Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype rs743572 polymorphism in 143 endometriosis patients and 148 healthy controls.	0
But we failed to @GENE$ any obvious association of rs743572 genotypes with @DISEASE$ stages and characteristics.T allele of rs743572 polymorphism might act as a risk factor for endometriosis, although it had no effects on the disease stages and basic features	0
Since microtubule severing is an important cellular mechanism of which malfunctions result in serious diseases such as spastic @DISEASE$, Alzheimer's disease and cell cycle related disorders, identification of @GENE$ transcriptional regulation is crucial in understanding the coordination of microtubule severing activity by different proteins in the cells.	0
In conclusion, our research results strongly recommend combination analysis of cytoplasmic and nuclear girdin for a precise prognostic prediction in breast @DISEASE$.-Zhang, H., Yu, F., @GENE$, F., Shao, Y., Chong, W., Guo, Z., Liu, X., Fu, L., Gu, F., Ma, Y.	0
We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, @DISEASE$, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in @GENE$, the gene encoding CK2α, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory (β) and two catalytic (α and/or α') subunits.	0
We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, @DISEASE$, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in @GENE$, the gene encoding CK2α, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory (β) and two catalytic (α and/or α') subunits.	0
Mutations in subunits of mitochondrial m-AAA proteases in the inner membrane cause neurodegeneration in spinocerebellar ataxia (@GENE$) and hereditary @DISEASE$ (HSP7).	0
Further, exposure to the Notch signaling inhibitor and gene silencing studies showed that Notch signaling inhibition or silencing Nothc4/Dll3 decreased endothelial markers and function of @DISEASE$-derived endothelial cells under chemotherapy treatment, which may be through @GENE$R3.	0
Here, we identify a cause of the @DISEASE$ @GENE$ class of inborn errors of vitamin B<sub>12</sub> metabolism that we name &quot;epi-cblC&quot;.	0
This study aimed to investigate @GENE$ expression in tamoxifen resistant (TAM-R) and tamoxifen sensitive (TAM-S) @DISEASE$ patients and analyze its correlation with clinicopathological characteristics and survival.	0
Immunohistochemical analysis was performed to evaluate @GENE$ protein expression in 36 TAM-R and 36 TAM-S formalin-fixed paraffin-embedded (FFPE) breast @DISEASE$ tissues.	0
Our data suggested that high expression of @GENE$ could be associated with better survival in estrogen receptor positive tamoxifen-treated @DISEASE$ patients	0
Deregulation of the phosphoinositide 3-kinase (@GENE$) pathway contributes to the development and progression of @DISEASE$.	1
Here, we determine that somatic mutations in @GENE$ (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast @DISEASE$ patients, with 60 novel mutations identified.	1
Here, we determine that somatic mutations in phosphorylation (44%), @GENE$ (17%), positive regulation of blood vessel endothelial cell migration (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast @DISEASE$ patients, with 60 novel mutations identified.	1
Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), @GENE$ (15%), and negative regulation of protein phosphorylation (12%) are prevalent and diverse in Chinese breast @DISEASE$ patients, with 60 novel mutations identified.	0
Here, we determine that somatic mutations in phosphorylation (44%), phosphatidylinositol 3-kinase signaling (17%), positive regulation of blood vessel endothelial cell migration (15%), and @GENE$ (12%) are prevalent and diverse in Chinese breast @DISEASE$ patients, with 60 novel mutations identified.	1
Collectively, these findings advance our understanding of @GENE$ impactful mutations in breast @DISEASE$ and have important implications for PI3K-targeted therapy in precision oncology	1
By way of whole-exome sequencing, we identified a homozygous missense mutation in @GENE$ in one subject with @DISEASE$ and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in @GENE$ in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with @DISEASE$ hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with @DISEASE$ and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (@GENE$) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with @DISEASE$ and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in @GENE$ in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and @DISEASE$ associated with isolated deficiency of the mitochondrial respiratory chain (@GENE$) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and @DISEASE$ associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in @GENE$ in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the @DISEASE$ respiratory chain (@GENE$) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the @DISEASE$ respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in @GENE$ in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (@GENE$) complex I and compound heterozygous mutations in mitochondrial threonyl-tRNA aminoacylation in two siblings presenting with @DISEASE$ hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
By way of whole-exome sequencing, we identified a homozygous missense mutation in tRNA aminoacylation for protein translation in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (negative regulation of NF-kappaB transcription factor activity) complex I and compound heterozygous mutations in @GENE$ in two siblings presenting with @DISEASE$ hypotonia and severe psychomotor delay associated with multiple MRC defects.	0
Expression of the corresponding wild-type transcripts in immortalized mutant fibroblasts rescued the biochemical impairment of @DISEASE$ respiration and yeast modeling of the @GENE$ mutation confirmed its pathogenic role.	0
Our study reports the first mutations in the @GENE$ and mitochondrial threonyl-tRNA aminoacylation genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial @DISEASE$.	0
Our study reports the first mutations in the tRNA aminoacylation for protein translation and @GENE$ genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial @DISEASE$.	0
De novo monoallelic mutations in the @GENE$ gene, encoding a β subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe @DISEASE$/intellectual disability, hypotonia and extrapyramidal symptoms.	1
De novo monoallelic mutations in the @GENE$ gene, encoding a β subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/@DISEASE$, hypotonia and extrapyramidal symptoms.	1
Similarly, homozygous loss-of-function mutations in @GENE$, one of the major RA-metabolizing enzymes, cause advanced bone age, premature epiphyseal fusion, and @DISEASE$.	1
Mutations in the @GENE$ gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or glomerular basement membrane development are responsible for @DISEASE$ Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	0
Mutations in the extracellular matrix organization gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or @GENE$ are responsible for @DISEASE$ Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	1
This result suggests that COL4A3 and COL4A4 digenic mutations in @GENE$ mimicking an autosomal dominant @DISEASE$ should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	0
The @DISEASE$-associated gene GRIN2A (glutamate ionotropic receptor NMDA @GENE$ subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.	0
The results also suggest that some @DISEASE$-related alleles may be subject to cognitive tradeoffs involving both positive and negative effects on psychological pheno@GENE$s, which may help to explain the maintenance of psychiatric-disorder risk alleles in human populations	0
The most significant association with childhood brain @DISEASE$ risk was for IVS1-401G&gt;C in the @GENE$ gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&gt;C of CASP14 was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).	0
Clinical trials have revealed that inhibition of sonic Hedgehog (SHH) signaling or histone deacetylase (@GENE$) holds promise as a treatment for liver @DISEASE$.	0
The results revealed that the dual use of the SHH inhibitor and the @GENE$ inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver @DISEASE$ cells.	0
Genetic variation in the @GENE$/regulation of cell growth region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical @DISEASE$, HPV persistence and progression to cervical cancer.	1
Genetic variation in the @GENE$/regulation of cell growth region has been linked to beta-type HPV infection and @DISEASE$, cervical cancer, HPV persistence and progression to cervical cancer.	0
Genetic variation in the neutrophil degranulation/@GENE$ region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical @DISEASE$, HPV persistence and progression to cervical cancer.	1
Genetic variation in the neutrophil degranulation/@GENE$ region has been linked to beta-type HPV infection and @DISEASE$, cervical cancer, HPV persistence and progression to cervical cancer.	0
Here, we have tested the hypothesis that the common @GENE$ SNP rs7208422 is associated with high-risk HPV infection and risk of head and neck @DISEASE$ (HNSCC).	1
The @GENE$ mutant epidermis development have been characterized for their propensity to develop congenital @DISEASE$, polycystic kidney disease, and some types of cancer.	1
The @GENE$ mutant epidermis development have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of @DISEASE$.	0
The negative regulation of transcription by RNA polymerase II mutant @GENE$ have been characterized for their propensity to develop congenital @DISEASE$, polycystic kidney disease, and some types of cancer.	0
The negative regulation of transcription by RNA polymerase II mutant @GENE$ have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of @DISEASE$.	0
In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast @DISEASE$ risk and the expression of @GENE$ (joint p-value: 3.6x10-06) and pyrimidine nucleoside biosynthetic process (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).	0
In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast @DISEASE$ risk and the expression of chromatin organization (joint p-value: 3.6x10-06) and @GENE$ (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).	0
While genome-wide association studies (GWAS) have implicated @GENE$ and protein export from nucleus in breast @DISEASE$ risk, they have not identified the remaining three genes.	0
Collectively, @GENE$L supports the induction of durable, antigen-specific Th17/Th1-mediated immunity in vivo, establishing a vaccination platform to enhance CD4<sup>+</sup> T cell-mediated antitumor immunity and providing a crucial component of an effective @DISEASE$ vaccine	1
Muscarinic acetylcholine receptor M3 (@GENE$) was reported as a key receptor in different @DISEASE$ types.	0
<i>@GENE$</i> is located at 1q42-43 which was reported to associate with bladder @DISEASE$.	0
Advanced @GENE$ involves a thickening of the cornea from stromal @DISEASE$ and changes in Descemet membrane.	1
Gen@GENE$lized @DISEASE$, particularly the idiopathic or genetic generalized epilepsies (GGEs), represent some of the most common epilepsies.	0
The first decade of the 21st century was marked by progress in understanding the basic biology of gen@GENE$lized @DISEASE$ including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, SCN1B, inhibitory synapse assembly, and GABRA1.	0
The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized @DISEASE$ including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in @GENE$, SCN1B, inhibitory synapse assembly, and GABRA1.	1
The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized @DISEASE$ including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, SCN1B, @GENE$, and GABRA1.	1
Genes for epileptic encephalopathies such as @GENE$ were rediscovered in GGE, highlighting the biological continuum between different @DISEASE$.	1
However, the role of circRNAs in age-related @DISEASE$ (@GENE$), the leading cause of visual impairment worldwide, is still unknown.	0
However, the role of circRNAs in age-related cataract (@GENE$), the leading cause of @DISEASE$ worldwide, is still unknown.	0
The short-rib polydactyly syndromes (@GENE$S) are autosomal recessively inherited, genetically @DISEASE$ skeletal ciliopathies.	0
Specifically, ADHFE1, @GENE$, and protein folding were hypermethylated and downregulated in colon @DISEASE$, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	0
Specifically, ADHFE1, positive regulation of cardiac muscle hypertrophy, and @GENE$ were hypermethylated and downregulated in colon @DISEASE$, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	0
The pH-sensing receptor ovarian @DISEASE$ G protein-coupled receptor 1 (inflammatory response; @GENE$) is expressed in the gut.	0
Congenital hypogonadotrophic @DISEASE$ (CHH) is a challenging inherited endocrine disorder characterised by absent or incomplete pubertal development and infertility as a result of the low action/secretion of the hypothalamic gonadotrophin-releasing hormone (@GENE$).	1
Previously, a homozygous missense mutation in @GENE$ in the Hutterite population was reported in association with syndromic @DISEASE$.	1
Our results expand the mutational and clinical spectrum of this rare disease, confirm that @GENE$ is an @DISEASE$ causing gene, while providing insight into the importance of the THO complex in neurodevelopment	1
Our study demonstrated that AURKA rs1047972 TT and (CC + CT) geno@GENE$s were significantly associated with an increased risk of gastric @DISEASE$.	0
Malfunction of mutant @GENE$ proteins triggers a severe form of Leber congenital amaurosis and leads to @DISEASE$.	1
Several mouse models have been described for this gene; @GENE$ heterozygous for loss-of-function defects display a rapidly progressive high-frequency @DISEASE$.	0
Up to now @GENE$ has only been reported as a modifier, or in a digenic mechanism with calcium ion transport for @DISEASE$ in humans.	0
Up to now cellular calcium ion homeostasis has only been reported as a modifier, or in a digenic mechanism with @GENE$ for @DISEASE$ in humans.	1
Although a @DISEASE$ pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and @GENE$, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	0
Although a digenic inheritance pattern of @DISEASE$ has been reported for heterozygous missense variants of ATP2B2 and @GENE$, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	1
Friedreich's @DISEASE$ (FA) is an autosomal recessive disease caused by an intronic @GENE$ triplet expansion in the regulation of ferrochelatase activity gene, leading to reduced expression of the mitochondrial protein frataxin.	0
Friedreich's @DISEASE$ (FA) is an autosomal recessive disease caused by an intronic glycogen catabolic process triplet expansion in the @GENE$ gene, leading to reduced expression of the mitochondrial protein frataxin.	1
Friedreich's ataxia (FA) is an @DISEASE$ disease caused by an intronic @GENE$ triplet expansion in the regulation of ferrochelatase activity gene, leading to reduced expression of the mitochondrial protein frataxin.	1
Friedreich's ataxia (FA) is an @DISEASE$ disease caused by an intronic glycogen catabolic process triplet expansion in the @GENE$ gene, leading to reduced expression of the mitochondrial protein frataxin.	1
@GENE$-positive regulation of transcription by RNA polymerase II promotes a @DISEASE$igenic phenotype in vitro, and is absent in 723 other salivary gland tumors.	0
epithelial to mesenchymal transition-@GENE$ promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland @DISEASE$.	1
Focal epilepsies, where seizures initiate in spatially limited networks, are the most frequent @DISEASE$ @GENE$, accounting for two-thirds of patients.	0
Brain somatic mutations in the gene encoding @GENE$ (regulation of cell growth) have recently been linked to focal @DISEASE$ and other associated brain pathologies including hemimegalencephaly.	1
Brain somatic mutations in the gene encoding @GENE$ (regulation of cell growth) have recently been linked to focal cortical dysplasia and other associated brain pathologies including @DISEASE$.	1
Brain somatic mutations in the gene encoding regulation of cell growth (@GENE$) have recently been linked to focal @DISEASE$ and other associated brain pathologies including hemimegalencephaly.	1
In subgroup analysis, compared with PD patients with initial symptom of tremor and @GENE$, the positive regulation of glucose transmembrane transport allele frequency of ribosomal large subunit export from nucleus rs34016896 in PD patients with initial symptoms of rigidity/@DISEASE$ was significantly lower.	0
In subgroup analysis, compared with PD patients with initial symptom of tremor and mitochondrion organization, the @GENE$ allele frequency of ribosomal large subunit export from nucleus rs34016896 in PD patients with initial symptoms of rigidity/@DISEASE$ was significantly lower.	0
We performed a quantitative proteomics study of EOC patient @DISEASE$ tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, extracellular matrix disassembly, PFN1, mitotic cytokinesis, CFN1) associated with loss of @GENE$ function.	1
We performed a quantitative proteomics study of EOC patient @DISEASE$ tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, @GENE$, PFN1, mitotic cytokinesis, CFN1) associated with loss of double-strand break repair via homologous recombination function.	0
By immunohistochemistry of ovarian @DISEASE$s with @GENE$(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated negative regulation of actin filament polymerization expression associated with BRCA1 deficiency.	1
Finally, we established a causal link between @GENE$ and double-strand break repair via homologous recombination-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian @DISEASE$ cell migration.	0
Finally, we established a causal link between negative regulation of actin filament polymerization and @GENE$-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian @DISEASE$ cell migration.	1
Mutations in Ankyrin repeat and sterile alpha motif domain containing 6 (@GENE$) play a causative role in @DISEASE$ formation in the PKD/Mhm(cy/+) rat model of polycystic kidney disease and in nephronophthisis in humans.	1
A network of protein partners of @GENE$ is emerging and their functional characterization provides important clues to understand the role of ANKS6 in renal biology and in mechanisms involved in the formation of @DISEASE$s.	1
Upregulated LINC00963 led to elevated expression of protein homooligomerization through inhibiting @GENE$-608, which consequently promoted @DISEASE$ malignant progression.	0
Taken together, our results illustrated that LINC00963-@GENE$-608-NACC1 pathway might be a potential target for @DISEASE$ therapy	0
We recently reported that centrosomal protein 164 (cilium assembly) regulates both cilia and the DNA @GENE$ response in the @DISEASE$ polycystic kidney disease nephronophthisis.	0
Jeune asphyxiating thoracic dystrophy (JATD) is a @DISEASE$ characterized by a small thoracic @GENE$ and a range of skeletal and extra-skeletal anomalies.	0
Inhibition of the @GENE$ ortholog in zebrafish produced pleiotropic phenotypes characteristic of cilia defects including abnormal body curvature, @DISEASE$, otolith defects and abnormal renal, head and craniofacial development.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, @DISEASE$, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, @DISEASE$, and retinal abnormalities, including retinal detachment.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, @DISEASE$, glaucoma, and retinal abnormalities, including retinal detachment.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, @DISEASE$, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, @DISEASE$, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including @DISEASE$.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, @DISEASE$, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, @DISEASE$, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, @DISEASE$, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, @DISEASE$, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, @GENE$, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including @DISEASE$.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, @GENE$, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, @DISEASE$, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, @GENE$, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, @DISEASE$, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, @GENE$, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, @DISEASE$, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, @GENE$, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including @DISEASE$.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, @DISEASE$, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, glycosaminoglycan biosynthetic process, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, @DISEASE$, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The @DISEASE$ and cataracts in this patient may thus have been caused by her @GENE$ mutation, but the colobomas are a novel phenotypic finding.	0
Mitochondrial dysfunction and epithelial-to-mesenchymal transition (@GENE$) play important roles in @DISEASE$ development and metastasis.	1
However, very little is known about the connection between @DISEASE$ and @GENE$.	0
@GENE$ expression level was positively correlated with that of E-cadherin and decreased significantly during the progression of human lung @DISEASE$.	0
Mechanistically, @GENE$ knockdown activated AMPK and phosphorylated GSK3β and increased the nuclear accumulation of β-catenin, leading to the induction of cytokine production and increased migration and metastasis of A549 lung @DISEASE$ cells.	0
Mechanistically, translational elongation knockdown activated AMPK and phosphorylated GSK3β and increased the nuclear accumulation of β-catenin, leading to the induction of @GENE$ and increased migration and metastasis of A549 lung @DISEASE$ cells.	1
Although @GENE$ knockdown also induced cytokine production of MCF7 breast @DISEASE$ cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.	0
Our work identifies @GENE$ as a novel regulator of cytokine production and suggests a molecular link between @DISEASE$ and EMT induction.	0
Our work identifies translational elongation as a novel regulator of @GENE$ and suggests a molecular link between @DISEASE$ and EMT induction.	0
In parallel, we recently reported that <i>Cc2d1a</i>-deficient @GENE$ present with cognitive and social deficits, @DISEASE$ and anxiety.	0
We generated <i>Cc2d1b</i> knockout (KO), <i>Cc2d1a/1b</i> double heterozygous and double KO @GENE$, then performed behavioral studies to analyze learning and memory, social interactions, anxiety, and @DISEASE$.	0
Cervical @DISEASE$ is the fourth most common malignancy among women worldwide, and continued research to discover biomarkers or therapeutic targets will @GENE$ early diagnosis and treatment of this cancer.	0
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: @GENE$, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.	0
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: post-translational protein modification, SYCP2, KIF4A, @GENE$, DNA topological change, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.	0
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, @GENE$, regulation of autophagy, microtubule bundle formation, MCM2, and APOBEC3B.	1
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, @GENE$, microtubule bundle formation, MCM2, and APOBEC3B.	0
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: post-translational protein modification, SYCP2, KIF4A, regulation of cytokinesis, DNA topological change, regulation of autophagy, @GENE$, MCM2, and APOBEC3B.	0
Finally, we validated these observations by investigating @GENE$ expression in cervical @DISEASE$ tissue and serum samples.	0
The diagnostic specificity of serum @GENE$ in cervical @DISEASE$ occurrence was also compared with other high incidence diseases.	0
All of these data indicate that @GENE$ may be a novel @DISEASE$ predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer	0
All of these data indicate that @GENE$ may be a novel cancer predictive marker and a potential therapeutic target for @DISEASE$ development and progression in cervical cancer	0
We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (@GENE$), whose expression was induced in the human @DISEASE$ cell line TGW expressing regulation of cell adhesion by neural crest cell migration stimulation and was also detected in mouse metanephric kidney.	0
We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (negative regulation of transcription by RNA polymerase II), whose expression was induced in the human @DISEASE$ cell line TGW expressing @GENE$ by neural crest cell migration stimulation and was also detected in mouse metanephric kidney.	1
In addition, @GENE$ expression was undetectable or very low in most cases of @DISEASE$ and Wilms tumors.	0
In addition, @GENE$ expression was undetectable or very low in most cases of renal cell carcinomas and Wilms @DISEASE$.	0
Results Clinical evaluations suggested @DISEASE$ nonsyndromic @GENE$.	1
Overall, our findings establish RASSF4 as a @DISEASE$-suppressive @GENE$ in MM and provide a mechanistic rationale for combining trametinib with negative regulation of transcription by RNA polymerase II inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	0
Overall, our findings establish RASSF4 as a @DISEASE$-suppressive mRNA splicing, via spliceosome in MM and provide a mechanistic rationale for combining trametinib with @GENE$ inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	0
@GENE$ is one of the nuclear genes responsible of autosomal dominant @DISEASE$ external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.	1
Further studies are needed to assess the prevalence of @DISEASE$ neurological manifestations in @GENE$ mitochondrial disease	0
Thus we conclude that the @DISEASE$ in the family described in this report is caused by a novel missense mutation in @GENE$.	1
While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (@GENE$) and regulation of autophagy (regulation of autophagy), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in @DISEASE$.	0
While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (regulation of cellular respiration) and @GENE$ (regulation of autophagy), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in @DISEASE$.	0
While there has been growing interest in the homodimeric gene products of regulation of cellular respiration (regulation of cellular respiration) and regulation of autophagy (@GENE$), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in @DISEASE$.	0
Thus loss of @GENE$ produces a unique set of @DISEASE$, and is associated with haematopoietic/immune symptoms affecting cell lineages where this isoform predominates.	1
RAD51C and @GENE$ have been defined as susceptibility genes for hereditary breast and ovarian @DISEASE$ syndrome in several studies.	1
The @GENE$ pathogenic variant c.404G &gt; A was identified in a breast and ovarian @DISEASE$ family (0.7%), while the strand invasion pathogenic variant c.694C &gt; T was described in an ovarian cancer family (1.3%).	1
The DNA repair pathogenic variant c.404G &gt; A was identified in a breast and ovarian @DISEASE$ family (0.7%), while the @GENE$ pathogenic variant c.694C &gt; T was described in an ovarian cancer family (1.3%).	1
These results increase our knowledge about the @GENE$ and strand invasion mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian @DISEASE$ syndrome	1
These results increase our knowledge about the DNA repair and @GENE$ mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian @DISEASE$ syndrome	1
Fc-@GENE$ receptor-IIb (FcγRIIb) and its ligand are reported to be associated with @DISEASE$ and muscle organ development 2 diabetes mellitus (T2DM).	0
Fc-histone H3 acetylation receptor-IIb (FcγRIIb) and its ligand are reported to be associated with @DISEASE$ and @GENE$ 2 diabetes mellitus (T2DM).	0
@GENE$ functions as a @DISEASE$ suppressor gene and has been reported in pancreatic tumor cells.	0
Here, we examined the expression level of @GENE$ in human response to hydroperoxide tissues and renal @DISEASE$ cells by real-time quantitative RT-PCR and western blot.	0
Here, we examined the expression level of mitotic chromosome condensation in human @GENE$ tissues and renal @DISEASE$ cells by real-time quantitative RT-PCR and western blot.	0
We found that the expression level of @GENE$ is significantly lower in RCC tissues and renal @DISEASE$ cells compared with adjacent non-tumorous tissues and normal renal cells.	0
Interestingly, overexpression of @GENE$ using a eukaryotic plasmid inhibited the proliferation of renal @DISEASE$ cells in vitro and the growth of renal tumor in vivo.	0
Thus, our results demonstrate that @GENE$ functions as a @DISEASE$ suppressor gene in renal cells and may be a useful target for treatment of RCC	0
Chylomicron retention disease (@GENE$) is a rare @DISEASE$ hereditary hypocholesterolemic disorder.	1
Heterotaxy, a birth defect involving left-right patterning defects, and primary @DISEASE$ (@GENE$), a sinopulmonary disease with dyskinetic/immotile cilia in the airway are seemingly disparate diseases.	1
Recent research published in the Journal of Pathology showed that genetic depletion of any of the @GENE$ subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	0
Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits @GENE$, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	0
Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, @GENE$, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	0
Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, @GENE$ and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	0
Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, Cybb, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and @GENE$ reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	0
p.(Arg320His) mutation in the @GENE$ gene in human 11p15.1 has recently been identified in patients with progressive @DISEASE$ epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	1
p.(Arg320His) mutation in the @GENE$ gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic @DISEASE$, and ataxia.	1
As previously observed in the mutant mouse carrying a disrupted @GENE$ gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present @DISEASE$ without seizure and epilepsy	0
No significant associations were detected between these SNPs and @DISEASE$ in Han Chinese and the @GENE$ data set.	0
However, we observed nominal significant associations of 2 SNPs in the @GENE$ gene and 4 SNPs in the response to oxidative stress gene with early onset @DISEASE$ (EOS), but none of these associations survived the Bonferroni correction.	0
However, we observed nominal significant associations of 2 SNPs in the apoptotic mitochondrial changes gene and 4 SNPs in the @GENE$ gene with early onset @DISEASE$ (EOS), but none of these associations survived the Bonferroni correction.	0
We initially selected 6 fluoropyrimidine metabolism-related genes (@GENE$, ORPT, TYMS, pyrimidine nucleoside metabolic process, TK1, and TK2) and 3 radiotherapy response-related genes (protein-containing complex assembly, HIF-1α, and HIF-2α) as targets for gene expression identification in 60 chemotaxis @DISEASE$ specimens.	0
We initially selected 6 fluoropyrimidine metabolism-related genes (thymine catabolic process, ORPT, TYMS, @GENE$, TK1, and TK2) and 3 radiotherapy response-related genes (protein-containing complex assembly, HIF-1α, and HIF-2α) as targets for gene expression identification in 60 chemotaxis @DISEASE$ specimens.	0
After CCRT, 39 of 60 (65%) @GENE$ patients were classified as responders (pathological @DISEASE$ regression grade 2 ~ 4).	0
We aimed to identify the genetic cause of the devastating @DISEASE$ amyotrophic lateral sclerosis (ALS) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, @GENE$, in a central European ALS cohort.	1
Additionally, novel or rare heterozygous @GENE$ missense variants predicted to be deleterious were detected in five @DISEASE$ signal transduction patients revealing an overall FIG4 variant frequency of 3% in our cohort.	0
Additionally, novel or rare heterozygous phosphatidylinositol biosynthetic process missense variants predicted to be deleterious were detected in five @DISEASE$ @GENE$ patients revealing an overall FIG4 variant frequency of 3% in our cohort.	0
Four of six variants identified were previously associated with @GENE$ or the motor and sensory @DISEASE$ Charcot-Marie-Tooth disease muscle organ development 4J (phosphatidylinositol biosynthetic process), whereas two variants were novel.	0
Four of six variants identified were previously associated with signal transduction or the motor and sensory @DISEASE$ Charcot-Marie-Tooth disease @GENE$ 4J (phosphatidylinositol biosynthetic process), whereas two variants were novel.	0
Four of six variants identified were previously associated with signal transduction or the motor and sensory @DISEASE$ Charcot-Marie-Tooth disease muscle organ development 4J (@GENE$), whereas two variants were novel.	1
@GENE$, a major transcription factor in transforming growth factor-β (TGF-β) signaling, plays critical roles in both @DISEASE$-suppressive and pro-oncogenic functions.	0
However, recent discoveries of @GENE$-interacting molecules that preferentially bind phosphorylated Smad3 linker serine/threonine residues have shown a multitude of signal transductions that either enhance or suppress TGF-β responses associated with Smad3 turnover or @DISEASE$ progression.	0
Recessive mutations in the secreted metalloprotease @GENE$ cause @DISEASE$ and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.	1
Recessive mutations in the secreted metalloprotease @GENE$ cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle @DISEASE$ and ectopia lentis in dogs.	1
We investigated the effects of heightened levels of @GENE$ on dopamine-regulated motor behaviors and molecular alterations in a mouse model of @DISEASE$.	0
Our results demonstrate that human @GENE$ overexpression confers a heightened susceptibility to l-DOPA-induced @DISEASE$ and alters molecular and neurochemical responses in the lesioned striatum of mice	0
@GENE$s display resistance to frontline cancer treatment and retain the ability to repopulate a @DISEASE$ after therapy, leading to cancer relapse.	0
@GENE$s display resistance to frontline @DISEASE$ treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.	0
We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast @DISEASE$ cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, @GENE$.	0
We further show that upregulation of @GENE$ is necessary for regulation of ARF protein signal transduction induction downstream of protein polyubiquitination-106b-25 in both ER + and TNBC breast @DISEASE$ cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	1
We further show that upregulation of cell cycle arrest is necessary for @GENE$ induction downstream of protein polyubiquitination-106b-25 in both ER + and TNBC breast @DISEASE$ cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	0
We further show that upregulation of cell cycle arrest is necessary for regulation of ARF protein signal transduction induction downstream of @GENE$-106b-25 in both ER + and TNBC breast @DISEASE$ cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	0
These data expand our knowledge of the mechanisms underlying NOTCH activation and @GENE$ induction in breast @DISEASE$, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells	0
Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast @DISEASE$, including @GENE$, biological_process, negative regulation of transcription by RNA polymerase II and ZNF367.	0
Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast @DISEASE$, including positive regulation of endothelial cell differentiation, @GENE$, negative regulation of transcription by RNA polymerase II and ZNF367.	0
Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast @DISEASE$, including positive regulation of endothelial cell differentiation, biological_process, @GENE$ and ZNF367.	0
Next-generation sequencing (NGS) of the genetic information of @DISEASE$ cells has revolutionized the field of cancer biology, including prostate cancer (@GENE$).	0
With its highly @DISEASE$ nature, @GENE$ continues to pose a tremendous challenge in terms of diagnosis and prognosis.	0
We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human @GENE$ (signal transduction(+) or HER2(-)) @DISEASE$ subtypes, mammographic density and tumor grade.	1
The best candidate causal variants for ER(-) @DISEASE$s lie in four separate enhancer elements, and their risk alleles reduce expression of @GENE$, positive regulation of mitochondrial translation and biological_process, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	0
The best candidate causal variants for ER(-) @DISEASE$s lie in four separate enhancer elements, and their risk alleles reduce expression of transcription by RNA polymerase II, @GENE$ and biological_process, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	0
The best candidate causal variants for ER(-) @DISEASE$s lie in four separate enhancer elements, and their risk alleles reduce expression of transcription by RNA polymerase II, positive regulation of mitochondrial translation and @GENE$, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	0
Genetic studies have identified a homozygous truncation mutation in @GENE$ that causes @DISEASE$ in mice.	1
Moreover, elevated @GENE$ protein expression is associated with several types of cancers and variants in Trak1 are linked to childhood absence @DISEASE$ in humans.	1
Biological activities of compounds 3-7 towards human @DISEASE$ cells, @GENE$-2, ROCK1, and interleukin-4-mediated signaling pathway were evaluated	0
Biological activities of compounds 3-7 towards human @DISEASE$ cells, generation of precursor metabolites and energy-2, ROCK1, and @GENE$ were evaluated	0
In this work, we functionally characterize two breast @DISEASE$ associated genes, the proteasome 26S subunit ATPase 3 interacting protein (@GENE$) and the epithelial-stromal interaction 1 (biological_process), to explore their potential apoptotic role in breast cancer.	0
In this work, we functionally characterize two breast @DISEASE$ associated genes, the proteasome 26S subunit ATPase 3 interacting protein (reciprocal meiotic recombination) and the epithelial-stromal interaction 1 (@GENE$), to explore their potential apoptotic role in breast cancer.	0
Based on the generated interaction network, we examine several apoptotic markers to determine the effect of @GENE$ and EPSTI1 gene expression modulation in two different human breast @DISEASE$ cell lines to suggest potential molecular mechanisms to unveil their role in the disease.	0
Our results show that reciprocal meiotic recombination and @GENE$ are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast @DISEASE$ cell lines, highlighting them as potential therapeutic targets.	0
Here we demonstrate association of variants in the mitochondrial asparaginyl-tRNA synthetase @GENE$ with human @DISEASE$ and Leigh syndrome.	0
p.Asn381Ser also disrupts dimerization of @GENE$, while the @DISEASE$ p.Val213Phe variant has no effect on NARS2 oligomerization.	0
The extracellular matrix (@GENE$) is a known factor in tumor invasion, and differences in the ECM of nontumor brain and @DISEASE$ has been proven.	0
This manuscript describes the case of a nine-year-old girl with @DISEASE$, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 @GENE$)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	0
This manuscript describes the case of a nine-year-old girl with microcephaly, mild @DISEASE$, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 @GENE$)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	0
This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic @DISEASE$, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 @GENE$)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	0
This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe @DISEASE$, with a de novo heterozygous c.320A&gt;G [p.(His 107 @GENE$)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	0
Serine biosynthesis defects result from deficiencies in @GENE$, PSAT, or antimicrobial humoral response and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with @DISEASE$ at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.	1
Serine biosynthesis defects result from deficiencies in L-serine biosynthetic process, PSAT, or @GENE$ and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with @DISEASE$ at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.	0
The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, @DISEASE$, contractures, hypertonia, distinctive facial features, and a homozygous mutation in @GENE$.	1
The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, @DISEASE$, distinctive facial features, and a homozygous mutation in @GENE$.	1
ATL3 is a paralogue of @GENE$, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory @DISEASE$.	1
Succinate dehydrogenase subunit B and D (@GENE$ and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and @DISEASE$ (Ptricarboxylic acid cycle).	1
In SDHB-related syndrome, P@GENE$ maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of @DISEASE$ cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	1
However, when @GENE$-@DISEASE$s give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with tricarboxylic acid cycle counterparts (p = 0.17 vs 0.89).	1
However, when tricarboxylic acid cycle-@DISEASE$s give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with @GENE$ counterparts (p = 0.17 vs 0.89).	1
These findings align with data suggesting that @GENE$-related PPGL require less genetic events for @DISEASE$ initiation and maintenance compared to those related to tricarboxylic acid cycle, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.	1
These findings align with data suggesting that tricarboxylic acid cycle-related PPGL require less genetic events for @DISEASE$ initiation and maintenance compared to those related to @GENE$, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.	1
By contrast, the higher number of genetic abnormalities required for @DISEASE$ initiation and maintenance in @GENE$ PPGL result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.	1
In our study, the protein expression of Na<sub>V</sub>1.3, Na<sub>V</sub>1.6 and @GENE$ was significantly increased in the @DISEASE$ compared to control tissue, while the level of p-CaMKII/CaMKII was significantly decreased in the tumor group as determined by Western Blotting and immunohistochemistry.	1
Furthermore, double-labeling immunofluorescence results showed that Na<sub>V</sub>1.3/Na<sub>V</sub>1.6 and @GENE$ co-localization was significantly increased in the @DISEASE$ group compared to control tissue.	1
This study represents the first evidence of the abnormal changes in VGSCs subtypes and @GENE$/CaMKII pathway in human brain low-grade @DISEASE$, providing new potential targets for molecular therapies of this disease	0
Membrane transporters (such as ABCs, SLCs and ATPases) @GENE$ in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian @DISEASE$ (EOC) remains poorly understood.	0
Mutations in the membrane frizzled-related protein (@GENE$/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior @DISEASE$ with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.	1
In @GENE$rd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).	1
In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (@GENE$, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).	0
In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, @GENE$, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and actin cytoskeleton organization).	0
In embryo development ending in birth or egg hatchingrd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (retinoid metabolic process, Lrat, Rgr), phototransduction (G protein-coupled receptor signaling pathway, receptor guanylyl cyclase signaling pathway, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and @GENE$).	0
Transcripts of @GENE$, a gene associated with angle-closure glaucoma, posterior @DISEASE$ and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.	1
Transcripts of @GENE$, a gene associated with angle-closure @DISEASE$, posterior microphthalmia and myopia, were increased in embryo development ending in birth or egg hatchingrd6 eyes by 17-fold.	1
Transcripts of camera-type eye development, a gene associated with angle-closure glaucoma, posterior microphthalmia and @DISEASE$, were increased in @GENE$rd6 eyes by 17-fold.	0
Prostate @DISEASE$ (@GENE$) is a leading cause of cancer‑associated mortality in negative regulation of phosphatase activity; however, the factors that contribute to disease development have yet to be fully elucidated.	0
Prostate @DISEASE$ (mitochondrial transport) is a leading cause of cancer‑associated mortality in @GENE$; however, the factors that contribute to disease development have yet to be fully elucidated.	0
Biallelic mutations in @GENE$ cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe @DISEASE$ to adolescent-onset spastic paraplegia.	0
Biallelic mutations in @GENE$ cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset @DISEASE$.	1
Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood @DISEASE$ in addition to various developmental abnormalities; the majority of cases are due to mutations in the @GENE$ gene.	1
Certain phenotypic features have been identified as being more prevalent in individuals with a @GENE$ mutation such as childhood @DISEASE$, infundibulocystic BCCs and trichoepitheliomas.	1
Certain phenotypic features have been identified as being more prevalent in individuals with a @GENE$ mutation such as childhood medulloblastoma, infundibulocystic BCCs and @DISEASE$.	0
Recently hamartomatous skin lesions have also been noted in families with childhood @DISEASE$, a &quot;Gorlin like&quot; phenotype and a @GENE$ mutation.	1
We used C@GENE$-C to investigate long-range interactions at three breast @DISEASE$ gene deserts mapping to 2q35, 8q24.21, and 9q31.2.	0
The genes with the highest number of hypermethylated CpG sites in INRG M @DISEASE$s are @GENE$, PCDHGA4, DLX5, and skeletal system development-AS1.	1
The genes with the highest number of hypermethylated CpG sites in INRG M @DISEASE$s are transcription, RNA-templated, PCDHGA4, DLX5, and @GENE$-AS1.	0
For validation, we used a @GENE$ of independent @DISEASE$s previously analyzed with the Illumina 27K methylation arrays, which confirmed the differentially methylated sites.	0
Mutations in the @GENE$ gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital @DISEASE$, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.	0
Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (@GENE$) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe @DISEASE$ and intrauterine growth restriction (IUGR).	1
Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (@GENE$) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and @DISEASE$ (IUGR).	1
Based on our and published data we propose that the @GENE$ gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenomuscle organ development characterised by @DISEASE$ and IUGR	1
Based on our and published data we propose that the mRNA splicing, via spliceosome gene is essential for fetal development and when disrupted, leads to a severe, male-lethal pheno@GENE$ characterised by @DISEASE$ and IUGR	0
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in @GENE$, is characterized by nephrocalcinosis, @DISEASE$, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	0
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in @GENE$, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, @DISEASE$ and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	0
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in @GENE$, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other @DISEASE$, including hypodontia and unerupted teeth with large dental follicles.	1
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in @GENE$, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic muscle organ development, gingival fibromatosis and other dental abnormalities, including @DISEASE$ and unerupted teeth with large dental follicles.	0
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by @DISEASE$, nephrolithiasis, amelogenesis imperfecta, hypoplastic @GENE$, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	0
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, @DISEASE$, amelogenesis imperfecta, hypoplastic @GENE$, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	0
Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in positive regulation of protein phosphorylation, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic @GENE$, gingival fibromatosis and other @DISEASE$, including hypodontia and unerupted teeth with large dental follicles.	0
Very recently, @GENE$ has been established as a new FA gene raising the question of its implication in breast @DISEASE$ risk.	1
This study aimed at answering this question sequencing the entire coding region of @GENE$ in 526 familial breast @DISEASE$ cases from Italy.	1
Our results indicate that testing for @GENE$ germline mutations is unlikely to be relevant for the identification of individuals at risk of breast @DISEASE$, at least in the Italian population	1
Here we show, using whole-exome and @DISEASE$ gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene KMT2D (also known as @GENE$) is a recurrent somatic event in aGCT.	0
Moreover, Adenomatous polyposis coli 2 (APC2), a @DISEASE$ suppressor and a negative regulator of Wnt signaling, was found to be the direct target of @GENE$-3648.	0
Exome sequencing of superior @DISEASE$ patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (@GENE$) and T-box transcription factor (negative regulation of transcription by RNA polymerase II).	0
Exome sequencing of superior @DISEASE$ patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (protein phosphorylation) and T-box transcription factor (@GENE$).	0
We found that @GENE$ is significantly upregulated in @DISEASE$ (phosphatidylinositol phosphorylation) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	0
We found that @GENE$ is significantly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) @DISEASE$ and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	0
We found that @GENE$ is significantly upregulated in hepatocellular carcinoma (phosphatidylinositol phosphorylation) tumors and cell lines compared with non-@DISEASE$ tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	0
We found that positive regulation of transcription by RNA polymerase II is significantly upregulated in hepatocellular carcinoma (@GENE$) @DISEASE$ and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	0
Primary hyperoxaluria @GENE$ 1 (PH1), a rare autosomal recessive disorder, is characterized by @DISEASE$, nephrocalcinosis, and chronic kidney disease.	0
Primary hyperoxaluria @GENE$ 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, @DISEASE$, and chronic kidney disease.	0
Our results reveal that current SZ diagnoses aggregate over at least two disease subtypes: one part resembles high intelligence and @DISEASE$ (@GENE$), while the other part is a cognitive disorder that is independent of BIP	0
In this study, we describe the phenotypic spectrum of @DISEASE$ hereditary motor neuropathy caused by mutations in the small heat shock proteins @GENE$ and cellular response to unfolded protein and investigate the functional consequences of newly discovered variants.	0
In this study, we describe the phenotypic spectrum of distal hereditary motor @DISEASE$ caused by mutations in the small heat shock proteins @GENE$ and cellular response to unfolded protein and investigate the functional consequences of newly discovered variants.	1
In this study, we describe the phenotypic spectrum of distal hereditary motor @DISEASE$ caused by mutations in the small heat shock proteins regulation of protein phosphorylation and @GENE$ and investigate the functional consequences of newly discovered variants.	1
Among 510 unrelated patients with distal motor @DISEASE$, we identified mutations in @GENE$ (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.	1
We demonstrate that @GENE$ and HSPB8 mutations are a major cause of inherited motor axonal @DISEASE$.	1
In this study, we aimed to assess the independent prognostic value of @GENE$-361-3p in terms of overall survival (OS) and recurrence-free survival (RFS) in cervical @DISEASE$, as well as its possible regulative network.	0
Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of @GENE$ and DNA replication in hematological @DISEASE$ and overexpression of NUP88 in a variety of human cancers.	1
Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of mRNA export from nucleus and @GENE$ in hematological @DISEASE$ and overexpression of NUP88 in a variety of human cancers.	0
Inherited mutations in @GENE$, encoding the catalytic subunit of the major N-terminal acetylation complex NatA have been associated with diverse, syndromic X-linked recessive disorders, whereas de novo missense mutations have been reported in one male and one female individual with severe @DISEASE$ but otherwise unspecific phenotypes.	1
The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe @DISEASE$, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	1
The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, @DISEASE$ with severe microcephaly, and skeletal or cardiac anomalies.	1
The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe @DISEASE$, and skeletal or cardiac anomalies.	1
Broad @GENE$ methylation abnormalities are also observed in most @DISEASE$ PHP1B (sporPHP1B) cases.	1
We now investigated 23 Japanese sporPHP1B cases, who presented with @DISEASE$, hyperphosphatemia, elevated @GENE$ levels, and occasionally with TSH elevations and mild AHO features.	1
Cases were reviewed for consanguinity, @GENE$, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, @DISEASE$, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	0
Cases were reviewed for consanguinity, @GENE$, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, @DISEASE$), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	0
Cases were reviewed for consanguinity, @GENE$, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/@DISEASE$, cystic white matter changes, ventriculomegaly).	0
The quality of care for LTC residents with @GENE$ is @DISEASE$ in regard to both the facility and the patient.	0
To investigate the direct effects of this SNP in the @DISEASE$ cellular context of the brain, we generated humanized transgenic epidermis development using a design that maximized the local transcriptional landscape of the human @GENE$ gene while also controlling for effects of genomic insertion location.	0
De novo @GENE$ mutations have been associated with @DISEASE$ (ID), motor delay, autistic features and a wide spectrum of speech difficulties.	1
By whole exome sequencing we identified a de novo splicing mutation in @GENE$ in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with @DISEASE$.	0
The patient reported here shares @DISEASE$, intellectual disability and autistic features with other @GENE$ syndrome patients, and thus the diagnosis for this patient should be changed.	1
The patient reported here shares speech difficulties, @DISEASE$ and autistic features with other @GENE$ syndrome patients, and thus the diagnosis for this patient should be changed.	1
Finally, since @DISEASE$ has not been previously reported in @GENE$ syndrome, it remains to be proved whether it may be associated with the FOXP1 mutation	0
Epithelial-stromal @GENE$ dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (quaternary ammonium group transport) showed 100% mutation detection rates, while endothelial @DISEASE$ showed lower detection rates of 3%.	1
Epithelial-stromal @GENE$ dystrophies, macular @DISEASE$ and Schnyder corneal dystrophy (quaternary ammonium group transport) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.	1
Epithelial-stromal angiogenesis dystrophies, macular @DISEASE$ and Schnyder corneal dystrophy (@GENE$) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.	0
Epithelial-stromal angiogenesis dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (@GENE$) showed 100% mutation detection rates, while endothelial @DISEASE$ showed lower detection rates of 3%.	0
As a result, we identified one gene @GENE$ with a joint effect significantly associated with @DISEASE$ and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).	0
As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with @DISEASE$ and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (@GENE$), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).	0
As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with @DISEASE$ and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (@GENE$, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).	0
As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with @DISEASE$ and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, @GENE$) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, negative regulation of transcription by RNA polymerase II).	0
As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with @DISEASE$ and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, @GENE$, negative regulation of transcription by RNA polymerase II).	0
As a result, we identified one gene negative regulation of transcription, DNA-templated with a joint effect significantly associated with @DISEASE$ and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (G protein-coupled glutamate receptor signaling pathway), GABAergic genes (chloride transmembrane transport, extrinsic apoptotic signaling pathway via death domain receptors) and genes located in the MHC region (antigen processing and presentation of peptide antigen via MHC class I, biological_process, @GENE$).	0
In our study, we identified a @GENE$ of susceptibility genes that had been missed in single-marker GWAS, and our findings could promote the study of the genetic mechanisms in @DISEASE$.	0
Chronic hepatitis B virus (HBV) infection is partly responsible for hepatitis, fatty liver disease and @DISEASE$ (@GENE$).	0
In addition to replicating previously reported loci, we identify five novel loci significantly associated with @DISEASE$ risk (P&lt;5 × 10<sup>-8</sup>), implicating genes involved in @GENE$ steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, Golgi organization and G protein-coupled receptor signaling pathway).	0
In addition to replicating previously reported loci, we identify five novel loci significantly associated with @DISEASE$ risk (P&lt;5 × 10<sup>-8</sup>), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, @GENE$, Golgi organization and G protein-coupled receptor signaling pathway).	0
In addition to replicating previously reported loci, we identify five novel loci significantly associated with @DISEASE$ risk (P&lt;5 × 10<sup>-8</sup>), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, @GENE$ and G protein-coupled receptor signaling pathway).	0
In addition to replicating previously reported loci, we identify five novel loci significantly associated with @DISEASE$ risk (P&lt;5 × 10<sup>-8</sup>), implicating genes involved in multicellular organism development steroid hormone pathways (FN1, CCDC170, transcription by RNA polymerase II, Golgi organization and @GENE$).	0
Conditional analysis identified five secondary association signals, including two at the @GENE$ locus, resulting in 19 independent single nucleotide polymorphisms (SNPs) robustly associated with @DISEASE$, which together explain up to 5.19% of variance in endometriosis.	0
However, the @GENE$ of protein polyubiquitination-145-3p (the passenger strand) on @DISEASE$ cells is still ambiguous.	0
However, the negative regulation of transcription by RNA polymerase II of @GENE$-145-3p (the passenger strand) on @DISEASE$ cells is still ambiguous.	0
Expression levels of @GENE$-145-5p and miR-145-3p were markedly reduced in @DISEASE$ tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.	0
Taken together, both strands of @GENE$-145, miR-145-5p and miR-145-3p are functional and play pivotal roles as anti@DISEASE$ miRNAs in lung SCC	0
@GENE$ defects result in congenital @DISEASE$ (CAH), an autosomal recessive disorder characterized by impaired adrenal steroidogenesis.	1
Complete identification of genes related to one @GENE$ of @DISEASE$ facilitates earlier diagnosis and effective treatments.	0
This is the first study to investigate the effect of vitamin D receptor ( @GENE$) gene single-nucleotide polymorphisms on the clinicopathologic features of papillary thyroid @DISEASE$ in Turkey.	0
@GENE$ gene polymorphisms BsmI, ApaI, and TaqI did not differ between the papillary thyroid @DISEASE$ group and control group (p &gt; 0.05, each).	0
@GENE$ gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid @DISEASE$; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer	0
@GENE$ gene FokI T allele and TT genotype correlated with @DISEASE$ of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer	0
After 1 year, because of worsening in @GENE$ orientation and the onset of dressing @DISEASE$, he was referred to our memory clinic.	0
Pathway analyses demonstrated that methylation levels associated with age and BMI are overrepresented among genes involved in cancer, @GENE$ 2 diabetes and @DISEASE$.	1
Our results highlight the @GENE$ of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, muscle organ development 2 diabetes and @DISEASE$ in human adipose tissue.	0
Our results highlight the @GENE$ of age, BMI and HbA1c on epigenetic variation of candidate genes for @DISEASE$, muscle organ development 2 diabetes and cancer in human adipose tissue.	0
Our results highlight the negative regulation of transcription by RNA polymerase II of age, BMI and HbA1c on epigenetic variation of candidate genes for @DISEASE$, @GENE$ 2 diabetes and cancer in human adipose tissue.	0
Mabry syndrome, @DISEASE$ mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (@GENE$), severe developmental delay, intellectual disability, and seizures.	0
Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an @DISEASE$ disease characterized by increased serum levels of alkaline phosphatase (@GENE$), severe developmental delay, intellectual disability, and seizures.	0
Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (@GENE$), severe developmental delay, @DISEASE$, and seizures.	0
We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, @DISEASE$, and persistent increased serum levels of @GENE$.	0
Nonsynonymous changes or frameshift mutations in @GENE$ have been identified in patients with CHIME syndrome, a rare @DISEASE$ disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	1
Nonsynonymous changes or frameshift mutations in @GENE$ have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, @DISEASE$, and ear abnormalities.	1
Nonsynonymous changes or frameshift mutations in @GENE$ have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by @DISEASE$, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	1
Nonsynonymous changes or frameshift mutations in @GENE$ have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, @DISEASE$, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	1
Nonsynonymous changes or frameshift mutations in @GENE$ have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset @DISEASE$ ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	0
The @DISEASE$ suppressor characteristics of cyclin‑dependent kinase 10 (@GENE$) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.	0
In the present study the expression status of @GENE$ and its prognostic significance in gastric @DISEASE$ was determined, as well as its role in cell proliferation and invasion.	0
Immunoblot analysis revealed that @GENE$ protein expression was notably decreased in gastric @DISEASE$ compared with normal tissues.	0
Immunohistochemistry demonstrated that the loss of @GENE$ expression, which was observed in 50.8% of primary gastric @DISEASE$ tissues (n=128), significantly correlated with advanced tumor stage (P&lt;0.001), frequent lymph node metastasis (P&lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&lt;0.001).	0
To date, over 150 disease-associated variants in @GENE$ have been described, resulting in a range of @DISEASE$ phenotypes including Leber congenital amaurosis and retinitis pigmentosa.	1
Genome-wide association studies have identified genomic loci, whose single-nucleotide polymorphisms (SNPs) predispose to prostate @DISEASE$ (@GENE$).	0
Higher melanophilin level in prostate tissue of patients with a favorable @GENE$ risk profile points out a @DISEASE$-suppressive effect.	0
@GENE$ encoding the beta subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors is the major @DISEASE$ gene.	1
Here, we present a comprehensive spectrum of @GENE$ mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with @DISEASE$.	1
A frequently reported @GENE$ing is that effects from common genetic variation are associated with a @DISEASE$-related structural endophenotype.	0
However, the prevalence and spectrum of @GENE$ mutations associated with @DISEASE$ DCM remain to be evaluated.	0
In this study, the coding regions and flanking introns of the @GENE$ gene, which encodes a cardiac transcription factor pivotal for cardiac development and structural remodeling, were sequenced in 210 unrelated patients with @DISEASE$ adult-onset DCM.	0
As a result, two novel heterozygous @GENE$ mutations, p.R139W and p.E167X, were identified in 2 unrelated patients with @DISEASE$ adult-onset DCM, with a mutational prevalence of approximately 0.95%.	0
This study is the first to associate @GENE$ loss-of-function mutations with enhanced susceptibility to @DISEASE$ DCM, which provides novel insight into the molecular etiology underpinning DCM, and suggests the potential implications for the genetic counseling and personalized treatment of the DCM patients	0
The @DISEASE$ disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either @GENE$ or PCCB genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.	1
Owing to the lack of universal and specific @DISEASE$ markers for neuroblastoma (NB), in this prospective study, we adopted an @GENE$-independent method to detect CTCs in the GPI anchor metabolic processipheral blood of NB patients.	1
Owing to the lack of universal and specific @DISEASE$ markers for neuroblastoma (NB), in this prospective study, we adopted an positive regulation of cell proliferation-independent method to detect CTCs in the @GENE$ipheral blood of NB patients.	0
Owing to the lack of universal and specific tumor markers for @DISEASE$ (NB), in this prospective study, we adopted an @GENE$-independent method to detect CTCs in the GPI anchor metabolic processipheral blood of NB patients.	1
Mutations in @GENE$ lead to various neuromuscular phenotypes with partial overlap, including @DISEASE$ type 1C (regulation of membrane potential), rippling muscle disease, distal myopathy and isolated hyperCKemia.	0
Mutations in regulation of membrane potential lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (@GENE$), rippling muscle disease, @DISEASE$ myopathy and isolated hyperCKemia.	0
This case series demonstrates that exercise intolerance, myalgia and @DISEASE$ may be caused by @GENE$ mutations and broadens the phenotypic spectrum of caveolinopathies.	0
The expression of the ID2, @GENE$ and positive regulation of endothelial cell migration genes was compared between the endometrium of women without @DISEASE$ in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.	0
The ID2 gene expression was increased in the most advanced stage of @DISEASE$ and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the @GENE$ was highly expressed in both peritoneal and endometrioma lesions.	0
Epidermal growth factor receptor (@GENE$) mutation is prevalently expressed in @DISEASE$ cases and acts as one of the major driving oncogenes.	0
@GENE$ tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and @DISEASE$ recurrence inevitably occurs.	1
Recently, cellular protein modification process-associate protein (@GENE$) has been reported to promote multiple @DISEASE$ cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance.	0
With reduced @GENE$ expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung @DISEASE$ patients analyzed by Taiwan National Health Insurance Research database.	0
With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft @DISEASE$ size in establishment of mitotic spindle orientation @GENE$ and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	0
With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in @GENE$ epidermis development and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung @DISEASE$ patients analyzed by Taiwan National Health Insurance Research database.	0
With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation @GENE$ and Moreover, combined positive regulation of protein phosphorylation TKI and a YAP inhibitor, statin, prolonged survival among lung @DISEASE$ patients analyzed by Taiwan National Health Insurance Research database.	0
With reduced regulation of cell cycle expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in establishment of mitotic spindle orientation epidermis development and Moreover, combined @GENE$ TKI and a YAP inhibitor, statin, prolonged survival among lung @DISEASE$ patients analyzed by Taiwan National Health Insurance Research database.	1
Progressive rod-cone degeneration (@GENE$) is a canine @DISEASE$ that maps to the centromeric positive regulation of protein phosphorylation of CFA9 in a region of synteny with the distal part of HSA17q.	1
Progressive rod-cone degeneration (visual perception) is a canine @DISEASE$ that maps to the centromeric @GENE$ of CFA9 in a region of synteny with the distal part of HSA17q.	1
The transcriptional coactivator peroxisome proliferator-activated receptor-histone H3 acetylation coactivator 1-alpha (@GENE$-1α) has been linked to multiple neurological and psychiatric disorders including @DISEASE$, but its involvement in the pathophysiology of these disorders is unclear.	0
We measured the mRNA expression of @GENE$-1α and these transcripts in postmortem cortical tissue from control and @DISEASE$ patients and found a reduction in PGC-1α-dependent transcripts without a change in PGC-1α.	0
While control subjects with high @GENE$-1α expression exhibited high PV and Nefh expression, @DISEASE$ subjects with high PGC-1α expression did not, suggesting dissociation between PGC-1α expression and these targets in schizophrenia.	0
@GENE$-1 mRNA expression was reduced in @DISEASE$, and its transcript levels predicted that of positive regulation of antibacterial peptide production-1α-dependent targets in schizophrenia.	0
negative regulation of transcription, DNA-templated-1 mRNA expression was reduced in @DISEASE$, and its transcript levels predicted that of @GENE$-1α-dependent targets in schizophrenia.	0
Interestingly, the positive correlation between positive regulation of antibacterial peptide production-1α and PV, Syt2, or @GENE$ expression was lost in @DISEASE$ patients with low negative regulation of transcription, DNA-templated-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	0
Interestingly, the positive correlation between positive regulation of antibacterial peptide production-1α and PV, Syt2, or exocytosis expression was lost in @DISEASE$ patients with low @GENE$-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	0
These data suggest that @DISEASE$ involves a disruption in @GENE$-1α and/or negative regulation of transcription, DNA-templated-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1α or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function	0
These data suggest that @DISEASE$ involves a disruption in positive regulation of antibacterial peptide production-1α and/or @GENE$-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1α or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function	0
Mutations in @GENE$ are implicated in @DISEASE$ development and in a severe congenital inflammatory disease known as Aicardi-Goutières syndrome.	0
This includes the first two genes linked to recessively inherited isolated @DISEASE$, that is, @GENE$ (hippocalcin) and COL6A3 (collagen VI alpha 3).	1
The novel myoclonus-@DISEASE$ genes KCTD17 and @GENE$ also implicate abnormal calcium signaling in dystonia.	1
Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex @DISEASE$s, for example those attributable to biallelic mutations in GCH1, TH, @GENE$, or to heterozygous negative regulation of microtubule polymerization mutations.	0
Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex @DISEASE$s, for example those attributable to biallelic mutations in GCH1, TH, positive regulation of cytosolic calcium ion concentration, or to heterozygous @GENE$ mutations.	1
MESP2, mesoderm development and @GENE$ genes have been proved to be involved in the etiopathogenesis of congenital @DISEASE$ (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.	0
@GENE$, HES7 and inactivation of MAPK activity genes may not be involved in the etiopathogenesis of @DISEASE$ and non-syndromic CS in Chinese Han population	0
regulation of transcription by RNA polymerase II, HES7 and @GENE$ genes may not be involved in the etiopathogenesis of @DISEASE$ and non-syndromic CS in Chinese Han population	0
Somatic defects at five loci, WT1, @GENE$, positive regulation of protein ubiquitination, TP53 and the imprinted 11p15 region, are implicated in Wilms @DISEASE$, the commonest childhood kidney cancer.	1
Somatic defects at five loci, WT1, @GENE$, positive regulation of protein ubiquitination, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney @DISEASE$.	1
Somatic defects at five loci, WT1, protein polyubiquitination, @GENE$, TP53 and the imprinted 11p15 region, are implicated in Wilms @DISEASE$, the commonest childhood kidney cancer.	0
Somatic defects at five loci, WT1, protein polyubiquitination, @GENE$, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney @DISEASE$.	0
We identified mutations of WTX in 32%, @GENE$ in 15%, WT1 in 12% and TP53 in 5% of @DISEASE$s.	1
Group 1 @DISEASE$s (63%) were defined as 11p15-mutant and WT1-normal; a third also had @GENE$ mutations.	0
Here, we determine that non-canonical IKKα-@GENE$ pathway activation of KRAS-mutant @DISEASE$ cells mediates MPE development and this is fueled by host-provided interleukin IL-1β.	0
Indeed, IKKα is required for the MPE-competence of @GENE$-mutant @DISEASE$ cells by activating non-canonical peripheral nervous system development-κB signaling.	1
Indeed, IKKα is required for the MPE-competence of positive regulation of protein phosphorylation-mutant @DISEASE$ cells by activating non-canonical @GENE$-κB signaling.	0
Importantly, IL-1β-mediated @GENE$-κB induction in positive regulation of protein phosphorylation-mutant @DISEASE$ cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKKα, a strategy that overcomes drug resistance to individual treatments.	0
Importantly, IL-1β-mediated peripheral nervous system development-κB induction in @GENE$-mutant @DISEASE$ cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKKα, a strategy that overcomes drug resistance to individual treatments.	1
These experiments identify a role for mitofusins in directly regulating mitochondrial transport and offer important insight into the cell muscle organ development specificity and molecular mechanisms of @DISEASE$ in @GENE$ and dominant optic atrophy	0
In a consanguineous Saudi family segregating Usher syndrome @GENE$ 1 (USH1), NGS of genes for Usher syndrome, deafness and @DISEASE$ and subsequent whole-exome sequencing each failed to identify a mutation.	0
Loss of @GENE$ contributes to the aggressive phenotype of @DISEASE$ through regulation of poor prognosis-associated signatures.	0
Restitution of @GENE$ expression reverses the phenotype and impairs @DISEASE$-forming ability.	0
These results indicate that @GENE$ functions as a @DISEASE$ suppressor in GBM through the regulation of genes associated with phenotypically aggressive properties.<b>Implications:</b> This study characterizes the role of the putative tumor suppressor ZBTB18 and its regulation by promoter hypermethylation, which appears to be a common mechanism to silence ZBTB18 in the mesenchymal subtype of GBM and provides a new mechanistic opportunity to specifically target this tumor subclass.	0
Mutations in @GENE$ lead to diseases ranging from isolated @DISEASE$ to severe syndromic ciliopathies.	1
In this study, we created a mouse model of @GENE$-associated @DISEASE$ to investigate the ocular disease mechanism.	1
We investigated molecular mechanisms of degeneration and show that cilium assembly protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, @GENE$), aberrant light-driven translocation of alpha transducin and altered localization of @DISEASE$-associated oncogene family member 1 (osteoblast differentiation).	0
We investigated molecular mechanisms of degeneration and show that cilium assembly protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, regulation of transcription by RNA polymerase II), aberrant light-driven translocation of alpha transducin and altered localization of @DISEASE$-associated oncogene family member 1 (@GENE$).	0
This mouse model exhibits key features of the retinal phenotype observed in patients with @GENE$-associated @DISEASE$ and can be used for in vivo testing of ciliopathy therapies	1
The latter SNP lies just outside exon 8 and is highly correlated (r2 = 0.96) with the missense SNP rs5756795 in exon 7 of @GENE$, a gene previously associated with prelingual nonsyndromic @DISEASE$.	1
We also tested variants within exons of 132 other previously-identified @DISEASE$ genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in @GENE$, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (mitotic spindle organization; p = 0.0019); and rs9493627 (missense change in visual perception, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).	1
We also tested variants within exons of 132 other previously-identified @DISEASE$ genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in protein homooligomerization, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (@GENE$; p = 0.0019); and rs9493627 (missense change in visual perception, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).	0
We also tested variants within exons of 132 other previously-identified @DISEASE$ genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in protein homooligomerization, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (mitotic spindle organization; p = 0.0019); and rs9493627 (missense change in @GENE$, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).	1
These data suggest a previously unrecognized mechanism by which EBNALP coactivates transcription through subverting of @GENE$ and thus affects the expression of LCL genes regulated by a broad range of host TFs.<b>IMPORTANCE</b> Epstein-Barr virus was the first human DNA @DISEASE$ virus discovered over 50 years ago.	1
Physical deconditioning is associated with the development of chronic diseases, including @GENE$ 2 diabetes and @DISEASE$.	1
Although mutations in @GENE$, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	1
Although mutations in @GENE$, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
Although mutations in keratan sulfate biosynthetic process, @GENE$, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	1
Although mutations in keratan sulfate biosynthetic process, @GENE$, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, @GENE$, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and @GENE$ typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in @GENE$, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, @GENE$, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, @GENE$, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, @GENE$1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	0
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, @GENE$1, cellular response to hormone stimulus, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, @GENE$, response to estradiol, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, @GENE$, cell activation, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, @GENE$, signal transduction, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	1
Although mutations in keratan sulfate biosynthetic process, fibroblast growth factor receptor signaling pathway, negative regulation of kinase activity, and positive regulation of transcription by RNA polymerase II typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, positive regulation of receptor internalization1, cellular response to hormone stimulus, response to estradiol, cell activation, @GENE$, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	0
Our study showed that targeted NGS is an effective tool for diagnosis of genetic @DISEASE$ and that p.G141R in <i>ILDR1</i> may be a relatively frequent mutation for @GENE$ in Chinese Hans	1
Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired @DISEASE$ (@GENE$), but no research has yet been conducted on the role of IRF5 gene polymorphisms in CAP.	0
Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by @DISEASE$ and natural killer cell activation involved in immune response dystrophy without other disorders, and @GENE$ is a pathogenic gene for ED-9.	1
Moreover, microRNA-22 sensitized breast @DISEASE$ cells to paclitaxel by regulation of @GENE$.	1
RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (<i>EXT1</i>, <i>EXT2</i>, <i>NDST1</i>, <i>NDST2</i>, <i>GLCE</i>, <i>HS2ST1</i>, <i>HS3ST1</i>, <i>HS3ST2</i>, <i>HS6ST1</i>, <i>HS6ST2</i>, <i>SULF1</i>, <i>SULF2</i>, <i>@GENE$</i>) was decreased by 1.5-2-fold in Grade II-III glioma (<i>p</i> &lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (<i>p</i> &lt; 0.05), as compared with the para-@DISEASE$ous tissue.	0
Heparanase (<i>@GENE$</i>) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intra@DISEASE$al heterogeneity of the presence of the HPSE protein.	0
The 21 genes comprised 8 @DISEASE$ suppressor candidates (@GENE$, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, @GENE$, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, @GENE$, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, @GENE$, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, @GENE$, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, @GENE$, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, @GENE$, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, positive regulation of cell proliferation, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (protein phosphorylation, MSH2, phosphatidylinositol 3-kinase signaling, positive regulation of cholesterol efflux, negative regulation of protein phosphorylation, 5-methylcytosine catabolic process, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, protein polyubiquitination, signal transduction, FGFR2, FLT3, HNF1A, KIT, regulation of cell growth, @GENE$, PPP2R1A, peptidyl-tyrosine dephosphorylation, and SF3B1).	1
We believe that this study will shed new @GENE$ on fundamental aspects for understanding the molecular pathogenesis of endometrial @DISEASE$ and may aid in the development of new targeted therapies.	0
Vegetarian and vegan diets have increased worldwide in the last decades, according to the knowledge that they might prevent coronary heart disease, @DISEASE$, and @GENE$ 2 diabetes.	0
Necropsy revealed extensive granulomatous @DISEASE$, from which @GENE$ was isolated and identified as a member of LAM3/F11 lineage; a common lineage found in humans in South Africa.	0
Herein, we report 3 patients with heterozygous constitutional @GENE$ mutations, who were ascertained through exome analysis of children with @DISEASE$ and minor anomalies, who lacked cardiac anomalies.	1
Herein, we report 3 patients with heterozygous constitutional @GENE$ mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked @DISEASE$.	1
Exposure to BMAA has been implicated in the development of @DISEASE$ including amyotrophic lateral sclerosis (@GENE$), Alzheimer's disease (AD) and Parkinson's disease (PD).	0
The present study aimed to identify novel @DISEASE$ (@GENE$)‑associated long noncoding (lnc)RNAs and genes.	0
<b>Objective:</b> To study the association between Thymidine Phosphorylase (@GENE$) genetic variation and clinical outcomes and safety of postoperative colorectal @DISEASE$ (CRC) patients.	0
Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of @GENE$ in @DISEASE$ tissues of the patients with CT or TT genomuscle organ developments were significantly higher than those of the wild type CC genotype patients (<i>P</i>=0.019).	0
Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of pyrimidine nucleoside metabolic process in @DISEASE$ tissues of the patients with CT or TT geno@GENE$s were significantly higher than those of the wild type CC genotype patients (<i>P</i>=0.019).	0
To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: @GENE$, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.	0
To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, @GENE$, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.	0
To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, @GENE$, negative regulation of receptor internalization, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.	0
To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, @GENE$, transmembrane transport, spliceosomal snRNP assembly, and UNC13A.	0
To dissect the genetic architecture of @DISEASE$ ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: response to superoxide, C9orf72, RNA splicing, regulation of transcription, DNA-templated, ANG, viral budding via host ESCRT complex, negative regulation of receptor internalization, transmembrane transport, @GENE$, and UNC13A.	0
We used Cytoscape network analysis and Search tool for retrieval of inter@GENE$ing genes/ proteins (STRING) to study the possible interactions to show the links between the antioxidants, antibiotics, anti-inflammatory and antimitotic agents and their targets for their possible use in @DISEASE$.	0
Crisponi syndrome (CS)/cold-induced sweating syndrome muscle organ development 1 (@GENE$) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: @DISEASE$ and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	1
Crisponi syndrome (CS)/cold-induced sweating syndrome muscle organ development 1 (@GENE$) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, @DISEASE$, and paradoxical sweating induced by cold since early childhood.	1
Although these data further support the pathogenic role of @GENE$ mutations in a CS/CISS1-like phenomuscle organ development, they do not explain all their clinical manifestations and highlight the high phenotypic @DISEASE$ associated with mutations in KLHL7.	0
Although these data further support the pathogenic role of protein ubiquitination mutations in a CS/CISS1-like pheno@GENE$, they do not explain all their clinical manifestations and highlight the high phenotypic @DISEASE$ associated with mutations in KLHL7.	0
In this study, we enrolled 16 individuals affected by tooth agenesis, prevalently @DISEASE$, and we carried out direct Sanger sequencing of paired box 9 (@GENE$) and negative regulation of transcription by RNA polymerase II homeobox 1 (MSX1) genes in 9 subjects.	0
In this study, we enrolled 16 individuals affected by tooth agenesis, prevalently @DISEASE$, and we carried out direct Sanger sequencing of paired box 9 (negative regulation of transcription, DNA-templated) and @GENE$ homeobox 1 (MSX1) genes in 9 subjects.	0
Overall, our study confirmed the major role played by @GENE$ in tooth agenesis and the genetic @DISEASE$ of this disease.	0
Mutations in @GENE$ have been associated with @DISEASE$ Crisponi or cold-induced sweating syndrome muscle organ development 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.	1
Mutations in @GENE$ have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome muscle organ development 1 (CS/CISS1), which among other symptoms also manifests with early onset @DISEASE$.	1
Mutations in positive regulation of cell proliferation have been associated with @DISEASE$ Crisponi or cold-induced sweating syndrome @GENE$ 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.	1
Growth abnormalities, motor dysfunction, hindlimb paralysis, @DISEASE$, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in <i>@GENE$</i>/S<i>cyl3</i> double-deficient epidermis development than in <i>Scyl1</i>-deficient mice.	0
Growth abnormalities, motor dysfunction, hindlimb paralysis, @DISEASE$, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in <i>cytoskeleton organization</i>/S<i>cyl3</i> double-deficient @GENE$ than in <i>Scyl1</i>-deficient mice.	0
Deficiency of the extracellular matrix molecule @GENE$, normally expressed by the ureteric bud, leads to bilateral @DISEASE$ in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) epidermis development.	0
Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to @DISEASE$ renal agenesis in humans with Fraser syndrome and blebbed (@GENE$(bl/bl)) epidermis development.	0
Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral @DISEASE$ in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) @GENE$.	0
This prevented @DISEASE$ in @GENE$(bl/bl) epidermis development, permitting kidney development and postnatal survival.	0
This prevented @DISEASE$ in morphogenesis of an epithelium(bl/bl) @GENE$, permitting kidney development and postnatal survival.	0
Developmental and epileptic @DISEASE$ with hypsarrhythmia is present in most patients with @GENE$ variants, and is drug-resistant in the majority of cases.	1
Developmental and epileptic encephalopathy with @DISEASE$ is present in most patients with @GENE$ variants, and is drug-resistant in the majority of cases.	1
The @GENE$ co-receptor activation of MAPK activity is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell @DISEASE$ in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.	1
The @GENE$ co-receptor activation of MAPK activity is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell @DISEASE$.	1
Here we investigated methylation of the @GENE$ promoter in mouse germ cells and human germ cell @DISEASE$ and correlated this with the level of activation of MAPK activity protein expression.	1
@GENE$ protein was strongly expressed in germ cell @DISEASE$ in situ along with embryonal carcinoma, yolk cAMP biosynthetic process tumor and seminomas.	1
@GENE$ protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk cAMP biosynthetic process @DISEASE$ and seminomas.	1
activation of MAPK activity protein was strongly expressed in germ cell @DISEASE$ in situ along with embryonal carcinoma, yolk @GENE$ tumor and seminomas.	0
activation of MAPK activity protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk @GENE$ @DISEASE$ and seminomas.	0
Accordingly, @GENE$ was detectable in serum from 6/15 patients with embryonal carcinoma, 5/15 patients with seminoma, 4/5 patients with germ cell @DISEASE$ in situ cells only and in 1/15 control patients.	1
These findings suggest that @GENE$ expression may be a useful serological marker for diagnostic and/or prognostic purposes during germ cell @DISEASE$ management.	1
We report the case of a patient with <i>@GENE$</i> mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing @DISEASE$ (PNH).	1
Targeted expression of a human @GENE$ transgene to tissues involved in ecdysteroidogenesis, <i>e.g.</i>, prothoracic gland, also partially rescues global @DISEASE$ in mutant homozygotes.	1
The most common and severe form, primary @DISEASE$ Type I, is due to the deficit of liver peroxisomal alanine/glyoxylate aminotransferase (@GENE$).	1
Primary @DISEASE$ @GENE$ II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (glyoxylate metabolic process) and 4-hydroxy-2-oxoglutarate aldolase (4-hydroxyproline catabolic process), respectively.	0
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (@GENE$) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic @DISEASE$, metabolic acidosis and hyperammonemia.	1
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (@GENE$) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and @DISEASE$.	1
This @DISEASE$ disease is caused by mutations in the gene encoding barttin, @GENE$, an essential subunit of the positive regulation of cell proliferation-K chloride channels expressed in renal and inner ear epithelia.	1
This @DISEASE$ disease is caused by mutations in the gene encoding barttin, ion transmembrane transport, an essential subunit of the @GENE$-K chloride channels expressed in renal and inner ear epithelia.	1
Previous work has demonstrated the effectiveness of inhibiting @GENE$ with small-molecule inhibitors, but the role of CHK1 mediated DDR in @DISEASE$ is unknown.	0
Overall, our results demonstrate that small-molecule inhibition of @GENE$ in combination with, cisplatin, is more advantageous than either treatment alone, especially for Group 3 @DISEASE$, and therefore this combined therapeutic approach serves as an avenue for further investigation	0
We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (@GENE$) bladder @DISEASE$ subgroups and predict outcome.	0
A retrospective design included the following paraffin-embedded primary inflammatory response @DISEASE$ types (n = 251): @GENE$ low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).	0
Methylation of RARB, CD44, PAX5A, GSTP1, @GENE$ (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.	0
Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), @GENE$, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.	0
Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and @GENE$ classified biological_process versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.	0
Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified @GENE$ versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.	0
Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, protein polyubiquitination, PYCARD, TP53, @GENE$, and GATA5 distinguished LG versus HG tumors.	1
Methylation of RARB, CD44, PAX5A, GSTP1, T cell mediated cytotoxicity (CADM1), activation of innate immune response, sprouting angiogenesis, TP53, and positive regulation of transcription by RNA polymerase II classified biological_process versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, @GENE$, PYCARD, TP53, protein phosphorylation, and GATA5 distinguished LG versus HG tumors.	0
Mutations within this gene are responsible for kinesigenic @DISEASE$ (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (@GENE$), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	1
Mutations within this gene are responsible for kinesigenic @DISEASE$ (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (@GENE$ muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (@GENE$) as well as for benign familial infantile @DISEASE$ (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (@GENE$) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and @DISEASE$ ataxia.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (@GENE$) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic @DISEASE$.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile @DISEASE$ (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (@GENE$ muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	1
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile @DISEASE$ (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration @GENE$ 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (@GENE$), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and @DISEASE$ ataxia.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (@GENE$), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic @DISEASE$.	1
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (@GENE$ muscle organ development 4), paroxysmal benign torticollis of childhood, and @DISEASE$ ataxia.	0
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (positive regulation of cytosolic calcium ion concentration @GENE$ 4), paroxysmal benign torticollis of childhood, and episodic @DISEASE$.	0
@GENE$ encodes a member of the ovarian @DISEASE$ domain (OTU)-containing subfamily of deubiquitinating enzymes.	0
Herein, we report biallelic pathogenic variants in @GENE$ in 12 individuals from 6 independent families with an @DISEASE$ syndrome associated with seizures and dysmorphic features.	1
Chorea-acanthocytosis (@GENE$), a @DISEASE$, results from loss-of-function-mutations of the chorein-encoding gene VPS13A.	0
Affected patients suffer from a progressive movement disorder including @DISEASE$, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and @GENE$ biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	0
Affected patients suffer from a progressive movement disorder including chorea, @DISEASE$, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and @GENE$ biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	0
Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, @DISEASE$, dysphagia, tongue and @GENE$ biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	0
Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and @GENE$ biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, @DISEASE$, and behavioral changes.	0
Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and @GENE$ biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and @DISEASE$.	0
Chorein, @GENE$, store-operated calcium entry and SOCE further confer survival of @DISEASE$ cells.	0
Chorein, regulation of cell growth, @GENE$ and SOCE further confer survival of @DISEASE$ cells.	0
Disruption of @GENE$ induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed @DISEASE$ growth in orthotopic models of glioblastoma.	1
Disruption of @GENE$ induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of @DISEASE$.	0
Our study supports the targeting of @GENE$ to break this GSC-specific autocrine/paracrine loop in order to improve @DISEASE$ treatment, potentially with a high therapeutic index.	0
Here we identified six different de novo missense mutations in @GENE$ in twelve unrelated individuals affected by global @DISEASE$ (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.	1
Here we identified six different de novo missense mutations in @GENE$ in twelve unrelated individuals affected by global developmental delay (GDD), @DISEASE$ (ID), severe speech impairment and gait abnormalities.	1
Here we identified six different de novo missense mutations in @GENE$ in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and @DISEASE$.	1
Review of exome sequencing data of the proband and her unaffected son for 40 known genes causing congenital nonsyndromic @DISEASE$s revealed two variants, namely c.139G&gt;A (p.Asp47Asn; D47N) in the <i>@GENE$</i> gene and c.2036C&gt;T in the <i>FYCO1</i> gene to be potentially pathogenic.	1
The mutation c.139G&gt;A in the <i>@GENE$</i> gene detected in the present study was also previously reported in Caucasian and Chinese families but with different phenotypes, i.e. nuclear and nuclear pulverulent @DISEASE$s.	1
Biallelic pathogenic variants in @GENE$ are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by @DISEASE$, developmental delay, and hypotonia.	1
Biallelic pathogenic variants in @GENE$ are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, @DISEASE$, and hypotonia.	1
Human placenta-derived mesenchymal stem cell (hPMSC) transplantation has a potential to restore ovarian dysfunction associated with @DISEASE$ (@GENE$), while the exact function of the Treg cells in the transplantation still needs to be further investigated.	1
Chudley-McCullough syndrome (@GENE$) is a rare autosomal recessive disorder characterized by sensorineural deafness, @DISEASE$, frontal polymicrogyria, interhemispheric cyst, and ventricular enlargement.	0
The combination of sensorineural @DISEASE$ and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the @GENE$ gene.	1
Aberrant expression of receptor intercoenzyme A biosynthetic processing protein kinase 4 (@GENE$), a crucial regulatory protein of Wnt/β-catenin signaling, has recently been reported to be involved in several @DISEASE$s.	0
Molecular diagnosis is consistent with the genetic @DISEASE$ of the guanine salvage gene responsible for @GENE$ deficiency.	0
Molecular diagnosis is consistent with the genetic @DISEASE$ of the @GENE$ gene responsible for guanine salvage deficiency.	0
We observed odds ratios (ORs) of 1.7-2.3 for lung @DISEASE$ (LC; P=4.0 × 10(-4)), chronic obstructive pulmonary disease (intracellular protein transport; P=9.3 × 10(-4)), peripheral artery disease (@GENE$; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2 × 10(-4)), COPD (OR=3.22, P=2.9 × 10(-4)), PAD (OR=3.47, P=9.2 × 10(-3)) and AAA (OR=6.44, P=6.3 × 10(-3)).	0
Although open hERG1 channels did not interact as strongly with β<sub>1</sub> integrins as did closed channels, current flow through hERG1 channels was necessary to activate the integrin-dependent phosphorylation of Tyr<sup>397</sup> in focal adhesion kinase (@GENE$) in both normal and @DISEASE$ cells.	0
Likewise, HCV replication is severely impaired within @DISEASE$ (@GENE$) tissue in vivo, but the mechanisms responsible for this restriction are presently unknown.	0
Here, we identify @DISEASE$-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary @GENE$ tissue, as a host factor that interacts with CLDN1 and cell-cell junction organization and regulates their cellular localization.	0
We report on the case of a 77-year-old male with genetically proven spinocerebellar @DISEASE$ @GENE$ 31 (biological_process) who had dystonia.	0
We report on the case of a 77-year-old male with genetically proven spinocerebellar @DISEASE$ muscle organ development 31 (@GENE$) who had dystonia.	1
We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia @GENE$ 31 (biological_process) who had @DISEASE$.	0
On the basis of his symptoms, we diagnosed him as @DISEASE$ (@GENE$), and prescribed taltirelin hydrate.	0
Our case report support clinical @DISEASE$ of biological_process, and highlight the importance of considering this @GENE$ in patients with dystonia and ataxia.	0
Our case report support clinical @DISEASE$ of @GENE$, and highlight the importance of considering this muscle organ development in patients with dystonia and ataxia.	0
Our case report support clinical heterogeneity of @GENE$, and highlight the importance of considering this muscle organ development in patients with dystonia and @DISEASE$.	1
Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this @GENE$ in patients with dystonia and @DISEASE$.	0
Our case report support clinical heterogeneity of biological_process, and highlight the importance of considering this @GENE$ in patients with @DISEASE$ and ataxia.	0
Patients with the combination of @DISEASE$ and ataxia and a family history of a neurodegenerative disorder should be tested for @GENE$.	0
Mutations in @GENE$ and oxidative phosphorylation were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, @DISEASE$, or mitochondrial myopathy (MM).	0
None of the patients showed positive regulation of transcription by RNA polymerase II mutations, whereas 1 @DISEASE$ MM patient carried a homozygous Pro96Thr substitution in @GENE$.	0
Focal alterations affected @GENE$, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 @DISEASE$ areas.	1
Focal alterations affected G1/S transition of mitotic cell cycle, @GENE$, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 @DISEASE$ areas.	1
Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, @GENE$, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 @DISEASE$ areas.	0
Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, @GENE$, TP53, and additional novel amplifications in CCNE1, activation of MAPK activity, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 @DISEASE$ areas.	1
Focal alterations affected G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, CCNE1, positive regulation of protein phosphorylation, EPHA3, angiogenesis, FGFR1, transforming growth factor beta receptor signaling pathway, NF1, RB1, regulation of cell adhesion, TP53, and additional novel amplifications in CCNE1, @GENE$, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 @DISEASE$ areas.	1
The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (@GENE$, biological_process), including a gene coding for mandibulofacial dysostosis with @DISEASE$ (mRNA splicing, via spliceosome).	0
Mutations in the elongation of very long chain fatty acid 4 (@GENE$) gene cause Stargardt @DISEASE$ 3 (fatty acid elongation, saturated fatty acid), a rare, juvenile-onset, autosomal dominant form of macular degeneration.	1
Mutations in the elongation of very long chain fatty acid 4 (@GENE$) gene cause Stargardt macular dystrophy 3 (fatty acid elongation, saturated fatty acid), a rare, juvenile-onset, autosomal dominant form of @DISEASE$.	1
Mutations in the elongation of very long chain fatty acid 4 (fatty acid elongation, saturated fatty acid) gene cause Stargardt @DISEASE$ 3 (@GENE$), a rare, juvenile-onset, autosomal dominant form of macular degeneration.	1
Mutations in the elongation of very long chain fatty acid 4 (fatty acid elongation, saturated fatty acid) gene cause Stargardt macular dystrophy 3 (@GENE$), a rare, juvenile-onset, autosomal dominant form of @DISEASE$.	1
However, this reduction in @GENE$-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate @DISEASE$ in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid epidermis development.	0
However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no @GENE$ on morphology or function and did not accelerate @DISEASE$ in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid epidermis development.	0
However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate @DISEASE$ in the R91W;Nrl-/-;fatty acid elongation, saturated fatty acid @GENE$.	0
However, this reduction in positive regulation of cell migration-VLC-PUFA content in the all-cone retina had no negative regulation of transcription by RNA polymerase II on morphology or function and did not accelerate @DISEASE$ in the R91W;Nrl-/-;@GENE$ epidermis development.	1
In OSCC samples, a high @GENE$ expression was associated with @DISEASE$ size but not with prognosis.	1
Both display heterotaxy, cardiopulmonary malformations and @DISEASE$, a syndrome also characteristic of mutations in @GENE$ and negative regulation of canonical Wnt signaling pathway, the other known components of the IC.	1
Both display heterotaxy, cardiopulmonary malformations and @DISEASE$, a syndrome also characteristic of mutations in negative regulation of canonical Wnt signaling pathway and @GENE$, the other known components of the IC.	1
Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative @DISEASE$ (@GENE$) remains incompletely understood.	0
@GENE$ is therefore a new gene implicated in the etiology of XLMR associated with @DISEASE$ and may cause disease by altering intracellular signaling pathways affecting cellular proliferation	1
Hereditary @DISEASE$ (HAE), due to @GENE$-inhibitor deficiency, is a rare autosomal dominant and potentially life-threatening disease characterised by recurrent oedema attacks of skin, mucosa and viscera.	0
Rarely, patients with severe, salt-wasting CAH have deletions of steroid biosynthetic process that extend into @GENE$, resulting in a &quot;@DISEASE$&quot; consisting of CAH and EDS.	0
Reliable biomarkers for @DISEASE$ (@GENE$) have yet to be determined.	0
In humans, <i>@GENE$</i> is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain @DISEASE$, including acoustic neurinoma and meningioma.	1
In humans, <i>@GENE$</i> is the gene responsible for the disease neurofibromatosis muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and @DISEASE$.	1
In humans, <i>negative regulation of cell proliferation</i> is the gene responsible for the disease neurofibromatosis @GENE$ II, which results in the development of brain tumors, including acoustic neurinoma and @DISEASE$.	0
<i>Drosophila</i> @GENE$ is involved in biological_process, @DISEASE$ suppression and Hippo (Hpo) signaling, which is associated with Mer.	0
<i>Drosophila</i> positive regulation of cell-matrix adhesion is involved in @GENE$, @DISEASE$ suppression and Hippo (Hpo) signaling, which is associated with Mer.	0
We have been investigating the pancreas specific transcription factor, 1a cre-recombinase; @GENE$-stop-lox- Kristen rat sarcoma, glycine to aspartic acid at the 12 codon (Ptf1a<sup>cre/+</sup>;LSL-Kras<sup>G12D/+</sup>) mouse strain as a model of human pancreatic @DISEASE$.	0
Although no overt changes in @DISEASE$ were detected by slit-@GENE$ examination, the corneas of homozygous mutant mice exhibited histological and ultrastructural epithelial cell fragility phenotypes.	0
Although the most severe phenotype is observed in the homozygous @GENE$, this model will still provide a test-bed for therapies not only for @DISEASE$ but also for other keratinopathies caused by similar mutations.	0
We present a 22-year old male with hypotonia, @DISEASE$, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the @GENE$ gene.	1
We present a 22-year old male with hypotonia, developmental delay, @DISEASE$ disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the @GENE$ gene.	1
These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of @DISEASE$ (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with @GENE$ variants.	1
These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. @DISEASE$, microphallus, cryptorchidism), which had been noted to be classic features of patients with @GENE$ variants.	1
These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, @DISEASE$, cryptorchidism), which had been noted to be classic features of patients with @GENE$ variants.	1
Biallelic mutations in @GENE$ cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive @DISEASE$, myopathy, and hearing loss.	1
Biallelic mutations in @GENE$ cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, @DISEASE$, and hearing loss.	1
We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, @DISEASE$, mild hearing loss, decreased muscle @GENE$, and a dissection of the celiac artery at age 41.	1
We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild @DISEASE$, decreased muscle @GENE$, and a dissection of the celiac artery at age 41.	1
@GENE$ is a p53 target gene with DNA binding function and represents a highly plausible candidate breast @DISEASE$ predisposition gene.	1
A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for @GENE$ and mitotic cytokinesis mutations and in 1/84 sporadic breast @DISEASE$ cases.	1
A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for @GENE$ and mitotic cytokinesis mutations and in 1/84 @DISEASE$ breast cancer cases.	0
A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for double-strand break repair via homologous recombination and @GENE$ mutations and in 1/84 @DISEASE$ breast cancer cases.	0
However, the variant was also detected in 2/182 families with known @GENE$ or mitotic cytokinesis mutations and in 2/464 non-@DISEASE$ controls.	1
Our data suggest that pathogenic mutations in @GENE$ are rare in breast @DISEASE$ families and the c.339_340delAG variant does not represent a high-penetrance breast cancer risk allele	1
To address this @GENE$, we performed a longitudinal exome-wide association study to identify susceptibility loci for @DISEASE$ and MetS in a Japanese population.	0
The association of single nucleotide polymorphisms (SNPs) with body @GENE$ index (BMI) or the prevalence of @DISEASE$ and MetS was examined in a generalized estimating equation model.	0
Consistent with a role in transition zone function, mutation of mouse @GENE$ disrupts the localization of proteins including smoothened signaling pathway and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of cilium assembly such as @DISEASE$ and kidney cysts.	1
Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including @GENE$ and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of cilium assembly such as @DISEASE$ and kidney cysts.	1
Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including smoothened signaling pathway and @GENE$ to cilia, resulting in phenotypes characteristic of cilium assembly such as @DISEASE$ and kidney cysts.	0
Consistent with a role in transition zone function, mutation of mouse smoothened signaling pathway disrupts the localization of proteins including smoothened signaling pathway and protein processing involved in protein targeting to mitochondrion to cilia, resulting in phenotypes characteristic of @GENE$ such as @DISEASE$ and kidney cysts.	1
Testing for high-risk (hr) @GENE$s of human papillomavirus (HPV) is highly sensitive as a screening test of high-grade cervical intraepithelial neoplastic (CIN2/3) disease, the precursor of cervical @DISEASE$.	0
@GENE$, a new member of the cell division cycle associated family of genes, is involved in embryonic development and dysregulated in various types of human @DISEASE$.	0
Furthermore, @GENE$ increased the expression of negative regulation of transcription by RNA polymerase II, a marker of aggressive breast @DISEASE$ that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.	0
Furthermore, @GENE$ increased the expression of negative regulation of transcription by RNA polymerase II, a marker of aggressive breast cancer that is involved in @DISEASE$ progression, by enhancing the transcriptional activity of its promoter.	0
Furthermore, regulation of cell proliferation increased the expression of @GENE$, a marker of aggressive breast @DISEASE$ that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.	0
@GENE$ is one of the essential proteins of this pathway and single-nucleotide polymorphisms (SNPs) of this gene are reported to be associated with @DISEASE$ risks.	1
the Partner and localizer of BRCA2 (@GENE$) gene and risk of breast @DISEASE$.	1
the association between SNPs in the @GENE$ gene and the susceptibility to breast @DISEASE$.	1
Since wo@GENE$ with breast @DISEASE$ and men and women with other disorders are often treated with androgen catabolic process inhibitors (AI), these populations might be especially vulnerable to cognitive deficits due to low neuroE2 synthesis, i.e., synthesis of E2 directly within the brain.	0
Since wonegative regulation of phosphatase activity with breast @DISEASE$ and men and women with other disorders are often treated with @GENE$ inhibitors (AI), these populations might be especially vulnerable to cognitive deficits due to low neuroE2 synthesis, i.e., synthesis of E2 directly within the brain.	0
This study investigated the role of potassium channel gene <i>(@GENE$)</i> polymorphisms in high @DISEASE$.	0
Five tag single-nucleotide polymorphisms (SNPs) of <i>@GENE$</i> were genotyped, and association testing with high @DISEASE$ was conducted using logistic regression analysis adjusted for multicellular organism development and age to give <i>P</i><sub>asym</sub> values, and multiple comparisons were corrected by permutation test to give <i>P</i><sub>emp</sub> values.	0
Five tag single-nucleotide polymorphisms (SNPs) of <i>potassium ion transmembrane transport</i> were genotyped, and association testing with high @DISEASE$ was conducted using logistic regression analysis adjusted for @GENE$ and age to give <i>P</i><sub>asym</sub> values, and multiple comparisons were corrected by permutation test to give <i>P</i><sub>emp</sub> values.	0
The SNP rs7744813, previously shown to be associated with refractive error and @DISEASE$ in two GWAS, showed an odds ratio of 0.75 (95% CI 0.63-0.90; <i>P</i><sub>emp</sub> = 0.0058) for the @GENE$ allele.	0
Clinical features of affected individuals with LGD variants in @GENE$ include variable levels of intellectual disability, delayed speech and motor milestones, and @DISEASE$ spectrum disorder.	0
Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving @GENE$ and surrounding genes can present with mild intellectual disability, mild dysmorphic features, @DISEASE$, and decreased growth.	0
Twenty-one genes showed single or cross-@DISEASE$ associations, including novel associations of @GENE$ in melanoma and double-strand break repair via homologous recombination in stomach adenocarcinoma.	1
Twenty-one genes showed single or cross-@DISEASE$ associations, including novel associations of succinate metabolic process in melanoma and @GENE$ in stomach adenocarcinoma.	1
The 659 predisposition variants and 18 additional large deletions in @DISEASE$ suppressors, including @GENE$, double-strand break repair via homologous recombination, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.	1
The 659 predisposition variants and 18 additional large deletions in @DISEASE$ suppressors, including protein phosphorylation, @GENE$, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.	1
Williams-Beuren syndrome (@GENE$, no. OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome 7q11.23 and characterized by @DISEASE$, mental retardation, and a specific facial dysmorphism.	1
Williams-Beuren syndrome (@GENE$, no. OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome 7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific @DISEASE$.	1
While the patient showed features overlapping with the reported phenotype, such as a @DISEASE$ and small hands and feet, he also presented with additional features like cleft @GENE$ and palate and an aberrant right subclavian artery.	0
The aim of this study was to look for genetic causes of Currarino Syndrome in @DISEASE$ patients after ruling out other causes, like chromosome aberrations, disease-causing variants in possible @GENE$ cooperating transcription factors and aberrant methylation in the promoter of the MNX1 gene.	0
Genetic analysis of a large Indian family with an autosomal dominant @DISEASE$ phenotype allowed us to identify a novel cataract gene, @GENE$.	1
Considering that CRYBA4 associates with @GENE$ and that the latter protein has been implicated in @DISEASE$, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).	0
This is the first report linking mutations in @GENE$ to @DISEASE$ogenesis and microphthalmia	1
@GENE$-122, the expression of which is regulated by several transcription factors, such as natural killer cell differentiation, was recently reported to be associated with type 2 diabetes (T2DM) and @DISEASE$.	0
protein polyubiquitination-122, the expression of which is regulated by several transcription factors, such as @GENE$, was recently reported to be associated with type 2 diabetes (T2DM) and @DISEASE$.	0
Lower serum @GENE$-122 is a unique feature of natural killer cell differentiation-protein phosphorylation patients and might partially explain the increased risk for liver @DISEASE$ and abnormal lipid metabolism in HNF1A-DM patients	0
Lower serum protein polyubiquitination-122 is a unique feature of @GENE$-protein phosphorylation patients and might partially explain the increased risk for liver @DISEASE$ and abnormal lipid metabolism in HNF1A-DM patients	1
In the present article, we review current evidence supporting the role of @GENE$ in thymic egress, inflammation, and @DISEASE$.	0
These 294 differentially expressed genes and non-coding RNA transcripts provide here a @GENE$ to specifically define skull base @DISEASE$ and to identify novel and potentially important targets for diagnosis, prognosis, and therapy of this cancer.	0
Therefore, quantification of @DISEASE$ extracellular @GENE$ (pHe) is of crucial importance.	0
This study is focused on the application of the YbHPDO3A (ytterbium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane) probe for in vivo @DISEASE$ @GENE$e quantification using chemical exchange saturation transfer (CEST)-MRI and its correlation with tumor metabolism assessed by immunohistochemistry.	0
In vivo MRI sequences consisted of T<sub>2w</sub> for @DISEASE$ localization, T<sub>2w</sub> * to assess YbHPDO3A biodistribution by exploiting its magnetic susceptibility effect and CEST for glioma @GENE$e mapping.	0
These immunohistochemical results are consistent with our @GENE$e mapping (Pearson correlation coefficient &gt; 0.70) and provide evidence for the feasibility of the CEST-MRI method with the YbHPDO3A probe for @DISEASE$ pHe quantification at 4.7 T.	0
Blocking the expression of @GENE$, female gamete generation, and RDX significantly inhibits breast @DISEASE$ cell migration induced by let-7b repression.	0
In an unrelated @DISEASE$ case of CGHT, we identified a 1.3 Mb nodal signaling pathway deletion of chr17q24.2-q24.3 encompassing @GENE$ and found that ABCA5 levels are dramatically reduced throughout patient hair follicles.	0
In an unrelated @DISEASE$ case of CGHT, we identified a 1.3 Mb @GENE$ deletion of chr17q24.2-q24.3 encompassing negative regulation of macrophage derived foam cell differentiation and found that ABCA5 levels are dramatically reduced throughout patient hair follicles.	0
Friedreich @DISEASE$ (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of @GENE$ trinucleotide repeats in the first intron of the regulation of ferrochelatase activity gene, which encodes for the mitochondrial frataxin protein.	0
The aim of the study was to understand the role of @GENE$-homophilic cell adhesion via plasma membrane adhesion molecules/2-CDC42 signalling pathways in development of breast @DISEASE$ (BC).	0
The aim of the study was to understand the role of axon guidance-@GENE$/2-CDC42 signalling pathways in development of breast @DISEASE$ (BC).	0
Significantly, higher alteration of @GENE$ locus was observed in triple negative breast @DISEASE$ (TNBC) over signal transduction subtype (P = 0.0014).	0
Significantly, higher alteration of axon guidance locus was observed in triple negative breast @DISEASE$ (TNBC) over @GENE$ subtype (P = 0.0014).	1
Results indicate the importance of axon guidance-homophilic cell adhesion via plasma membrane adhesion molecules-@GENE$ signalling pathway in predicting @DISEASE$ progression.	0
The lack of good molecular markers for diagnosis as well as treatment assessment has rendered the @DISEASE$ (@GENE$) a major challenge in health care.	0
An analysis approach combing supervised significant analysis of microarray (SAM), prediction analysis of microarray (@GENE$), and unsupervised hierarchical cluster methodologies statistically determined 211 upregulated and 78 downregulated genes between liver @DISEASE$ and non-cancer liver tissues, and demonstrated &gt; or = 93% accuracy in classifying the tissue samples.	0
Numerous genes found in this study were also differentially expressed in human @GENE$ and many other human @DISEASE$s including breast, prostate and lung cancers, etc., serving as tumor suppressors, promoters, prognostic markers or chemotherapy targets.	0
In humans and @GENE$ hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including @DISEASE$, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	0
In humans and @GENE$ hair follicle development mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, @DISEASE$, and body agenesis.	0
In humans and epidermis development @GENE$ mutations or loss of function result in a number of skeletal and organ malformations, including @DISEASE$, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	0
In humans and epidermis development @GENE$ mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, @DISEASE$, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	1
In humans and epidermis development @GENE$ mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal @DISEASE$, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	1
In humans and epidermis development @GENE$ mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, @DISEASE$, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	1
By using exome and capillary sequencing, we here identify biallelic @GENE$ mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a @DISEASE$, facial dysmorphisms, and low cholesterol levels.	1
By using exome and capillary sequencing, we here identify biallelic @GENE$ mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, @DISEASE$, and low cholesterol levels.	1
Brain MRI showed diffuse @DISEASE$, suggesting @GENE$.	1
5'-Aza-2'-deoxycytidine (5-Aza-@GENE$) is a demethylating drug that causes genome-wide hypomethylation resulting in the expression of several @DISEASE$ suppressor genes causing growth arrest of cancer cells.	0
Induction of p53 by 5-Aza-@GENE$ was tested in vitro using @DISEASE$ cells.	0
Through genetic mapping of disease loci and whole-exome sequencing in four unrelated multiplex families presenting with severe AMC, we identified biallelic loss-of-function mutations in @GENE$ (leucine-rich @DISEASE$-inactivated 4).	0
This is consistent with previous studies reporting @DISEASE$ in @GENE$-deficient mice due to peripheral hypomyelination.	1
Limb-girdle muscular dystrophies (LGMD) are a highly @DISEASE$ group of muscle disorders, which first affect the voluntary muscles of the @GENE$ and shoulder areas.	0
The @DISEASE$ forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (telethonin), LGMD2H (@GENE$), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (protein O-linked mannosylation), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (protein O-linked mannosylation), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
The @DISEASE$ forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (telethonin), LGMD2H (protein polyubiquitination), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (@GENE$), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (protein O-linked mannosylation), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
The @DISEASE$ forms (proteolysis) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (telethonin), LGMD2H (protein polyubiquitination), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (protein O-linked mannosylation), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (@GENE$), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
Our data indicate that 5-hmC might serve as a metastasis marker for @DISEASE$ and that the decreased expression of @GENE$ is likely one of the mechanisms of genome instability underlying 5-hmC loss in cancer	0
It has been reported that functionally distinct @DISEASE$ stem cells (CSCs) exist in human bladder cancer (@GENE$).	1
Sox2 expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder @DISEASE$ and continues to be expressed in invasive mouse @GENE$.	1
Using s as a reporter of @GENE$ transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of @DISEASE$ cells that fuel the growth of established intracellular signal transduction.	1
Response rates in both treatment @GENE$s were less than 5% in the overall population and in the @DISEASE$ subgroup.	0
@GENE$ and KRT6 (KRT6A, KRT6B &amp; KRT6C) gene expression was assessed in publically available serous ovarian @DISEASE$ data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.	1
Survival analyses showed that high epidermis development mRNA in stage III/IV serous ovarian @DISEASE$s was significantly associated with reduced progression-free (HR 1.38, P &lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high @GENE$ mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).	0
KRT5 but not @GENE$C mRNA expression was increased in chemotherapy resistant primary serous ovarian @DISEASE$ cells compared to chemotherapy sensitive cells.	0
Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, @GENE$, regulation of transcription, DNA-templated, RAF1, and interleukin-2-mediated signaling pathway might be associated with the development of @DISEASE$.	0
Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, protein phosphorylation, regulation of transcription, DNA-templated, RAF1, and @GENE$ might be associated with the development of @DISEASE$.	0
Patients with physical findings suggestive of Treacher Collins syndrome (@GENE$) or @DISEASE$ (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (monocyte chemotaxis) have been reported.	0
Patients with physical findings suggestive of Treacher Collins syndrome (regulation of translation) or @DISEASE$ (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (@GENE$) have been reported.	0
We conclude that the phenotype combining features of @GENE$ with monocyte chemotaxis is genetically @DISEASE$.	0
We conclude that the phenotype combining features of regulation of translation with @GENE$ is genetically @DISEASE$.	0
In vitro head and neck @DISEASE$ studies have demonstrated that epidermal growth factor receptor kinase substrate 8 (@GENE$) overexpression contributes to squamous carcinogenesis.	0
We then correlated our findings with clinicopathologic data including @DISEASE$-node-metastasis stage, p16 status, age, @GENE$, and smoking and alcohol history.	0
In conclusion, our data offer in vivo support that, in HNSCCs, @GENE$ is involved in @DISEASE$ invasion but not necessarily the development of regional LN metastasis.	0
A case with @GENE$ (C.905A&gt;G) had @DISEASE$ controlled for 3 mouths.	1
Pedigree analysis in the Haflinger breed supports a simple recessive @DISEASE$ and a genome-wide association study (N = 23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal @GENE$ (P<sub>corrected</sub> = 0.04).	0
Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous @GENE$ and @DISEASE$, is explained by mutations in DDB2.	0
The knock out animals were protected from HFD induced @DISEASE$, @GENE$ty liver and insulin resistance.	0
Here, using a microarray screen, we found that knocking down @GENE$ in human @DISEASE$ cells results in down-regulation of microRNA-221 (protein polyubiquitination-221).	0
Here, using a microarray screen, we found that knocking down DNA repair in human @DISEASE$ cells results in down-regulation of microRNA-221 (@GENE$-221).	0
Gap junction beta-1 (@GENE$) gene mutations affecting the gap junction protein connexin32 (Cx32) cause the X-linked Charcot-Marie-Tooth disease (CMT1X), a common inherited @DISEASE$.	1
Mutations in the glucosylceramidase beta (@GENE$) gene are strongly associated with @DISEASE$s marked by protein aggregation.	0
Of the included 24 CNS patients with @DISEASE$ (14 intracranial and 10 spinal hemangioblastomas), 5 patients (20.8%) were diagnosed with Von Hippel-Lindau disease (@GENE$).	1
We studied a consanguineous Pakistani family with postnatal @DISEASE$, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a @GENE$-like presentation.	1
We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, @DISEASE$ with myelination delay, suggestive of a @GENE$-like presentation.	1
The regulation of the post-mitotic neural survival activity of @GENE$ depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal @DISEASE$ syndrome.	0
We found monoallelic truncating/functionally deleterious mutations in seven genes, including @GENE$ and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in @DISEASE$ predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.	1
We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and @GENE$, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in @DISEASE$ predisposing recessive disorders, namely DNA repair, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.	1
We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in @DISEASE$ predisposing recessive disorders, namely @GENE$, response to gamma radiation, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.	1
We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in @DISEASE$ predisposing recessive disorders, namely DNA repair, @GENE$, positive regulation of protein ubiquitination, fibroblast growth factor receptor signaling pathway and RECQL4.	1
We found monoallelic truncating/functionally deleterious mutations in seven genes, including protein phosphorylation and regulation of transcription, DNA-templated, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in @DISEASE$ predisposing recessive disorders, namely DNA repair, response to gamma radiation, @GENE$, fibroblast growth factor receptor signaling pathway and RECQL4.	1
Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian @DISEASE$ and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &quot;likely pathogenic&quot; missense variants in @GENE$, mitochondrial translational elongation, regulation of transcription, DNA-templated and TP53.	1
Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian @DISEASE$ and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &quot;likely pathogenic&quot; missense variants in protein phosphorylation, mitochondrial translational elongation, @GENE$ and TP53.	1
Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian @DISEASE$ and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &quot;likely pathogenic&quot; missense variants in protein phosphorylation, @GENE$, regulation of transcription, DNA-templated and TP53.	0
Homeobox A11 (@GENE$) is one of the hypermethylated genes in breast @DISEASE$ and its function in breast tumorigenesis remains elusive.	0
Homeobox A11 (@GENE$) is one of the hypermethylated genes in breast cancer and its function in breast @DISEASE$igenesis remains elusive.	0
In this study, we analyzed the methylation status of @GENE$ in 264 paired breast @DISEASE$ and normal tissue as well as in matched serum samples by MethyLight assay.	0
We found that @GENE$ was hypermethylated in @DISEASE$ tissues (45.08%), especially in invasive ductal carcinomas (P&lt;0.001), patients with a family history of cancer (P=0.033), cases with metastatic lymph nodes (P=0.004) and P53 positive group (P=0.017).	0
These disorders include cancer, bipolar disorder, @DISEASE$, autism, Cri-du-@GENE$ syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	0
These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-@GENE$ syndrome, myopia, cortical @DISEASE$-linked Alzheimer's disease, and infectious diseases.	0
Primary ciliary dyskinesia (@GENE$) is an @DISEASE$ disease characterized by chronic respiratory infections of the upper and lower airways, hypofertility, and, in approximately half of the cases, situs inversus.	1
Interestingly, protein insertion into membrane mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary @DISEASE$ (HSP) and distal hereditary motor neuropathy @GENE$ V (dHMN-V).	0
In 20/23 cases, MDR@GENE$ BSI occurred during @DISEASE$.	0
MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDR@GENE$ BSI, particularly during @DISEASE$, as well as a higher probability of unfavourable outcomes in positive regulation of cytosolic calcium ion concentration-rel BSIs.	0
Solute carrier family 34 member 2 (@GENE$) is a well-known sodium-dependent phosphate transporter that has recently been linked to @DISEASE$ development.	0
Our results indicate that the protein expression level of @GENE$ in pancreatic @DISEASE$ tissue is a good predictor of PFS, and thus dCK may be the chloride transport biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.	0
Our results indicate that the protein expression level of pyrimidine nucleotide metabolic process in pancreatic @DISEASE$ tissue is a good predictor of PFS, and thus dCK may be the @GENE$ biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.	0
Our recent determination of a microRNA (@GENE$NA) expresmelanosome organizationon signature in prostate @DISEASE$ (mitochondrial transport) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.	0
Our recent determination of a microRNA (protein polyubiquitinationNA) expres@GENE$on signature in prostate @DISEASE$ (mitochondrial transport) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.	0
Our recent determination of a microRNA (protein polyubiquitinationNA) expresmelanosome organizationon signature in prostate @DISEASE$ (@GENE$) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.	0
We show that morpholino-mediated @GENE$ loss of function in the zebrafish results in shortened body axis, @DISEASE$ with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.	0
Altogether these data demonstrate that mutations in @GENE$ cause a congenital muscular dystrophy syndrome with @DISEASE$, cataracts, and intellectual disability	1
Bardet-Biedl syndrome (@GENE$) is a rare ciliopathy disorder that is clinically and genetically @DISEASE$ with 18 known genes.	0
After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung @DISEASE$ outcome such as the targeting of DNA @GENE$ repair mechanisms firstly anti-PARPs, inhibitory molecules of negative regulation of transcription by RNA polymerase II, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the negative regulation of apoptotic process promoter.	0
After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung @DISEASE$ outcome such as the targeting of DNA cellular protein catabolic process repair mechanisms firstly anti-PARPs, inhibitory molecules of @GENE$, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the negative regulation of apoptotic process promoter.	0
After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-neuropeptide signaling pathway addresses pathways to improve small-cell lung @DISEASE$ outcome such as the targeting of DNA cellular protein catabolic process repair mechanisms firstly anti-PARPs, inhibitory molecules of negative regulation of transcription by RNA polymerase II, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the @GENE$ promoter.	1
An analysis of human SCLC specimens revealed that @GENE$ is expressed exclusively in variant SCLC @DISEASE$s that lack expression of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells.	0
Moreover, we show that most SCLC @DISEASE$s can be classified into one of three lineages based on the expression of @GENE$, ASCL1, or NEUROD1.	0
The study was conducted to determine the effect of DHA on the distribution of @GENE$ and apelin receptor (APJ) in the @DISEASE$ nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model.	0
Epithelial-mesenchymal transition (@GENE$) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate @DISEASE$ metastasis.	1
However, @GENE$ also contributes to the initiation and development of primary @DISEASE$.	1
@GENE$ is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	0
superoxide metabolic process is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the @GENE$ (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	0
superoxide metabolic process is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), @GENE$ (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	0
superoxide metabolic process is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and @GENE$ (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	0
superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the @GENE$ (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	0
superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), @GENE$ (OMIM #608515) and antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), NCF1 (OMIM #608512), antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (OMIM #608515) and @GENE$ (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
In this study, we evaluated the clinical, laboratory and genetic findings and the prognostic effects of molecular inheritance of our 24 @GENE$ cases (14 XR, 10 @DISEASE$-AR).	0
We describe a multigenerational Saudi family with an autosomal dominant form of hypohidrotic @DISEASE$ in which positional mapping and exome sequencing identified a novel variant in @GENE$ that fully segregates with the phenotype.	0
In a unique case from a consanguineous union presenting with overgrowth, @DISEASE$, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense @GENE$ variant.	1
In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, @DISEASE$, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense @GENE$ variant.	0
Spinocerebellar @DISEASE$ type 17 (@GENE$) is caused by CAG repeat expansion in the TATA-box binding protein gene.	1
The lifestyle gradually transformed from Bedouin life to urban sedentary life, along with a @GENE$ increase in @DISEASE$ and other comorbidities.	0
The percentage of @DISEASE$ forms due to mutations in @GENE$, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).	1
The percentage of @DISEASE$ forms due to mutations in proteolysis, @GENE$, protein folding, negative regulation of angiogenesis, and positive regulation of cell proliferation was unusually high (48%).	1
The percentage of @DISEASE$ forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, @GENE$, and positive regulation of cell proliferation was unusually high (48%).	1
The percentage of @DISEASE$ forms due to mutations in proteolysis, protein peptidyl-prolyl isomerization, protein folding, negative regulation of angiogenesis, and @GENE$ was unusually high (48%).	1
Estrogens and estrogen receptors (ERs), such as ERα and ERβ, prolactin (@GENE$) and prolactin receptor (PRLR) have been reported to be involved in the physiopathology of uterine cervical @DISEASE$ (UCC).	0
The results revealed that ERα, ERβ, @GENE$R and Ki67 expression levels were increased during the progression of @DISEASE$.	0
Mutation in the @GENE$o signalingay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an @DISEASE$ chronic tubulointerstitial nephropathy.	1
Mutation in the negative regulation of canonical Wnt signaling pat@GENE$ay gene causes nephronophthisis muscle organ development II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive @DISEASE$ tubulointerstitial nephropathy.	0
Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis @GENE$ II (negative regulation of canonical Wnt signaling pathway), an @DISEASE$ chronic tubulointerstitial nephropathy.	1
Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis @GENE$ II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive @DISEASE$ tubulointerstitial nephropathy.	0
Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis @GENE$ II (negative regulation of canonical Wnt signaling pathway), an autosomal recessive chronic tubulointerstitial @DISEASE$.	0
Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (@GENE$), an @DISEASE$ chronic tubulointerstitial nephropathy.	1
Mutation in the negative regulation of canonical Wnt signaling pathippo signalingay gene causes nephronophthisis muscle organ development II (@GENE$), an autosomal recessive @DISEASE$ tubulointerstitial nephropathy.	0
Here, integrated analysis of gene expression in non-small cell lung @DISEASE$ revealed that @GENE$ expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).	0
@GENE$ silencing by lentivirus-mediated shRNA blocked human lung @DISEASE$ cell epithelial-mesenchymal transition and metastasis in vitro and in vivo, respectively.	0
Moreover, @GENE$ knockdown enhanced @DISEASE$ cell sensitivity to cisplatin-induced death by inhibiting stemness in lung cancer cells.	0
Collectively, these data suggest that @GENE$ may be a novel therapeutic target and predictive marker of @DISEASE$ metastasis in non-small cell lung cancer	0
Biallelic @GENE$ mutations were described in children with @DISEASE$, neurodevelopmental delay, and dystonia.	0
Biallelic @GENE$ mutations were described in children with hyperphenylalaninemia, @DISEASE$, and dystonia.	1
Biallelic @GENE$ mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and @DISEASE$.	1
We identified @GENE$ homozygous null variants (c.187A&gt;T;p.K63* and c.79-2A&gt;G;p.V27Wfs*14) in two kindreds with early-onset @DISEASE$.	1
Our results suggest that @GENE$ mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive @DISEASE$ in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.	1
Our results suggest that @GENE$ mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive @DISEASE$ parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.	0
Mutations of <i>@GENE$</i>/<i>lysosome organization</i> have been implicated in inherited @DISEASE$ in both humans and mice.	1
This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in @GENE$ from a microtubule-based movement family with an atypical clinical symptom of prominent @DISEASE$ weakness.	0
This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in neurofilament bundle assembly from a @GENE$ family with an atypical clinical symptom of prominent @DISEASE$ weakness.	0
Therefore, this study suggests that the @GENE$ loss and translational elongations by the 3' UTR of the neurofilament bundle assembly mutations may be a relatively frequent genetic cause of axonal peripheral neuropathy with the specific characteristics of @DISEASE$ dominant weakness	0
<b>Rationale:</b> Oncogenic @GENE$ signaling activation and 3p22-21.3 locus alteration are common in multiple @DISEASE$, especially carcinomas of the nasopharynx, esophagus and lung.	1
<i>@GENE$</i> was frequently downregulated in ESCC, lung and NPC cell lines and primary @DISEASE$, but was readily expressed in normal tissues and immortalized normal epithelial cells, with mutations rarely detected.	1
<i>@GENE$</i> methylation was frequently detected in ESCC @DISEASE$ and correlated with lymph node metastasis, tumor recurrence and progression, with <i>DLEC1</i> as the most frequently methylated among the established 3p22.2 tumor suppressors (<i>RASSF1A, PLCD1</i> and <i>ZMYND10/BLU</i>).	1
Mutations in the Pejvakin (@GENE$) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory @DISEASE$ spectrum disorder (ANSD) or cochlear dysfunction.	0
Here, we demonstrate that @GENE$ with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound @DISEASE$.	0
Here, we demonstrate that @GENE$ with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset @DISEASE$ hearing loss.	0
In humans, recessive and dominant @GENE$ mutations cause hypophosphatasia (HPP), a metabolic bone disease with highly @DISEASE$ clinical manifestations, ranging from lethal perinatal hypomineralization to a relatively mild dental disease.	0
We determined that @GENE$ was over-expressed in GBC @DISEASE$ tissues compared with normal tissues, which was also an independent prognostic factor for the overall survival of GBC patients by tissue microarrays analysis.	0
The SNPs rs2124437 (RASGRP3), rs1335022 (protein retention in ER lumen), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (@GENE$) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	0
A significant association of the SNPs in oral @DISEASE$ was observed in MAPK cascade AA (rs2124437) (p &lt; 0.000, OR 1.34, 95 % confidence interval (CI) 1.01-1.76), @GENE$ TT (rs1335022) (p = 0.008, OR 1.58, 95 % CI 1.23-2.03), G protein-coupled receptor signaling pathway CC (p = 0.008, OR 1.56, 95 % CI 1.15-2.1), and TT (p &lt; 0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p = 0.029, OR 0.68, 95 % CI 0.53-0.87) and PREX2 CT (p = 0.004, OR 0.49, 95 % CI 0.37-0.64), indicating protection.	0
A significant association of the SNPs in oral @DISEASE$ was observed in MAPK cascade AA (rs2124437) (p &lt; 0.000, OR 1.34, 95 % confidence interval (CI) 1.01-1.76), protein retention in ER lumen TT (rs1335022) (p = 0.008, OR 1.58, 95 % CI 1.23-2.03), @GENE$ CC (p = 0.008, OR 1.56, 95 % CI 1.15-2.1), and TT (p &lt; 0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p = 0.029, OR 0.68, 95 % CI 0.53-0.87) and PREX2 CT (p = 0.004, OR 0.49, 95 % CI 0.37-0.64), indicating protection.	0
Phosphatase and tensin homolog (@GENE$) is a well‑known @DISEASE$ suppressor and serves a vital role in cancer progression.	1
@GENE$ mutations have been found to be responsible for Tricho-Dento-Osseous (TDO) syndrome, characterized by kinky hair, thin-pitted enamel and @DISEASE$.	1
Here we show that the @GENE$ mutation (c.533 A&gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a tryptophan catabolic process to kynurenine patient, providing a molecular explanation for abnormal @DISEASE$.	1
Here we show that the blood vessel development mutation (c.533 A&gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a @GENE$ patient, providing a molecular explanation for abnormal @DISEASE$.	0
The discovery of mutations in genes encoding the metabolic enzymes isocitrate dehydrogenase (IDH), succinate dehydrogenase (@GENE$), and fumarate hydratase (FH) has expanded our understanding not only of altered metabolic pathways but also epigenetic dysregulation in @DISEASE$.	0
@GENE$ deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal @DISEASE$ (GIST).	0
@GENE$ deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/@DISEASE$ and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).	0
<b>Methods:</b> Using immunohistochemical method detected the expression level of @GENE$ in 60 cases of @DISEASE$s (including WHO grades Ⅱ, Ⅲ and Ⅳ, each for 20 cases) and 20 cases of non-tumor brain tissues.	0
<b>Results:</b> Immunohistochemistry results showed that the percentages of @GENE$ expression in glioma was 90%(54/60) compared with 30%(6/20) in non-@DISEASE$ brain tissues(<i>P</i>&lt;0.01).	0
Real-time fluorescence quantitative PCR and Western blot showed that the expression level of @GENE$ 2 in @DISEASE$s was significantly higher than that in para-cancerous tissues (<i>P</i>&lt;0.01), and those in WHO grades Ⅳ and Ⅲ gliomas were significantly higher than that in WHO grade Ⅱ glioma (<i>P</i>&lt;0.01).	0
The expression of N-cadherin and vimentin was positively associated with @GENE$ in @DISEASE$(<i>r</i>=0.971, <i>P</i>&lt;0.01; <i>r</i>=0.968, <i>P</i>&lt;0.01).	0
Global-genome nucleotide excision repair (GG-NER) prevents ultraviolet (UV) light-induced skin @DISEASE$ by removing mutagenic cyclobutane pyrimidine dimers (@GENE$s).	0
Superficial @GENE$-positive fibroblastic @DISEASE$ is a recently described soft-tissue tumor entity.	0
A 48 year-old-male presented with a gradually increasing soft-tissue @GENE$ in his right forearm of 2 years' duration, along with multiple subcutaneous soft-tissue nodular lesions, and reminiscent of @DISEASE$ over his body.	0
Microscopic sections showed a circumscribed @DISEASE$ in the dermis and subcutaneous @GENE$, composed of spindle cells, inflammatory cells, including lymphocytes, plasma cells, and eosinophils, along with interspersed markedly pleomorphic giant cells containing moderate-to-abundant &quot;glassy&quot; cytoplasm, vesicular nuclei, exhibiting prominent nucleoli, and intranuclear pseudoinclusions.	0
By immunohistochemistry, the @DISEASE$ cells were diffusely positive for @GENE$ while negative for cytokeratin (CK), pan CK (AE1/AE3), S100 protein, CD30, and CD31.	0
Diagnosis of superficial @GENE$-positive fibroblastic @DISEASE$ was offered.	0
Fluorescence in situ hybridisation (@GENE$) targeting specific genes has been used as an ancillary method for differential diagnosis of melanocytic @DISEASE$, but most previous studies have focused on non-acral lesions which may have genetic alterations different from acral lesions.	0
We evaluated use of multi-site @GENE$ in the diagnosis of acral melanoma in a series of 82 acral melanocytic @DISEASE$.	0
Recessive mutations in @GENE$ cause lethal neonatal @DISEASE$ and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	1
Recessive mutations in @GENE$ cause lethal neonatal rigidity and @DISEASE$ seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	0
Recessive mutations in @GENE$ cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal @DISEASE$, hypertonia, and refractory epilepsy with premature death by age 2 years.	1
Mildly affected individuals with @GENE$ mutations show that BRAT1 must be considered as a cause in childhood refractory @DISEASE$ and microcephaly with survival beyond infancy.	1
Moreover, we demonstrated that pharmacological inhibition of 15-@GENE$ enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the oxidation-reduction process-positive subset in both human PDAC cells and @DISEASE$ cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	0
Moreover, we demonstrated that pharmacological inhibition of 15-L-serine biosynthetic process enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the @GENE$-positive subset in both human PDAC cells and @DISEASE$ cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	0
Finally, ATRA replacement suppressed 15-@GENE$ inhibition-induced @DISEASE$ progression in KC mice, and ATRA treatment attenuated oxidation-reduction process activity in tumor cells isolated from the pancreas of 15-L-serine biosynthetic process<sup>-/-</sup> KC mice.	0
Finally, ATRA replacement suppressed 15-L-serine biosynthetic process inhibition-induced @DISEASE$ progression in KC mice, and ATRA treatment attenuated oxidation-reduction process activity in tumor cells isolated from the pancreas of 15-@GENE$<sup>-/-</sup> KC mice.	0
Finally, ATRA replacement suppressed 15-L-serine biosynthetic process inhibition-induced @DISEASE$ progression in KC mice, and ATRA treatment attenuated @GENE$ activity in tumor cells isolated from the pancreas of 15-L-serine biosynthetic process<sup>-/-</sup> KC mice.	0
These findings provide evidence that 15-@GENE$ inhibition enhances positive regulation of protein phosphorylation-driven @DISEASE$ progression via ATRA depletion in the pancreas.	0
These findings provide evidence that 15-L-serine biosynthetic process inhibition enhances @GENE$-driven @DISEASE$ progression via ATRA depletion in the pancreas.	1
Blood and tissue samples from 48 @DISEASE$ patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, @GENE$ 829C&gt;T, regulation of histone methylation 677C&gt;T, MTHFR 1298A&gt;C, and nucleobase-containing compound metabolic process 347C&gt;G.	0
Blood and tissue samples from 48 @DISEASE$ patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, negative regulation of translation 829C&gt;T, @GENE$ 677C&gt;T, MTHFR 1298A&gt;C, and nucleobase-containing compound metabolic process 347C&gt;G.	0
Blood and tissue samples from 48 @DISEASE$ patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, negative regulation of translation 829C&gt;T, regulation of histone methylation 677C&gt;T, MTHFR 1298A&gt;C, and @GENE$ 347C&gt;G.	0
Even though the role of single nucleotide polymorphisms of @GENE$ in chemotherapy-induced @DISEASE$ necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after lactation treatment, which may affect the histologic response of osteosarcoma.	0
Even though the role of single nucleotide polymorphisms of nucleobase-containing compound metabolic process in chemotherapy-induced @DISEASE$ necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after @GENE$ treatment, which may affect the histologic response of osteosarcoma.	0
Even though the role of single nucleotide polymorphisms of nucleobase-containing compound metabolic process in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after @GENE$ treatment, which may affect the histologic response of @DISEASE$.	0
A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and @DISEASE$ named Helsmoortel-@GENE$ der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the regulation of transcription by RNA polymerase II gene (OMIM#611386) as biological cause.	0
A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and @DISEASE$ named Helsmoortel-glycoprotein biosynthetic process der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the @GENE$ gene (OMIM#611386) as biological cause.	1
We report on two children, displaying @DISEASE$ (ID) and peculiar congenital eyes anomalies, both carrying a de novo nonsense mutation in the @GENE$ gene.	1
Genes involved in tissue development, differentiation, and oncogenesis such as @GENE$, HES5, negative regulation of transcription by RNA polymerase II, diet induced thermogenesis, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, @GENE$, diet induced thermogenesis, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, negative regulation of transcription by RNA polymerase II, @GENE$, positive regulation of transcription, DNA-templated, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
Genes involved in tissue development, differentiation, and oncogenesis such as protein refolding, HES5, negative regulation of transcription by RNA polymerase II, diet induced thermogenesis, @GENE$, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
Partial loss-of-function variants in the @GENE$ immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of @DISEASE$, but the molecular bases for these connections are unknown.	1
Excess accumulation of endogenous all-trans-retinal (atRAL) contributes to degeneration of the retinal pigment epithelium (@GENE$) and photoreceptor cells, and plays a role in the etiologies of age-related @DISEASE$ (AMD) and Stargardt's disease.	0
Progressive @DISEASE$ (@GENE$) is the canine equivalent of retinitis pigmentosa (RP).	0
Therefore, we evaluated the roles of @GENE$, regulation of double-strand break repair via homologous recombination, and phosphorylated SIRT6 and their relationships in @DISEASE$.	0
Therefore, we evaluated the roles of peptidyl-serine phosphorylation, @GENE$, and phosphorylated SIRT6 and their relationships in @DISEASE$.	0
Inhibition of @GENE$ decreased the proliferative and invasive activity of @DISEASE$ cells.	0
Glioblastoma (GBM) is the most prevalent and lethal @GENE$ of primary malignant brain @DISEASE$.	0
We found that @GENE$-UL112-3p expression was significantly elevated in GBM, and its expression levels were highly associated with @DISEASE$ size, differentiation, WHO stage and the overall and disease-free survival of patients.	0
This study identifies a @GENE$ of candidate genes and their potential regulatory variants, and provides additional evidence showing the role of long-range chromatin interactions in prostate @DISEASE$ etiology	0
Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (@GENE$), acute @DISEASE$ (MI), and healthy control subjects (protein catabolic process).	0
Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (inflammatory response), acute @DISEASE$ (MI), and healthy control subjects (@GENE$).	0
It is caused by recessive mutations in <i>@GENE$</i>, resulting in @DISEASE$ and myelofibrosis.	0
Despite promising therapeutic avenues, there is currently no effective treatment for Duchenne @DISEASE$ (@GENE$), a lethal monogenic disorder caused by the loss of the large cytoskeletal protein, dystrophin.	1
The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes @GENE$, RNU4ATAC, negative regulation of fat cell differentiation, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically @DISEASE$ cohort	0
The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes GPI anchor biosynthetic process, RNU4ATAC, @GENE$, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically @DISEASE$ cohort	0
However, mutation screening of these genes revealed two mutated alleles in only just over half of our @GENE$ cohort (46 families), suggesting an even greater level of genetic @DISEASE$.	0
The fetus inherited an additional likely pathogenic novel missense change to a second @GENE$ gene, CEP290; p.R2210C, suggesting @DISEASE$ in this disorder	0
Single nucleotide polymorphisms in @GENE$ genes have been associated with increased risk of several diseases, including type 1 and type 2 diabetes, @DISEASE$, and neurological disorders.	1
The proband carried the two kinds of mutations and expressed various clinical manifestations of heart failure and had history of @DISEASE$, paraxial atrial fibrillation, pacemaker implantation, electrocardiogram showed right bundle branch block and echocardiography examination evidenced thickened interventricular septum (23.3 mm) and @GENE$ and reduced wall motion of these segments.	0
Homozygous, loss of function variants in @GENE$ was initially implicated in @DISEASE$ IGD; however, most IGD-associated PROKR2 variants are heterozygous.	1
Hyperpolarization-@GENE$ivated cyclic nucleotide-gated channels (HCN) can act as pacemakers in the brain making them strong candidates for driving aberrant hypersynchronous network activity seen in @DISEASE$.	0
However, only recently have genetic studies demonstrated sequence variation in HCN1 and @GENE$ genes associated with human @DISEASE$.	0
These include a triple proline deletion in @GENE$ that increases channel function and occurs more often in patients with febrile @DISEASE$ syndromes.	0
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in @GENE$ (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness @DISEASE$ muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).	1
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in @GENE$ (~70 mutations, 31 point mutations) and Pendred Syndrome or @DISEASE$ autosomal recessive muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).	0
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in @GENE$ (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness @DISEASE$ muscle organ development 4 in regulation of pH (~500 mutations, 203 point mutations).	1
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or @DISEASE$ autosomal recessive muscle organ development 4 in @GENE$ (~500 mutations, 203 point mutations).	1
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness @DISEASE$ @GENE$ 4 in regulation of pH (~500 mutations, 203 point mutations).	1
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in sulfate transmembrane transport (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in sperm capacitation (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness @DISEASE$ muscle organ development 4 in @GENE$ (~500 mutations, 203 point mutations).	1
To identify other possible transcriptional targets of @GENE$-1α in neural tissue, we conducted a microarray on @DISEASE$ cells overexpressing PGC-1α, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in epidermis development with underexpression and overexpression of PGC-1α.	0
To identify other possible transcriptional targets of positive regulation of antibacterial peptide production-1α in neural tissue, we conducted a microarray on @DISEASE$ cells overexpressing PGC-1α, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in @GENE$ with underexpression and overexpression of PGC-1α.	0
In order to investigate essential molecular causes for hearing loss and mutation frequency of @DISEASE$-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (@GENE$) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes.	0
Treacher Collins syndrome (@GENE$, OMIM 154500) is a well-defined @DISEASE$ characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	0
Treacher Collins syndrome (@GENE$, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of @DISEASE$, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	1
Here we describe three unrelated patients showing clinical features overlapping with @GENE$, but who in addition have developmental delay, @DISEASE$ and a distinct facial gestalt.	0
Because of the distinct ear anomalies and the @DISEASE$ a @GENE$ mutation was taken into account.	1
We and others have recently demonstrated that @GENE$ is a key mediator of growth, invasion, and metastasis, and therefore represents a promising therapeutic target in thyroid @DISEASE$.	1
Consistently, @GENE$ deficiency associates with @DISEASE$ and coloboma, a congenital eye disease.	0
Consistently, @GENE$ deficiency associates with neural tube defects and @DISEASE$, a congenital eye disease.	1
Relevant to @DISEASE$, clinical studies indicate that @GENE$ is deregulated in various cancers and is a specific biomarker for Synovial Sarcoma.	0
We specifically discuss the role of SALL2 in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 @DISEASE$ suppressor and @GENE$ oncogene.	1
Special attention is given to p53-independent @GENE$ regulation of pro-apoptotic genes BAX and proteasomal protein catabolic process, and the implication of these findings on the apoptotic response of @DISEASE$ cells to therapy.	0
Special attention is given to p53-independent eye development regulation of pro-apoptotic genes BAX and @GENE$, and the implication of these findings on the apoptotic response of @DISEASE$ cells to therapy.	0
Signs and symptoms are blisters, @DISEASE$, erosions hy@GENE$pigmentation, sclerodermoid plaques.	0
In keeping with a @DISEASE$ suppressive role of @GENE$ in human gastric cancer, we cellular response to interleukin-4 an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	0
In keeping with a @DISEASE$ suppressive role of protein ubiquitination in human gastric cancer, we @GENE$ an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	0
Mechanistically, we cellular response to interleukin-4 that stabilization of @GENE$ in gastric @DISEASE$ cells suppresses E-integrin-mediated signaling pathway expression, subsequently promoting gastric cancer metastasis.	0
Mechanistically, we cellular response to interleukin-4 that stabilization of nucleosome disassembly in gastric @DISEASE$ cells suppresses E-@GENE$ expression, subsequently promoting gastric cancer metastasis.	0
Hence, this previously unknown FBW7/@GENE$ signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric @DISEASE$s	0
A panel of hypermethylated genes including @GENE$, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
A panel of hypermethylated genes including cellular response to DNA damage stimulus, @GENE$, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	0
A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, @GENE$, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, chromatin organization, and TWIST1 predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	0
A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, @GENE$, PITX2, chromatin organization, and TWIST1 predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	0
A panel of hypermethylated genes including cellular response to DNA damage stimulus, osteoblast differentiation, EPHA5, EYA4, endothelial cell activation, IPF1, ISL1, interleukin-4-mediated signaling pathway, PITX2, @GENE$, and TWIST1 predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	0
Genome-wide association studies have identified loci at 15q25 (iron ion transport) and 4q22 (@GENE$), associated with lung @DISEASE$ (LC) and chronic obstructive pulmonary disease (intracellular protein transport).	0
Genome-wide association studies have identified loci at 15q25 (iron ion transport) and 4q22 (regulation of small GTPase mediated signal transduction), associated with lung @DISEASE$ (LC) and chronic obstructive pulmonary disease (@GENE$).	0
Further experiments demonstrated that the biological_process ceRNA sequestered miR-30c-2-3p from binding its targets @GENE$ and transforming growth factor beta receptor signaling pathway mRNAs, which in turn leading to constitutive activation of TGF-β signaling and @DISEASE$ progression in NSCLC.	1
The dopamine hypothesis of @DISEASE$ is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as @GENE$, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.	0
The dopamine hypothesis of @DISEASE$ is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, @GENE$, negative regulation of phosphoprotein phosphatase activity, synapse assembly or catecholamine catabolic process are closely related to dopaminergic system functioning.	0
The dopamine hypothesis of @DISEASE$ is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, @GENE$ or catecholamine catabolic process are closely related to dopaminergic system functioning.	0
The dopamine hypothesis of @DISEASE$ is based on the nucleosome disassembly that all common treatments involve antidopaminergic mechanisms and genes such as adenylate cyclase-inhibiting dopamine receptor signaling pathway, G protein-coupled receptor internalization, negative regulation of phosphoprotein phosphatase activity, synapse assembly or @GENE$ are closely related to dopaminergic system functioning.	1
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (@GENE$, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).	0
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, @GENE$ biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).	0
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport @GENE$, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).	0
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, @GENE$, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).	0
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, @GENE$, NRG1, ErbB4, neuron projection development, DAAO, G72/30, G protein-coupled receptor signaling pathway).	0
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (neurotransmitter uptake, L-glutamate transmembrane transport biological_process, response to ethanol, ER to Golgi vesicle-mediated transport, NRG1, ErbB4, neuron projection development, DAAO, G72/30, @GENE$).	0
However, to the @GENE$ of our knowledge, the role of regulation of transcription by RNA polymerase II in human colorectal @DISEASE$ (CRC) is still unclear.	0
Overexpression of @GENE$ significantly inhibited the proliferation in vitro and CRC @DISEASE$ growth in nude mice.	0
Taken together, our study demonstrates that @GENE$ inhibits proliferation and @DISEASE$igenesis through inactivation of the Wnt/β-catenin pathway in CRC cells.	0
Heritability-based analyses are demonstrating strong links between migraine and other neuropsychiatric disorders and brain phenotypes, high@GENE$ing genetic links between migraine and major depressive disorder and attention-deficit @DISEASE$ disorder, among others.	0
In @GENE$, @DISEASE$ first becomes evident at the motor nerve terminals in neuromuscular junctions (NMJs), the cholinergic synapse between motor neuron and skeletal muscle; degeneration then progresses proximally, implicating the NMJ as a therapeutic target.	0
Then the inflammatory @DISEASE$ (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of @GENE$ as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.	0
Then the inflammatory @DISEASE$ (CorNV) model and fungal corneal infections were induced in Balb/c @GENE$, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.	0
Then the inflammatory @DISEASE$ (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (@GENE$, collagen catabolic process, positive regulation of endothelial cell proliferation, positive regulation of cell proliferation) were monitored with RT-PCR.	0
Then the inflammatory @DISEASE$ (CorNV) model and fungal corneal infections were induced in Balb/c epidermis development, and mRNA levels of biological_process as well as several matrix-remodeling related genes (proteolysis, collagen catabolic process, @GENE$, positive regulation of cell proliferation) were monitored with RT-PCR.	0
This work provides a relevant @DISEASE$ mouse model and demonstrates that <i>@GENE$</i> is essential to maintain integrity of the ependyma	0
These @GENE$ displayed hypertension, @DISEASE$, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function ion homeostasis.	0
These epidermis development displayed @DISEASE$, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function @GENE$.	1
These epidermis development displayed hypertension, @DISEASE$, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function @GENE$.	1
We discover that proline catabolism via proline dehydrogenase (@GENE$) supports growth of breast @DISEASE$ cells in 3D culture.	0
In particular, we find that @GENE$ expression and proline catabolism is increased in metastases compared to primary breast @DISEASE$s of patients and mice.	0
We describe a neurological disorder with @DISEASE$ and prominent choreoathetosis caused by biallelic pathogenic variants in @GENE$, which encodes an AMPA receptor outer-core protein.	1
Expression of miR-17-92a miRNAs caused decreased cell proliferation, reduced activation of @GENE$ and MAP kinases, delayed @DISEASE$igenicity and reduced tumor growth in animals.	1
Progressive @DISEASE$ (@GENE$) is the collective name of a class of hereditary retinal dystrophies in the dog and is often described as the equivalent of retinitis pigmentosa in humans.	0
Progressive retinal atrophy (@GENE$) is the collective name of a class of hereditary @DISEASE$ in the dog and is often described as the equivalent of retinitis pigmentosa in humans.	0
@GENE$ is characterized by @DISEASE$ due to degeneration of the photoreceptors in the retina, usually leading to blindness.	0
@GENE$ is characterized by visual impairment due to degeneration of the photoreceptors in the retina, usually leading to @DISEASE$.	0
@GENE$ has been reported in dogs from more than 100 breeds and can be genetically @DISEASE$ both between and within breeds.	0
The study indicated genetic @DISEASE$ as the mutation was present in all @GENE$-affected individuals in one large family of Shelties, whereas some other cases in the studied Sheltie population were not associated with this rhodopsin mediated signaling pathway mutation.	0
To this @GENE$, we generated a set of @DISEASE$ and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.	0
To this @GENE$, we generated a set of melanoma and @DISEASE$ cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against cellular calcium ion homeostasis.	0
To this positive regulation of protein phosphorylation, we generated a set of @DISEASE$ and neuroblastoma cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against @GENE$.	0
To this positive regulation of protein phosphorylation, we generated a set of melanoma and @DISEASE$ cell lines stably overexpressing wild-muscle organ development (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against @GENE$.	0
Reactive oxygen species (@GENE$) play a vital role in the pathogenesis of many @DISEASE$s.	0
Promyelocytic leukemia (@GENE$) is a pleiotropic @DISEASE$ suppressor, but its role in tumor microenvironment regulation is poorly characterized.	0
@GENE$ is frequently downregulated in many @DISEASE$ types, including lung cancer.	0
Clinically, this @GENE$ degradation pathway is hyperactivated in lung @DISEASE$ and correlates with poor prognosis.	0
The @GENE$/response to hypoxia axis induces a negative regulation of transcription, DNA-templated of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (positive regulation of DNA binding), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung @DISEASE$ models.	0
The tRNA modification/response to hypoxia axis induces a @GENE$ of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (positive regulation of DNA binding), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung @DISEASE$ models.	0
The tRNA modification/response to hypoxia axis induces a negative regulation of transcription, DNA-templated of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (@GENE$), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung @DISEASE$ models.	0
In xenograft and genetically engineered mouse models, the @GENE$/PML axis elevates intra@DISEASE$al Tregs and M2-like macrophages and reduces CD8+ T cells to promote lung tumor growth.	0
Our study identifies @GENE$ as an oncoprotein that negatively regulates response to hypoxia via ubiquitination to promote lung @DISEASE$ progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	0
Our study identifies tRNA modification as an oncoprotein that negatively regulates @GENE$ via ubiquitination to promote lung @DISEASE$ progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	0
Loss-of-function mutations of @GENE$ have recently been defined to cause a recognizable syndrome with @DISEASE$ (ID).	1
We herein report an infant with feeding difficulty, @DISEASE$, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped @GENE$, and clinodactyly.	1
We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including @DISEASE$, telecanthus, sparse hair and eyebrow, cup-shaped @GENE$, and clinodactyly.	0
X-linked retinitis pigmentosa (XLRP) caused by mutations in the @GENE$ gene is an early onset and severe cause of @DISEASE$.	1
@GENE$ overexpression promotes @DISEASE$igenesis and is associated with poor prognosis in several cancers.	0
Increased @GENE$ expression during the late pathological stage has been detected in the Oncomine liver dataset and @DISEASE$ (phosphatidylinositol phosphorylation) specimens.	0
Increased protein phosphorylation expression during the late pathological stage has been detected in the Oncomine liver dataset and @DISEASE$ (@GENE$) specimens.	0
However, the precise roles and mechanisms of @GENE$ in liver @DISEASE$ progression remain largely unknown.	0
Results from the current study showed that @GENE$ mediates @DISEASE$ growth, metastasis and angiogenesis in vivo.	0
Moreover, @GENE$ mediated liver @DISEASE$ cell migration via ppositive regulation of protein phosphorylation/peripheral nervous system development-κB signaling and matrix metalloproteinase (MMP) activation.	0
Moreover, protein phosphorylation mediated liver @DISEASE$ cell migration via p@GENE$/peripheral nervous system development-κB signaling and matrix metalloproteinase (MMP) activation.	1
Moreover, protein phosphorylation mediated liver @DISEASE$ cell migration via ppositive regulation of protein phosphorylation/@GENE$-κB signaling and matrix metalloproteinase (MMP) activation.	0
Tenascin-C (@GENE$), an extracellular matrix glycoprotein, has been implicated in progression of various types of @DISEASE$.	0
However, few reports exist on @GENE$ expression in gastrointestinal stromal @DISEASE$ (GISTs).	0
The @GENE$ mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred @DISEASE$ progression during the follow-up period (P &lt; .05).	0
Primary @DISEASE$ (@GENE$) is a clinical rare peculiar disorder, mainly featured by respiratory infection, tympanitis, nasosinusitis, and male infertility.	1
In contrast, among the factors supporting the resistance in @GENE$ can be an elevated concentration of MP-positive regulation of receptor-mediated endocytosis which, together with the coexistence of @DISEASE$, may constitute an important mechanism of resistance to clopidogrel	0
The authors report here a brief summary of findings from 12 lines of genetically engineered @GENE$ that presented with @DISEASE$ congenital hydrocephalus.	1
Even though the direct relevance of mouse models to @DISEASE$ in humans remains uncertain, the high prevalence of familial patterns of inheritance for congenital hydrocephalus in humans suggests that identification of genes responsible for development of hydrocephalus in @GENE$ may lead to the identification of homologous modifier genes and susceptibility alleles in humans.	0
A hypomorphic variant in @GENE$ was previously reported in association with a familial case of syndromic X-linked @DISEASE$, which shows phenotypic overlap with RSS/3C syndrome.	1
Small cell lung @DISEASE$ (SCLC) is the most aggressive @GENE$ of lung cancer.	0
In particular, the TMEM132D, @GENE$ and protein transport genes were commonly mutated in both early and late stage @DISEASE$, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	0
In particular, the TMEM132D, MAPK cascade and @GENE$ genes were commonly mutated in both early and late stage @DISEASE$, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	0
We found that the expression of @GENE$ mRNA was relatively low in normal tissues, but was upregulated in 82% of @DISEASE$ (phosphatidylinositol phosphorylation), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.	0
We found that the expression of chromosome segregation mRNA was relatively low in normal tissues, but was upregulated in 82% of @DISEASE$ (@GENE$), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.	0
Recent studies have suggested possible therapeutic targets for some patients with early-onset @DISEASE$ based on the molecular and cellular events caused by osteoblast differentiation, OPTN and @GENE$ mutations.	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (@GENE$, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, @GENE$, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, @GENE$, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, @GENE$, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (@GENE$, CHAT, GLIS3, cell-matrix adhesion, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, @GENE$, GPI anchor biosynthetic process-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (lysosome organization, regulation of signal transduction, GDP-mannose metabolic process, protein glycosylation, TGFBR3, biological_process, ARHGEF12, GAS7, eye development, negative regulation of receptor internalization, TXNRD2); PACG (primary angle-closure glaucoma (cell-matrix adhesion, CHAT, GLIS3, cell-matrix adhesion, @GENE$-FAM102); and exfoliation syndrome (XFS) glaucoma (positive regulation of cytosolic calcium ion concentration).	0
In total sixteen genomic regions have been associated with POAG (including the normal tension @DISEASE$ (@GENE$) subgroup), 8 with PACG and 2 with XFS.	0
Recent studies reported germline variants in @GENE$ in @DISEASE$ families.	1
So, in conclusion, @DISEASE$ associated @GENE$ germline variants seem to be rare.	1
The classical mammalian isoforms of PLD are @GENE$ and PLD2, and the levels of both mRNA were higher at the primary @DISEASE$ sites than in normal kidney tissues.	0
Notably, shRNA-mediated knockdown of PLD2 suppressed the growth and invasion of @DISEASE$s in @GENE$ mouse xenograft models.	0
As for genes relating to the @DISEASE$ invasion of @GENE$, we found that angiogenin (ANG) was positively regulated by PLD2.	0
In @GENE$, the expression levels of angiogenesis were elevated in @DISEASE$ tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.	0
In nucleosome disassembly, the expression levels of @GENE$ were elevated in @DISEASE$ tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.	0
We will systematically examine seven genes (motor neuron axon guidance, @GENE$, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three @DISEASE$.	0
We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, @GENE$, RTN1, urea transmembrane transport, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three @DISEASE$.	0
We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, @GENE$, neurotransmitter secretion and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three @DISEASE$.	0
We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, @GENE$ and positive regulation of insulin secretion involved in cellular response to glucose stimulus) that are altered in the three @DISEASE$.	0
We will systematically examine seven genes (motor neuron axon guidance, gluconeogenesis, positive regulation of neuron differentiation, RTN1, urea transmembrane transport, neurotransmitter secretion and @GENE$) that are altered in the three @DISEASE$.	0
Ectodysplasin-A2 (positive regulation of NF-kappaB transcription factor activity) is a recently isolated member of the @DISEASE$ necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (@GENE$).	0
Ectodysplasin-A2 (positive regulation of NF-kappaB transcription factor activity) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked @DISEASE$ receptor (@GENE$).	0
Limb girdle @DISEASE$ muscle organ development 2 G (@GENE$) is caused by mutations in the cardiac muscle hypertrophy gene.	1
Limb girdle @DISEASE$ muscle organ development 2 G (cardiac muscle hypertrophy) is caused by mutations in the @GENE$ gene.	1
Sjögren-Larsson syndrome (@GENE$) is a rare autosomal recessive disorder characterized by ichthyosis, @DISEASE$ and intellectual disability.	1
Sjögren-Larsson syndrome (@GENE$) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and @DISEASE$.	1
We report a case of @GENE$-positive @DISEASE$ coincident with Hodgkin lymphoma.	0
The variety of growth patterns and cell features led us to speculate a possibility of @GENE$-positive @DISEASE$ (ALK + RCC).	0
Primary @DISEASE$ (@GENE$) is a recessively inherited disease that leads to chronic respiratory disorders owing to impaired mucociliary clearance.	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (@GENE$), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic α-spectrin-1 (MAPK cascade), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1α subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)	0
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (@GENE$), nonerythrocytic α-spectrin-1 (MAPK cascade), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1α subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic α-spectrin-1 (@GENE$), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1α subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic α-spectrin-1 (MAPK cascade), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (@GENE$), sodium channel neuronal muscle organ development 1α subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic α-spectrin-1 (MAPK cascade), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal @GENE$ 1α subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)	0
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic α-spectrin-1 (MAPK cascade), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1α subunit (@GENE$), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (pyridoxal phosphate biosynthetic process)	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (protein sumoylation), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (protein localization to plasma membrane), solute carrier family 25 member 22 (L-glutamate transmembrane transport), nonerythrocytic α-spectrin-1 (MAPK cascade), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (response to oxidative stress), sodium channel neuronal muscle organ development 1α subunit (cardiac muscle cell action potential involved in contraction), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (@GENE$)	1
These clinical and imaging findings are unlike that of any recognized severe forms of @DISEASE$ which is believed to be a new microcephalic primordial dwarfism (@GENE$) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs	0
These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (@GENE$) with developmental brain malformations with most probably @DISEASE$ inheritance based on consanguinity and similarly affected male and female sibs	0
These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (@GENE$) with developmental brain malformations with most probably autosomal recessive @DISEASE$ based on consanguinity and similarly affected male and female sibs	0
The patients were classified according to the presence of significant coronary atherosclerosis (@GENE$) and history of @DISEASE$ (MI).	0
Corticosteroid-binding globulin (@GENE$) deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/@DISEASE$ and muscle fatigue.	1
LncRNA <i>pancEts-1</i> promoted the growth, invasion, and metastasis of @DISEASE$ cells <i>in vitro</i> and <i>in vivo</i> Mechanistically, <i>pancEts-1</i> bound to @GENE$ to facilitate its physical interaction with β-catenin, whereas hnRNPK stabilized the β-catenin by inhibiting proteasome-mediated degradation, resulting in transcriptional alteration of target genes associated with neuroblastoma progression.	0
A better understanding of the mechanisms coupling thermoregulation to energy homeostasis, including the involvement of thermosensitive @GENE$s, may uncover additional mechanisms underlying the pathogenesis of @DISEASE$ and its metabolic consequences in humans, opening new strategies for the diagnosis, treatment, and prevention of this disease	0
Meier-Gorlin syndrome (MGS) is a genetically @DISEASE$ primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: @GENE$, ORC4, ORC6, DNA replication checkpoint, and CDC6.	0
Meier-Gorlin syndrome (MGS) is a genetically @DISEASE$ primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: urea cycle, ORC4, ORC6, @GENE$, and CDC6.	0
Genetic mutations to a specific subset of mitochondrial @GENE$/S cluster delivery proteins are broadly categorized as disease-related under multiple @DISEASE$ syndrome (MMDS), with symptoms indicative of a general failure of the metabolic system.	0
Multiple @DISEASE$ syndrome 1 (MMDS1) arises as a result of the missense mutation in NFU1, an @GENE$/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).	0
T cell-related @DISEASE$ (@GENE$) syndrome may occur concomitantly.	0
Locations of mutations linked to human disease, including those responsible for Southeast Asian ovalocytosis, he@GENE$itary stomatocytosis, hereditary spherocytosis, and @DISEASE$, provide molecular insights into their effect on Band 3 folding.	0
We show that maternal @GENE$ variants have a significant genome-wide interaction with maternal pre-pregnancy overweight/@DISEASE$ on regulation of alternative mRNA splicing, via spliceosome risk, with rs11161721 (P<sub>G × E</sub>=1.8 × 10<sup>-8</sup>; empirical P<sub>G × E</sub>=1.2 × 10<sup>-8</sup>) as the top hit.	0
Subsequent @GENE$ analysis with region-specific YAC clones was used to relate the phenotypic findings such as @DISEASE$ split hand formation, specific cardiac and kidney anomalies, microtia, and hypoplastic thorax more exactly to the partial trisomy of the segment 4q26-qter	0
On the other hand, @GENE$-34a inhibitor could partly counter the anti@DISEASE$ effect of luteolin.	0
Therefore, our findings firstly suggested that @GENE$-34a could modulate the susceptibility of gastric @DISEASE$ cell to luteolin via targeting HK1, potentially benefiting GC patients' treatment in the future	0
This case unravels a previously unrecognized phenotype of @DISEASE$ due to a significant skeletal deformity of PRS with a heterogeneous @GENE$ mutation of hexanucleotide duplication.	0
Functional studies have elucidated the role of the mammalian target of rapamycin (@GENE$) pathway in breast carcinogenesis, but to date, there is a paucity of data on its contribution to breast @DISEASE$ risk in women of African ancestry.	0
We examined 47628 SNPs in 61 @GENE$ pathway genes in the genome wide association study of breast @DISEASE$ in the African Diaspora study (The Root consortium), which included 3686 participants (1657 cases).	0
PRKAG3 (Padj = 0.0018) and @GENE$ (Padj = 0.061) were the leading genes for the associations with overall breast @DISEASE$ risk and ER- breast cancer risk, respectively.	0
Although the expression pattern and functions of the @GENE$ in the colonic microenvironment are far from being completely understood, evidence has been accumulating that the CaSR might play a protective role against both colonic inflammation and colorectal @DISEASE$.	0
For example, @GENE$ agonists such as dipeptides have been suggested to reduce colonic inflammation, while dietary calcium was shown to reduce the risk of colorectal @DISEASE$.	0
This dual anti-inflammatory and anti-tumourigenic role of the @GENE$ makes it especially interesting in colitis-associated colorectal @DISEASE$.	0
In this review, we describe the clinical and experimental evidence for the role of the @GENE$ in colonic inflammation and colorectal @DISEASE$, the intracellular signalling pathways which are putatively involved in these actions, and the possibilities to exploit these actions of the CaSR for future therapies of colonic inflammation and cancer	0
We characterize @GENE$-CFZS as a congenital myopathy with marked @DISEASE$ and additional clinical and pathologic features that distinguish it from other congenital neuromuscular syndromes.	1
Independently, another group has recently observed @GENE$ mutations in several families with a type 1 congenital disorder of glycosylation (CDG type Ix, OMIM 212067), mental retardation, @DISEASE$ and eye disorders.	0
More important, Col5a2 haploinsufficiency markedly increased the incidence and severity of abdominal @DISEASE$, and caused aortic @GENE$ ruptures and dissections, indicating that α2(V) chain deficits may play roles in these pathologies in humans	0
By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and @GENE$ were significantly higher in tumour tissues than those of the adjacent non-@DISEASE$ous tissues in 969 NSCLC patients (P &lt; 0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r = 0.90, P &lt; 0.001).	0
Osteopetrosis (@GENE$) is a rare skeletal disorder with phenotypic and genotypic @DISEASE$: a variety of clinical features besides the bony defect may be present, and at least ten different genes are known to be involved in the disease pathogenesis.	0
In the framework of this heterogeneity, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant @GENE$, such as visual or @DISEASE$.	0
monoubiquitinated histone H2A deubiquitination (additional @GENE$ combs like 1) is a gene that is mutated in a number of hematological @DISEASE$.	0
A systematic study of serial samples from 30 patients show that @GENE$ c.1934dupG is a somatic mutation in haematological @DISEASE$ including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.	1
A systematic study of serial samples from 30 patients show that @GENE$ c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.	1
A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, @GENE$ and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.	0
A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, @GENE$, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.	0
A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, @GENE$, hemopoiesis, Ras protein signal transduction and DNMT3A.	0
A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological @DISEASE$ including microtubule-based process, AML, @GENE$ and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, hemopoiesis, Ras protein signal transduction and DNMT3A.	0
A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological @DISEASE$ including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, @GENE$, hemopoiesis, Ras protein signal transduction and DNMT3A.	1
A systematic study of serial samples from 30 patients show that monoubiquitinated histone H2A deubiquitination c.1934dupG is a somatic mutation in haematological @DISEASE$ including microtubule-based process, AML, proteolysis and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, isocitrate metabolic process, @GENE$, Ras protein signal transduction and DNMT3A.	1
Transcription @GENE$ors (TFs) are major cell fate regulators frequently involved in @DISEASE$, particularly in leukemia.	0
In keeping with this key role in cell @GENE$, <i>negative regulation of transcription by RNA polymerase II</i> is emerging as a gene involved in @DISEASE$, which also includes solid tumors.	0
In keeping with this key role in cell @GENE$, <i>negative regulation of transcription by RNA polymerase II</i> is emerging as a gene involved in cancer, which also includes solid @DISEASE$.	0
In keeping with this key role in cell negative regulation of apoptotic process, <i>@GENE$</i> is emerging as a gene involved in @DISEASE$, which also includes solid tumors.	1
In keeping with this key role in cell negative regulation of apoptotic process, <i>@GENE$</i> is emerging as a gene involved in cancer, which also includes solid @DISEASE$.	1
In @GENE$, abnormal activation of <i>negative regulation of transcription by RNA polymerase II</i> and <i>negative regulation of transcription by RNA polymerase II</i> has been related to human @DISEASE$ and is also likely to be relevant in blood malignancies.	0
In nucleosome disassembly, abnormal activation of <i>@GENE$</i> and <i>negative regulation of transcription by RNA polymerase II</i> has been related to human @DISEASE$ and is also likely to be relevant in blood malignancies.	0
In nucleosome disassembly, abnormal activation of <i>negative regulation of transcription by RNA polymerase II</i> and <i>@GENE$</i> has been related to human @DISEASE$ and is also likely to be relevant in blood malignancies.	0
When stratified by @DISEASE$ histology, three SNPs (@GENE$ rs2274971A &gt; G, fructose 6-phosphate metabolic process rs11168417C &gt; T, and PDK2 rs3785921G &gt; A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
When stratified by @DISEASE$ histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A &gt; G, @GENE$ rs11168417C &gt; T, and PDK2 rs3785921G &gt; A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
When stratified by tumor histology, three SNPs (@GENE$ rs2274971A &gt; G, fructose 6-phosphate metabolic process rs11168417C &gt; T, and PDK2 rs3785921G &gt; A) were significantly associated with OS and/or DFS only in @DISEASE$, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
When stratified by tumor histology, three SNPs (negative regulation of transcription by RNA polymerase II rs2274971A &gt; G, @GENE$ rs11168417C &gt; T, and PDK2 rs3785921G &gt; A) were significantly associated with OS and/or DFS only in @DISEASE$, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
Missense mutations in the human @GENE$ biosynthesis enzyme GPI anchor biosynthetic process are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and @DISEASE$.	0
Missense mutations in the human glucosamine catabolic process biosynthesis enzyme @GENE$ are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and @DISEASE$.	0
In this study, we found that @GENE$ acted as a @DISEASE$ suppressor and that its expression was downregulated in UM.	0
In this study, we present a male child demonstrating recurrent febrile episodes, @DISEASE$, and basal ganglia calcification suggestive of Aicardi-Goutières syndrome, who carries the same Arg822Gln mutation in protein sumoylation previously associated with @GENE$.	0
In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and @DISEASE$ suggestive of Aicardi-Goutières syndrome, who carries the same Arg822Gln mutation in @GENE$ previously associated with positive regulation of transcription, DNA-templated.	1
In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and @DISEASE$ suggestive of Aicardi-Goutières syndrome, who carries the same Arg822Gln mutation in protein sumoylation previously associated with @GENE$.	0
His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal @GENE$ with a @DISEASE$, and a large mouth with a thin upper vermilion, and small chin.	0
His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal @GENE$ with a short columella, and a @DISEASE$ with a thin upper vermilion, and small chin.	0
De novo missense and frameshift mutations and deletions involving @GENE$ have been described in patients with @DISEASE$ and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.	1
His distinctive facial and digital features are further evidence that p.Tyr446Cys results in a clinically recognizable, syndromic form of @DISEASE$ in contrast to other @GENE$ mutations	1
This study is the first to associate a component of the @GENE$ pathway with @DISEASE$ in humans	0
Here, we report mutations in @GENE$, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, @DISEASE$, and reduced cerebral white-matter volume.	1
Morpholino-based knockdown of a zebrafish @GENE$ ortholog, pycr1b, recapitulated the human @DISEASE$ phenotype, which was rescued by wild-type human PYCR2 mRNA, but not by mutant mRNAs, further supporting the pathogenicity of the identified variants.	1
However, whether and how @GENE$ participates in the process of DNA repair, which is often associated with @DISEASE$igenesis, has not been investigated.	0
In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of @GENE$ and CtIP in para@DISEASE$, but the correlation turned insignificant in mammary tumors.	0
Using vectors encoding GATA3 with mutations frequently occurring in mammary @DISEASE$, we found that several mutations on GATA3 led to a dysregulation of @GENE$, and therefore HR repair.	0
In summary, our data delineates the regulatory mechanisms of @GENE$ in DNA DSB repair and strongly suggests that it might act as a @DISEASE$ suppressor by promoting double-strand break repair via homologous recombination expression and HR to stabilize genomes	0
Altered @GENE$ expression or function is closely associated with @DISEASE$ development and progression.	0
This study determined the association of @GENE$ expression with protein phosphorylation expression, clinicopathological characteristics, and survival of esophageal @DISEASE$ (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P &lt; .01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P &lt; .01).	0
This study determined the association of nucleotide-excision repair expression with @GENE$ expression, clinicopathological characteristics, and survival of esophageal @DISEASE$ (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P &lt; .01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P &lt; .01).	0
Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the @GENE$ gene in infants from consanguineous families who suffered from life-threatening @DISEASE$, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.	1
This is the first report of a @GENE$-related disease in humans, manifesting by @DISEASE$, thrombasthenia, myelofibrosis, and progressive bone marrow failure	1
We presented the significant clinical @DISEASE$ among three Chinese late-onset MADD patients with similar @GENE$ genotype by collecting clinical information, muscle histology, and genetic analysis.	0
To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian @DISEASE$ stem/initiating cell marker, @GENE$, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.	1
Interestingly, ChIP-PCR and bisulphite pyrosequencing showed that E2F6 also epigenetically suppresses miR-193a, through recruitment of @GENE$, and by a complex ceRNA mechanism in ovarian @DISEASE$ cell lines.	0
In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the @GENE$ gene in mouse, the @DISEASE$-brachyectrodactyly syndrome might be caused by mutations in a HOX gene.	0
In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the @GENE$ gene in mouse, the triphalangeal thumb-brachy@DISEASE$ syndrome might be caused by mutations in a HOX gene.	0
Asthma is characterised by @DISEASE$ clinical pheno@GENE$s.	0
Our objective was to determine molecular pheno@GENE$s of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, @DISEASE$ necrosis factor-α- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	0
Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): @GENE$ (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, @DISEASE$ necrosis factor-α- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	0
Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), @GENE$ (characterised by interferon-, @DISEASE$ necrosis factor-α- and inflammasome-associated genes) and G protein-coupled receptor signaling pathway (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	0
Our objective was to determine molecular phenomuscle organ developments of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): positive regulation of cytosolic calcium ion concentration (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), positive regulation of cytosolic calcium ion concentration (characterised by interferon-, @DISEASE$ necrosis factor-α- and inflammasome-associated genes) and @GENE$ (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	0
TAC1 showed the highest enrichment of gene signatures for interleukin-13/T-helper cell @GENE$ 2 (Th2) and innate lymphoid cell type 2. TAC1 had the highest sputum @DISEASE$ and exhaled nitric oxide fraction, and was restricted to severe asthma with oral corticosteroid dependency, frequent exacerbations and severe airflow obstruction.	0
@GENE$ showed the highest sputum @DISEASE$, serum C-reactive protein levels and prevalence of eczema.	0
Here, integrative genomic analysis identified @GENE$ as a potential oncogene target that is frequently amplified in breast @DISEASE$.	0
Interestingly, @GENE$ depletion drastically inhibited proliferation in MYST3-high, ER+ breast @DISEASE$ cells, but not in benign breast epithelial cells or in MYST3-low breast cancer cells.	0
We investigated the @GENE$ of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (negative regulation of transcription by RNA polymerase II) and geminin (negative regulation of DNA replication), on disease progression in @DISEASE$.	0
We investigated the negative regulation of transcription by RNA polymerase II of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (@GENE$) and geminin (negative regulation of DNA replication), on disease progression in @DISEASE$.	0
We investigated the negative regulation of transcription by RNA polymerase II of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (negative regulation of transcription by RNA polymerase II) and geminin (@GENE$), on disease progression in @DISEASE$.	0
The expression of @GENE$ and negative regulation of DNA replication was studied by immunostaining 84 @DISEASE$.	0
The PI for both markers was significantly higher in @DISEASE$ from patients with unfavorable clinical (high-risk group, advanced stage, age ≥18 months at presentation, primary abdominal compared to extra-abdominal sites), biological (@GENE$ amplification, 1p deletion, 17q gain), and pathological (undifferentiated or poorly differentiated status, high mitosis-karyorrhexis index, [MKI], unfavorable histology) factors.	0
Recent studies have revealed severe cases of @DISEASE$ resulting from human mutations in the @GENE$ gene, which is involved in the regulation of cytoplasmic dynein.	1
These results reveal that the severity of @GENE$-associated @DISEASE$ results not from defects in mitosis, but rather the inability of neural progenitors to ever reach this stage	1
Remarkably, @DISEASE$ of the human phenotype can be recapitulated in @GENE$ mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout epidermis development while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.	0
Remarkably, @DISEASE$ of the human phenotype can be recapitulated in mRNA splicing, via spliceosome mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout @GENE$ while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.	0
The @DISEASE$ suppressor gene TP53 is mutated exclusively with the @GENE$, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	0
The @DISEASE$ suppressor gene TP53 is mutated exclusively with the epithelial cell development, @GENE$, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	1
The @DISEASE$ suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and @GENE$ genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	1
The tumor suppressor gene TP53 is mutated exclusively with the @GENE$, positive regulation of protein phosphorylation, and negative regulation of protein phosphorylation genes in large intestine, lung, and endometrial @DISEASE$s respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	0
The tumor suppressor gene TP53 is mutated exclusively with the epithelial cell development, positive regulation of protein phosphorylation, and @GENE$ genes in large intestine, lung, and endometrial @DISEASE$s respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	1
We use the BMI- and @DISEASE$-associated @GENE$ locus as a subject as it poses an illustrative example on the value of these resources.	1
Polo-Like Kinase 1 (@GENE$), a serine-threonine kinase that is often overexpressed across multiple @DISEASE$ types, is one of the key regulators of CIN and is considered as a potential therapeutic target.	0
Rather than directly inhibiting @GENE$, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, @DISEASE$, and prostate cancer cells.	0
Rather than directly inhibiting @GENE$, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate @DISEASE$ cells.	0
Anaplastic thyroid @DISEASE$ (@GENE$) is associated with poor prognosis and is often untreatable.	1
Tumor proliferation promoted by the regulation of protein polyubiquitinationNA expression can be regulated in thyroid @DISEASE$ by upregulating transforming growth factor-β1 (TGF-β1), which is thought to interact with @GENE$.	0
When compared with adjacent non-@DISEASE$ tissues, we found that @GENE$-483 was upregulated and protein targeting to membrane was downregulated in 80 thyroid tumor samples.	0
Our previous studies reported gastric @DISEASE$ cells are insensitive to @GENE$.	0
In our present study, β-elemene prevented gastric @DISEASE$ cell viability in dose-dependent manner, and when combined with @GENE$, obviously inhibited proliferation and promoted apoptosis in gastric cancer cells.	0
<i>Background:</i> @GENE$/positive regulation of cell proliferation have been reported to be highly expressed in malignant @DISEASE$.	0
<i>Background:</i> regulation of cell cycle/@GENE$ have been reported to be highly expressed in malignant @DISEASE$.	0
This research was aimed to study the expression of @GENE$/regulation of cell cycle protein in @DISEASE$ and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.	0
This research was aimed to study the expression of positive regulation of cell proliferation/@GENE$ protein in @DISEASE$ and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.	0
Relationship between @GENE$/regulation of cell cycle and clinical data of @DISEASE$ were analyzed.	0
Relationship between positive regulation of cell proliferation/@GENE$ and clinical data of @DISEASE$ were analyzed.	0
<i>Results:</i> The number of positive cells of @GENE$ and regulation of cell cycle in @DISEASE$ tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and regulation of transcription by RNA polymerase III stages (P &lt;0.05), and increased with TNM staging.	0
<i>Results:</i> The number of positive cells of positive regulation of cell proliferation and @GENE$ in @DISEASE$ tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and regulation of transcription by RNA polymerase III stages (P &lt;0.05), and increased with TNM staging.	0
<i>Results:</i> The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in @DISEASE$ tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and @GENE$ stages (P &lt;0.05), and increased with TNM staging.	0
<i>Results:</i> The number of positive cells of positive regulation of cell proliferation and regulation of cell cycle in malignant melanoma @DISEASE$ tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and @GENE$ stages (P &lt;0.05), and increased with TNM staging.	0
High expression of @GENE$/regulation of cell cycle significantly reduced the postoperative survival rate in patients with @DISEASE$.	0
High expression of positive regulation of cell proliferation/@GENE$ significantly reduced the postoperative survival rate in patients with @DISEASE$.	0
<i>Conclusion:</i> @GENE$/regulation of cell cycle is highly expressed in @DISEASE$ tumor tissues.	0
<i>Conclusion:</i> @GENE$/regulation of cell cycle is highly expressed in malignant melanoma @DISEASE$ tissues.	0
<i>Conclusion:</i> positive regulation of cell proliferation/@GENE$ is highly expressed in @DISEASE$ tumor tissues.	0
<i>Conclusion:</i> positive regulation of cell proliferation/@GENE$ is highly expressed in malignant melanoma @DISEASE$ tissues.	0
Few studies have examined the roles of CRELD1 and @GENE$ in @DISEASE$ or their association with pulmonary artery histopathology.	1
Children with DS have an elevated risk of @DISEASE$ (@GENE$).	0
Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the @DISEASE$ necrosis factor-α (TNF-α)-stimulated human umbilical cord vascular endothelial cell (HUVEC) @GENE$ formation.	0
Therefore, we performed this preliminary clinical study to investigate the possible association between 2 adipokines, C1q/@DISEASE$ necrosis factor-related protein-3 and -5 (CTRP-3 and CTRP-5), with lung function and other markers of inflammation in @GENE$.	0
Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of @DISEASE$, analyzing the prevalence of genetic defects in @GENE$, ossification, and ATP6V1B1 genes and the clinical phenotype.	1
Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of @DISEASE$, analyzing the prevalence of genetic defects in anion transport, @GENE$, and ATP6V1B1 genes and the clinical phenotype.	1
Their phosphorylation activity has also linked them to the development of @DISEASE$ like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar ataxia @GENE$ 11.	0
Their phosphorylation activity has also linked them to the development of neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar @DISEASE$ @GENE$ 11.	0
The final analysis of all this information led us to propose @GENE$ as a new target for the treatment of @DISEASE$ and its selective inhibitors as potential effective drugs for the treatment of these severe unmet disorders	0
Differently from other digestive malignancies, gastric cancer (@GENE$) carcinogenesis seems more @DISEASE$ and unclear.	0
As a reason why the present case showed lethal pheno@GENE$ despite the in-frame deletion mutation, rapid degradation of neo-synthesized α6 protein and/or impaired transport of integrin were suggested from previous reports, and the lack of localization of integrin α6β4 to the epidermal basement membrane resulted in @DISEASE$.	0
The @DISEASE$ were characterized by immunohistochemistry for pituitary hormones, cytokeratins, @GENE$, and the neuronal markers mRNA processing, neurofilaments (NFP), and MAP2.	0
The @DISEASE$ were characterized by immunohistochemistry for pituitary hormones, cytokeratins, positive regulation of I-kappaB kinase/NF-kappaB signaling, and the neuronal markers @GENE$, neurofilaments (NFP), and MAP2.	0
These @GENE$ develop prostate @DISEASE$ similar to a subset of poor outcome, treatment-associated human PC tumors.	0
Correlation analysis using microarray data from (@GENE$ × PWK/PhJ) F2 prostate @DISEASE$ identified 35 metastasis-associated transcripts within the two loci.	0
A protective effect was observed for the fetal @GENE$ SNP on @DISEASE$ only, opposite in direction to the effect on CLO.	0
This study investigates the soluble factors released by tumor-associated dendritic cells (TADCs) responsible for increasing @DISEASE$ stem cell (CSC) properties, cell mobility, and epithelial-to-mesenchymal transition (@GENE$).	1
Dendritic cells (DCs) of colon @DISEASE$ patients were collected for phenotype and @GENE$ expression by flow cytometry and Luminex assays.	0
The transcriptome of @GENE$-treated @DISEASE$ cells was established by next generation sequencing.	0
Additionally, CXCL1 increases the metastatic ability of a @DISEASE$ by enhancing cell migration, matrix metalloproteinase-7 expression and @GENE$.	1
The enhanced @GENE$ expression in DCs is also noted in mice transplanted with colon @DISEASE$ cells.	0
Concurrently, @GENE$ displays a specific microRNA (protein polyubiquitination) upregulated by the prototypical colon @DISEASE$ onco-miR miR-105.	0
Analysis of publicly available data reveals @GENE$-driven oncogenes and protein polyubiquitination-105 have a negative prognostic impact on the outcome of colon @DISEASE$.	0
Analysis of publicly available data reveals chemotaxis-driven oncogenes and @GENE$-105 have a negative prognostic impact on the outcome of colon @DISEASE$.	0
WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (@GENE$, membrane protein ectodomain proteolysis), lysosomal (proteolysis, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly @DISEASE$ FTD.	1
WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (membrane protein ectodomain proteolysis, @GENE$), lysosomal (proteolysis, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly @DISEASE$ FTD.	0
WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (membrane protein ectodomain proteolysis, membrane protein ectodomain proteolysis), lysosomal (@GENE$, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly @DISEASE$ FTD.	0
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes @GENE$, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of @DISEASE$ simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, @GENE$ and spliceosomal snRNP assembly for the autosomal dominant form of @DISEASE$ simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and @GENE$ for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the @DISEASE$ forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	0
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and @GENE$ for the autosomal dominant form of @DISEASE$ simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of @DISEASE$ simplex, and the genes @GENE$, lipid catabolic process and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of @DISEASE$ simplex, and the genes keratinization, @GENE$ and G protein-coupled receptor signaling pathway for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of @DISEASE$ simplex, and the genes keratinization, lipid catabolic process and @GENE$ for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, @GENE$ and G protein-coupled receptor signaling pathway for the @DISEASE$ forms of hypotrichosis as well as U2HR for hypotrichosis muscle organ development Marie Unna.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes cell-cell adhesion, negative regulation of Wnt signaling pathway and spliceosomal snRNP assembly for the autosomal dominant form of hypotrichosis simplex, and the genes keratinization, lipid catabolic process and G protein-coupled receptor signaling pathway for the @DISEASE$ forms of hypotrichosis as well as U2HR for hypotrichosis @GENE$ Marie Unna.	1
A growing body of literature indicates that YY1 is overexpressed in multiple @DISEASE$ @GENE$s and that increased YY1 levels correlate with poor clinical outcomes in many cancers.	0
However, the role of YY1 in the promotion or suppression of @DISEASE$ growth remains controversial and its regulatory effects may be tumor cell @GENE$ dependent at least in experimental systems.	0
For example, YY1's roles in @DISEASE$ growth involve stabilization of hypoxia-inducible factor HIF-1α in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular @GENE$ and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving negative regulation of T cell mediated cytotoxicity, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	0
On the other hand, @DISEASE$ suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor double-strand break repair via homologous recombination, increased @GENE$ transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of osteoblast differentiation overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	0
On the other hand, @DISEASE$ suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor double-strand break repair via homologous recombination, increased B cell apoptotic process transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of @GENE$ overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	1
YY1 expression is associated with that of @DISEASE$ stem cell markers @GENE$, positive regulation of ubiquitin-protein transferase activity and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	1
YY1 expression is associated with that of @DISEASE$ stem cell markers osteoblast differentiation, @GENE$ and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	0
Intraepithelial @DISEASE$ in FGPs, referred to as FGP with dysplasia, is often seen in patients with familial adenomatous polyposis (@GENE$).	0
In sporadic FGPs, low-grade dysplasia (LGD) is rare, and high-grade dysplasia (@GENE$) or @DISEASE$ arising from sporadic FGPs is extremely rare.	0
In the present case, a @DISEASE$ FGP with LGD did not develop into invasive carcinoma, but contained foci of @GENE$ 14 years after diagnosis.	0
The pathological diagnosis of the resected specimen was FGP with @GENE$ mixed in LGD, with no invasive @DISEASE$.	0
We find that @GENE$-mediated VRAC is augmented in hypertrophic murine and human adipocytes in the setting of @DISEASE$.	0
Molecular genetic tests for @DISEASE$ ataxia @GENE$ 2 (EA2) usually target only the specific calcium channel gene (<i>CACNA1A</i>) that is known to cause EA2.	0
Molecular genetic tests for episodic @DISEASE$ @GENE$ 2 (EA2) usually target only the specific calcium channel gene (<i>CACNA1A</i>) that is known to cause EA2.	0
Here we present a case of a proband with a complex episodic @DISEASE$s (EA)/seizure pheno@GENE$ with an EA-affected father; and an unaffected mother, all negative for <i>CACNA1A</i> gene mutations.	0
Here we present a case of a proband with a complex episodic ataxias (EA)/@DISEASE$ pheno@GENE$ with an EA-affected father; and an unaffected mother, all negative for <i>CACNA1A</i> gene mutations.	0
The @GENE$ was studied by whole-exome sequencing to identify candidate genes responsible for causing the complex EA/@DISEASE$ phenotype.	1
We identified a recurrent de novo @GENE$ c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global @DISEASE$, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.	1
We identified a recurrent de novo @GENE$ c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, @DISEASE$, axonal neuropathy, and hypertrophic cardiomyopathy.	1
We identified a recurrent de novo @GENE$ c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal @DISEASE$, and hypertrophic cardiomyopathy.	1
We identified a recurrent de novo @GENE$ c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic @DISEASE$.	1
Hepatocyte growth factor (@GENE$)/c-MET signaling plays an important role in cell proliferation, survival, migration and motility of @DISEASE$ cells.	0
The scope of the present review is to recapitulate and review the evidence of @GENE$ participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse @DISEASE$.	0
Most studies are in agreement as to the belief that, in a large range of human @DISEASE$s, the @GENE$ gene promoter is frequently methylated, resulting in the epigenetic silence of this gene.	0
Functional assays indicate that SPINT2 reactivation ameliorates the malignant pheno@GENE$, specifically reducing cell viability, migration and invasion in diverse @DISEASE$ cell lines.	0
In sum, the @GENE$ gene is epigenetically silenced or downregulated in human @DISEASE$s, altering the balance of neutrophil apoptotic process activation/inhibition ratio, which contributes to cancer development and progression	0
Using a new conditional allele, we first show that mRNA splicing, via spliceosome haploinsufficiency phenocopies aberrant neurogenesis and @DISEASE$ of @GENE$ and Rbm8a mutant mice.	0
GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi @GENE$ aminoaciduria, cholestasis, iron overload, @DISEASE$ lactic acidosis, and early death.	0
GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi @GENE$ @DISEASE$, cholestasis, iron overload, profound lactic acidosis, and early death.	0
The clinical presentation of both patients was initially thought to be suggestive of Lin-Gettig syndrome (@GENE$), a multiple malformation syndrome associated with @DISEASE$ that was initially reported in two brothers in 1990, with a third patient reported in 2003.	0
Here we report that @GENE$ ubiquitylates and triggers degradation of the @DISEASE$-suppressive sirtuin regulation of double-strand break repair via homologous recombination in hepatocellular carcinoma.	0
Here we report that @GENE$ ubiquitylates and triggers degradation of the tumor-suppressive sirtuin regulation of double-strand break repair via homologous recombination in @DISEASE$.	0
Here we report that positive regulation of protein ubiquitination ubiquitylates and triggers degradation of the @DISEASE$-suppressive sirtuin @GENE$ in hepatocellular carcinoma.	0
Here we report that positive regulation of protein ubiquitination ubiquitylates and triggers degradation of the tumor-suppressive sirtuin @GENE$ in @DISEASE$.	0
In mouse models of @DISEASE$, SIRT6 downregulation and consequent induction of @GENE$ were critical for positive regulation of protein ubiquitination-mediated tumorigenesis.	0
In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of @GENE$ were critical for positive regulation of protein ubiquitination-mediated @DISEASE$igenesis.	0
In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of positive regulation of receptor recycling were critical for @GENE$-mediated @DISEASE$igenesis.	0
Furthermore, in clinical specimens, increased @GENE$ levels correlated with reduced regulation of double-strand break repair via homologous recombination levels and elevated positive regulation of receptor recycling levels in increasing @DISEASE$ grades.	0
Furthermore, in clinical specimens, increased positive regulation of protein ubiquitination levels correlated with reduced @GENE$ levels and elevated positive regulation of receptor recycling levels in increasing @DISEASE$ grades.	0
Overall, our findings show how the tumor suppressor @GENE$ is regulated in @DISEASE$ and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	0
Several studies have shown that reproductive factors, such as age at natural @GENE$opause, parity and polycystic ovarian syndrome (PCOS), may play a role in the development of @DISEASE$.	0
However, age at @GENE$arche, gestational diabetes and PCOS were found to be genetically linked to risk factors for @DISEASE$, such as atrial fibrillation, diabetes and smoking.	0
Corresponding implicated genes, such as @GENE$, ErbB3, MKL2, glucose homeostasis and protein phosphorylation, may explain the associations between reproductive factors and @DISEASE$.	1
Corresponding implicated genes, such as protein phosphorylation, ErbB3, MKL2, @GENE$ and protein phosphorylation, may explain the associations between reproductive factors and @DISEASE$.	0
Corresponding implicated genes, such as protein phosphorylation, ErbB3, MKL2, glucose homeostasis and @GENE$, may explain the associations between reproductive factors and @DISEASE$.	0
The insulin-secreting pancreatic neuroendocrine @DISEASE$, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor @GENE$ that interacts with NONO/p54NRB, a survival factor.	1
Our studies implicate therapeutic strategies for either reducing β-cell proliferation in @DISEASE$ or alleviating normal β-cell deficiency in diabetes through the modulation of @GENE$ phosphorylation	0
A frame-shift carboxyl-terminal deletion was reported in @GENE$ in an American family with @DISEASE$, but subsequently found in two controls.	0
Hirschsprung disease (@GENE$) is a congenital and @DISEASE$ disorder characterized by the absence of intramural nervous plexuses along variable lengths of the hindgut.	1
Smith-Magenis syndrome (@GENE$), a neurodevelopmental disorder characterized by dysmorphic features, @DISEASE$ (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.	1
We @GENE$ NF1 mutations in @DISEASE$ cell lines and in primary tumors.	0
Our study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) of claudin 10 (@GENE$) (rs1325774, rs7333503, rs3751334) and breast @DISEASE$ and the clinical characteristics of patients.A total of 104 patients with breast cancer and 118 healthy controls were recruited in our study between 2013 and 2015.	0
The expression level of @GENE$ was reduced in breast @DISEASE$ tissues compared with normal breast tissues according to the analysis of The Cancer Genome Atlas (TCGA) data through GEPIA.Our results suggest that the polymorphism of rs1325774 associate with increase the breast cancer risk.	0
Recessively inherited, pathogenic defects in @GENE$ have been previously reported to underlie cerebral, ocular, dental, auricular and @DISEASE$ (CODAS) syndrome, a complex multisystemic and developmental disorder.	1
Among these genes, mutations in @GENE$ gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (double-strand break repair), familial amyotrophic lateral sclerosis (ALS), @DISEASE$ spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	0
Among these genes, mutations in double-strand break repair gene involve in inclusion body myopathy with Paget disease of bone and @DISEASE$ (@GENE$), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	1
These subjects share a @GENE$ of common facial features that include a prominent maxilla and upper nuclear-transcribed mRNA catabolic process, nonsense-mediated decay that readily reveal the upper gingiva, @DISEASE$, and a broad nasal tip.	0
These subjects share a negative regulation of transcription, DNA-templated of common facial features that include a prominent maxilla and upper @GENE$ that readily reveal the upper gingiva, @DISEASE$, and a broad nasal tip.	0
Grossly, the @DISEASE$ was lobulated, with a fleshy @GENE$ surface and a diameter ranging between 0.8 and 8 cm (mean 3.4 cm).	0
Primary @DISEASE$ (@GENE$) can manifest in the neonatal period with severe respiratory distress.	1
We chose to study @GENE$-branching involved in blood vessel morphogenesis rather than wild muscle organ development branching involved in blood vessel morphogenesis because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote @DISEASE$ metastasis in addition to its anti-angiogenic activity.	0
We chose to study protein transport-@GENE$ rather than wild muscle organ development branching involved in blood vessel morphogenesis because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote @DISEASE$ metastasis in addition to its anti-angiogenic activity.	0
We chose to study protein transport-branching involved in blood vessel morphogenesis rather than wild muscle organ development @GENE$ because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote @DISEASE$ metastasis in addition to its anti-angiogenic activity.	0
We generated calpain-1 knockout Townes sickle (SSCKO) @GENE$ to investigate the role of calpain-1 in steady state and hypoxia/reoxygenation (H/R)-induced sickle platelet activation and aggregation, clot retraction, and @DISEASE$.	0
To investigate the role of @GENE$ variants with putative transcription regulatory function in the etiology of @DISEASE$, we performed a family-based association study in 410 Chinese Han trios.	0
Alterations in @GENE$ signaling are involved both in @DISEASE$ progression and in osteoclast differentiation.	0
While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as @GENE$, ATXN2, ATXN3, ATXN7, CACNA1A and transcription by RNA polymerase II, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as negative regulation of transcription, DNA-templated, ATXN2, ATXN3, ATXN7, CACNA1A and @GENE$, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
Clinical comparisons showed that @DISEASE$ due to channelopathies had a significantly earlier age at onset with an average of 24.6 years, versus 40.9 years for polyglutamine expansion spinocerebellar ataxias and 37.8 years for @GENE$-related forms (P = 0.001).	1
In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar @DISEASE$, and confirmed positive regulation of cytosolic calcium ion concentration and @GENE$ as major ataxia genes.	1
In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed @GENE$ and regulation of mitochondrial membrane permeability as major @DISEASE$ genes.	1
@GENE$Ks and SSH promote @DISEASE$ cell invasion and metastasis and represent novel anti-cancer targets.	0
We show that active cofilin, @GENE$K1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with @DISEASE$ progression parameters.	0
In addition, immunofluorescence analysis showed increased expression of active cofilin, regulation of synapse assemblyK1, LIMK2, and @GENE$ in HT29 colon @DISEASE$ cells resistant to 5-fluorouracil compared to parental HT29 cells.	0
Our results suggest that F-actin regulators LIMK/cofilin pathway and @GENE$ are associated with CRC progression and chemoresistance representing promising @DISEASE$ biomarkers and therapeutic targets in CRC	0
We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the @GENE$ gene characterized by @DISEASE$, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.	0
The mutations in both @GENE$ and LPAR6/P2RY5 are responsible for @DISEASE$ woolly hair with or without hypotrichosis (ARWH/HT).	1
The main objective of this study is to provide a brief version of the Spanish translation of the @GENE$, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus muscle organ development I (20.9% of the sample; n = 97), @DISEASE$ (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): @GENE$, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, @GENE$, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, @GENE$, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, @GENE$, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	1
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, @GENE$, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, @GENE$, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, @GENE$, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, @GENE$, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	1
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, @GENE$, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, @GENE$, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: @GENE$, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	1
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, @GENE$, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	1
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, @GENE$, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	1
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, @GENE$, SPG11, mitochondrion organization, positive regulation of cell migration, and biological_process; or an X-linked transmission: RAB39B.	1
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, @GENE$, and biological_process; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): MAPK cascade, positive regulation of receptor recycling, positive regulation of gene expression, tetrahydrobiopterin biosynthetic process, negative regulation of receptor internalization, endosome organization, synaptic vesicle transport, GIGYF2, proteolysis, protein folding, positive regulation of mRNA cap binding, UCHL1, positive regulation of transcription by RNA polymerase II, and glucosylceramide catabolic process; or @DISEASE$ (AR) inheritance: protein polyubiquitination, positive regulation of protein phosphorylation, DJ1, cellular calcium ion homeostasis, PLA2G6, ubiquitin-dependent protein catabolic process, synaptic vesicle uncoating, phosphatidylinositol dephosphorylation, SPG11, mitochondrion organization, positive regulation of cell migration, and @GENE$; or an X-linked transmission: RAB39B.	0
Duplication in @GENE$ encoding lamin B1 causes autosomal dominant @DISEASE$ and mutations in biological_process encoding lamin B2 are associated with acquired partial lipodystrophy.	1
Duplication in interleukin-12-mediated signaling pathway encoding lamin B1 causes autosomal dominant @DISEASE$ and mutations in @GENE$ encoding lamin B2 are associated with acquired partial lipodystrophy.	0
Thus, our data indicate that @GENE$-132 induces temozolomide resistance and promotes the formation of @DISEASE$ stem cell phenotypes by targeting magnesium ion transport in glioblastoma	0
To investigate the mechanism by which the α-crystallin mutations negative regulation of intracellular transport-R49C and @GENE$-R120G lead to @DISEASE$ formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis.	1
Surprisingly, germline variants in @GENE$ or SAMD9L were present in 17% of primary microtubule-based process patients, and these variants were routinely lost in the @DISEASE$ cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH).	1
Amyotrophic lateral sclerosis (@GENE$) is a fatal @DISEASE$.	0
Progressive and systemic loss of motor neurons with gliosis in the @DISEASE$ nervous system (CNS) is a neuropathological hallmark of @GENE$.	0
Anti-@GENE$ antibodies were also observed in systemic lupus erythematosus (SLE), @DISEASE$ (RA), and Sjögren's syndrome (SS) patients at a positive rate of 17.3, 14.5, and 10.1% respectively.	0
The Aicardi-Goutières syndrome (@GENE$) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with @DISEASE$, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon α activity.	0
The Aicardi-Goutières syndrome (@GENE$) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, @DISEASE$, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon α activity.	0
The Aicardi-Goutières syndrome (@GENE$) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and @DISEASE$, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon α activity.	0
Wnt transgenic @GENE$ provide convincing evidence that Wnt signaling is involved in breast @DISEASE$ initiation and progression, which is further strengthened by observations on human clinical breast cancer patients and studies on in vitro cultured human breast cancer cells.	0
Genetic discoveries have established the importance of @GENE$ for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia muscle organ development 2 (MAPK cascade) (OMIM: 606002), which is the third most common form of recessive @DISEASE$, after Friedreich's ataxia and Ataxia-Telangiectasia.	1
Genetic discoveries have established the importance of MAPK cascade for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia @GENE$ 2 (MAPK cascade) (OMIM: 606002), which is the third most common form of recessive @DISEASE$, after Friedreich's ataxia and Ataxia-Telangiectasia.	0
Genetic discoveries have established the importance of MAPK cascade for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia muscle organ development 2 (@GENE$) (OMIM: 606002), which is the third most common form of recessive @DISEASE$, after Friedreich's ataxia and Ataxia-Telangiectasia.	1
Over the last decade, altered RNA regulation and aberrant RNA-binding protein function have emerged as a central theme in motor neuron disease pathogenesis, with evidence suggesting that @DISEASE$ @GENE$ disease pathology may overlap with the molecular pathology uncovered in familial ALS.	0
While we do not yet know which @GENE$ activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in signal transduction and @DISEASE$ disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell	1
While we do not yet know which MAPK cascade activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in @GENE$ and @DISEASE$ disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell	0
Previously, the combination of @DISEASE$, deafness, and renal dysplasia has been proposed to represent a specific syndrome (negative regulation of epithelial cell proliferation 146255) under the acronym @GENE$.	1
Previously, the combination of hypoparathyroidism, @DISEASE$, and renal dysplasia has been proposed to represent a specific syndrome (@GENE$ 146255) under the acronym negative regulation of mammary gland epithelial cell proliferation.	0
Previously, the combination of hypoparathyroidism, deafness, and @DISEASE$ has been proposed to represent a specific syndrome (negative regulation of epithelial cell proliferation 146255) under the acronym @GENE$.	1
Hemizygosity of the distal region, designated @GENE$1, can cause hypoparathyroidism and in addition sensorineuronal deafness and @DISEASE$/insufficiency or a subset of this triad	1
A heterozygous nonsense variant was identified in @GENE$, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with @DISEASE$, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	1
A heterozygous nonsense variant was identified in @GENE$, antagonist of protein polyubiquitination, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or @DISEASE$.	1
A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of @GENE$, 1 (negative regulation of transcription by RNA polymerase II) via whole-exome sequencing in family members with @DISEASE$, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	0
A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (@GENE$) via whole-exome sequencing in family members with @DISEASE$, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	1
A heterozygous nonsense variant was identified in negative regulation of transcription by RNA polymerase II, antagonist of protein polyubiquitination, 1 (@GENE$) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or @DISEASE$.	1
The @GENE$ c.1256G&gt;A;p.Trp419<sup>*</sup> variant segregated appropriately in the family consistent with an autosomal dominant @DISEASE$.	0
@GENE$ is a member of the Wnt-signaling pathway, and epidermis development homozygous for null alleles display multiple congenital anomalies including @DISEASE$ with blind-ending colon and genitourinary malformations.	1
negative regulation of transcription by RNA polymerase II is a member of the Wnt-signaling pathway, and @GENE$ homozygous for null alleles display multiple congenital anomalies including @DISEASE$ with blind-ending colon and genitourinary malformations.	0
To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, @GENE$ and vascular endothelial growth factor A (negative regulation of transcription by RNA polymerase II), were analyzed in their @DISEASE$.	1
To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, endothelial cell morphogenesis and vascular endothelial growth factor A (@GENE$), were analyzed in their @DISEASE$.	0
Compared to normal tissues, decorin expression was reduced in CRC patients' @DISEASE$, while there were increased Met and @GENE$ levels.	0
Mutations in a proline-rich-repeat region (@GENE$) of regulation of macroautophagy cause amyotrophic lateral sclerosis (signal transduction)/@DISEASE$ (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.	0
Mutations in a proline-rich-repeat region (angiotensin maturation) of @GENE$ cause amyotrophic lateral sclerosis (signal transduction)/@DISEASE$ (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.	1
@GENE$-related @DISEASE$ is caused by mutations in the gene encoding the p21-activated kinase (PAK) protein.	0
The authors report a patient with a novel @GENE$ mutation, who presented with intellectual disability, severe automutilation, and @DISEASE$.	0
This is the first case of @GENE$-related @DISEASE$ presenting with severe self-injury with improvement following treatment.	0
Spinal muscular atrophy (@GENE$) is a lethal @DISEASE$ neurological disease characterized by selective degeneration of motor neurons in the spinal cord.	1
Previous studies have shown that c-@GENE$ is overexpressed in cases of aggressive bladder @DISEASE$ (intracellular signal transduction).	0
We also highlight @GENE$ as another compelling candidate in a large family with autosomal dominant mild @DISEASE$ that fully segregates with a heterozygous truncating variant.	0
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in @GENE$, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.	1
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, @GENE$, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.	1
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, @GENE$, neural crest formation, and protein dephosphorylation have been recently proposed to increase CRC risk.	1
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, @GENE$, and protein dephosphorylation have been recently proposed to increase CRC risk.	0
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in base-excision repair, AP site formation, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, FANCM, nucleotide-excision repair, DNA incision, TP53, BUB1, attachment of spindle microtubules to kinetochore, neural crest formation, and @GENE$ have been recently proposed to increase CRC risk.	0
Pyridoxine-dependent @DISEASE$ (@GENE$) is a rare disease characterized by mutations in the lysine degradation gene <i>ALDH7A1</i> leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).	1
Remarkably, as is the case in human @GENE$, the @DISEASE$ show an almost immediate sensitivity to pyridoxine and pyridoxal 5'-phosphate, with a resulting extension of the life span.	1
Impaired lysine degradation with accumulation of @GENE$ biomarkers, B6 deficiency, and low γ-aminobutyric acid levels were observed in the <i>cellular aldehyde metabolic process</i><sup>-/-</sup> larvae, which may play a significant role in the @DISEASE$ phenotype and PDE pathogenesis.	1
Impaired lysine degradation with accumulation of cellular aldehyde metabolic process biomarkers, B6 deficiency, and low γ-aminobutyric acid levels were observed in the <i>@GENE$</i><sup>-/-</sup> larvae, which may play a significant role in the @DISEASE$ phenotype and PDE pathogenesis.	1
@GENE$ mutations are rare cause of @DISEASE$ juvenile-onset Parkinson disease.	1
Both single-gene and gene-@GENE$ enrichment analyses in genome-wide association data from the largest @DISEASE$ sample to date of 13,689 cases and 18,226 controls show significant association of negative regulation of transcription by RNA polymerase II and MAPK3, and enrichment of our PSD proteome.	0
Both single-gene and gene-negative regulation of transcription, DNA-templated enrichment analyses in genome-wide association data from the largest @DISEASE$ sample to date of 13,689 cases and 18,226 controls show significant association of @GENE$ and MAPK3, and enrichment of our PSD proteome.	0
The importance of @GENE$ coenzyme A biosynthetic processions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as @DISEASE$.	1
The importance of positive regulation of protein phosphorylation @GENE$ions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as @DISEASE$.	0
By @GENE$ exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and @DISEASE$, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.	0
By @GENE$ exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature @DISEASE$/palate, and without intellectual disability, or short stature.	0
By @GENE$ exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or @DISEASE$.	0
In Japan, 26 mutations in the @GENE$ gene in 7 pedigrees and 19 @DISEASE$ cases with DD have been reported, among which one pedigree and one sporadic case were accompanied by neuropsychiatric symptoms.	0
Zinc finger protein 687 (@GENE$), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell @DISEASE$ of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.	0
Herein, we report that @GENE$ was markedly upregulated in @DISEASE$ (HCC) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.	0
@GENE$ overexpression greatly enhanced phosphatidylinositol phosphorylation cell capability for @DISEASE$sphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.	0
regulation of transcription by RNA polymerase II overexpression greatly enhanced @GENE$ cell capability for @DISEASE$sphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.	0
Importantly, extreme limiting dilution analysis revealed that even 1 × 10<sup>2</sup> regulation of transcription by RNA polymerase II-transduced cells could form @DISEASE$s in vivo, indicating that ZNF687 contributes to @GENE$ recurrence.	0
Mechanistically, the role of @GENE$ in pancreatic @DISEASE$ might attribute to its regulation of c-Myc, HIF1α and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	0
Here, we report that hypoxia-inducible factor (HIF-1α) and @DISEASE$-associated fibroblasts (CAFs)-secreted TGF-β2 converge to activate the expression of hedgehog transcription factor @GENE$ in CSCs, resulting in increased stemness/dedifferentiation and intrinsic resistance to chemotherapy.	1
Importantly, high expression levels of HIF-1α/TGF-β2/@GENE$ correlated robustly with the patient relapse following chemotherapy, highlighting a potential biomarker and therapeutic target for chemoresistance in colorectal @DISEASE$.	1
The aim of this study was to investigate the expression of the long intergenic non-protein coding RNA 665 (LINC00665) gene and the cell cycle in @DISEASE$ (@GENE$) using database analysis including The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and quantitative real-time polymerase chain reaction (qPCR).	0
RESULTS Overexpression of LINC00665 in patients with @GENE$ was significantly associated with gender, @DISEASE$ grade, stage, and tumor cell type.	0
However, the ectopic expression of @GENE$ was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine @DISEASE$).	0
The possible involvement of @GENE$ in @DISEASE$ progression and the use of FSHR examination for diagnostic purposes is also reviewed.	0
All three and two patients with @GENE$ variants had @DISEASE$ and developmental delay, respectively.	1
All three and two patients with @GENE$ variants had hypothyroidism and @DISEASE$, respectively.	1
Similarly, SEPT4 has lymphoid and non-lymphoid forms; @GENE$ has lymphoid and @DISEASE$ nervous system (CNS) forms; and mitotic cytokinesis and protein heterooligomerization are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	0
Similarly, SEPT4 has lymphoid and non-lymphoid forms; mitotic cytokinesis has lymphoid and @DISEASE$ nervous system (CNS) forms; and @GENE$ and protein heterooligomerization are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	0
Overexpression of @GENE$ and SERPINH1 was observed in clinical specimens of lung @DISEASE$ and fibrotic lesions.	0
Downregulation of miR-29a caused overexpression of @GENE$ and SERPINH1 in lung @DISEASE$ and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases	0
The reported @DISEASE$ in @GENE$ mutation carriers could be attributed to a half dose effect of the laminin α3 chain (haploinsufficiency)	0
Low-density lipoprotein receptor-related protein 4 (@GENE$) is a multi-functional protein implicated in bone, kidney and neurological diseases including Cenani-Lenz @DISEASE$ (CLS), sclerosteosis, osteoporosis, congenital myasthenic syndrome and myasthenia gravis.	1
The clinical pheno@GENE$ of CMT1A is determined by the degree of @DISEASE$, and patients suffer from progressive muscle weakness and impaired sensation.	0
BACKGROUND Previous research found that @GENE$ is associated with cervical @DISEASE$, but the role of ALG3 in breast cancer was still unknown.	0
MATERIAL AND METHODS The expression of @GENE$ in @DISEASE$ tissues was determined by immunochemistry.	0
@GENE$ expression was significantly increased in @DISEASE$ samples with advanced stages (stage III/IV) compared with those in the early stages of disease (stage I/II) (p&lt;0.05).	0
The staining intensity of @GENE$ was significantly correlated to the @DISEASE$ grade (grades 2-3 versus 1, p&lt;0.05).	0
The created databases include @GENE$ (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include @GENE$ (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), @GENE$ (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), @GENE$ (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (@GENE$) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), @GENE$ (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), @GENE$ (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), @GENE$ (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), @GENE$ (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), @GENE$ (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	1
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), @GENE$ (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), @GENE$ (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), @GENE$ (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	1
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), @GENE$ (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	1
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), @GENE$ (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	1
The created databases include branched-chain amino acid catabolic process (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), cholesterol biosynthetic process (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), IRE1-mediated unfolded protein response (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and @GENE$ (Kohlschütter-Tönz syndrome).	0
Homozygous null mutation of @DISEASE$ suppressor <i>WWOX/@GENE$</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, epidermis development and rats.	1
Homozygous null mutation of @DISEASE$ suppressor <i>WWOX/negative regulation of Wnt signaling pathway</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, @GENE$ and rats.	0
<i>In vitro</i> analysis revealed that knockdown of @GENE$ protein in @DISEASE$ cells results in aggregation of TRAPPC6AΔ, I-kappaB kinase/NF-kappaB signaling, amyloid β, and microtubule cytoskeleton organization in a sequential manner.	0
<i>In vitro</i> analysis revealed that knockdown of negative regulation of Wnt signaling pathway protein in @DISEASE$ cells results in aggregation of TRAPPC6AΔ, @GENE$, amyloid β, and microtubule cytoskeleton organization in a sequential manner.	0
<i>In vitro</i> analysis revealed that knockdown of negative regulation of Wnt signaling pathway protein in @DISEASE$ cells results in aggregation of TRAPPC6AΔ, I-kappaB kinase/NF-kappaB signaling, amyloid β, and @GENE$ in a sequential manner.	0
This study aimed to investigate the expression of @GENE$ by immunohistochemistry in different grade as well as metastatic PCa and to correlate the alteration of PLZF expression with PCa @DISEASE$.	0
These data demonstrated that down-regulation of @GENE$ is an important molecular process for @DISEASE$ progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for mitochondrial transport aggressiveness and metastasis in the personalized care of PCa.	0
These data demonstrated that down-regulation of @GENE$ is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for mitochondrial transport @DISEASE$ and metastasis in the personalized care of PCa.	0
Mutations in <i>Matrin 3</i> (<i>@GENE$</i>), a poorly understood DNA- and RNA-binding protein, cause familial signal transduction/FTD, and MATR3 pathology is a feature of @DISEASE$ disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.	0
Mutations in <i>Matrin 3</i> (<i>activation of innate immune response</i>), a poorly understood DNA- and RNA-binding protein, cause familial @GENE$/FTD, and MATR3 pathology is a feature of @DISEASE$ disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.	0
Peroxisome biogenesis disorders (PBD) are a @DISEASE$ group of disorders due to @GENE$ genes mutations, with a broad clinical spectrum comprising severe neonatal disease to mild presentation.	0
MicroRNA-200a (@GENE$-200a) is frequently downregulated in most @DISEASE$ types and plays an important role in carcinogenesis and cancer progression.	0
In this study, we determined that protein polyubiquitination-200a was downregulated in @DISEASE$ (@GENE$) tissues and cell lines, consistent with the results of our previous study.	0
Taken together, these data provide novel information for comprehending the @DISEASE$-suppressive role of @GENE$-200a in phosphatidylinositol phosphorylation pathogenesis through inhibition of GAB1 translation	0
Taken together, these data provide novel information for comprehending the @DISEASE$-suppressive role of protein polyubiquitination-200a in @GENE$ pathogenesis through inhibition of GAB1 translation	0
Moreover, myostatin inhibitors are known to promote muscle regeneration and ameliorate fibrosis in animal models of Duchenne @DISEASE$ (@GENE$), a human disease characterized by chronic muscle degeneration.	1
The ability of @GENE$ to promote proliferation and differentiation of activated T cells fueled present attempts to modulate this immune checkpoint to reinforce anti@DISEASE$ immunity.	1
The data presented thus not only identify the yet unknown involvement of @GENE$/OX40L in ALL pathophysiology and NK cell immunosurveillance but also point to the necessity to thoroughly consider the consequences of modulating the OX40/OX40L molecule system beyond its effects on T cells when developing OX40-targeting approaches for @DISEASE$ immunotherapy	1
Mutations in @GENE$, a mitochondrially targeted serine/threonine kinase, cause @DISEASE$ Parkinson's disease (PD).	1
We show that signaling through herpes virus entry mediator (@GENE$), a member of the @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.	0
We show that signaling through herpes virus entry mediator (T cell costimulation), a member of the @DISEASE$ necrosis factor (@GENE$) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.	0
Introduction Despite some new treatment possibilities, the improvement in survival rate for @DISEASE$ (@GENE$) patients is still poor due to late diagnosis.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), @GENE$-3 (GP3), Cystatin B (negative regulation of peptidase activity), @DISEASE$ antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (@GENE$), @DISEASE$ antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), @DISEASE$ antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for @GENE$ in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), @DISEASE$ antigen 1 (@GENE$) and hepatocyte growth factor (neutrophil apoptotic process) as potential tumour markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (@GENE$) and hepatocyte growth factor (neutrophil apoptotic process) as potential @DISEASE$ markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (@GENE$) as potential @DISEASE$ markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential @DISEASE$ markers for @GENE$ in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (negative regulation of peptidase activity) and hepatocyte growth factor (neutrophil apoptotic process) as potential @DISEASE$ markers for phosphatidylinositol phosphorylation in patients with alcoholic liver cirrhosis (@GENE$) using imaging techniques (MSCT and MRI) as reference standards.	0
The '@GENE$' combination of @DISEASE$ markers in our study includes all tested markers with AUC of 0.967.	0
Conclusion While novel diagnostic @DISEASE$ markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing @GENE$ in biological_process.	0
Conclusion While novel diagnostic @DISEASE$ markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing phosphatidylinositol phosphorylation in @GENE$.	0
Furthermore, probably the future is in finding the @GENE$ optimal combination of @DISEASE$ markers for diagnosing phosphatidylinositol phosphorylation based on cost-effectiveness	0
Furthermore, probably the future is in finding the chloride transport optimal combination of @DISEASE$ markers for diagnosing @GENE$ based on cost-effectiveness	0
Based on screening results, five unique genes (ether lipid biosynthetic process, protein sumoylation, @GENE$, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a protein phosphorylation mutated @DISEASE$ line (P &lt; 0.001).	0
Based on screening results, five unique genes (ether lipid biosynthetic process, protein sumoylation, negative regulation of cell-cell adhesion, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a @GENE$ mutated @DISEASE$ line (P &lt; 0.001).	1
Our findings indicate that GNPAT, @GENE$, negative regulation of cell-cell adhesion, FLI1, and regulation of transcription, DNA-templated play critical roles in synergy with inflammation pathways in modulating @DISEASE$ cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	0
Our findings indicate that GNPAT, protein sumoylation, @GENE$, FLI1, and regulation of transcription, DNA-templated play critical roles in synergy with inflammation pathways in modulating @DISEASE$ cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	0
We conducted a @GENE$-expression quantitative trait loci (cis-eQTL) analysis using normal or @DISEASE$ breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project.	0
Furthermore, we performed in vitro assays in breast @DISEASE$ cell lines, and our results indicated that telomere maintenance, @GENE$, and protein modification by small protein conjugation played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	0
Furthermore, we performed in vitro assays in breast @DISEASE$ cell lines, and our results indicated that telomere maintenance, apoptotic process, and @GENE$ played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	0
Furthermore, we performed in vitro assays in breast cancer cell lines, and our results indicated that @GENE$, apoptotic process, and protein modification by small protein conjugation played a vital role in breast @DISEASE$igenesis via certain disruption of cell behaviors.	0
Furthermore, we performed in vitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, @GENE$, and protein modification by small protein conjugation played a vital role in breast @DISEASE$igenesis via certain disruption of cell behaviors.	0
Furthermore, we performed in vitro assays in breast cancer cell lines, and our results indicated that telomere maintenance, apoptotic process, and @GENE$ played a vital role in breast @DISEASE$igenesis via certain disruption of cell behaviors.	0
Identification of novel genetic and epigenetic alterations is required for optimal stratification of patients with @DISEASE$ (@GENE$) at risk for recurrence and adverse prognosis.	0
@GENE$ is a putative @DISEASE$ suppressor, and promoter hypermethylation is a key regulatory mechanism in HCC.	0
Mutations in @GENE$ have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (signal transduction) and ALS linked to @DISEASE$ (FTD).	1
Mutations in regulation of macroautophagy have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (@GENE$) and ALS linked to @DISEASE$ (FTD).	0
Here, we report 1 known (c.1489C&gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&gt;T, p.Pro494Leu, P494L; c.1498C&gt;T, p.Pro500Ser, P500S; and c.1516C&gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of UBQLN2 in familial motor neuron diseases including @GENE$ and @DISEASE$ (SP).	0
Mosaicism was identified for autosomal dominant (JAG1, COL3A1), @DISEASE$ (@GENE$), and X-linked (PHKA2, PDHA1, OTC, and creatine transmembrane transport) disorders.	1
Mosaicism was identified for autosomal dominant (JAG1, COL3A1), @DISEASE$ (glycogen metabolic process), and X-linked (PHKA2, PDHA1, OTC, and @GENE$) disorders.	0
@GENE$ is an @DISEASE$ generalized connective tissue disorder associated with extreme corneal thinning and a high risk of corneal rupture.	1
We hypothesized that heterozygous variants in @GENE$ and regulation of transcription by RNA polymerase II predispose to the development of isolated @DISEASE$.	1
We hypothesized that heterozygous variants in negative regulation of transcription by RNA polymerase II and @GENE$ predispose to the development of isolated @DISEASE$.	1
We found a significant enrichment of potentially pathologic heterozygous alleles in @GENE$ associated with the development of @DISEASE$ (P = 0.00102) resulting in a relative risk of 12.0.	1
This enrichment of rare potentially pathogenic alleles in @GENE$ in 12.5% of @DISEASE$ patients represents a significant mutational load and highlights ZNF469 as the most significant genetic factor responsible for keratoconus identified to date.	1
Integration of cell culture genomes, transcriptomes and @DISEASE$ phenotypes with functional studies and human data reveals additional widespread effects of oncogenic dosage variation on cell morphology and plasticity, histopathology and clinical outcome, with the highest @GENE$<sup>MUT</sup> levels underlying aggressive undifferentiated phenotypes.	1
Mechanistically, different oncogenic gains and dosages evolve along distinct evolutionary routes, licensed by defined allelic states and/or combinations of hallmark @DISEASE$ suppressor alterations (@GENE$, Trp53, Tgfβ-pathway).	1
Risdiplam (RG7916; RO7034067) is an orally administered, small-molecule <i>@GENE$2</i> pre-mRNA splicing modifier that distributes into the @DISEASE$ nervous system (CNS) and peripheral tissues.	0
Primary macronodular @DISEASE$ (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (@GENE$)-independent macronodular adrenal hyperplasia, is a rare muscle organ development of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.	0
Primary macronodular adrenal hyperplasia (PMAH), also known in the past as @DISEASE$ macronodular adrenalhyperplasia or adrenocorticotropin (@GENE$)-independent macronodular adrenal hyperplasia, is a rare muscle organ development of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.	0
In addition, haploid clone of @DISEASE$ DNA was confirmed by germline mutation and somaticmutation, which suggested the pathogenic mechanism of &quot;two-hit-model.&quot; @GENE$ was the causative gene of AIMAH pedigrees.	1
Whereas the majority of mammalian cells carry no more than two centrosomes @GENE$ cell, exceptions to this rule apply in certain specialized tissues and in select disease states, including @DISEASE$.	0
Extensive IDS gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire @GENE$ gene, and @DISEASE$ developed in only one of them.	0
Wide allelic @DISEASE$ was noted, with large gene alterations (e.g. @GENE$/IDSP1 gene inversions, partial to extensive IDS deletions, and one chimeric IDS-IDSP1 allele) that occurred at higher frequencies than previously reported (36% vs 18.9-29%).	0
Our findings suggest a wide allelic @DISEASE$ in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting pheno@GENE$ for glycosaminoglycan catabolic process and neighboring loci deletions	0
Our findings suggest a wide allelic @DISEASE$ in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting phenomuscle organ development for @GENE$ and neighboring loci deletions	0
We evaluated the uptake and efflux of <sup>131</sup>I-MIBG both in vitro and in vivo in @GENE$ bearing transfected @DISEASE$.	0
In vivo ex@GENE$iments were performed in establishment of mitotic spindle orientation epidermis development bearing transfected @DISEASE$; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	0
In vivo exGPI anchor metabolic processiments were performed in @GENE$ epidermis development bearing transfected @DISEASE$; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	0
In vivo exGPI anchor metabolic processiments were performed in establishment of mitotic spindle orientation @GENE$ bearing transfected @DISEASE$; results revealed that negative regulation of transcription, DNA-templated-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	0
In vivo exGPI anchor metabolic processiments were performed in establishment of mitotic spindle orientation epidermis development bearing transfected @DISEASE$; results revealed that @GENE$-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	0
Meanwhile, @GENE$-chemical synaptic transmission-coexpressing and NET-expressing @DISEASE$ displayed 0.54% and 0.19%, respectively, of the injected dose GPI anchor metabolic process gram of tissue 24 h after <sup>131</sup>I-MIBG administration.	0
Meanwhile, negative regulation of transcription, DNA-templated-@GENE$-coexpressing and NET-expressing @DISEASE$ displayed 0.54% and 0.19%, respectively, of the injected dose GPI anchor metabolic process gram of tissue 24 h after <sup>131</sup>I-MIBG administration.	0
Meanwhile, negative regulation of transcription, DNA-templated-chemical synaptic transmission-coexpressing and NET-expressing @DISEASE$ displayed 0.54% and 0.19%, respectively, of the injected dose @GENE$ gram of tissue 24 h after <sup>131</sup>I-MIBG administration.	0
<b>Result:</b> Three mutant genes (@GENE$ gene in chromosome 12, Ras protein signal transduction gene in chromosome 1 and activation of MAPKK activity gene in chromosome 3) in five cases all had been reported to be related to hypertrophic @DISEASE$.	1
<b>Result:</b> Three mutant genes (peptidyl-tyrosine dephosphorylation gene in chromosome 12, @GENE$ gene in chromosome 1 and activation of MAPKK activity gene in chromosome 3) in five cases all had been reported to be related to hypertrophic @DISEASE$.	1
<b>Result:</b> Three mutant genes (peptidyl-tyrosine dephosphorylation gene in chromosome 12, Ras protein signal transduction gene in chromosome 1 and @GENE$ gene in chromosome 3) in five cases all had been reported to be related to hypertrophic @DISEASE$.	1
The reported hypertrophic @DISEASE$ relevant genes @GENE$, MYH6 and MYBP3 had also been found in case 1 and 2.	1
A total of 3128 people participated and were divided into 5 groups: healthy controls, natural clearance, chronic hepatitis B(CHB), liver cirrhosis and @DISEASE$ (@GENE$).	0
Given the lack of specific targeted genes and pathways known to be involved in @DISEASE$ cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3 @GENE$ genes (intracellular sequestering of iron ion, GRM1 and negative regulation of transcription by RNA polymerase II).	0
Given the lack of specific targeted genes and pathways known to be involved in @DISEASE$ cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3 mRNA splicing, via spliceosome genes (@GENE$, GRM1 and negative regulation of transcription by RNA polymerase II).	0
Given the lack of specific targeted genes and pathways known to be involved in @DISEASE$ cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3 mRNA splicing, via spliceosome genes (intracellular sequestering of iron ion, GRM1 and @GENE$).	1
As a result, patients with @GENE$ suffer from severe bacterial infections and impaired wound healing, accompanied by @DISEASE$.	0
But the role of @GENE$ in breast @DISEASE$ remains unclear.	0
Functionally, @GENE$ overexpression accelerated breast @DISEASE$ cell proliferation and migration, while an opposite effect was observed when MFAP5 was knocked down.	0
These findings may provide a better understanding about the mechanism of breast @DISEASE$ and suggest that @GENE$ may be a potential prognostic biomarker and therapeutic target for breast cancer, especially for bone metastasis of breast cancer	0
In the gene expression and network-level information, we revealed significant alterations of molecules related to @GENE$ and metabolic pathways in the hypoxic-conditioned lung @DISEASE$ cells.	0
We also observed that glycogen biosynthetic process and HK2 are downstream of @GENE$ pathway important in hypoxia-conditioned lung @DISEASE$ cell.	0
Furthermore, we used publicly available datasets to validate that the late-stage @DISEASE$ patients showed higher expression HK2 and @GENE$ than early-stage ones.	0
Interestingly, dysregulated expression of KDM4 members is involved in the progression of several @DISEASE$ types and plays a role in the DNA @GENE$ response; however, the gene expression profile and the importance of KDM4 members in CLL are still unknown.	0
In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (@GENE$), positive regulation of gene expression, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, protein-DNA complex disassembly, and @DISEASE$ protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	0
In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), @GENE$, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, protein-DNA complex disassembly, and @DISEASE$ protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	1
In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), positive regulation of gene expression, @GENE$, protein-DNA complex disassembly, and @DISEASE$ protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	0
The sisters reported here display the distinguishing clinical features of @GENE$: pre- and post-natal growth restriction, @DISEASE$, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.	1
The sisters reported here display the distinguishing clinical features of @GENE$: pre- and post-natal growth restriction, microcephaly, @DISEASE$, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.	1
The sisters reported here display the distinguishing clinical features of @GENE$: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural @DISEASE$ with cochlear abnormalities, and facial dysmorphic features.	1
Schwartz-Jampel syndrome type 1 (@GENE$) is a rare @DISEASE$ disease caused by mutations in the gene heparan sulfate proteoglycan 2 (receptor-mediated endocytosis; also known as basement membrane‑specific heparin sulfate).	1
Schwartz-Jampel syndrome type 1 (receptor-mediated endocytosis) is a rare @DISEASE$ disease caused by mutations in the gene heparan sulfate proteoglycan 2 (@GENE$; also known as basement membrane‑specific heparin sulfate).	1
The key clinical features of the patient with @GENE$ included @DISEASE$, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.	1
The key clinical features of the patient with @GENE$ included short stature, joint @DISEASE$, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.	1
The key clinical features of the patient with @GENE$ included short stature, joint contractures, pigeon breast, and @DISEASE$ that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible kyphosis was also noted.	1
The key clinical features of the patient with receptor-mediated endocytosis included short stature, joint contractures, pigeon breast, and @DISEASE$ that led to progressive stiffness of the @GENE$ and limbs; barely discernible kyphosis was also noted.	0
In @GENE$, cells which simultaneously express both sets of markers have the highest @DISEASE$ initiating capacity.	0
Missense mutations in @GENE$ (p.Leu1342Pro) and KCNQ2 (p.Ala306Thr) were found in two patients with no history of @DISEASE$ before the onset of ISs.	1
The PCH1sub-@GENE$s with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global @DISEASE$, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	0
The PCH1sub-@GENE$s with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without @DISEASE$, nystagmus and optic atrophy.	0
The PCH1sub-@GENE$s with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and @DISEASE$.	0
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/@GENE$ or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global @DISEASE$, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	1
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or @GENE$ mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global @DISEASE$, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	1
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or @GENE$ mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and @DISEASE$, with or without microcephaly, nystagmus and optic atrophy.	0
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or @GENE$ mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and @DISEASE$.	1
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a @GENE$ type 1-like clinical presentation but with global @DISEASE$, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	0
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a @GENE$ type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without @DISEASE$, nystagmus and optic atrophy.	0
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a @GENE$ type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and @DISEASE$.	0
Mutations with milder presentation (homozygous p.D132A/@GENE$ or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or @DISEASE$ and die at age between 5 and 18 years.	0
Reported susceptibility SNPs for @DISEASE$ in the Japanese population, @GENE$ (carnitine palmitoyltransferase 1B), TRA@ (T-cell receptor alpha) and P2RY11 (purinergic receptor P2Y, G-protein coupled, 11), were found to explain 0.8% of narcolepsy onset (P<sub>whole genome without HLA-DQB1*06:02</sub>=9.74 × 10<sup>-2</sup>).	0
In addition, splicing variants of @GENE$ mRNA is associated with a variety of cancers and Alzheimer's disease, and mutations of the CIZ1 gene lead to @DISEASE$.	1
A putative @DISEASE$ suppressor @GENE$ mapped on the chromosomal 3p21 region, is frequently lost in human tumors including nasopharyngeal carcinoma (NPC).	0
To explore the underlying mechanism of @DISEASE$ suppression by BLU, its potential to promote apoptosis induced by @GENE$, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.	0
In conclusion, @GENE$ suppressed @DISEASE$ formation by strengthening the antitumor immunity	0
Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (ER to Golgi vesicle-mediated transport), retinoic acid early transcript 1E (@GENE$), and V-positive regulation of protein phosphorylation murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal @DISEASE$.	0
Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (ER to Golgi vesicle-mediated transport), retinoic acid early transcript 1E (natural killer cell mediated cytotoxicity), and V-@GENE$ murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal @DISEASE$.	0
No clinical replication cohort is available, so we validated the role of one of these targets, @GENE$, in a pneumococcal @DISEASE$ mouse model.	0
Here we identify a negative regulation of transcription, DNA-templated of genes that is highly expressed in breast @DISEASE$ bone metastasis and activated by @GENE$.	0
Identifying the central and @DISEASE$ vestibular mechanisms responsible for pathology can aid in management of @GENE$.	0
We therefore examined whether maternal or fetal folate status, together with indices of placental folate transport, were modulated by either maternal pre-pregnancy body @GENE$ index (BMI i.e., overweight: 25 ≤ BMI &lt; 30 or @DISEASE$: BMI ≥ 30 kg/m²) and/or gestational diabetes mellitus (GD).	0
5-20% of @DISEASE$ families have germline mutations in the @GENE$ gene.	1
In a few (non-Swedish) @DISEASE$ families, mutations in other genes have been found, including CDK4, TERT, @GENE$, telomere maintenance and TERF2IP.	1
In a few (non-Swedish) @DISEASE$ families, mutations in other genes have been found, including CDK4, TERT, telomere maintenance via telomerase, @GENE$ and TERF2IP.	1
In some families with multiple cases of uveal and cutaneous @DISEASE$ (including a few Swedish families), mutations in the @GENE$ gene have been found.	0
In genes that regulate cellular pigmentation pathways, including MC1R, @GENE$, positive regulation of interleukin-10 biosynthetic process, TYR, TYRP1 and OCA, there are different common variants that determine complexion negative regulation of transcription by RNA polymerase II, and those variants are also associated with different risks of @DISEASE$.	0
In genes that regulate cellular pigmentation pathways, including MC1R, protein targeting to membrane, @GENE$, TYR, TYRP1 and OCA, there are different common variants that determine complexion negative regulation of transcription by RNA polymerase II, and those variants are also associated with different risks of @DISEASE$.	0
In genes that regulate cellular pigmentation pathways, including MC1R, protein targeting to membrane, positive regulation of interleukin-10 biosynthetic process, TYR, TYRP1 and OCA, there are different common variants that determine complexion @GENE$, and those variants are also associated with different risks of @DISEASE$.	0
Individuals with known mutations in @DISEASE$ suppressor genes such as CDKN2A and @GENE$ require, in addition, follow up for other cancers	0
BACKGROUND Latent transforming growth factor b binding protein 2 (supramolecular fiber organization) is proven to be associated with @GENE$ and involved in the advancement of several kinds of @DISEASE$.	0
Vitamin-B<sub>6</sub>-dependent @DISEASE$ are a heterogenous group of treatable disorders due to mutations in several genes (<i>ALDH7A1, @GENE$, ALPL</i> or <i>ALDH4A1</i>).	1
In neonatal @DISEASE$, defects in <i>ALDH7A1 and @GENE$</i> explain a major fraction of cases.	1
Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in @GENE$ as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, @DISEASE$, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	1
Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in @GENE$ as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, @DISEASE$, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	1
Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in @GENE$ as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, @DISEASE$, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	1
Mutations affecting human @GENE$, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, @DISEASE$ protein glycosylation.	1
Mutations affecting human ER to Golgi vesicle-mediated transport, @GENE$ and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, @DISEASE$ protein glycosylation.	1
Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-@GENE$ cause monogenic forms of inherited, @DISEASE$ protein glycosylation.	1
Mutations affecting human ER to Golgi vesicle-mediated transport, intra-Golgi vesicle-mediated transport and retrograde vesicle-mediated transport, Golgi to ER-ER to Golgi vesicle-mediated transport cause monogenic forms of inherited, @DISEASE$ @GENE$.	1
In our study, @GENE$ mRNA and protein were significantly overexpressed in cervical @DISEASE$ tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.	0
In our study, @GENE$ mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical @DISEASE$ tissues and cell lines.	0
We tried to elucidate the role of three 3p21.3 TSGs: @GENE$, cell adhesion and mismatch repair, in non-small cell lung @DISEASE$ (NSCLC).	1
We tried to elucidate the role of three 3p21.3 TSGs: negative regulation of cell proliferation, @GENE$ and mismatch repair, in non-small cell lung @DISEASE$ (NSCLC).	0
In case of @GENE$ and ITGA9, expression levels were decreased in 71-78 % of @DISEASE$ samples and significantly different between tumor and normal tissues (P = 0.0001).	1
@GENE$ could also be regarded as a diagnostic marker differentiating NSCLC subtypes, as its expression level was significantly lower in @DISEASE$ (P = 0.001).	0
A @GENE$ of ten plasma and serum samples from subjects with multiple sclerosis, @DISEASE$, and without any disease diagnosis were profiled on a peptide array representing the whole proteome, hosting 2.2 million 12-mer peptides with a six amino acid lateral shift.	0
The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: @GENE$ in multiple sclerosis and NRXN1 in @DISEASE$.	0
@GENE$-CDG is an @DISEASE$ disease with a large phenotypic spectrum, and is associated with mutations in the <i>PMM2</i> gene.	1
This case represents the third pedigree with @GENE$ mutations resulting in inherited @DISEASE$.	1
Cognitive impairment or @DISEASE$-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo @GENE$ gene mutations were found in their epilepsy gene protein polyubiquitination sequencing.	0
Cognitive impairment or @DISEASE$-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo homophilic cell adhesion via plasma membrane adhesion molecules gene mutations were found in their epilepsy gene @GENE$ sequencing.	0
Nagashima-type palmoplantar keratosis (NPPK) is an @DISEASE$ form of palmoplantar keratoderma (PPK), which is caused by mutations in the @GENE$ gene.	1
Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of @DISEASE$ (PPK), which is caused by mutations in the @GENE$ gene.	1
Gastrointestinal stromal @DISEASE$ (GISTs) are the most common @GENE$ of mesenchymal tumor of the digestive tract.	0
Gastrointestinal stromal tumors (GISTs) are the most common @GENE$ of mesenchymal @DISEASE$ of the digestive tract.	0
Dysregulated protein polyubiquitinationNAs are involved in various @GENE$s of human disease, including @DISEASE$.	0
Breast tissue and blood from patients with invasive breast @DISEASE$ (n = 38) and benign breast disease (n = 30) were compared with those from healthy individuals (n = 36), matched with the cancer patients by age at diagnosis, ethnicity, body @GENE$ index, menopausal status and familial history of cancer.	0
Tumor-specific methylation changes at positive regulation of cell proliferation @GENE$2 were observed in 59% of @DISEASE$ patients, IGF2 DMR0 in 38%, regulation of cyclin-dependent protein serine/threonine kinase activity DMR in 36%, negative regulation of Wnt signaling pathway ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	0
This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, @DISEASE$ suppressors (TP53, @GENE$, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).	0
This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, @DISEASE$ suppressors (TP53, response to virus, and @GENE$), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, nucleosome disassembly, and EP300).	0
This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, @DISEASE$ suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (@GENE$, histone H2A monoubiquitination, nucleosome disassembly, and EP300).	0
This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, @DISEASE$ suppressors (TP53, response to virus, and starch catabolic process), the JAK/STAT cascade, and epigenetic modifiers (response to estrogen, histone H2A monoubiquitination, @GENE$, and EP300).	0
At present, four loci associated with non‑syndromic auditory @DISEASE$ have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (@GENE$) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	0
At present, four loci associated with non‑syndromic auditory @DISEASE$ have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (@GENE$) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	0
At present, four loci associated with non‑syndromic auditory @DISEASE$ have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (@GENE$) gene]; and AUNX1, linked to chromosome X.	0
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive @DISEASE$‑9 [DFNB9; the otoferlin (@GENE$) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	1
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive @DISEASE$‑9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (@GENE$) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	1
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (@GENE$) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive @DISEASE$; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	0
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (@GENE$) gene], associated with autosomal recessive @DISEASE$; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	0
@GENE$ gene mutations exert a significant role in auditory @DISEASE$.	0
Thus, the present study aimed to investigate molecular changes in the @GENE$ gene in patients with auditory @DISEASE$, and to develop a DNA chip for the molecular diagnosis of auditory neuropathy using mass spectrometry for genotyping.	0
Genetic alterations were investigated in 47 patients with @DISEASE$ and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the @GENE$ gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.	1
Genetic alterations were investigated in 47 patients with hearing loss and clinical diagnosis of auditory @DISEASE$, and the c.35delG mutation in the @GENE$ gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.	0
Several candidate genes for @DISEASE$ and T2D (e.g., @GENE$ and VEGFA) were differentially expressed in discordant twins.	0
The sensory perception of sound locus harbors @GENE$ mutations in which have been reported in a few families with @DISEASE$.	1
Four frameshift mutations in @GENE$ have been described to cause severe or severe-to-profound @DISEASE$ in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.	1
Four frameshift mutations in @GENE$ have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with @DISEASE$ hearing loss in deaf individuals in a Dutch family.	0
The mutations in the @GENE$ gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast @DISEASE$, and colorectal cancer.	0
The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth @DISEASE$ @GENE$ 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	0
The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth @DISEASE$ muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, @GENE$ syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	0
The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy @GENE$ 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked @DISEASE$-1, breast cancer, and colorectal cancer.	0
The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (@GENE$), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked @DISEASE$-1, breast cancer, and colorectal cancer.	1
The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (@GENE$), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked deafness-1, breast @DISEASE$, and colorectal cancer.	0
The mutations in the purine nucleobase metabolic process gene leads to X-linked Charcot-Marie-Tooth neuropathy muscle organ development 5 (purine nucleobase metabolic process), PRS super activity, @GENE$ syndrome, X-linked @DISEASE$-1, breast cancer, and colorectal cancer.	0
Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and @DISEASE$, understanding @GENE$ in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.	0
Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding @GENE$ in depth may lead to uncovering novel mechanisms in the development of @DISEASE$.	0
The results were validated in a second @DISEASE$ @GENE$ (n = 41), in lymphoblastoid cell lines (LCLs) (n = 38), and using the GTEx Portal.	0
The findings indicate the functionality of the PrCa death-predisposing SNPs rs143975731, rs12277366, rs2155225, and rs2155222 as @GENE$ regulators in prostate @DISEASE$.	0
The mechanistic target of rapamycin (@GENE$) is an established therapeutic target in @DISEASE$ (response to hydroperoxide).	0
We identified six patients with metastatic response to hydroperoxide who initially responded to @GENE$ inhibitor therapy and then progressed, and had pre-treatment and post-treatment @DISEASE$ samples available for analysis.	0
Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon @DISEASE$-associated translational initiation-@GENE$ and PTPRK-positive regulation of Wnt signaling pathway chromosome rearrangements in vivo.	0
Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon @DISEASE$-associated translational initiation-positive regulation of Wnt signaling pathway and PTPRK-@GENE$ chromosome rearrangements in vivo.	0
We show that both @GENE$ and Rspo3 fusion events are sufficient to initiate hyperplasia and @DISEASE$ development in vivo, without additional cooperating genetic events.	0
Altogether, our study provides direct evidence that endogenous @GENE$ and positive regulation of Wnt signaling pathway chromosome rearrangements can initiate and maintain @DISEASE$ development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers	0
Altogether, our study provides direct evidence that endogenous positive regulation of Wnt signaling pathway and @GENE$ chromosome rearrangements can initiate and maintain @DISEASE$ development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers	0
In respect to @DISEASE$, circadian regulation of gene expression-oral endoscopic myotomy (@GENE$) which was developed in Japan, has become an alternative to the traditional Heller's myotomy.	0
In regard to BE, endoscopic submucosal dissection (@GENE$) which is well established in Asia, is now becoming more mainstream in the West for the treatment of BE with high grade dysplasia, as well as early esophageal @DISEASE$.	0
Importantly, in regard to early gastric @DISEASE$ and submucosal tumors (SMTs) of the stomach, glutathione derivative biosynthetic process and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and @GENE$forations.	0
Importantly, in regard to early gastric @DISEASE$ and submucosal tumors (SMTs) of the stomach, @GENE$ and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and circadian regulation of gene expressionforations.	0
Importantly, in regard to early gastric cancer and submucosal @DISEASE$ (SMTs) of the stomach, glutathione derivative biosynthetic process and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and @GENE$forations.	0
Importantly, in regard to early gastric cancer and submucosal @DISEASE$ (SMTs) of the stomach, @GENE$ and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and circadian regulation of gene expressionforations.	0
Amyotrophic lateral sclerosis (@GENE$) is a complex @DISEASE$, characterized genetically by a disproportionately large contribution of rare genetic variation.	0
<i>GPX2</i> and <i>TXNRD3</i> showed a higher expression and <i>GPX3</i>, <i>@GENE$</i>, <i>SELENOS</i>, and <i>SEPHS2</i> exhibited a lower expression in the disease tissue from adenomas and both @DISEASE$ groups (<i>p</i>-values from 0.023 to &lt;0.001).	0
The roles of @GENE$ in human breast @DISEASE$ remains elusive.	0
Here we report that @GENE$ acts as an oncogenic protein in human breast @DISEASE$.	0
The mRNA and protein levels of @GENE$ are significantly up-regulated in human breast @DISEASE$ compared with matched adjacent non-cancer tissues.	0
Lentivirus-mediated knockdown of @GENE$ represses in vitro proliferation and colony formation and in vivo growth of breast @DISEASE$ cells, whereas STX3 overexpression promotes the growth of breast cancer cells in vitro and in vivo.	0
We @GENE$ that positive regulation of cell proliferation promotes the proliferation of breast @DISEASE$ cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.	0
We cellular response to interleukin-4 that @GENE$ promotes the proliferation of breast @DISEASE$ cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.	0
We cellular response to interleukin-4 that positive regulation of cell proliferation promotes the proliferation of breast @DISEASE$ cells by increasing the activation of the Akt-@GENE$ signaling, and Akt inhibitor Ipatasertib or positive regulation of keratinocyte proliferation-2206 represses STX3 effects on the growth of breast cancer cells.	0
We cellular response to interleukin-4 that positive regulation of cell proliferation promotes the proliferation of breast @DISEASE$ cells by increasing the activation of the Akt-regulation of cell growth signaling, and Akt inhibitor Ipatasertib or @GENE$-2206 represses STX3 effects on the growth of breast cancer cells.	0
Therefore, @GENE$ promotes the growth of breast @DISEASE$ cells by regulating the negative regulation of protein phosphorylation-phosphorylation-Akt-mTOR signaling	0
Therefore, positive regulation of cell proliferation promotes the growth of breast @DISEASE$ cells by regulating the @GENE$-phosphorylation-Akt-mTOR signaling	1
Therefore, positive regulation of cell proliferation promotes the growth of breast @DISEASE$ cells by regulating the negative regulation of protein phosphorylation-@GENE$-Akt-mTOR signaling	1
No differences were found in age, @GENE$, mean arterial pressure, heart rate, HDL, cirrhosis etiology, degree of alcohol consumption, @DISEASE$, variceal bleeding history, or hepatocellular carcinoma between patients with or without adrenal insufficiency.	0
However, HoFH is clinically @DISEASE$, reflecting residual low-density lipoprotein receptor (@GENE$) activity.	0
Here, we show that TILs from @GENE$ deleted in protocadherin-18 had enhanced anti@DISEASE$ activity and that coblockade of PD-1 and protocadherin-18 in wild-type mice significantly enhanced TIL effector phase function.	0
We report on an 8-year-old girl born to consanguineous Iraqi parents presenting with slowly progressive encephalomyopathy, severe @DISEASE$, significant delays in verbal and communicative skills and bilateral retinal cherry @GENE$ spots on fundoscopy.	0
We report on an 8-year-old girl born to consanguineous Iraqi parents presenting with slowly progressive encephalomyopathy, severe failure to thrive, significant delays in verbal and communicative skills and @DISEASE$ retinal cherry @GENE$ spots on fundoscopy.	0
The @DISEASE$ retinal cherry protein phosphorylation spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with @GENE$ mutations.	0
The bilateral retinal cherry protein phosphorylation spots and @DISEASE$ observed in our patient are unique features, which have not been described, in previously reported patients with @GENE$ mutations.	0
We performed a clinical, neurophysiological (in vivo electroencephalography-auditory-evoked related potentials) and genetic (whole-exome sequencing) follow-up analysis of two families with known deleterious @GENE$ gene mutations (either truncating or overexpressing) present in individuals with ASD and/or with @DISEASE$ (ID).	1
Recently, defects of @GENE$, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including @DISEASE$ and autism.	1
Recently, defects of @GENE$, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and @DISEASE$.	1
In contrast, a single nucleotide variant identified in patients with @DISEASE$ and located at the C-terminus of @GENE$ affected dendritic arborization and dendritic length but had no effect on dendritic spine morphology.	1
Deficits in @GENE$NA biogenesis have been linked to neurological deficits in humans, and widespread changes in miRNA levels occur in @DISEASE$, traumatic brain injury, and in response to less dramatic brain insults in rodent models.	0
Recently, microdeletions encompassing <i>MIR137HG</i>, the host gene which encodes the @GENE$NA miR-137, have been linked to @DISEASE$ and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.	0
Recently, microdeletions encompassing <i>MIR137HG</i>, the host gene which encodes the @GENE$NA miR-137, have been linked to autism and @DISEASE$, and genome wide association studies have linked this locus to schizophrenia.	0
Molecular biomarkers in blood are needed to @GENE$ the early diagnosis and clinical assessment of @DISEASE$ (GBM).	0
The plasma concentrations of @GENE$, positive regulation of gene expression, and C9 showed significant positive correlations with @DISEASE$ size (R2 = 0.534, 0.495, and 0.452, respectively)	0
The plasma concentrations of neutrophil degranulation, @GENE$, and C9 showed significant positive correlations with @DISEASE$ size (R2 = 0.534, 0.495, and 0.452, respectively)	0
Hepatocellular carcinoma (@GENE$) is an aggressive and deadly @DISEASE$.	0
We compared the early transcriptome profile between DKD-resistant C57BL/6J and DKD-susceptible DBA/2J (D2) glomeruli and demonstrated a significant downregulation of essential mitochondrial genes in glomeruli from diabetic D2 @GENE$, but not in C57BL/6J, with comparable @DISEASE$.	0
Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by @GENE$-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, @DISEASE$, and glomerulosclerosis	0
The deleted in colorectal @DISEASE$ (DCC) gene encodes the netrin-1 (@GENE$) receptor DCC, a transmembrane protein required for the guidance of commissural axons.	0
Germline @GENE$ mutations disrupt the development of predominantly commissural tracts in the @DISEASE$ nervous system (CNS) and cause a spectrum of neurological disorders.	0
It is a genetic disorder caused by a mutation in the dysferlin gene (@GENE$) with an autosomal recessive @DISEASE$.	0
Our results therefore confirm the @GENE$R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant @DISEASE$, congenital onset, and disease pathology	0
Besides, previous evidence suggested that @GENE$ expression was changed in @DISEASE$ patients.	0
Pathogenic mutations have been identified in the nervous system development (@GENE$) and visual perception (visual perception) genes and are linked to Mohr-Tranebjærg syndrome and dilated cardiomyopathy syndrome (with and without @DISEASE$), respectively.	0
Pathogenic mutations have been identified in the nervous system development (nervous system development) and @GENE$ (visual perception) genes and are linked to Mohr-Tranebjærg syndrome and dilated cardiomyopathy syndrome (with and without @DISEASE$), respectively.	1
Pathogenic mutations have been identified in the nervous system development (nervous system development) and visual perception (@GENE$) genes and are linked to Mohr-Tranebjærg syndrome and dilated cardiomyopathy syndrome (with and without @DISEASE$), respectively.	1
PDT is a promising new modality in the treatment of cancers, which employs the interaction between a @DISEASE$-localizing photosensitizer and light of an appropriate wavelength to bring about @GENE$-induced cell death.	0
In vivo multispectral fluorescent imaging, the EGFP-@GENE$ conjugated nanoparticles showed significantly higher accumulation in @DISEASE$ tissues than non-conjugated ones.	0
Tumor tissue slides further presented that EGFP-@GENE$ conjugated nanoparticles showed significantly higher accumulation in @DISEASE$ vasculature than non-conjugated ones.	0
These promising results indicated that PDT enhanced EGFP-@GENE$modified PEG-PLGA nanoparticle accumulation in @DISEASE$ vaculature.	0
A combination of both EGFP-@GENE$ modification and PDT provided a positive feed-back target effect to @DISEASE$ vessels and might have a great potential for tumor therapy	0
Here we show that a series of transcription factors, including C/EBPβ, @GENE$, and negative regulation of transcription by RNA polymerase II, could act as potential modulators of histone methylation in @DISEASE$ cells.	0
Of note, C/EBPβ, an independent prognostic f@GENE$or for patients with ovarian @DISEASE$, mediates an important mechanism through which epigenetic enzyme modifies groups of functionally related genes in a context-dependent manner.	0
Here, we report two novel @GENE$ (the gene for guanylate cyclase activating protein 1) mutations identified in unrelated Spanish families affected by autosomal dominant @DISEASE$ (adRD) with cone and rod involvement.	1
The expression of @GENE$ in non‑small cell lung @DISEASE$ (NSCLC) remains unclear.	0
The protein levels of @GENE$ were decreased in the @DISEASE$ tissues of NSCLC patients and lung cancer cell lines.	0
Adolescent idiopathic @DISEASE$ (@GENE$) and pectus excavatum (PE) are common pediatric musculoskeletal disorders.	0
Silencing expression of @GENE$, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated in the human oral @DISEASE$ cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.	1
Our study identified a unique gene signature - @GENE$, transforming growth factor beta receptor signaling pathway and regulation of transcription, DNA-templated - which may be involved in oral @DISEASE$ lymph node metastasis	1
Our study identified a unique gene signature - G1/S transition of mitotic cell cycle, transforming growth factor beta receptor signaling pathway and @GENE$ - which may be involved in oral @DISEASE$ lymph node metastasis	0
Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, @DISEASE$, and insulin tolerance in negative regulation of signal transduction<sup>-/-</sup> @GENE$, implicating the microbiota.	0
HFD-fed negative regulation of signal transduction<sup>-/-</sup> @GENE$ display dysbiosis marked by increased @DISEASE$-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis.	0
These findings reveal that @GENE$ reduces HFD-induced @DISEASE$ by maintaining beneficial microbiota	0
The presence of @GENE$ loss-of-function variants in negative regulation of transcription by RNA polymerase II predicted isolated diabetes, isolated deafness, or isolated congenital @DISEASE$ without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	0
The presence of positive regulation of glucose transmembrane transport loss-of-function variants in @GENE$ predicted isolated diabetes, isolated @DISEASE$, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	1
The presence of positive regulation of glucose transmembrane transport loss-of-function variants in @GENE$ predicted isolated diabetes, isolated deafness, or isolated congenital @DISEASE$ without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	1
A major susceptibility locus, HIVAN1, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and @GENE$/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing HIVAN1 from CAST into TgFVB resulted in accelerated development of @DISEASE$.	0
Of these, craniofacial suture morphogenesis, @GENE$, and Setd7 have been implicated in the pathogenesis of @DISEASE$.	0
The sterile alpha motif (SAM) domain of the protein @GENE$, a protein-protein interaction domain, is responsible for autosomal dominant polycystic @DISEASE$.	1
Oral-facial-digital syndromes (OFDS) gather rare genetic disorders characterised by facial, oral and digital abnormalities associated with a wide range of additional features (polycystic @DISEASE$, cerebral malformations and several others) to delineate a growing list of OFDS sub@GENE$s.	0
Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing @GENE$ (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung @DISEASE$ generated in epidermis development using a combination of a mutagen followed by chronic pulmonary inflammation.	0
Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing positive regulation of cell proliferation (to amplify immune responses) successfully blocks the outgrowth of an implantable @DISEASE$ (Lewis lung carcinoma; LLC) and lung tumors generated in @GENE$ using a combination of a mutagen followed by chronic pulmonary inflammation.	0
Examination of @DISEASE$-infiltrating immune cells from @GENE$ vaccinated with the positive regulation of cell proliferation-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	0
Examination of tumor-infiltrating immune cells from @GENE$ vaccinated with the positive regulation of cell proliferation-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the @DISEASE$.	0
Examination of tumor-infiltrating immune cells from epidermis development vaccinated with the @GENE$-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the @DISEASE$.	0
Deleted in lung and esophageal cancer 1 (@GENE$) is a @DISEASE$ suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.	1
Here we @GENE$, launching from Drosophila models of amyotrophic lateral sclerosis and @DISEASE$, that RNA splicing impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler covalent chromatin modification to chromatin.	0
Here we cellular response to interleukin-4, launching from Drosophila models of amyotrophic lateral sclerosis and @DISEASE$, that @GENE$ impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler covalent chromatin modification to chromatin.	1
For instance, mutations in both @GENE$ and visual perception cause @DISEASE$ in humans.	1
In the case-control analysis, the rs9607195 A&gt;G on intergenic area 250 kb away from the ISX gene and the rs12738007 A&gt;G on the intron of the @GENE$ gene were the most strongly associated SNPs with the risk of @DISEASE$ (P = 6.2 × 10(-8) , OR = 0.50 and P = 3.7 × 10(-7) , OR = 2.39, respectively).	0
In subsequent fine-mapping analysis, 6 SNPs of @GENE$ were genotyped with 310 @DISEASE$ patients and 604 control subjects.	0
Furthermore, we identified some potential lung @DISEASE$ driver genes, such as TBX2, MCM4, @GENE$, BIRC5, and anaphase-promoting complex-dependent catabolic process, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	0
Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including @GENE$ and inactivation of @DISEASE$ suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.	1
However, siRNA-based therapeutics @GENE$ important challenges, including rapid serum degradation, poor @DISEASE$ cell uptake and cellular uptake, leading to off-target effects.	1
Therefore, there is a @GENE$ need for the development of safe and effective nanoparticles for better tumor-specific delivery of anti-@DISEASE$ therapeutics.	0
Therefore, there is a @GENE$ need for the development of safe and effective nanoparticles for better @DISEASE$-specific delivery of anti-cancer therapeutics.	0
We show that @DISEASE$ cells specifically induce @GENE$ activity in mesenchymal stromal cells (MSCs) required for the transcription of the complement factor C1q.	0
@GENE$ activation in the microenvironment is a pre-requisite for the activation of canonical Wnt signalling in @DISEASE$ cells	0
Posterior @DISEASE$ (PM) is a relatively infrequent @GENE$ of microphthalmos where posterior segment is predominantly affected with normal anterior segment measurements.	0
We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in non⁻small-cell lung @DISEASE$ cells, induced by both interferon (IFN)-γ and epidermal growth factor (@GENE$).	0
Furthermore, 0.3% GTE in drinking water reduced the average number of @DISEASE$ per mouse from 4.1 ± 0.5 to 2.6 ± 0.4 and the percentage of PD-L1 positive cells from 9.6% to 2.9%, a decrease of 70%, in lung tumors of A/J @GENE$ given a single intraperitoneal injection of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).	0
We identified 22 genes including @GENE$, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and phosphorylation with non-silent mutations in the @DISEASE$ Census Genes.	1
We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, @GENE$, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and phosphorylation with non-silent mutations in the @DISEASE$ Census Genes.	1
We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, @GENE$, ARID2, and phosphorylation with non-silent mutations in the @DISEASE$ Census Genes.	1
We identified 22 genes including cellular response to DNA damage stimulus, KRAS, TP53, adenylate cyclase-activating G protein-coupled receptor signaling pathway, NRAS, transforming growth factor beta receptor signaling pathway, ARID2, and @GENE$ with non-silent mutations in the @DISEASE$ Census Genes.	1
Five HGCAs harbored either mono-allelic (four HGCAs) or bi-allelic (one HGCA) @GENE$ mutation or 18q loss that had been known as early @DISEASE$-specific changes.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and @GENE$ mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, @GENE$, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, @GENE$, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, @GENE$, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, @GENE$, EP300, nucleosome disassembly, regulation of cell adhesion and cellular response to mechanical stimulus mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, @GENE$ and cellular response to mechanical stimulus mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (APC, positive regulation of protein phosphorylation, NRAS and adenylate cyclase-activating G protein-coupled receptor signaling pathway mutations), but there are newly identified SMAD4, regulation of cell growth, G1/S transition of mitotic cell cycle, GNAQ, protein phosphorylation, negative regulation of transcription by RNA polymerase II, EP300, nucleosome disassembly, regulation of cell adhesion and @GENE$ mutations in this study.	0
PITPNM3, known as a human homologue of the Drosophila @DISEASE$ B (@GENE$), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (ERG) response to light.	0
Intravascular lithotripsy (@GENE$) with the Shockwave™ system has recently been evaluated as a familiar angioplasty-balloon-based but effective technique for the management of @DISEASE$.	0
The mean pulmonary arterial pressure (mPAP), right @DISEASE$ index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor α (TNFα), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first @GENE$ injection.	0
The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum @DISEASE$ necrosis factor α (TNFα), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first @GENE$ injection.	0
We describe an infant with the pheno@GENE$ of a congenital muscular dystrophy, with borderline @DISEASE$, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.	0
We describe an infant with the pheno@GENE$ of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, @DISEASE$, severe motor delay, and elevated creatine kinase.	0
We describe an infant with the pheno@GENE$ of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe @DISEASE$, and elevated creatine kinase.	0
Neurofibromatosis muscle organ development 2 (NF2) is a @DISEASE$-forming disease of the nervous system caused by deletion or by loss-of-function mutations in NF2, encoding the tumor suppressing protein neurofibromin 2 (also known as schwannomin or @GENE$).	1
The correlation of the @DISEASE$-suppressive function and conformation (open or closed) of neurofibromin 2 has been subject to much speculation, often based on extrapolation from other @GENE$ proteins, and controversy.	0
These data suggest @GENE$-related PCH as a potentially treatable early-onset @DISEASE$.	0
Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, @GENE$, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and @DISEASE$ (e.g. negative regulation of tumor necrosis factor production, response to ischemia).	0
Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic pheno@GENE$s (e.g. INPP5E, endocytic recycling, ERAP2, post-translational protein modification), and @DISEASE$ (e.g. negative regulation of tumor necrosis factor production, response to ischemia).	0
Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RNA processing, UFSP1), gluco-metabolic phenomuscle organ developments (e.g. INPP5E, endocytic recycling, ERAP2, @GENE$), and @DISEASE$ (e.g. negative regulation of tumor necrosis factor production, response to ischemia).	0
Single-gene variant analysis showed significant associations of the TT genotype of @GENE$ and the rare GG genotype of transcription-coupled nucleotide-excision repair with bladder @DISEASE$ susceptibility (OR = 1.34, 95% CI 1.22-1.40, P &lt; 0.0001).	0
Single-gene variant analysis showed significant associations of the TT genotype of lipid hydroxylation and the rare GG genotype of @GENE$ with bladder @DISEASE$ susceptibility (OR = 1.34, 95% CI 1.22-1.40, P &lt; 0.0001).	1
Although Sur8 has been shown to be a scaffold protein of the Ras-@GENE$ pathway, its interaction with other signaling pathways and its involvement in @DISEASE$ malignancy has not been reported.	0
At surgery, the @GENE$ was located within the epineurium, could be bluntly dissected from the nerve fascicles, and was suspected to be a @DISEASE$.	0
Fluorescence in situ hybridization, with a break-apart probe strategy, demonstrated @GENE$ rearrangement, consistent in this morphological context with the low-grade fibromyxoid @DISEASE$-associated FUS-CREB3L2 or FUS-CREB3L1 fusions.	0
We conducted a large-scale genome-wide association study of @DISEASE$ in 36,649 @GENE$ in the multiethnic Kaiser Permanente Northern California Genetic Epidemiology Research in Adult Health and Aging cohort.	0
Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (@GENE$, PRPF8, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited @DISEASE$.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (@GENE$) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (@GENE$) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (@GENE$)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and @GENE$ interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (@GENE$) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (@GENE$) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, @GENE$-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (@GENE$ or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or @GENE$) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (@GENE$), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (@GENE$), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), @GENE$ proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (@GENE$)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (@GENE$) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and @GENE$ interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (@GENE$) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, @GENE$-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (@GENE$ or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, @GENE$ proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (@GENE$), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (@GENE$), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, @GENE$ proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (@GENE$), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), Ras protein signal transduction proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (positive regulation of oxidoreductase activity) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (protein glycosylation)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (actin filament bundle assembly) syndrome, due to Ras and mRNA export from nucleus interactor 2 (small GTPase mediated signal transduction) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (carbohydrate metabolic process) gene; Gerodermia osteodysplastica due to mutations in the golgin, peptidyl-cysteine methylation-interacting (hair follicle morphogenesis or hair follicle morphogenesis) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (regulation of neurotransmitter receptor localization to postsynaptic specialization membrane), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (G protein-coupled receptor signaling pathway), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), @GENE$ proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (activation of MAPKK activity)], which regulate the Ras-MAPK cascade.	1
According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 @DISEASE$ 7 (SPG7) variant is associated with CAD as it bypasses the regulation of tyrosine phosphorylation of @GENE$ and enhances the processing and maturation of SPG7 protein.	0
In this study, we @GENE$ that distinct expression patterns of those @DISEASE$ genes in the cochlea of a non-human primate, the common marmoset (Callithrix jacchus).	0
The @DISEASE$ genes in utero embryonic development, CRYM, @GENE$, DFNA5, and ossification were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	1
The @DISEASE$ genes in utero embryonic development, CRYM, epidermis development, DFNA5, and @GENE$ were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	1
We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic TDP-43 protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from @DISEASE$ FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or @GENE$ repeat expansion mutations (FTLD-TDP-C9+).	0
Circulating soluble @GENE$ has been found to be associated with various @DISEASE$, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.	0
Circulating soluble @GENE$ has been found to be associated with various cardiovascular diseases, such as @DISEASE$, heart failure, myocardial infarction, preeclampsia, and stroke.	0
Circulating soluble @GENE$ has been found to be associated with various cardiovascular diseases, such as hypertension, @DISEASE$, myocardial infarction, preeclampsia, and stroke.	0
Circulating soluble @GENE$ has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, @DISEASE$, preeclampsia, and stroke.	0
Through gene @GENE$ enrichment analysis and bi-clustering, we also found that most of the differential expressed lncRNAs were closely associated with @DISEASE$ functions (e.g. mitochondrion organization, P=3.21×10<sup>-17</sup>; mitochondrial ATP synthesis coupled electron transport, P=1.73×10<sup>-19</sup> and mitochondrial membrane organization, P=4.04×10<sup>-8</sup>).	0
Absence @DISEASE$ (AE) is a common @GENE$ of genetic generalized epilepsy (GGE), particularly in children.	0
By creating new Pcnxl2 frameshift alleles using TALEN mutagenesis, we show that Pcnxl2 deficiency is responsible for mitigating the @DISEASE$ pheno@GENE$ - making Pcnxl2 the first known modifier gene for absence seizures in any species.	0
Together these new findings expand our knowledge of how natural variation modulates @DISEASE$, and highlights the feasibility of characterizing and validating modifiers in mouse strains and substrains in the post-genome sequence @GENE$.	0
The @GENE$ gene is mutated in a form of @DISEASE$ myopathy and amyotrophic lateral sclerosis (signal transduction).	0
The @GENE$ gene is mutated in a form of distal @DISEASE$ and amyotrophic lateral sclerosis (signal transduction).	0
The activation of innate immune response gene is mutated in a form of distal @DISEASE$ and amyotrophic lateral sclerosis (@GENE$).	0
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, @GENE$, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, @GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, @GENE$, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, @GENE$, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, @GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, @GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, @GENE$, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, @GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, @GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, @GENE$, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, VHL, NF1, mitochondrial electron transport, succinate to ubiquinone, succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, and MAX.	1
Using whole-exome sequencing (WES), we identified four de novo variants in @GENE$ in a total of seven unrelated individuals with @DISEASE$ (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.	1
Using whole-exome sequencing (WES), we identified four de novo variants in @GENE$ in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including @DISEASE$ spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.	0
Using whole-exome sequencing (WES), we identified four de novo variants in @GENE$ in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, @DISEASE$, hypotonia, seizures, and dysmorphic features.	1
Using whole-exome sequencing (WES), we identified four de novo variants in @GENE$ in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, @DISEASE$, and dysmorphic features.	1
Our current study found that phosphoserine aminotransferase 1 (@GENE$), an enzyme catalyzing serine biosynthesis, was significantly up-regulated in non-small cell lung @DISEASE$ (NSCLC) and was involved in the regulation of E2F activity.	0
Loss- and gain-of-function experiments demonstrated that @GENE$ promoted cell cycle progression, cell proliferation and @DISEASE$igenesis.	0
Correlation analysis showed that @GENE$ expression positively correlated with the levels of phosphorylated GSK-3β, cyclin D1 and phosphorylated Rb in NSCLC primary @DISEASE$s.	0
A genetically determined generalized hyperexcitability had been predicted in primarily generalized @DISEASE$, but surprisingly the first epilepsy gene discovered, response to hypoxia, was in a focal (frontal @GENE$)-onset syndrome.	0
A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first @DISEASE$ gene discovered, @GENE$, was in a focal (frontal negative regulation of protein kinase activity)-onset syndrome.	1
A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first @DISEASE$ gene discovered, response to hypoxia, was in a focal (frontal @GENE$)-onset syndrome.	0
The reason why @GENE$ causes focal-onset @DISEASE$ is unknown.	1
Recently, the second focal (temporal @GENE$)-onset @DISEASE$ gene, axon guidance (unknown function), was discovered.	0
Recently, the second focal (temporal negative regulation of protein kinase activity)-onset @DISEASE$ gene, @GENE$ (unknown function), was discovered.	1
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, @GENE$, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).	1
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, @GENE$, potassium ion transmembrane transport, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).	1
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, @GENE$, negative regulation of gene expression, homophilic cell adhesion via plasma membrane adhesion molecules, SCN1A, or SCN2A).	1
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, inhibitory synapse assembly, response to ethanol, potassium ion transmembrane transport, negative regulation of gene expression, @GENE$, SCN1A, or SCN2A).	1
However, unconditioned NRGS @GENE$ developed less clinically relevant disease, with CDXs forming solid @DISEASE$ throughout the body, whereas unconditioned NRG mice were incapable of efficiently supporting PDX or human hematopoietic stem cell engraftment.	0
Importantly, the role of @GENE$ overexpression in adult tissues in promoting the progression of multiple @DISEASE$ types through their ability to modulate the transcription of developmental genes ectopically is explored.	1
@GENE$ overexpression is known to be pro@DISEASE$igenic and affects the regulation of gene networks associated with &quot;cancer hallmarks&quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.	1
As a transcriptional regulator of broad developmental processes capable of promoting malignant growth in adult tissues, therapeutically targeting the @GENE$ corepressor has the potential to be an effective method for the treatment of diverse @DISEASE$ types.	1
Fanconi anemia (@GENE$) is a rare disease characterized by bone marrow failure, developmental abnormalities, and increased @DISEASE$ risk that is caused by defective repair of DNA interstrand crosslinks (ICLs).	0
Progressive @DISEASE$ (@GENE$) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.	0
Progressive retinal atrophy (@GENE$) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete @DISEASE$.	0
Mutations in the @GENE$ gene cause @DISEASE$ mental retardation syndrome-3.	1
The genetic diagnosis is difficult owing to the large genetic @DISEASE$ of the 6p21.3 region, which contains the @GENE$ gene, especially with respect to the use of new-generation techniques of sequencing.	0
This study aimed to elucidate the potential functional mechanism of miR-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (@GENE$) of pancreatic @DISEASE$ cells.	1
By real-time PCR and analysis of GEO database, we determined the up-regulated expression of @GENE$-135b-5p in pancreatic @DISEASE$ tissues and cell lines.	0
Functionally, Transwell assays indicated that @GENE$-135b-5p was a promoter for migration and invasion of pancreatic @DISEASE$ cells.	0
Additionally, immunohistochemistry staining and Western blot showed that highly expressed @GENE$-135b-5p accelerated EMT process of pancreatic @DISEASE$ cells.	0
Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of @GENE$-135b-5p in pancreatic @DISEASE$ cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and cytokine production.	0
Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of @GENE$-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the @DISEASE$ cells migration, invasion and cytokine production.	0
Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of protein polyubiquitination-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the @DISEASE$ cells migration, invasion and @GENE$.	1
In conclusion, protein polyubiquitination-135b-5p, maybe a novel therapeutic target for pancreatic @DISEASE$, promoted migration, invasion and @GENE$ of pancreatic cancer cells by targeting NR3C2	1
Similar to the human phenotype, <i>@GENE$</i>-deficient epidermis development displayed reduced cholesterol absorption and were resistant to diet-induced @DISEASE$.	0
Similar to the human phenotype, <i>negative regulation of actin filament depolymerization</i>-deficient @GENE$ displayed reduced cholesterol absorption and were resistant to diet-induced @DISEASE$.	0
Dominantly inherited digitotalar dysmorphism (@GENE$), which is characterised by flexion @DISEASE$ of digits and 'rocker-bottom' feet due to a vertical talus, was first described in a South African family of European stock in 1972.	0
Dominantly inherited digitotalar dysmorphism (@GENE$), which is characterised by flexion contractures of digits and 'rocker-bottom' feet due to a @DISEASE$, was first described in a South African family of European stock in 1972.	0
The human Shwachman-Diamond syndrome (@GENE$) is an @DISEASE$ disease caused by mutations in a highly conserved ribosome assembly factor mitotic spindle organization.	1
The human Shwachman-Diamond syndrome (mitotic spindle organization) is an @DISEASE$ disease caused by mutations in a highly conserved ribosome assembly factor @GENE$.	1
Besides dramatic metabolic alterations, cancer cells display severe changes in the @GENE$ phenotype with likely consequences in @DISEASE$ progression and treatment response.	0
In this study, we use a comprehensive systems-driven approach to investigate the effect of @GENE$ disruption on metabolic pathways and its negative regulation of transcription by RNA polymerase II on drug response in a cellular model of colon @DISEASE$ progression.	0
In this study, we use a comprehensive systems-driven approach to investigate the effect of protein acetylation disruption on metabolic pathways and its @GENE$ on drug response in a cellular model of colon @DISEASE$ progression.	0
A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24 h-oscillating transcripts and pointed to a @GENE$-driven metabolic reprogramming in @DISEASE$igenesis.	0
We further identified a reciprocal connection of @GENE$ to the protein acetylation in the primary @DISEASE$, which is lost in the metastatic cells.	0
Joubert syndrome exhibits genetic @DISEASE$, with mutations identified in more than 30 genes, including @GENE$, a gene encoding inositol polyphosphate 5-phosphatase E, which is important in the development and stability of the primary cilium.	0
A pathogenic R474Q mutation of axon guidance, which does not exceptionally affect either the secretion or the @GENE$ binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial @DISEASE$.	1
Haplotype GAT for @GENE$ markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high @DISEASE$.	1
The mechanism of @GENE$ in the development of high @DISEASE$ need to be further investigated.	1
Aminoacyl-tRNA synthetase complex (@GENE$)-interacting multifunctional protein 1 (negative regulation of endothelial cell proliferation) is a cytokine that is known to amplify the actions of @DISEASE$ necrosis factor-α and to be involved in microglial activation and neuronal death.	0
Aminoacyl-tRNA synthetase complex (negative regulation of cell proliferation)-interacting multifunctional protein 1 (@GENE$) is a cytokine that is known to amplify the actions of @DISEASE$ necrosis factor-α and to be involved in microglial activation and neuronal death.	0
Additional predictors included age, as well as gender and the interaction of <i>MTHFR</i> 677 with overweight status (measured by body @GENE$ index) in predicting CRC, with the @DISEASE$ group having more negative regulation of phosphatase activity and overweight cases.	0
Additional predictors included age, as well as gender and the interaction of <i>MTHFR</i> 677 with overweight status (measured by body cell adhesion mediated by integrin index) in predicting CRC, with the @DISEASE$ group having more @GENE$ and overweight cases.	0
The molecular chaperone @GENE$ is overexpressed in prostate @DISEASE$ (mitochondrial transport) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.	0
The molecular chaperone positive regulation of protein phosphorylation is overexpressed in prostate @DISEASE$ (@GENE$) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.	0
This review highlights recent advances in understanding how the @GENE$-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin @DISEASE$ including squamous cell carcinoma and malignant melanoma.	0
This review highlights recent advances in understanding how the @GENE$-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including @DISEASE$ and malignant melanoma.	0
This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-@GENE$ axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin @DISEASE$ including squamous cell carcinoma and malignant melanoma.	0
This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-@GENE$ axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and @DISEASE$.	0
Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) @DISEASE$ and insulin resistance, where @GENE$ inhibits positive regulation of cell-matrix adhesion cell differentiation in vitro and multicellular organism development may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	0
Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) @DISEASE$ and insulin resistance, where positive regulation of cell differentiation inhibits @GENE$ cell differentiation in vitro and multicellular organism development may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	0
Key steps where regulation of cyclin-dependent protein serine/threonine kinase activity may play a pathogenic metabolic role include: (i) @DISEASE$ and insulin resistance, where positive regulation of cell differentiation inhibits positive regulation of cell-matrix adhesion cell differentiation in vitro and @GENE$ may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	0
Taken together, we show here that mutations leading either to @GENE$ haploinsufficiency or to a truncated BCL11B protein clinically cause a non-syndromic neuro@DISEASE$.	1
TCIRG1 knockdown suppressed @DISEASE$ cell growth and proliferation in phosphatidylinositol phosphorylation cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (@GENE$) regulatory proteins E-integrin-mediated signaling pathway, N-cadherin, Fibronectin, Snail and negative regulation of transcription by RNA polymerase II; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	1
TCIRG1 knockdown suppressed @DISEASE$ cell growth and proliferation in phosphatidylinositol phosphorylation cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (cytokine production) regulatory proteins E-@GENE$, N-cadherin, Fibronectin, Snail and negative regulation of transcription by RNA polymerase II; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	0
For individual RP patients, our study may help to predict time-courses for @GENE$-related @DISEASE$ and thereby facilitate the definition of a window-of-opportunity for clinical interventions.	0
Some aspects of the disease are now well known, such as @DISEASE$ and craniosynostosis, related to the natural course of the disease, which persisted despite the @GENE$.	0
Some aspects of the disease are now well known, such as nephrocalcinosis and @DISEASE$, related to the natural course of the disease, which persisted despite the @GENE$.	0
@GENE$ is known to be responsible for autosomal dominant @DISEASE$ and autosomal recessive acromesomelic chondrodysplasia.	1
@GENE$ is known to be responsible for autosomal dominant brachydactyly and @DISEASE$ acromesomelic chondrodysplasia.	1
This study establishes @GENE$ variants as a cause of early-onset @DISEASE$ and uses biospecimens and cell lines, yeast, and zebrafish models to elucidate the fundamental role of PYROXD1 in skeletal muscle.	0
Mutations of @GENE$ result in the inherited disorders Charcot-Marie-Tooth disease muscle organ development 4J, Yunis-Varón syndrome, and polymicrogyria with @DISEASE$.	1
Raptor-cKO @GENE$ developed @DISEASE$ considerably more slowly than WT littermates.	0
Conversely, @GENE$ loss led to the early-onset death of cochlear hair cells and consequently accelerated @DISEASE$.	0
@GENE$ deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)@DISEASE$ and late-onset progressive external ophthalmoplegia	1
@GENE$ deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset @DISEASE$ external ophthalmoplegia	0
Planar cell polarity (@GENE$) signaling has been shown in different studies to either promote or inhibit the malignancy of breast @DISEASE$.	0
We thus provide evidence that biological_process signaling can @GENE$ in a context dependent manner to promote breast @DISEASE$ progression.	0
The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A&gt;G mutation in MT-RNR1 gene associated to the m.8527A&gt;G (p.M&gt;V) and the m.8392C&gt;T (p.136P&gt;S) variations in the mitochondrial @GENE$ gene in patient1 and his family members with variable phenotype including @DISEASE$.	0
Herewith we provide a biological and pathophysiological characterization of the immunological layer of @DISEASE$ous (@GENE$) versus benign (BPH) disease, derived from antibody profiling on protein microarrays	0
Prostate @DISEASE$ (@GENE$) is one of the most common types of cancer in the urinary system in men.	0
These @DISEASE$ often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for @GENE$ fusions in plasma cell neoplasms.	1
These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for @GENE$ fusions in plasma cell @DISEASE$.	1
Biallelic loss-of-function mutations in @GENE$ and TREM2 cause a rare disease that resembles early-onset @DISEASE$ with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	0
Biallelic loss-of-function mutations in @GENE$ and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing @DISEASE$ (PLOSL).	1
The toxic subcellular accumulation of lipids predisposes several human metabolic syndromes, including @DISEASE$, @GENE$ 2 diabetes, and some forms of neurodegeneration.	0
Bcl2-associated athanogene 3 (@GENE$) mutations have been reported to cause the myofibrillar @DISEASE$ (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.	1
We aimed to @GENE$ the genetic cause of Korean patients with sensory motor @DISEASE$, myopathy and rigid spine.	0
We aimed to @GENE$ the genetic cause of Korean patients with sensory motor polyneuropathy, @DISEASE$ and rigid spine.	0
We found @GENE$ mutation in one patient with neuropathy, @DISEASE$ and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.	1
Mutations in eight of them (@GENE$, PDSS2, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a @DISEASE$ group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	0
Mutations in eight of them (ubiquinone biosynthetic process, PDSS2, @GENE$, ubiquinone biosynthetic process, ubiquinone biosynthetic process, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a @DISEASE$ group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	0
Mutations in eight of them (ubiquinone biosynthetic process, PDSS2, ubiquinone biosynthetic process, ubiquinone biosynthetic process, @GENE$, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a @DISEASE$ group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	0
We have previously identified a role for the secreted serine protease @GENE$ in ocular size determination and PRSS56 variants have been implicated in the etiology of both @DISEASE$ and myopia, highlighting its importance in refrcoenzyme A biosynthetic processive development.	1
We have previously identified a role for the secreted serine protease camera-type eye development in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and @DISEASE$, highlighting its importance in refr@GENE$ive development.	0
Here, we use a combination of genetic mouse models to demonstrate that @GENE$ mutations leading to reduced ocular size and @DISEASE$ coenzyme A biosynthetic process via a loss of function mechanism.	1
Here, we use a combination of genetic mouse models to demonstrate that camera-type eye development mutations leading to reduced ocular size and @DISEASE$ @GENE$ via a loss of function mechanism.	0
Overall, our findings identify @GENE$ as a potential therapeutic target for modulating ocular growth aimed at preventing or slowing down @DISEASE$, which is reaching epidemic proportions	0
Primary @DISEASE$ (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and @GENE$ stage renal disease (ESRD).	0
Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, @DISEASE$ and @GENE$ stage renal disease (ESRD).	0
Their @DISEASE$ started within the first day and could not be controlled by pyridoxine or pyridoxal-5'-phosphate (@GENE$) completely.	1
In this review, we will focus on the ability of TRIM32 to @GENE$ specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or @DISEASE$ suppressive role for TRIM32 in the context of different types of cancer	0
Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a @DISEASE$ in <i>@GENE$</i> PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the cellular response to DNA damage stimulus on erythrocytes.	1
the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the @GENE$ sensitivity and adaptation in intact rods; 2. functional differences between positive regulation of guanylate cyclase activity and receptor guanylyl cyclase signaling pathway in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to @DISEASE$ in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	0
the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the T cell costimulation sensitivity and adaptation in intact rods; 2. functional differences between @GENE$ and receptor guanylyl cyclase signaling pathway in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to @DISEASE$ in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	1
the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the T cell costimulation sensitivity and adaptation in intact rods; 2. functional differences between positive regulation of guanylate cyclase activity and @GENE$ in intact rod photoreceptors; and 3. whether positive regulation of guanylate cyclase activity mutants with impaired Ca2+ binding lead to @DISEASE$ in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	1
Mice with a neuronal deletion of Arv1 recapitulated the human pheno@GENE$, exhibiting @DISEASE$s and a severe survival defect in adulthood.	0
Our data support @GENE$ deficiency as a cause of @DISEASE$ epileptic encephalopathy	1
The major question to be solved is the genetic basis of @DISEASE$ adrenal hyperplasia (@GENE$).	0
The major question to be solved is the genetic basis of bilateral @DISEASE$ (@GENE$).	0
In two large Turkish consanguineous families, a locus for @DISEASE$ nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (@GENE$), DFNB66, and ion transport.	1
In two large Turkish consanguineous families, a locus for @DISEASE$ nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (collagen fibril organization), DFNB66, and @GENE$.	1
In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic @DISEASE$ (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (@GENE$), DFNB66, and ion transport.	1
In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic @DISEASE$ (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (collagen fibril organization), DFNB66, and @GENE$.	1
Fine mapping excluded @GENE$ and subsequently homozygous mutations were identified in the @DISEASE$ negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two ion transport-linked families from Pakistan.	0
Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the @DISEASE$ @GENE$ fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two ion transport-linked families from Pakistan.	0
Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the @DISEASE$ negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named @GENE$ membrane protein of hair cell stereocilia (ion transport) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two ion transport-linked families from Pakistan.	0
Fine mapping excluded collagen fibril organization and subsequently homozygous mutations were identified in the @DISEASE$ negative regulation of transcription by RNA polymerase II fusion partner-like 5 (LHFPL5) gene, also named protein-containing complex assembly membrane protein of hair cell stereocilia (@GENE$) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two ion transport-linked families from Pakistan.	0
Thus, the geographic imbalance in colorectal @DISEASE$, in part, may reflect chronic exposure to ST-producing organisms that restore @GENE$ signaling silenced by hormone loss during transformation.	0
Moreover, @GENE$ colonized with ST-producing <i>E. coli</i> exhibited a 50% reduction in carcinogen-induced colorectal @DISEASE$ burden.	0
Fusion gene detection using a next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) was performed on both the primary renal @DISEASE$ that showed the morphology of a LGFMS, and a cervical metastasis that showed the morphology of @GENE$.	0
We show that hypermethylation of p16/Ink4a and p19/Arf in CNT- and asbestos-induced inflammatory lesions precedes mesothelioma; this results in silencing of @GENE$ (Ink4a/Arf) and loss of p16 and p19 protein, consistent with epigenetic alterations playing a gatekeeper role in @DISEASE$.	1
B cell-associated protein 31 (@GENE$) was shown to participate in the apoptosis, and to be an immunotherapy target and a, prognostic factor for @DISEASE$, but its role in CRC has not been elucidated.	0
Gain-of-function mutations in @GENE$ underlie Tylosis with oesophageal @DISEASE$ (negative regulation of protein secretion), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.	1
Gain-of-function mutations in negative regulation of protein secretion underlie Tylosis with oesophageal @DISEASE$ (@GENE$), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.	1
Autosomal recessive spastic @DISEASE$ of Charlevoix-Saguenay (@GENE$) is a neurodegenerative disease that is caused by mutations in the <i>SACS</i> gene.	1
Levels of serum CysC might become elevated regardless of renal function, and CysC-@GENE$ might become unpredictable during the active phase of @DISEASE$s.	1
In addition, conditions such as Gitelman's syndrome, @DISEASE$ and pseudohypoaldosteronism @GENE$ II, as well as a mitochondrial defect associated with hypomagnesaemia, all change the renal handling of divalent cations.	0
In addition, conditions such as Gitelman's syndrome, distal renal tubular acidosis and @DISEASE$ @GENE$ II, as well as a mitochondrial defect associated with hypomagnesaemia, all change the renal handling of divalent cations.	0
The second most frequently mutated gene, histone methyltransferase <i>@GENE$</i>, has known roles in multiple cancers, but has not previously been strongly implicated in @DISEASE$.	0
The second most frequently mutated gene, histone methyltransferase <i>@GENE$</i>, has known roles in multiple @DISEASE$s, but has not previously been strongly implicated in osteosarcoma.	1
This study points to the likely importance of histone modifications in @DISEASE$ and highlights the strong genetic similarities between human and dog osteosarcoma, suggesting that canine osteosarcoma may serve as an excellent model for developing treatment strategies in both species.<b>Significance:</b> Canine osteosarcoma genomics identify @GENE$ as a possible oncogenic driver of osteosarcoma, and findings establish the canine model as a useful comparative model for the corresponding human disease.	0
@GENE$ is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	0
superoxide metabolic process is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the @GENE$ gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	0
superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the @GENE$ gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	0
superoxide metabolic process is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the CYBA, protein targeting to membrane, @GENE$, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	1
Triple-negative breast @DISEASE$ (TNBC), lacking the steroid hormone receptors ER and PR and the oncoprotein @GENE$, is characterized by its aggressive pattern and insensitivity to endocrine and HER2-directed therapy.	1
Primary @DISEASE$ (@GENE$) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary disease and situs abnormalities.	1
These results revealed that mutations in cilium movement are a cause of ciliary dysmotility and @GENE$ and further demonstrate the utility of exome sequencing to identify genetic causes in @DISEASE$ recessive disorders	0
Prion proteins (@GENE$ and acrosome reaction), known mostly for its involvement in neurodegenerative spongiform @DISEASE$, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.	1
Prion proteins (positive regulation of peptidyl-tyrosine phosphorylation and @GENE$), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, @DISEASE$igenesis, proliferation, and metastasis.	0
PRNP and @GENE$ are significantly over-expressed in @DISEASE$.	0
@GENE$ and PRND appear involved with some important genes related to @DISEASE$igenesis and apoptosis.	0
Promoter CpG island hypermethylation is an important mechanism for inactivating key cellular enzymes that mediate epigenetic processes in hepatitis-related @DISEASE$ (@GENE$).	0
Alazami syndrome (AS) (MIM# 615071) is an @DISEASE$ microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in @GENE$.	1
By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, @DISEASE$, full lips and abnormally @GENE$ teeth.	1
In this study, we performed exome-wide association studies (EWASs) to identify genetic variants that confer susceptibility to ischemic stroke, @DISEASE$ (ICH), or subarachnoid hemorrhage (@GENE$).	0
Multivariable logistic regression analysis with adjustment for age, @GENE$ and the prevalence of @DISEASE$ and diabetes mellitus revealed that 4 of these SNPs [rs3212335 of GABRB3 (P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis (P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related (P&lt;0.01) to ischemic stroke.	0
Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of @DISEASE$ and diabetes mellitus revealed that 4 of these SNPs [rs3212335 of GABRB3 (P=0.0036; odds ratio, 1.29), rs147783135 of @GENE$ (P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related (P&lt;0.01) to ischemic stroke.	0
Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of @DISEASE$ and diabetes mellitus revealed that 4 of these SNPs [rs3212335 of GABRB3 (P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis (P=0.0024; odds ratio, 0.37), rs2292661 of @GENE$ (P=0.0054; odds ratio, 0.35) and rs191885206 of very long-chain fatty acid metabolic process (P=0.0082; odds ratio, 2.60)] were related (P&lt;0.01) to ischemic stroke.	0
Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of @DISEASE$ and diabetes mellitus revealed that 4 of these SNPs [rs3212335 of GABRB3 (P=0.0036; odds ratio, 1.29), rs147783135 of proteolysis (P=0.0024; odds ratio, 0.37), rs2292661 of protein folding (P=0.0054; odds ratio, 0.35) and rs191885206 of @GENE$ (P=0.0082; odds ratio, 2.60)] were related (P&lt;0.01) to ischemic stroke.	0
Multivariable logistic regression analysis with adjustment for age, @GENE$ and the prevalence of @DISEASE$ revealed that rs138533962 of peptidyl-tyrosine phosphorylation (P&lt;1.0x10-23; odds ratio, 111.3) was significantly (P&lt;2.60x10-4) associated with ICH and that rs117564807 of hemidesmosome assembly (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&lt;0.0010) associated with regulation of blood pressure.	0
Multivariable logistic regression analysis with adjustment for age, multicellular organism development and the prevalence of @DISEASE$ revealed that rs138533962 of peptidyl-tyrosine phosphorylation (P&lt;1.0x10-23; odds ratio, 111.3) was significantly (P&lt;2.60x10-4) associated with ICH and that rs117564807 of hemidesmosome assembly (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&lt;0.0010) associated with @GENE$.	0
We identified the first de novo variant in @GENE$ (c.2984 A &gt; G (p.(N995S)))-encoding the BK channel-that causes @DISEASE$, but not paroxysmal dyskinesia, in two independent families.	1
Amyotrophic lateral sclerosis (@GENE$) and @DISEASE$ (FTD) are neurodegenerative diseases that overlap in their clinical presentation, pathology and genetics, and likely represent a spectrum of one underlying disease.	0
While mutations in @GENE$ are known to cause human 'congenital disorders of glycosylation', a recessive autosomal metabolic disease, the potential association of this protein with human @DISEASE$ development has not been explored to date.	0
In the present study, we revealed that @GENE$ is overexpressed in HCC and its depletion weakens the invasive activity of @DISEASE$ cells through suppression of matrix metalloproteinase‑2 (MMP‑2) expression.	0
The 2016 revised World Health Organization (WHO) classification of lymphoid @DISEASE$ included the category of high-grade B cell lymphomas (HGBLs) with combined @GENE$ and protein polyubiquitination and/or BCL6 rearrangements (double-hit, DH).	1
The 2016 revised World Health Organization (WHO) classification of lymphoid @DISEASE$ included the category of high-grade B cell lymphomas (HGBLs) with combined negative regulation of transcription by RNA polymerase II and @GENE$ and/or BCL6 rearrangements (double-hit, DH).	1
The significance of the ubiquitin-proteasome system (@GENE$) for protein degradation has been highlighted in the context of @DISEASE$, including retinal dystrophies.	0
The significance of the ubiquitin-proteasome system (@GENE$) for protein degradation has been highlighted in the context of neurodegenerative diseases, including @DISEASE$.	0
The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous @GENE$ knockout epidermis development have the earliest known onset of @DISEASE$ seen in a mouse model.	0
The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous exocytosis knockout @GENE$ have the earliest known onset of @DISEASE$ seen in a mouse model.	0
Recently, a homozygous truncating variant in @GENE$ was suggested to be causative for migrating @DISEASE$ and structural brain abnormalities.	1
However, the currently limited knowledge on @GENE$ suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, @DISEASE$ and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants	1
However, the currently limited knowledge on @GENE$ suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic @DISEASE$ to unravel the phenotypic spectrum of carriers of CPLX1 variants	1
Defects in Membrane Frizzled-related Protein (@GENE$) cause @DISEASE$ retinitis pigmentosa (biological_process).	1
Cystinosis is an @DISEASE$ lysosomal storage disease caused by mutations in @GENE$.	1
In this study, breast @DISEASE$ tissue samples were obtained from Zhejiang University (ZJU @GENE$).	0
The prognostic significance and performance of @GENE$ mRNA were validated on 13 worldwide independent microarray data negative regulation of transcription, DNA-templateds, composed of 2500 assessable breast @DISEASE$ cases.	0
Our findings revealed that both @GENE$ mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast @DISEASE$s.	0
Our findings revealed that both @GENE$ mRNA and protein expression were significantly associated with @DISEASE$ size, grade and invasive molecular subtypes of breast cancers.	0
Therefore, @GENE$ might serve as a prognostic biomaker for either ER-positive or ER-negative breast @DISEASE$ subtypes and can also be a potential target for breast cancer therapy	0
@GENE$ is predominantly inherited as an @DISEASE$ trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.	0
@GENE$ is predominantly inherited as an autosomal recessive trait and contributes to 5% of all @DISEASE$; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.	0
@GENE$ is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of @DISEASE$ in children and young adults.	0
Here we have studied eleven consanguineous @GENE$ and one @DISEASE$ RP (arRP) south Indian families to know the prevalence of mutations in known genes and also to know the involvement of novel loci, if any.	0
Amyotrophic lateral sclerosis (@GENE$) is the major adult-onset motor neuron disease, and is clinisister chromatid cohesiony, pathologically, and genetically associated with @DISEASE$, the second cause of dementia in the elderly.	0
Amyotrophic lateral sclerosis (signal transduction) is the major adult-onset motor neuron disease, and is clini@GENE$y, pathologically, and genetically associated with @DISEASE$, the second cause of dementia in the elderly.	0
Pulmonary veno-occlusive disease (PVOD) is a rare and fatal cause of @DISEASE$ (@GENE$).	0
Here, we reported a @DISEASE$ PVOD patient evidenced by pathology and @GENE$ biallelic mutation.	0
Germline @GENE$ mutations confer increased @DISEASE$ risk, for breast and other types, which is variable depending on the specific mutation.	1
Popliteal pterygium syndrome shares features with @GENE$ der Woude syndrome but, in addition, is characterized by @DISEASE$, syndactyly of fingers and toes, and toenail dysplasia.	0
Popliteal pterygium syndrome shares features with @GENE$ der Woude syndrome but, in addition, is characterized by genital anomalies, syndactyly of fingers and toes, and @DISEASE$.	0
Renal manifestations of @DISEASE$ (MM) including @GENE$ nephropathy, amyloidosis, and renal calcification have been widely recognized.	0
Based on the elastic @GENE$, 33 genes out of 1381 genes related to bladder @DISEASE$ were selected.	0
Patients with @GENE$ show &lt;50% of normal activity and those with the rare @DISEASE$ harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the CPOX reaction.	0
@GENE$ knockdown inhibits proliferation and promotes the apoptosis of ALL cells in vitro as well as attenuates @DISEASE$ growth in vivo.	0
The membrane-type frizzled-related protein (@GENE$) is the only gene so far reported implicated in @DISEASE$, non-syndromic and syndromic forms of PM.	1
To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, @GENE$, SOX2, visual perception-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of @DISEASE$.	1
To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, @GENE$-3 and visual perception) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of @DISEASE$.	0
To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (regulation of transcription by RNA polymerase II, transcription initiation from RNA polymerase II promoter, positive regulation of gene expression, SOX2, visual perception-3 and @GENE$) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of @DISEASE$.	0
MATERIAL AND METHODS We analyzed BC microarray studies GSE37751, GSE7390, and GSE21653 to investigate the expression of positive regulation of cell proliferation gene between BC patients and their normal counterparts and the relationship between FGF5 expression and age, @DISEASE$ size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, clinical risk group according to @GENE$ criteria, clinical risk group according to Veridex signature, distant metastasis-free survival (DMFS), time to distant metastasis (TDM), disease-free survival (DFS), and overall survival (OS) of BC patients.	0
The results showed that the concentration of inflammatory cytokines [interleukin 1β (IL1β) and @DISEASE$ necrosis factor α (TNF-α)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (phagocytosis), nuclear factor κB (NF-κB, p65), phosphorylated p65 (p-p65), inhibitor κBα (IκBα), and phosphorylated IκBα (p-IκBα), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-κB, IL1β, interleukin 6 (IL6), and TNF-α, were significantly upregulated in the @GENE$ group compared to the PBS group.	0
Among these diseases, X-linked @DISEASE$ (proteolysis), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (proteolysis) gene, is the most prevalent form of genetic @GENE$-related hypophosphatemic rickets.	1
Among these diseases, X-linked @DISEASE$ (@GENE$), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (proteolysis) gene, is the most prevalent form of genetic regulation of phosphate transport-related hypophosphatemic rickets.	1
Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, @GENE$) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, @DISEASE$, cardiomyopathy and acidosis.	1
This case of malonic aciduria with @DISEASE$ demonstrates improvement in cardiac function attributable to @GENE$-restricted/MCT-supplemented diet	0
The @GENE$-MC was also validated against measurements and simulations in @DISEASE$ phantoms created by placing lung or bone slabs in a water phantom.	1
We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in @GENE$, which were sometimes found with accelerated growth rather than @DISEASE$ as described previously.	1
Further validation in cohorts with severe @DISEASE$ and engineering the variants in model organisms will be needed to explore whether human variants in angiogenesis and other genes that lead to obesity when deleted in @GENE$, do contribute to obesity.	0
The condition was initially termed @GENE$ syndrome (macrocephaly, alopecia, cutis laxa, and @DISEASE$), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined small GTPase mediated signal transduction syndrome.	0
The condition was initially termed actin filament bundle assembly syndrome (macrocephaly, alopecia, cutis laxa, and @DISEASE$), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined @GENE$ syndrome.	1
Patients with @GENE$ syndrome present phenotypic overlap with other conditions, including EDS (especially the dermatosparaxis and kypho@DISEASE$ subtypes).	1
Besides the hallmark features, this patient also presents problems not previously associated with @GENE$ syndrome, including @DISEASE$, mild hearing loss, and colonic fibrosis.	0
Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and @DISEASE$, is caused by the transcriptional silencing of @GENE$ encoding the fragile X mental retardation protein (regulation of alternative mRNA splicing, via spliceosome).	1
Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and @DISEASE$, is caused by the transcriptional silencing of regulation of alternative mRNA splicing, via spliceosome encoding the fragile X mental retardation protein (@GENE$).	1
Patients with @GENE$ imprinting syndrome demonstrate congenital hypotonia, variable @DISEASE$, normal MRIs and EEGs, delayed development, and feeding problems.	1
Associated facial dysmorphic features include dolichocephaly with @DISEASE$, short philtrum, tented upper @GENE$, palatal abnormalities, and small mandible.	0
Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, @DISEASE$, tented upper @GENE$, palatal abnormalities, and small mandible.	0
Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper @GENE$, palatal abnormalities, and @DISEASE$.	0
In clinical practices, the therapeutic outcomes and prognosis of @DISEASE$ (@GENE$) patients with different tumor numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.	0
In clinical practices, the therapeutic outcomes and prognosis of hepatocellular carcinoma (@GENE$) patients with different @DISEASE$ numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.	0
These information revealed that there might be different molecular mechanisms of the @DISEASE$igenesis and development of the @GENE$ with single and multiple lesions.	0
The spontaneous mutant mouse staggerer, with an @DISEASE$ caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades @GENE$ to result from homozygous intragenic Rora deletions.	0
Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving @GENE$ in 16 individuals from 13 families with variable @DISEASE$ and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	1
In summary, we show that variants in @GENE$ result in a neurological syndrome combining @DISEASE$ and spinal motoneuronopathy, thus expanding the list of human exosomopathies	1
Additionally, despite @GENE$ affecting mitochondrial functionality, and hence being of great importance to cellular function, the GDAP1‑associated Charcot-Marie-Tooth disease is mainly characterized by @DISEASE$.	1
Gastric stump cancer (@GENE$) is a @DISEASE$ arising from the remnant stomach following gastric surgery for benign or malignant disease, and is more common in men.	0
Treatments in @GENE$ and primary gastric @DISEASE$ are the same and include resection of the lesion and radical lymph node dissection.	0
Here, we examined the effects of @GENE$ on the progression of gastric @DISEASE$.	1
@GENE$ was highly expressed in gastric @DISEASE$ and gastric cancer cells.	1
Suppression of @GENE$ also attenuated the invasive and metastatic abilities of gastric @DISEASE$ cells by altering expression of epithelial-mesenchymal transition (cytokine production)-related factors.	1
Suppression of protein monoubiquitination also attenuated the invasive and metastatic abilities of gastric @DISEASE$ cells by altering expression of epithelial-mesenchymal transition (@GENE$)-related factors.	1
A xenograft model in which nude @GENE$ were injected with protein monoubiquitination knockdown human gastric @DISEASE$ cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	0
A xenograft model in which nude @GENE$ were injected with protein monoubiquitination knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased @DISEASE$ formation and growth in vivo.	0
A xenograft model in which nude epidermis development were injected with @GENE$ knockdown human gastric @DISEASE$ cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	1
We investigated @DISEASE$-associated oncogene protein-1 (@GENE$-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.	0
MATERIAL AND METHODS @GENE$-1 in @DISEASE$ tissue was measured by immunohistochemistry (IHC).	1
Despite their clinical @DISEASE$, which remains an open question, laminopathies are commonly caused by mutations in the @GENE$ gene, encoding the nuclear proteins Lamin A and C.	1
Individuals had @DISEASE$, developmental delay, epilepsy, and recessive mutations in @GENE$.	0
Individuals had microcephaly, @DISEASE$, epilepsy, and recessive mutations in @GENE$.	1
Diamond-Blackfan anemia (@GENE$), an inherited bone marrow failure syndrome characterized by anemia that usually presents before the first birthday or in early childhood, is associated with birth defects and an increased risk of @DISEASE$.	1
MIR22HG is an lncRNA that contributes to the initiation and progression of many human cancers, including @DISEASE$ (@GENE$).	0
We report that MIR22HG was downregulated in 120 @GENE$ samples compared with adjacent non@DISEASE$ liver tissues.	0
Important factors @GENE$1 and GLI2 were always expressed, only exceptionally one of them was lowered, suggesting the functionality of HH in all @DISEASE$s tested.	1
Progression of prostate @DISEASE$ (PC) to castration-recurrent growth (CRPC) remains dependent on sustained expression and transcriptional activity of the androgen receptor (@GENE$).	0
By comparing the @GENE$-induced oxidation-reduction process-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 @DISEASE$, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.	1
In the present review, 22 loci of @DISEASE$ are presented, including the relevant genes (myocilin, interleukin 20 receptor subunit B, optineurin, ankyrin repeat‑ and @GENE$ box‑containing protein 10, WD repeat‑containing protein 36, EGF‑containing fibulin‑like extracellular matrix protein 1, neurotrophin 4, TANK‑binding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor β binding protein 2 and TEK tyrosine kinase endothelial) and 74 other genes (including toll‑like receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortin‑like kinase 1, RE repeats‑encoding gene, retinitis pigmentosa GTPase regulator‑interacting protein, lysyl oxidase‑like protein 1, heat‑shock 70‑kDa protein 1A, baculoviral positive regulation of cell proliferation repeat‑containing protein 6, 5,10‑methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos 1) that are more closely associated with glaucoma.	0
In the present review, 22 loci of @DISEASE$ are presented, including the relevant genes (myocilin, interleukin 20 receptor subunit B, optineurin, ankyrin repeat‑ and interleukin-7-mediated signaling pathway box‑containing protein 10, WD repeat‑containing protein 36, EGF‑containing fibulin‑like extracellular matrix protein 1, neurotrophin 4, TANK‑binding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor β binding protein 2 and TEK tyrosine kinase endothelial) and 74 other genes (including toll‑like receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortin‑like kinase 1, RE repeats‑encoding gene, retinitis pigmentosa GTPase regulator‑interacting protein, lysyl oxidase‑like protein 1, heat‑shock 70‑kDa protein 1A, baculoviral @GENE$ repeat‑containing protein 6, 5,10‑methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos 1) that are more closely associated with glaucoma.	0
Mutation in @GENE$ causes a wide spectrum of disease including @DISEASE$, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.	1
Mutation in @GENE$ causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, @DISEASE$ and intestinal obstruction.	1
Reviewing the emerging dataset, we underline this unanticipated phenotypic consequence of pathogenic @GENE$ mutation-associated pulmonary disease.Conclusion: From the emerging data, we suggest that while reviewing complex cases with a sustained oxygen requirement against a clincial background of cardiac concerns or @DISEASE$ to have a high index of suspicion for FLNA related pathology and to instigate early MRI brain scan and FLNA mutation analysis.	0
The expression of CD133, @GENE$ and positive regulation of canonical Wnt signaling pathway was found to be positive in 55.6, 47.2 and 78.9% of the primary @DISEASE$ samples, respectively.	0
The expression of CD133, oxidation-reduction process and @GENE$ was found to be positive in 55.6, 47.2 and 78.9% of the primary @DISEASE$ samples, respectively.	0
The present study intended to identify the association between three severe @GENE$s of gynecological @DISEASE$, specifically ovarian cancer, cervical cancer and endometrial cancer, and to identify the connective driver genes, microRNAs (miRNAs) and biological processes associated with these types of gynecological cancer.	0
Survival analysis revealed that the expression of cellular response to DNA damage stimulus, @GENE$, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological @DISEASE$ muscle organ developments.	0
Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, @GENE$ and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological @DISEASE$ muscle organ developments.	1
Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and @GENE$ was associated with the prognosis of the aforementioned gynecological @DISEASE$ muscle organ developments.	0
Survival analysis revealed that the expression of cellular response to DNA damage stimulus, proteolysis, positive regulation of epithelial to mesenchymal transition and transforming growth factor beta receptor signaling pathway was associated with the prognosis of the aforementioned gynecological @DISEASE$ @GENE$s.	0
In the single-locus analysis, two variants, the @GENE$ rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and DNA repair rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with @DISEASE$ risk.	0
In the single-locus analysis, two variants, the MAPK cascade rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and @GENE$ rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with @DISEASE$ risk.	0
Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with @GENE$ual dimorphism of @DISEASE$ (phosphatidylinositol phosphorylation) risk.	0
Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with multicellular organism developmentual dimorphism of @DISEASE$ (@GENE$) risk.	0
Moreover, results from our real-time quantitative polymerase chain reaction (qPCR) using 72 normal liver tissues adjacent to the @DISEASE$ showed that @GENE$ expression was significantly different among different genotypes of this variant (GG versus CC: P = 0.032; Group test: P = 0.060).	0
Limb girdle @DISEASE$ type 2I (LGMD2I) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (@GENE$).	1
@GENE$ displays clinical @DISEASE$ with onset of severe symptoms in early childhood to mild calf and thigh hypertrophy in the second or third decade.	1
We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of @DISEASE$ and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (@GENE$), and Preso1 (positive regulation of synapse structural plasticity), which regulate mGluR5 localization, internalization and signaling.	0
@GENE$ protein was significantly associated with mGluR5 mRNA and mGluR5 endogenous regulators in control subjects, but these associations were lost in @DISEASE$ subjects.	0
The results from our study provide compelling evidence that @GENE$ regulation is altered in @DISEASE$, likely contributing to the altered glutamatergic signaling that is associated with the disorder	0
Whereas transcription by RNA polymerase II heterozygote @GENE$ have no detectable cardiac defects, loss of a Klf13 allele in cell-cell signaling heterozygote mice significantly increases the penetrance of cell-cell signaling-dependent @DISEASE$ including atrial, atrial-ventricular and ventricular septal defects.	0
Whereas transcription by RNA polymerase II heterozygote epidermis development have no detectable cardiac defects, loss of a Klf13 allele in @GENE$ heterozygote mice significantly increases the penetrance of cell-cell signaling-dependent @DISEASE$ including atrial, atrial-ventricular and ventricular septal defects.	1
Whereas transcription by RNA polymerase II heterozygote epidermis development have no detectable cardiac defects, loss of a Klf13 allele in cell-cell signaling heterozygote mice significantly increases the penetrance of @GENE$-dependent @DISEASE$ including atrial, atrial-ventricular and ventricular septal defects.	1
Mutations in the @GENE$ gene have been associated with the X-linked form of Opitz Syndrome, a developmental disorder characterized by midline defects and @DISEASE$.	0
Next, using @GENE$-1 colon @DISEASE$ cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.	0
@GENE$ upregulation in colon @DISEASE$ was also revealed in the Cancer Genome Atlas (TCGA) data and was shown to be an independent predictor of poor survival (multivariate analysis: hazard ratio, 2.805; 95% confidence interval, 1.244‑7.512; P=0.0112).	0
Finally, further analysis of the TCGA data demonstrated @GENE$ upregulation in a modest manner in 8 of 11 @DISEASE$ types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.	0
Our present findings revealed that the upregulation of @GENE$ expression is involved in the pathogenesis of CRC and is associated with a poor prognosis among patients with colon @DISEASE$.	0
Squamous cell carcinoma (@GENE$) can progress to malignant metastatic @DISEASE$, including an aggressive subtype known as spindle cell carcinoma (spSCC). spSCC formation involves epithelial-to-mesenchymal transition (EMT), yet the molecular basis of this event remains unknown.	0
Here, we show that human spSCC @DISEASE$ also feature strong nuclear localisation of YAP and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in @GENE$.	0
sp@GENE$ @DISEASE$ arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo cytokine production to generate spSCC.	0
spnegative regulation of peptidase activity @DISEASE$ arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo @GENE$ to generate spSCC.	1
spnegative regulation of peptidase activity tumours arise at sites of epithelial scratch wounding, where @DISEASE$-initiating epithelial cells undergo @GENE$ to generate spSCC.	1
Group 1 pulmonary hypertension or pulmonary arterial hypertension (@GENE$) is a rare disease characterized by proliferation and occlusion of small pulmonary arterioles, leading to progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, and @DISEASE$.	0
@GENE$ in children is much more @DISEASE$ than in adults, and can be associated with several genetic syndromes, congenital heart disease, pulmonary disease, and vascular disease.	0
The aim of our study was to determine the @GENE$ of genetic polymorphisms in the caspase (CASP) genes on prognosis of @DISEASE$ (phosphatidylinositol phosphorylation).	0
We genotyped 7 potentially functional polymorphisms in @GENE$3, CASP7, CASP8, CASP9, CASP10 genes in 362 phosphatidylinositol phosphorylation patients of receiving surgical resection of HCC @DISEASE$.	0
In @DISEASE$, elevated @GENE$ expression has been associated with malignancy, poor prognosis, and treatment resistance.	1
Mutations in @GENE$ have been reported in @DISEASE$ and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.	1
The colonic expression of @GENE$ is decreased in ulcerative colitis (UC) patients at baseline who progress to @DISEASE$.	0
Craniofrontonasal syndrome (@GENE$) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, @DISEASE$, and a bifid nasal tip.	1
Duchenne @DISEASE$ (@GENE$) is characterized by a severe and progressive destruction of muscle fibers associated with altered Ca<sup>2+</sup> homeostasis.	1
Spinocerebellar @DISEASE$ type 1 (@GENE$) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein negative regulation of transcription, DNA-templated.	1
Spinocerebellar @DISEASE$ type 1 (negative regulation of transcription, DNA-templated) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein @GENE$.	1
@GENE$ expression and molecular mechanisms by which PAX6 modifies the migration capacity of breast @DISEASE$ cells	1
The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant @DISEASE$ renal tubular acidosis associated with a de novo mutation in exon 14 of the @GENE$ gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered	0
Functional studies support intraocular pressure-related influences of @GENE$ and LMX1B, with certain Lmx1b mutations causing high IOP and @DISEASE$ resembling POAG in mice.	0
This study aimed to evaluate the interactions between single nucleotide polymorphisms of @GENE$ (rs1917799) and protein polyubiquitination (rs158572 and rs158916) in gastric @DISEASE$ and its precancerous diseases.	1
This study aimed to evaluate the interactions between single nucleotide polymorphisms of response to oxidative stress (rs1917799) and @GENE$ (rs158572 and rs158916) in gastric @DISEASE$ and its precancerous diseases.	0
@GENE$ rs1917799 also showed a significant interaction with ERCC8 rs158916 to reduce gastric @DISEASE$ risk.	1
The expressions of @GENE$, protein polyubiquitination and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric @DISEASE$.	1
The expressions of response to oxidative stress, @GENE$ and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric @DISEASE$.	0
@GENE$ mutations have been linked to neurodegenerative PHARC (polyneuropathy, @DISEASE$, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.	1
Of these five genes, the brain expressed peptidyl-serine phosphorylation gene constitutes a good candidate for the @DISEASE$, while the @GENE$ gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue	0
BRAF mutations occur in about 40-45% of all @DISEASE$ (@GENE$s) and of which 99.7% is the BRAFV600E mutation.	0
A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to @DISEASE$ (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/@GENE$ signaling in the development of biological_processs.	1
A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to @DISEASE$ (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/cell surface receptor signaling pathway signaling in the development of @GENE$s.	0
A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent @DISEASE$ cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/@GENE$ signaling in the development of biological_processs.	0
A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent @DISEASE$ cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/cell surface receptor signaling pathway signaling in the development of @GENE$s.	0
BBN @DISEASE$ showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), @GENE$ (70%), and regulation of megakaryocyte differentiation (90%) mutations by exome sequencing, similar to human MIBC.	0
BBN tumors showed overexpression of markers of basal @DISEASE$ subtype, and had a high mutation burden with frequent Trp53 (80%), @GENE$ (70%), and regulation of megakaryocyte differentiation (90%) mutations by exome sequencing, similar to human MIBC.	0
BBN tumors showed overexpression of markers of basal @DISEASE$ subtype, and had a high mutation burden with frequent Trp53 (80%), response to estrogen (70%), and @GENE$ (90%) mutations by exome sequencing, similar to human MIBC.	0
Here, we report that @GENE$ is highly overexpressed in multiple @DISEASE$ cell lines and tumor tissues.	0
Clinically, @GENE$ expression is positively associated with @DISEASE$ size, T-stage, and N-stage, and Kaplan-Meier analysis revealed that heightened TRIP13 expression is associated with lower overall survival.	1
@GENE$ promotes @DISEASE$ cell proliferation, clonogenicity, and migration while inhibiting apoptosis and G2/M phase shift in vitro.	0
In conclusion, heightened @GENE$ expression appears to promote @DISEASE$ tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma	0
Bartter syndrome @GENE$ 3 is a clinically @DISEASE$ hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (<i>excretion</i>), which encodes the positive regulation of cell proliferation-Kb chloride channel involved in NaCl reabsorption in the renal tubule.	0
Bartter syndrome muscle organ development 3 is a clinically @DISEASE$ hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (<i>@GENE$</i>), which encodes the positive regulation of cell proliferation-Kb chloride channel involved in NaCl reabsorption in the renal tubule.	1
Bartter syndrome muscle organ development 3 is a clinically @DISEASE$ hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (<i>excretion</i>), which encodes the @GENE$-Kb chloride channel involved in NaCl reabsorption in the renal tubule.	0
Among patients, 29.5% had a pheno@GENE$ of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, @DISEASE$, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).	0
Among patients, 29.5% had a pheno@GENE$ of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of @DISEASE$ with hypomagnesemia and/or hypocalciuria in childhood or adulthood).	0
Among patients, 29.5% had a pheno@GENE$ of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with @DISEASE$ and/or hypocalciuria in childhood or adulthood).	0
Among patients, 29.5% had a pheno@GENE$ of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or @DISEASE$ in childhood or adulthood).	0
Our findings imply that microcephaly is a variable pheno@GENE$ in nucleus organization-related disease, suggest WDR73 to be a candidate gene of severe @DISEASE$ and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	0
Our findings imply that microcephaly is a variable phenomuscle organ development in @GENE$-related disease, suggest WDR73 to be a candidate gene of severe @DISEASE$ and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	1
Our findings imply that microcephaly is a variable phenomuscle organ development in @GENE$-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and @DISEASE$, and expand the molecular spectrum of WDR73-related disease	0
Two rare pathogenic variants were identified in the @GENE$ gene: one in a @DISEASE$ case and another was found to segregate in a family with six affected individuals with CD.	0
Mutations in heat shock transcription factor 4 (@GENE$) have been associated with @DISEASE$; however, the mechanisms regarding how mutations in HSF4 cause cataract are still obscure.	1
The mutant zebra@GENE$ developed an early-onset @DISEASE$ with multiple developmental defects in lens.	0
The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in @DISEASE$ (@GENE$) of the tongue: the vascular endothelial growth factor (negative regulation of transcription by RNA polymerase II)‑C and VEGF‑D, which bind to the cell surface tyrosine kinase receptor VEGF receptor‑3 (VEGFR‑3); C‑C motif chemokine receptor 7 (myeloid dendritic cell chemotaxis); neuropilin (positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E (branching involved in blood vessel morphogenesis).	0
The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in @DISEASE$ (negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor (@GENE$)‑C and VEGF‑D, which bind to the cell surface tyrosine kinase receptor VEGF receptor‑3 (VEGFR‑3); C‑C motif chemokine receptor 7 (myeloid dendritic cell chemotaxis); neuropilin (positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E (branching involved in blood vessel morphogenesis).	0
The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in @DISEASE$ (negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor (negative regulation of transcription by RNA polymerase II)‑C and VEGF‑D, which bind to the cell surface tyrosine kinase receptor VEGF receptor‑3 (VEGFR‑3); C‑C motif chemokine receptor 7 (@GENE$); neuropilin (positive regulation of neurogenesis)1 and NRP2; and semaphorin 3E (branching involved in blood vessel morphogenesis).	0
The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in @DISEASE$ (negative regulation of peptidase activity) of the tongue: the vascular endothelial growth factor (negative regulation of transcription by RNA polymerase II)‑C and VEGF‑D, which bind to the cell surface tyrosine kinase receptor VEGF receptor‑3 (VEGFR‑3); C‑C motif chemokine receptor 7 (myeloid dendritic cell chemotaxis); neuropilin (@GENE$)1 and NRP2; and semaphorin 3E (branching involved in blood vessel morphogenesis).	0
Subsequent quantitative PCR experiments confirmed that @GENE$, CKS2, female pregnancy, and an protein phosphorylation (GenBank accession number BF696304) were expressed at significantly higher levels in @DISEASE$ with metastasis.	0
We investigated this issue by analyzing the expression patterns of @GENE$, APP-processing secretases, and APP metabolites in mitochondria separated from human @DISEASE$ SH-SY5Y cells and those expressing Swedish mutant APP.	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic @GENE$ between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor @DISEASE$ and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic @GENE$ between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and @DISEASE$; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor @DISEASE$ and stereotypy; downregulation of tyrosine hydroxylase, @GENE$, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor @DISEASE$ and stereotypy; downregulation of tyrosine hydroxylase, monoamine transport, @GENE$, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and @DISEASE$; downregulation of tyrosine hydroxylase, @GENE$, regulation of transcription, DNA-templated, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and @DISEASE$; downregulation of tyrosine hydroxylase, monoamine transport, @GENE$, transcription, DNA-templated, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and @DISEASE$; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, @GENE$, lens development in camera-type eye and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic epidermis development between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and @DISEASE$; downregulation of tyrosine hydroxylase, monoamine transport, regulation of transcription, DNA-templated, transcription, DNA-templated, @GENE$ and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
The neurophenotype of these GFAP.HMOX1<sup>8.5-19m</sup> @GENE$ is highly consistent with @DISEASE$ and differs dramatically from the schizophrenia-like features previously documented in younger GFAP.HMOX1<sup>0-12m</sup> mice.	0
A key aspect of several adult lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (@GENE$), including @DISEASE$, is aberrant tissue repair, which leads to an accumulation of cellular protein catabolic process and impaired respiratory function.	0
A key aspect of several adult lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (intracellular protein transport), including @DISEASE$, is aberrant tissue repair, which leads to an accumulation of @GENE$ and impaired respiratory function.	0
In addition, we show that <i>Vangl2<sup>Lp/+</sup></i> lungs exhibit many of the hallmarks of tissue @GENE$, including an altered macrophage population, abnormal elastin deposition and elevated levels of the elastin-modifying enzyme, <i>Mmp12</i>, all of which are observed in @DISEASE$.	0
Schnyder @DISEASE$ (quaternary ammonium group transport) is a rare autosomal dominant disease in humans, characterized by abnormal deposition of cholesterol and phospholipids in cornea caused by mutations in the UbiA prenyltransferase domain containing 1 (@GENE$) gene.	1
To further characterize CD164 as a potential biomarker for malignant CD4<sup>+</sup> T cells, CD164<sup>+</sup> and CD164<sup>-</sup>CD4<sup>+</sup> T cells isolated from patients with high-circulating @DISEASE$ burden, B2 stage, and medium/low tumor burden, @GENE$-B0 stage, were assessed for the expression of genes reported to differentiate SS from normal controls, and associated with malignancy and poor prognosis.	0
Oral and pharyngeal @DISEASE$s combined were associated with loci at 6p21.32 (rs3828805, @GENE$), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, G protein-coupled receptor signaling pathway-TRIM5).	0
Oral @DISEASE$ was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, @GENE$), and with known cancer-related loci-9p21.3 (rs8181047, regulation of cyclin-dependent protein serine/threonine kinase activity-AS1) and 5p15.33 (rs10462706, apoptotic process).	0
Oral @DISEASE$ was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, extracellular matrix organization), and with known cancer-related loci-9p21.3 (rs8181047, @GENE$-AS1) and 5p15.33 (rs10462706, apoptotic process).	1
Oral @DISEASE$ was associated with two new regions, 2p23.3 (rs6547741, biological_process) and 9q34.12 (rs928674, extracellular matrix organization), and with known cancer-related loci-9p21.3 (rs8181047, regulation of cyclin-dependent protein serine/threonine kinase activity-AS1) and 5p15.33 (rs10462706, @GENE$).	0
We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic @DISEASE$ predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), @GENE$ (3), DNA repair (1), DNA repair (1)].	1
We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic @DISEASE$ predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), mitotic cytokinesis (3), @GENE$ (1), DNA repair (1)].	1
We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic @DISEASE$ predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), mitotic cytokinesis (3), DNA repair (1), @GENE$ (1)].	1
The contiguous deletion of @GENE$ and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as @DISEASE$, intellectual disability, and epilepsy.	1
The contiguous deletion of @GENE$ and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and @DISEASE$.	1
The contiguous deletion of positive regulation of transcription, DNA-templated and its neighbouring genes, MAOA/B and @GENE$, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and @DISEASE$.	0
This familial study demonstrates that a deficiency in one of two MAO genes may not lead to psychomotor delay, and deletion of @GENE$ may not cause @DISEASE$.	0
Main subtypes of the disease are @DISEASE$ 1b (@GENE$1b) and pseudohypoparathyroidism 1a (PHP1a).	0
Since this is an atypical but previously described rare presentation of @GENE$1b, we reemphasize retrograde transport, endosome to Golgi deletions and PHP1b as a rare cause for early onset obesity and @DISEASE$.	0
Since this is an atypical but previously described rare presentation of @GENE$1b, we reemphasize retrograde transport, endosome to Golgi deletions and PHP1b as a rare cause for early onset @DISEASE$ and macrosomia.	1
Since this is an atypical but previously described rare presentation of sex determination1b, we reemphasize @GENE$ deletions and PHP1b as a rare cause for early onset obesity and @DISEASE$.	0
Here, we identified three families with mutations in @GENE$, encoding for adducin-γ, with intellectual disability, microcephaly, @DISEASE$ and skeletal defects.	0
In one of the families with additional @DISEASE$ and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in @GENE$, encoding the lysine acetyltransferase 2B, with negative regulation of transcription by RNA polymerase II on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.	0
In one of the families with additional @DISEASE$ and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in chromatin remodeling, encoding the lysine acetyltransferase 2B, with @GENE$ on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.	0
Colorectal @DISEASE$ cell lines with @GENE$ methylation demonstrated increased sensitivity to irinotecan.	0
The @DISEASE$ neurodegenerative disease spinal muscular atrophy (@GENE$) results from low levels of survival motor neuron (mRNA splicing, via spliceosome) protein; however, it is unclear how reduced SMN promotes SMA development.	1
The @DISEASE$ neurodegenerative disease spinal muscular atrophy (spliceosomal snRNP assembly) results from low levels of survival motor neuron (@GENE$) protein; however, it is unclear how reduced SMN promotes SMA development.	0
The autosomal recessive @DISEASE$ spinal muscular atrophy (spliceosomal snRNP assembly) results from low levels of survival motor neuron (@GENE$) protein; however, it is unclear how reduced SMN promotes SMA development.	0
Aberrant expression of different family members of the @GENE$/ephrin system, which comprises the Eph receptors (Ephs) and their ligands (ephrins), has been implicated in various malignancies including breast @DISEASE$.	0
This review reflects the existing @GENE$/ephrin literature while focusing on breast cancer @DISEASE$.	0
Hormone positive, @GENE$ positive and triple negative breast @DISEASE$ (TNBC) cell lines, xenografts/mutant animal models and patient samples are examined separately as, in humans, they represent entities with differences in prognosis and treatment.	1
@GENE$A2, EphB4 and EphB6 are the members most extensively studied in breast @DISEASE$.	0
Existing research points to the potential use of various @GENE$/ephrin members as biomarkers for assessing prognosis and selecting the most suitable thtranscription by RNA polymerase IIpeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast @DISEASE$ heterogeneity	0
Existing research points to the potential use of various positive regulation of cell-matrix adhesion/ephrin members as biomarkers for assessing prognosis and selecting the most suitable th@GENE$peutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast @DISEASE$ heterogeneity	0
Further, high @GENE$ expression level was correlated with higher @DISEASE$ stage, lymph node metastasis, myometrial invasion, and lower survival rate.	0
These collective data indicated that @GENE$ overexpression promotes EC @DISEASE$igenesis by activating mitotic cell cycle and cell division pathways, and IRAK1 may serve as a promising therapeutic strategy for EC	0
More importantly, overexpression of @GENE$-L could increase tumorigenic potential of regulation of low-density lipoprotein particle clearance-depleted @DISEASE$ cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	0
More importantly, overexpression of mitochondrial translational elongation-L could increase tumorigenic potential of @GENE$-depleted @DISEASE$ cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	0
Finally, we found that inclusion of @GENE$ exon 3 was promoted in human colorectal @DISEASE$ tissues and this was correlated with regulation of low-density lipoprotein particle clearance levels.	0
Finally, we found that inclusion of mitochondrial translational elongation exon 3 was promoted in human colorectal @DISEASE$ tissues and this was correlated with @GENE$ levels.	0
In summary, our findings underscore the biological significance of @GENE$-L and regulation of low-density lipoprotein particle clearance in the @DISEASE$ formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells	0
In summary, our findings underscore the biological significance of mitochondrial translational elongation-L and @GENE$ in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in @DISEASE$ cells	0
In summary, our findings underscore the biological significance of mitochondrial translational elongation-L and @GENE$ in the @DISEASE$ formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells	0
Glutaric aciduria type I (@GENE$-I) is a rare @DISEASE$ caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	0
Glutaric aciduria type I (@GENE$-I) is a rare organic aciduria caused by the @DISEASE$ inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	0
Disruption of @GENE$ has previously been implicated in the causation of @DISEASE$ (but not aniridia).	1
In functional assays performed with RNA knockdown, loss of @GENE$ attenuated aggressive phenotypes in glioma cells, including cell proliferation, invasion, and sphere formation in vitro and @DISEASE$ growth in vivo.	0
The correlations between the expressions of @GENE$ with clinicopathologic features,E-cadherin and Vimentin expression were analyzed.<b>Result:</b>CTHRC1 protein expression levels in @DISEASE$ tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(<i>P</i>&lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(<i>P</i>&lt;0.05).	0
In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, @GENE$, negative regulation of cell proliferation and negative regulation of very-low-density lipoprotein particle clearance, in a cohort of 187 independent Chinese patients with high @DISEASE$.	1
In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, eye development, @GENE$ and negative regulation of very-low-density lipoprotein particle clearance, in a cohort of 187 independent Chinese patients with high @DISEASE$.	1
In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, eye development, negative regulation of cell proliferation and @GENE$, in a cohort of 187 independent Chinese patients with high @DISEASE$.	1
The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases @DISEASE$-telangiectasia mutated (@GENE$) and ATM and Rad3-related (actin cytoskeleton reorganization), and proteins with double-strand break repair via homologous recombination COOH-terminal (BRCT) domains.	1
The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases @DISEASE$-telangiectasia mutated (protein phosphorylation) and ATM and Rad3-related (@GENE$), and proteins with double-strand break repair via homologous recombination COOH-terminal (BRCT) domains.	0
The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases @DISEASE$-telangiectasia mutated (protein phosphorylation) and ATM and Rad3-related (actin cytoskeleton reorganization), and proteins with @GENE$ COOH-terminal (BRCT) domains.	0
Single marker-based association tests for corneal @DISEASE$ identified four genome-wide significant loci (P &lt; 5 × 10<sup>-8</sup>) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), HERC2/OCA2 (15q13.1) and @GENE$/TSPAN10 (17q25.3).	0
Three of these loci also demonstrated genome-wide significant association with refractive @DISEASE$: LINC00340, @GENE$/OCA2 and ubiquitin-dependent protein catabolic process/TSPAN10.	0
Three of these loci also demonstrated genome-wide significant association with refractive @DISEASE$: LINC00340, cellular response to DNA damage stimulus/OCA2 and @GENE$/TSPAN10.	0
These loci have previously demonstrated association with axial length (ZC3H11B), @DISEASE$ (NPLOC4), spherical equivalent refractive error (LINC00340) and eye colour (@GENE$).	1
Importantly, cardiac @GENE$ has been shown to be highly induced in various cardiomyopathies and in @DISEASE$, although it is still unclear what negative regulation of transcription by RNA polymerase II this may have on the pathophysiology of heart failure.	0
Importantly, cardiac positive regulation of DNA damage response, signal transduction by p53 class mediator has been shown to be highly induced in various cardiomyopathies and in @DISEASE$, although it is still unclear what @GENE$ this may have on the pathophysiology of heart failure.	0
@GENE$ mRNA was measured in 121 @DISEASE$ samples of soft tissue sarcoma patients using quantitative real-time PCR.	1
@GENE$ protein was evaluated in 52 @DISEASE$ samples by ELISA.	1
Low @GENE$ mRNA expression was correlated with a worsened patients' disease-specific survival in Kaplan-Meier analyses (mean patient survival was 25 vs. 96 months; <i>p</i> = 0.013), especially in high-stage @DISEASE$s.	1
A decreased @GENE$ expression is a negative prognostic factor for soft tissue @DISEASE$ patients.	1
reproductive process may be an interesting candidate gene for the further exploration of soft tissue @DISEASE$ @GENE$ and progression	0
In this study, we found that @GENE$ protein level was positively related to International Federation of Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian @DISEASE$ patients.	0
A significantly lower messenger RNA (mRNA) and protein level of @GENE$ was seen in 3AO cell compared with those in other types of ovarian @DISEASE$ cells.	0
The oncogenic capacity of @GENE$ in ovarian @DISEASE$ may be mediated by increased expression of YAP/TAZ.	0
Mutations in the @GENE$ showed a wide phenotypic spectrum from hereditary @DISEASE$ (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy muscle organ development 2 (microtubule-based movement).	1
Mutations in the @GENE$ showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral @DISEASE$ muscle organ development 2 (microtubule-based movement).	1
Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth @DISEASE$ neuropathy muscle organ development 2 (@GENE$).	0
Mutations in the vesicle-mediated transport showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral @DISEASE$ muscle organ development 2 (@GENE$).	1
The p.Arg204Trp mutation was identified from a CMT2 patient with additional complex pheno@GENE$s of HSP, @DISEASE$, fatigability and pyramidal sign, but the p.Arg280His and p.Leu588Pro mutations were identified in each axonal CMT2 patient.	0
As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal @DISEASE$ neuropathy with or without the HSP pheno@GENE$.	0
Backgorund: Sanjad-Sakati syndrome (SSS) is a rare @DISEASE$ disease caused by a deletion mutation (155-166del) in exon 3 of the @GENE$ gene on chromosome 1q42-43.	1
@GENE$ is an RNase III endoribonuclease central to miRNA biogenesis, and germline <i>DICER1</i> mutations result in a @DISEASE$ predisposition syndrome, associated with an increased risk of many tumor types.	1
@GENE$ is an RNase III endoribonuclease central to miRNA biogenesis, and germline <i>DICER1</i> mutations result in a cancer predisposition syndrome, associated with an increased risk of many @DISEASE$ types.	1
Angio@DISEASE$s in <i>aP2-Cre;@GENE$<sup>Flox/-</sup></i> epidermis development histologically and genetically resemble human angiosarcoma.	1
Angiosarcomas in <i>aP2-Cre;@GENE$<sup>Flox/-</sup></i> epidermis development histologically and genetically resemble human @DISEASE$.	0
These studies illustrate that @GENE$ can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of @DISEASE$ development and metastasis.	0
The original @DISEASE$ harbors mutations in @GENE$, while the second harbors mutations in KDM5C.	0
In this study, we reported the identification of Calcium Binding Protein 39-Like (@GENE$) as a novel regulator of @DISEASE$ metabolism in GC.	0
@GENE$-lipid biosynthetic process activation in GC cell lines was @DISEASE$ suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the cell cycle arrest-silenced cells.	1
protein phosphorylation-@GENE$ activation in GC cell lines was @DISEASE$ suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the cell cycle arrest-silenced cells.	0
protein phosphorylation-lipid biosynthetic process activation in GC cell lines was @DISEASE$ suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the @GENE$-silenced cells.	0
Moreover, knockdown of @GENE$ reversed growth inhibitory effect of CAB39L, indicating that @DISEASE$ suppression by CAB39L depended on LKB1-lipid biosynthetic process.	1
Moreover, knockdown of protein phosphorylation reversed growth inhibitory effect of CAB39L, indicating that @DISEASE$ suppression by CAB39L depended on LKB1-@GENE$.	0
Our data demonstrate that @GENE$ is a novel @DISEASE$ suppressor which suppresses tumorigenesis by promoting protein phosphorylation-AMPK-PGC1α axis, thereby preventing a metabolic shift that drives carcinogenesis.	0
Our data demonstrate that cell cycle arrest is a novel @DISEASE$ suppressor which suppresses tumorigenesis by promoting @GENE$-AMPK-PGC1α axis, thereby preventing a metabolic shift that drives carcinogenesis.	1
of @GENE$ gene (one of the netrin-1 receptors) in colorectal @DISEASE$ patients of Kashmiri population (North India).	0
Results: @GENE$ promoter hypermethylation was significantly found to be associated with colorectal @DISEASE$ cases	0
One hundred and forty-eight @GENE$ mutation carriers have been reported; patients showed @DISEASE$, recurrent infectious diseases, various autoimmune diseases, and lymphocytic infiltration into multiple organs.	1
We also functionally characterized two @GENE$ mutants that are associated with a congenital variant of human night @DISEASE$ and other closely related nonstationary retinal diseases.	0
We also functionally characterized two @GENE$ mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary @DISEASE$.	1
Bartter syndrome (BS) is a hereditary condition transmitted as an @DISEASE$ (Bartter @GENE$ 1 to 4) or dominant trait (Bartter type 5).	1
Here we presented a case (BS @GENE$ Ⅱ) of a 17 years old female presented with @DISEASE$, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).	0
Here we presented a case (BS @GENE$ Ⅱ) of a 17 years old female presented with polyhydramnios, @DISEASE$, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).	0
Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of @DISEASE$ ataxia associated with @GENE$.	1
Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive @DISEASE$ associated with @GENE$.	1
The Rb @DISEASE$ suppressor gene performs a critical role in controlling cell proliferation and tumorigenesis; it recruits @GENE$ protein into the E2F complexes to repress transcription.	0
In this study, we demonstrate that mRNA splicing, via spliceosome, RB and @GENE$ were significantly expressed in same lung @DISEASE$ tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).	0
High expression level of @GENE$ in @DISEASE$ patients was significantly correlated with poor prognosis in NSCLC (log-rank P for OS = 0.01, log-rank P for DFS = 0.001).	0
Knockdown of @GENE$ reduced colony formation ability of lung @DISEASE$ cells.	0
These findings may indicate the involvement of @GENE$ in progression of lung @DISEASE$ by regulating the RB/negative regulation of transcription by RNA polymerase II interaction	0
These findings may indicate the involvement of mRNA splicing, via spliceosome in progression of lung @DISEASE$ by regulating the RB/@GENE$ interaction	0
3-Methylglutaconic aciduria is associated with variants in genes encoding @DISEASE$ inner membrane organizing determinants, including @GENE$, visual perception, intracellular cholesterol transport and QIL1/MIC13	0
3-Methylglutaconic aciduria is associated with variants in genes encoding @DISEASE$ inner membrane organizing determinants, including positive regulation of cell proliferation, @GENE$, intracellular cholesterol transport and QIL1/MIC13	0
3-Methylglutaconic aciduria is associated with variants in genes encoding @DISEASE$ inner membrane organizing determinants, including positive regulation of cell proliferation, visual perception, @GENE$ and QIL1/MIC13	0
Glioblastoma multiforme (GBM) is a highly malignant @GENE$ of brain @DISEASE$ found in humans.	0
Additional plasma and 52 brain tissues obtained from patients with @DISEASE$ were used to validate the association rate of serum amyloid A1 (@GENE$) in different grades of gliomas and its distribution in tumors.	0
Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (@GENE$) in different grades of gliomas and its distribution in @DISEASE$s.	0
Microarray database analysis further validated the coefficient of @GENE$ levels in @DISEASE$.	0
Magnetic resonance imaging and @DISEASE$ region-specific microarray analysis identified a correlation between @GENE$ and GBM cell infiltration in patients.	0
In summary, our results demonstrate that @GENE$ in combination with integrin αV and β3 can serve as an indicator of high @DISEASE$ risk.	0
cDNA-encoded FLAG-tagged human wildtype @GENE$ (<i>a</i>2) and ossification (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing @DISEASE$, dRTA), were transiently expressed in peptidyl-tyrosine phosphorylation 293 cells.	0
cDNA-encoded FLAG-tagged human wildtype cellular iron ion homeostasis (<i>a</i>2) and @GENE$ (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing @DISEASE$, dRTA), were transiently expressed in peptidyl-tyrosine phosphorylation 293 cells.	1
cDNA-encoded FLAG-tagged human wildtype cellular iron ion homeostasis (<i>a</i>2) and ossification (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing @DISEASE$, dRTA), were transiently expressed in @GENE$ 293 cells.	0
Global developmental delay associated with @DISEASE$, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, @DISEASE$ ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive @DISEASE$, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, @DISEASE$ muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle @DISEASE$, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor @DISEASE$, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while @DISEASE$ with widely spaced eyes, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with @DISEASE$, exotropia, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, @DISEASE$, thin upper @GENE$, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	0
Our findings expand the clinical phenotype and further demonstrate the clinical @DISEASE$ related to @GENE$ variants	0
Keratitis-ichthyosis-@DISEASE$ (@GENE$) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.	0
Although @GENE$R2 has been linked to human @DISEASE$, its role in cervical cancer remains unknown.	1
In this study, we investigated the expression and clinical significance of @GENE$R2 in early-stage cervical @DISEASE$.	1
@GENE$R2 expression is significantly upregulated at both mRNA and protein levels in cervical @DISEASE$ cells and tissues, compared with that in matched normal cervical cells and tissues, respectively.	1
Patients with high @GENE$R2 expression have a shorter overall survival (OS) and disease-free survival (DFS). p53R2 is an independent factor for predicting OS and DFS of cervical @DISEASE$ patients.	1
We further show that @GENE$R2 is important for oncogenic growth, migration and invasion in cervical @DISEASE$ cells.	1
In conclusion, our study demonstrates for the first time that @GENE$R2 protein is overexpressed in early-stage cervical @DISEASE$ and unravels some unconventional oncogenic functions of p53R2. p53R2 may be a useful prognostic biomarker and therapeutic target for cervical cancer	1
@GENE$ (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and @DISEASE$.	0
Based on a patient with a full deletion of @GENE$ clinically followed from neonate to adulthood, we investigated a common pituitary origin for @DISEASE$ and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.	1
Based on a patient with a full deletion of @GENE$ clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and @DISEASE$, and the role of IGSF1 as regulator of pituitary hormone secretion.	0
In conclusion, two relevant molecular mechanisms linked to central @DISEASE$ and macroorchidism in @GENE$ deficiency are identified, revealing IGSF1 as an important regulator of TGFβ/Activin pathways in the pituitary	1
The mitochondrial protein @GENE$ has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth muscle organ development 2, Leigh syndrome, progressive myoclonic @DISEASE$ and lethal congenital pontocerebellar hypoplasia.	1
The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited @DISEASE$, Charcot-Marie-Tooth @GENE$ 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	0
The mitochondrial protein mitochondrial membrane fission has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth @GENE$ 2, Leigh syndrome, progressive myoclonic @DISEASE$ and lethal congenital pontocerebellar hypoplasia.	0
Mutant @GENE$ manifest the main clinical features identified in patients, including ataxia, optic atrophy and @DISEASE$, which were completely rescued by expression of the human ortholog.	0
The dystrobrevin-binding protein 1 (@GENE$) gene is a candidate risk factor for @DISEASE$ and has been associated with cognitive ability in both patient populations and healthy controls.	0
@GENE$ encodes neuron projection development protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with @DISEASE$, indicating a potential role in schizophrenia etiology.	0
neuron projection development encodes @GENE$ protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with @DISEASE$, indicating a potential role in schizophrenia etiology.	0
The purpose of these recommendations is to answer the following question: in case of deeply infiltrating @DISEASE$ associated infertility, what is the best therapeutic strategy? First-line surgery and then in vitro fertilization (@GENE$) in case of persistent infertility or first-line IVF, without surgery? After exhaustive literature analysis, we suggest the following recommendations: studies focusing on spontaneous fertility of infertile patients with deeply infiltrating endometriosis found spontaneous pregnancy rates about 10%.	0
The use of @GENE$ in the indication &quot;deep infiltrating @DISEASE$&quot; allows satisfactory pregnancy rates without significant risk, regarding disease progression or oocyte retrieval procedure morbidity	0
Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, @GENE$ 1 and type 2 diabetes, hepatic steatosis, @DISEASE$, and inflammatory bowel diseases	1
Large-scale @DISEASE$ sequencing has revolutionized the identification of somatic driver alterations but has had limited @GENE$ on the identification of cancer predisposition genes (CPGs).	0
Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier @GENE$ - that contribute to @DISEASE$ through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).	1
Pulmonary arterial hypertension (@GENE$) is a progressive disease characterised by @DISEASE$ and pulmonary artery remodelling as result of increased vascular tone and vascular cell proliferation, respectively.	0
Jalili syndrome (JS) is an @DISEASE$ disease characterized by a combination of cone-rode retinal dytrophy (@GENE$) and amelogenesis imperfect (AI).	1
However, the associations between @GENE$ germline mutations and the survival and risk of breast @DISEASE$ have not been fully elucidated.	1
Our study suggested that @GENE$ germline mutations are not associated with an increased risk of breast @DISEASE$, but patients with RAD50 germline mutations have unfavourable survival compared to patients without these mutations	1
In summary, our results reveal that rare loss-of-function variants in @GENE$ increase the risk for a varying combination of epilepsy, intellectual disability/@DISEASE$ and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	0
In summary, our results reveal that rare loss-of-function variants in @GENE$ increase the risk for a varying combination of @DISEASE$, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	0
Mutations in the gene encoding the nuclear matrix protein Matrin 3 have been found in familial cases of @GENE$, as well as autosomal dominant @DISEASE$ myopathy with vocal cord and pharyngeal weakness.	0
We previously found that spinal cord and muscle, organs involved in either @GENE$ or distal @DISEASE$, have relatively lower levels of Matrin 3 compared to the brain and other peripheral organs in the murine system.	0
Canine @GENE$ cell @DISEASE$ (CMCT) are one of the most common skin tumours in dogs with a major negative regulation of transcription by RNA polymerase II on canine health.	0
BACKGROUND @GENE$ rearrangements have been reported in 30% of @DISEASE$ and 1-2% of non-small cell lung cancer (NSCLC).	0
In this investigation we assessed the positivity rate of @GENE$ gene rearrangement in primary and metastatic non-small cell lung @DISEASE$ and explored their relationships.	1
The @GENE$ rearrangement uniformity in metastatic lymph nodes and @DISEASE$ specimens were contrasted and the relationships between RET rearrangement and patients' clinical features were investigated.	1
Among the 246 paired cases, 3 (1.22%) cases of primary @DISEASE$ had identified @GENE$ rearrangement and 2 (0.81%) cases of metastases had identified RET rearrangement.	1
CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung @DISEASE$ can predict @GENE$ rearrangement of the primary tumor tissue in the majority of cases.	1
CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict @GENE$ rearrangement of the primary @DISEASE$ tissue in the majority of cases.	1
Testing for @GENE$ rearrangement in metastases can be used as an alternative to testing of primary @DISEASE$ tissue if it is inaccessible	1
We further replicated pleiotropic associations of @GENE$ in a childhood @DISEASE$ study (n=482) and in a gestational diabetes study (n=1710), respectively.	0
Depending on the @DISEASE$ cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., @GENE$AT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.	0
Depending on the @DISEASE$ cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, @GENE$) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.	0
Depending on the @DISEASE$ cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene @GENE$, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.	0
Depending on the @DISEASE$ cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, @GENE$, FOXA1, positive regulation of protein phosphorylation, S100P, ossification) and glutamate transporter gene SLC1A1.	1
Depending on the @DISEASE$ cell muscle organ development, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, peptidyl-tyrosine phosphorylation) and fatty acid oxidation gene temperature homeostasis, and decreased mRNA levels of oncogenes (e.g., peripheral nervous system developmentAT5, MALAT1, endothelial cell morphogenesis, FOXA1, positive regulation of protein phosphorylation, S100P, @GENE$) and glutamate transporter gene SLC1A1.	0
@GENE$-centric molecules were found to be predominately implicated in the hypoxia-inducible factor-1α (HIF-1α) signaling pathway, and @DISEASE$ and development signaling networks.	0
We analyzed the nucleotide repeat lengths of 6 genes (@GENE$, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with signal transduction and healthy control subjects.	0
We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, @GENE$, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with signal transduction and healthy control subjects.	0
We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, @GENE$, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with signal transduction and healthy control subjects.	0
We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, @GENE$, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with signal transduction and healthy control subjects.	0
We analyzed the nucleotide repeat lengths of 6 genes (biological_process, ATXN10, apoptotic process, rRNA processing, protein phosphorylation, and regulation of ryanodine-sensitive calcium-release channel activity) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with @GENE$ and healthy control subjects.	0
Cyclooxygenase (generation of precursor metabolites and energy)-2 is upregulated in @DISEASE$ (@GENE$).	0
Bio-functional investigation revealed that LTBP1 inhibited cell proliferation in @GENE$ cell lines, suggesting its potential role as a @DISEASE$ suppressor in HCC.	0
In conclusion, this study demonstrated for the first time that enhanced @GENE$-2 expression in hepatocytes is sufficient to induce phosphatidylinositol phosphorylation through inducing promoter hypermethylation by reducing TET1, silencing @DISEASE$-suppressive genes and activating key oncogenic pathways.	0
In conclusion, this study demonstrated for the first time that enhanced generation of precursor metabolites and energy-2 expression in hepatocytes is sufficient to induce @GENE$ through inducing promoter hypermethylation by reducing TET1, silencing @DISEASE$-suppressive genes and activating key oncogenic pathways.	0
This mutation was also found in a second unrelated family with the same clinical phenotype, while no germline or somatic <i>@GENE$</i> mutations were identified in nine patients with @DISEASE$ insulinomatosis.	0
Nephronophthisis (NPHP), Joubert (JBTS), and Meckel-Gruber (@GENE$) syndromes are autosomal-recessive ciliopathies presenting with cystic kidneys, @DISEASE$, and cerebellar/neural tube malformation.	0
This study investigated the @GENE$ gene mutation muscle organ developments in outpatients clinically diagnosed with granular @DISEASE$ (GCD) prior to phototherapeutic keratectomy (positive regulation of endothelial cell migration), also calculated the mutation rate of subjects with normal corneas, but positive family history.	1
This study investigated the angiogenesis gene mutation @GENE$s in outpatients clinically diagnosed with granular @DISEASE$ (GCD) prior to phototherapeutic keratectomy (positive regulation of endothelial cell migration), also calculated the mutation rate of subjects with normal corneas, but positive family history.	0
This study investigated the angiogenesis gene mutation muscle organ developments in outpatients clinically diagnosed with granular @DISEASE$ (GCD) prior to phototherapeutic keratectomy (@GENE$), also calculated the mutation rate of subjects with normal corneas, but positive family history.	0
In this study, we expand the genotype-phenotype repertoire of @GENE$ by describing the novel protein tetramerization deletion p.Pro583_Pro585del highlighting the allelic @DISEASE$ observed in SCA13 patients.	0
In this study, we expand the genotype-phenotype repertoire of protein tetramerization by describing the novel @GENE$ deletion p.Pro583_Pro585del highlighting the allelic @DISEASE$ observed in SCA13 patients.	0
We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound @DISEASE$ not previously associated with the @GENE$ phenotype.	0
Primary ciliary dyskinesia (@GENE$) is a rare, @DISEASE$ disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.	1
Primary ciliary dyskinesia (@GENE$) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, @DISEASE$ and abnormal sperm motility with male infertility.	0
Primary ciliary dyskinesia (@GENE$) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and @DISEASE$ with male infertility.	0
Here, with a comprehensive literature review, we report a couple with an infertility history of 9 years and three unsuccessful @GENE$ treatments, where male partner has Kartagener's Syndrome, a subtype of PCD, displaying recurrent respiratory infections, @DISEASE$ and total asthenozoospermia.	0
Mutations in four genes (@GENE$, positive regulation of macrophage derived foam cell differentiation, negative regulation of receptor recycling and LDLRAP1) account for the majority of cases with familial @DISEASE$.	1
Mutations in four genes (intestinal cholesterol absorption, @GENE$, negative regulation of receptor recycling and LDLRAP1) account for the majority of cases with familial @DISEASE$.	1
Mutations in four genes (intestinal cholesterol absorption, positive regulation of macrophage derived foam cell differentiation, @GENE$ and LDLRAP1) account for the majority of cases with familial @DISEASE$.	1
Nearly 80 genes involved in lipid metabolism (encoding structural components of lipoproteins, lipoprotein receptors and related proteins, enzymes, lipid transporters, lipid transfer proteins, and activators or inhibitors of protein function and gene transcription) with single nucleotide variants (SNVs) that are recognized to be associated with @DISEASE$ and serum lipid @GENE$ in genome-wide association studies and candidate gene studies were identified.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (@GENE$, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (@GENE$, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, @GENE$, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, @GENE$, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, @GENE$, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, @GENE$, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, @GENE$, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, @GENE$, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, @GENE$, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, @GENE$, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, @GENE$, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, @GENE$, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, @GENE$, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, @GENE$, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, @GENE$P1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, @GENE$, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (actin filament organization, post-translational protein modification, double-strand break repair via homologous recombination, protein O-linked glycosylation via serine, ERH, zinc ion transport, biological_process, biological_process, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, bile acid and bile salt transport, eye development, SLC8A3, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, @GENE$, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Our case presented the specific characteristics: @DISEASE$, midline cleft-@GENE$, cleft palate, polydactyly of both hands and feet but without occipitoschisis, considered as the pathognomonic sign of the syndrome.	0
Leiomyoma of deep soft tissue is a rare @GENE$ of benign smooth muscle @DISEASE$ that mostly occurs in the retroperitoneum or abdominal cavity of women, and about which very little genetic information exists.	0
G-banding showed that three @DISEASE$s carried rearrangements of the long @GENE$ of chromosome 12, three others had 8q rearrangements, the 7th tumor had deletion of the long arm of chromosome 7, del(7)(q22), and the 8th had aberrations of chromosome bands 3q21~23 and 11q21~22.	0
In the leiomyomas with 12q rearrangements, both HMGA2 and @GENE$ were expressed whereas in the @DISEASE$s with 8q aberrations, only PLAG1 was expressed.	1
In two @DISEASE$s with 12q rearrangements, RPSAP52 on 12q14.3 was fused with non-coding RNA (accession number XR_944195) from 14q32.2 or @GENE$ from14q24.1.	0
We recently found that @GENE$ is a principal triglyceride hydrolase in the @DISEASE$ nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (positive regulation of macroautophagy) accumulation in neurons throughout the brain.	0
We recently found that phosphatidic acid biosynthetic process is a principal triglyceride hydrolase in the @DISEASE$ nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (@GENE$) accumulation in neurons throughout the brain.	0
The genetic and functional evidences here reported suggest a possible role of the @GENE$ gene in the pathology of @DISEASE$ and also in the therapeutic effects of antipsychotic drugs	0
Mechanical compression induced protein polyubiquitination-9 downregulation by @GENE$-dependent promoter methylation in the MDA-MB-231 and biological_process-474 breast @DISEASE$ cell lines and in cancer-associated fibroblasts.	1
Mechanical compression induced protein polyubiquitination-9 downregulation by DNA methylation-dependent promoter methylation in the MDA-MB-231 and @GENE$-474 breast @DISEASE$ cell lines and in cancer-associated fibroblasts.	0
This paper deals with the molecular investigation of Waardenburg syndrome (WS) in a sample of 49 clinically diagnosed probands (most from southeastern Brazil), 24 of them having the @GENE$ 1 (WS1) variant (10 familial and 14 @DISEASE$) and 25 being affected by the type 2 (WS2) variant (five familial and 20 isolated cases).	0
Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the @GENE$ gene in a patient from a consanguineous Turkish family who presented with congenital @DISEASE$, lissencephaly, short stature, polysyndactyly, and dental abnormalities.	1
Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the @GENE$ gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, @DISEASE$, short stature, polysyndactyly, and dental abnormalities.	1
Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the @GENE$ gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, @DISEASE$, polysyndactyly, and dental abnormalities.	0
Homozygous and compound heterozygous mutations in @GENE$ have very recently been described as a cause of @DISEASE$ with brain malformations and seizures.	1
Homozygous and compound heterozygous mutations in @GENE$ have very recently been described as a cause of microcephaly with brain malformations and @DISEASE$.	1
Interestingly, de novo loss-of-function and missense variants in @GENE$ were identified in patients with intellectual disability (ID) and @DISEASE$ spectrum disorder (ASD) but also in unaffected individuals.	0
The c.808 + 1G &gt; A variant was identified in a boy with mild ID and @DISEASE$ negative regulation of transcription by RNA polymerase II and is associated with a significant reduced @GENE$ mRNA expression without alteration of its H3K4me3 pattern.	0
The c.808 + 1G &gt; A variant was identified in a boy with mild ID and @DISEASE$ @GENE$ and is associated with a significant reduced histone H3-K4 demethylation mRNA expression without alteration of its H3K4me3 pattern.	0
Our data reinforces the recent observation that the @GENE$ haploinsufficiency is not a mechanism involved in @DISEASE$ and that KDM5B disorder associated with LOF variants is a recessive disorder.	0
Proteomic analysis of 12 @DISEASE$ from an @GENE$-driven hepatocellular carcinoma mouse model revealed that positive regulation of DNA binding and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.	0
Proteomic analysis of 12 @DISEASE$ from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that @GENE$ and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.	1
Proteomic analysis of 12 @DISEASE$ from an regulation of cell growth-driven hepatocellular carcinoma mouse model revealed that positive regulation of DNA binding and @GENE$, the only known mammalian histidine kinases, were upregulated.	0
Proteomic analysis of 12 tumours from an regulation of cell growth-driven @DISEASE$ mouse model revealed that @GENE$ and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.	0
Conversely, expression of the putative histidine phosphatase @GENE$ was downregulated specifically in the @DISEASE$.	0
Sustained, hepatic expression of @GENE$ in the @DISEASE$ mouse model reduced tumour burden and prevented the loss of liver function.	0
Sustained, hepatic expression of @GENE$ in the hepatocellular carcinoma mouse model reduced @DISEASE$ burden and prevented the loss of liver function.	0
Finally, in patients with hepatocellular carcinoma, low expression of @GENE$ correlated with increased @DISEASE$ severity and reduced overall survival.	0
@GENE$ knockdown in MDA-MB-231 breast @DISEASE$ cells significantly impeded cell proliferation and resulted in the accumulation of G1 and G2/M cells by decreasing the mRNA levels of G1/S transition- and G2/M-related transcription factors and their target genes.	0
We also confirmed that @GENE$ is highly expressed in breast @DISEASE$ tissues by bioinformatic analysis and immunohistochemistry.	0
Thus, we propose that @GENE$ is required for breast @DISEASE$ cell proliferation and is associated with poor prognosis in breast cancer.	0
To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (@GENE$, MAPK10, protein phosphorylation, protein phosphorylation, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.	0
To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (protein phosphorylation, MAPK10, @GENE$, protein phosphorylation, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.	0
To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (protein phosphorylation, MAPK10, protein phosphorylation, @GENE$, MAPK1, cellular response to transforming growth factor beta stimulus and VEGF), were calculated.	0
To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (protein phosphorylation, MAPK10, protein phosphorylation, protein phosphorylation, MAPK1, @GENE$ and VEGF), were calculated.	0
The cause was identified in only 7 patients and included @DISEASE$, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (@GENE$) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (post-translational protein modification) mutation (Woodhouse-Sakati syndrome).	0
The cause was identified in only 7 patients and included @DISEASE$, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (nervous system development) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (@GENE$) mutation (Woodhouse-Sakati syndrome).	0
A large, complex, and robust gene network containing well-known lung @DISEASE$-related genes, including @GENE$ and transcription, RNA-templated, was identified from combined gene lists for lung adenocarcinoma.	1
A large, complex, and robust gene network containing well-known lung cancer-related genes, including positive regulation of protein phosphorylation and @GENE$, was identified from combined gene lists for @DISEASE$.	0
Intracerebroventricular infusion of Hm1a rescues Dravet syndrome @GENE$ from @DISEASE$ and premature death.	0
Here we found that perilipin-1 (@GENE$) mRNA expression is significantly downregulated in human breast @DISEASE$.	0
Further Cox proportional hazard models analysis revealed that the reduced expression of @GENE$ is an independent predictor of overall survival in estrogen receptor positive (p &lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast @DISEASE$ patients.	0
We also demonstrated that the exogenous expression of @GENE$ in human breast @DISEASE$ MCF-7 and MDA-MB-231 cells significantly inhibits cell proliferation, migration, invasion and in vivo tumorigenesis in mice.	0
Together, these data provide novel insights into a prognostic significance of @GENE$ in human breast @DISEASE$ and reveal a potentially new gene therapy target for breast cancer	0
We investigated the @GENE$ of these polymorphisms on the clinical outcome of 103 patients with recurrent or metastatic @DISEASE$ of the head and neck treated with a platinum compound, fluorouracil and cetuximab as palliative first-line therapy.	0
Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) @GENE$ mutation in a patient with global @DISEASE$, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.	1
Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) @GENE$ mutation in a patient with global developmental delay, @DISEASE$, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.	1
We present a case of a patient with long-standing @DISEASE$ and erythematous papules over his chest, abdomen, back and @GENE$, suggestive of Dowling-Degos disease (DDD).	0
Although mutations in the gene encoding tricellulin are known to cause @DISEASE$ in humans (@GENE$) and mice, the influence of its systemic deletion in vivo remains unknown.	1
When we generated tricellulin-knockout mice (@GENE$(-/-)), we found an early-onset rapidly progressive @DISEASE$ associated with the degeneration of hair cells (mitochondrion organization); however, their body size and overall appearance were normal.	1
When we generated tricellulin-knockout mice (sensory perception of sound(-/-)), we found an early-onset rapidly @DISEASE$ hearing loss associated with the degeneration of hair cells (@GENE$); however, their body size and overall appearance were normal.	0
Spinocerebellar @DISEASE$ @GENE$ 11 (negative regulation of microtubule depolymerization) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.	0
Spinocerebellar @DISEASE$ muscle organ development 11 (@GENE$) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.	1
Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the @GENE$ features include primary microcephaly and @DISEASE$ global developmental delay.	0
Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the @GENE$ features include primary microcephaly and profound global @DISEASE$.	0
However, the biological function and mechanism of @GENE$ in @DISEASE$ remain largely unknown.	0
In this study, we have found that TPI1 expression was greatly decreased in clinical @GENE$ samples, positively correlated with overall survival, and negatively associated with histological differentiation, @DISEASE$ size and organ metastasis.	0
Moreover, overexpression of @GENE$ led to slowed @DISEASE$ growth and decreased tumor weight in vivo.	0
Therefore, our data suggested that @GENE$ functioned as a @DISEASE$ suppressor in phosphatidylinositol phosphorylation and might serve as a potential therapeutic target for the treatment of HCC	0
We also found that multiple @DISEASE$s are genetically correlated with non-cancer @GENE$ including smoking, psychiatric diseases and metabolic characteristics.	0
Five variants were previously reported to confer risk of various malignant or benign @DISEASE$ (rs78378222 in TP53, rs10069690 in @GENE$, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).	1
Five variants were previously reported to confer risk of various malignant or benign @DISEASE$ (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in @GENE$, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).	1
Five variants were previously reported to confer risk of various malignant or benign @DISEASE$ (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related @GENE$ (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).	0
Five variants were previously reported to confer risk of various malignant or benign @DISEASE$ (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (@GENE$), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).	0
Five variants were previously reported to confer risk of various malignant or benign @DISEASE$ (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (@GENE$), and 6q26.2 (SYNE1/ESR1).	0
Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in @GENE$, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast @DISEASE$) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).	1
Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast @DISEASE$) at 1q36.12 (CDC42/WNT4), 2p25.1 (@GENE$), 20p12.3 (cellular response to DNA damage stimulus), and 6q26.2 (SYNE1/ESR1).	0
Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in transcription, RNA-templated, rs1800057 and rs1801516 in protein phosphorylation, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast @DISEASE$) at 1q36.12 (CDC42/WNT4), 2p25.1 (biological_process), 20p12.3 (@GENE$), and 6q26.2 (SYNE1/ESR1).	0
In the present case, magnetic resonance imaging (MRI) obtained during infancy revealed symmetric lesions in the substantia nigra of a patient with Leigh syndrome with an @GENE$ mutation; lesions of the @DISEASE$ putamen and brainstem were subsequently observed.	0
We provide functional evidence to support the pathogenicity of these @GENE$ variants, including evidence of founder effects for both variants, and establish defects within this gene as a cause of complex I deficiency in association with either pure myopathy in adulthood or, in one individual, a severe multisystem presentation (chronic @DISEASE$ and cardiomyopathy) in infancy.	0
negative regulation of transcription by RNA polymerase II expression was positively associated with multiple @DISEASE$ nodes, venous infiltration, and advanced @GENE$ tumor stage.	0
There is increasing evidence of a clinical, neuropathological and genetic overlap between @DISEASE$ (FTD) and amyotrophic lateral sclerosis (@GENE$).	0
Although the molecular role of the peroxisomal protein corpus callosum morphogenesis in neuronal excitability and brain development remains to be defined, corpus callosum morphogenesis has been shown to influence @DISEASE$ threshold and epileptogenesis in @GENE$, consistent with our findings in humans.	0
We conclude that mutations in @GENE$ cause a severe muscle organ development of autosomal-recessive infantile @DISEASE$ with intractable seizures and distinct neuroradiological anomalies.	1
We conclude that mutations in @GENE$ cause a severe muscle organ development of autosomal-recessive infantile encephalopathy with intractable @DISEASE$s and distinct neuroradiological anomalies.	1
We conclude that mutations in corpus callosum morphogenesis cause a severe @GENE$ of autosomal-recessive infantile encephalopathy with intractable @DISEASE$s and distinct neuroradiological anomalies.	0
Here, we found that cervical @DISEASE$ cells undergo massive death by @GENE$ knockdown, but this effect is reversed by SIRT1 restoration.	0
Interestingly, pyroptotic death signaling in @GENE$-knocked-down cells was transmitted to naïve cervical @DISEASE$ cells, which was mediated by extracellular vesicles carrying activation of innate immune response inflammasome proteins.	0
Immunohistochemical analyses showed that @GENE$ expression correlated with poor clinical outcomes in cervical @DISEASE$.	0
In conclusion, @GENE$ enabled HPV-infected cervical @DISEASE$ cells to continue growing by nullifying AIM2 inflammasome-mediated immunity.	0
Without @GENE$, cervical @DISEASE$ cells could no longer survive because of the derepression of the AIM2 inflammasome.	0
Clinicopathologic features such as menarche age, body @GENE$ index, personal @DISEASE$ history, grade, and histologic muscle organ development were compared between the 2 groups.	0
Colorectal, lung, endometrial, breast, and @DISEASE$ accounted for 58.6% of all cancer @GENE$s among 1st- and 2nd-degree relatives.	0
Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all @DISEASE$ @GENE$s among 1st- and 2nd-degree relatives.	0
Our study identifies @GENE$ as a key regulator of TSH/cell surface receptor signaling pathway-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal @DISEASE$ and prevents goiter development	1
Our study identifies negative regulation of transcription by RNA polymerase II as a key regulator of TSH/@GENE$-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal @DISEASE$ and prevents goiter development	1
Appraisal of the present case against previously reported patients indicate that @GENE$ mutations result in a distinctive @DISEASE$ phenotype, with minimal blistering compared with other forms of basal EBS	1
In this study, we investigated the expression of @GENE$ in temporal lobe @DISEASE$ (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron cellular protein catabolic process induced by KA.	0
In this study, we investigated the expression of @GENE$ in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic @DISEASE$, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron cellular protein catabolic process induced by KA.	0
In this study, we investigated the expression of activation of JUN kinase activity in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic @DISEASE$, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron @GENE$ induced by KA.	0
We found that @GENE$ was markedly increased in TLE patients and a mouse model of epileptic seizures; epidermis development underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first @DISEASE$ and decreased seizure duration response to the epileptogenic properties of KA.	0
We found that activation of JUN kinase activity was markedly increased in TLE patients and a mouse model of epileptic seizures; @GENE$ underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first @DISEASE$ and decreased seizure duration response to the epileptogenic properties of KA.	0
Subsequently, a decreased activation of @GENE$ following @DISEASE$ induction was observed in epidermis development underexpressing activation of JUN kinase activity, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.	0
Subsequently, a decreased activation of protein phosphorylation following @DISEASE$ induction was observed in epidermis development underexpressing @GENE$, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.	0
Subsequently, a decreased activation of protein phosphorylation following @DISEASE$ induction was observed in @GENE$ underexpressing activation of JUN kinase activity, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.	0
We also found that @GENE$ underexpressing activation of JUN kinase activity exhibited a delayed pentylenetetrazole (PTZ)-induced kindling @DISEASE$ process	0
We also found that epidermis development underexpressing @GENE$ exhibited a delayed pentylenetetrazole (PTZ)-induced kindling @DISEASE$ process	0
Cerebral, ocular, dental, auricular, skeletal (CODAS) syndrome is a rare @DISEASE$ multisystem disorder caused by mutations in @GENE$.	1
We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital @DISEASE$ cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on @GENE$-weighted images.	0
We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive @DISEASE$ with hyperintensity of the cerebellar cortex on @GENE$-weighted images.	0
Here, we investigated whether synonymous changes could affect expression of the potassium voltage-gated channel subfamily H member 2 (<i>KCNH2</i>) gene, encoding the human ether-a-go-go-related gene (@GENE$) ion channel, which is linked to hereditary @DISEASE$.	1
Urofacial syndrome (@GENE$) is an @DISEASE$ disease with severe dysfunctional urination including urinary incontinence (UI).	1
Ltd), a vascular @GENE$othelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitor, has been proven to be safe and to significantly prolong survival in advanced chemotherapy-refractory gastric @DISEASE$.	1
Four established @DISEASE$ susceptibility genes achieved nominal statistical significance, MC1R (p = .0014), positive regulation of gene expression (p = .0165) @GENE$ (p = .0206), and MTAP (p = .0393).	1
We also observed a suggestive association for @GENE$ (p = .002), a gene previously implicated in @DISEASE$ survival.	0
Although MC1R carriers were represented proportionally among the four molecular @DISEASE$ sub@GENE$s, these individuals accounted for 69% of ultraviolet (UV) radiation mutational signatures among triple-wild type tumors (p = .040), highlighting the increased sensitivity to UV exposure among individuals with loss-of-function variants in MC1R	0
We confirmed that this nonsense @GENE$ mutation segregated with @DISEASE$ in this family.	1
In conclusion, we described a novel nonsense @GENE$ mutation that was responsible for the @DISEASE$ in a Brazilian family.	1
Human bladder @DISEASE$ (@GENE$) is one of the most commonly diagnosed malignancies worldwide.	1
@GENE$ is a small nuclear protein associated with @DISEASE$ and neural development in humans.	1
We show here that @GENE$ depletion in MYCN-driven @DISEASE$ cell lines strongly induces cell death, mostly mediated by apoptotic programs.	0
Our study identified a group of cell cycle-promoting genes regulated by @GENE$, being both predictors of unfavorable patient outcome and essential for @DISEASE$ cell viability.	0
Mutations in GJB2 or @GENE$ and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -@DISEASE$ syndromes were not detected by Sanger sequencing.	1
To retrospectively analyze and quantitatively correlate UGT1A1 (bilirubin UDP- glucuronosyltransferase gene) geno@GENE$s and unconjugated @DISEASE$ (UCH) phenotypes among Chinese children.We retrospectively reviewed UCH patients, quantitatively analyzed genotype-phenotype correlation by comparing with healthy controls.	0
Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-@GENE$), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, @DISEASE$, cholestasis and early infantile death.	0
Although fatty acid beta-oxidation is responsible for X-linked fatty acid beta-oxidation (X-@GENE$), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, @DISEASE$ and early infantile death.	0
Lastly, a syndromic form of @GENE$ with @DISEASE$ results in normal ciliary ultrastructure through mutations in the visual perception gene.	0
Lastly, a syndromic form of motile cilium assembly with @DISEASE$ results in normal ciliary ultrastructure through mutations in the @GENE$ gene.	1
Mutations and post-translational modifications of @GENE$ may lead to dilated cardiomyopathy (DCM) and @DISEASE$.	1
Here we @GENE$ that a lymphocyte lineage-restricted transcription factor, positive regulation of transcription by RNA polymerase II, is frequently expressed in human lung @DISEASE$ tissues.	0
Here we cellular response to interleukin-4 that a lymphocyte lineage-restricted transcription factor, @GENE$, is frequently expressed in human lung @DISEASE$ tissues.	1
The Spi-B-expressing @DISEASE$ cells coexpressed vimentin but repressed E-@GENE$ and exhibited invasive behavior.	0
Increased @GENE$ expression was associated with @DISEASE$ grade, lymphatic metastasis, and short overall survival.	1
These data suggest that @GENE$ participates in mesenchymal invasion, linking epithelial @DISEASE$ metastasis with a lymphatic transcriptional program.	1
Candidate markers were further characterized for concentration- and time-dependent responses to the central nervous system development inhibitor ABBV-075 in vitro and in vivo @GENE$ was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple @DISEASE$ indications and surrogate tissues.	0
Markers such as positive regulation of neuron projection development, @GENE$, and negative regulation of cell migration were modulated by ABBV-075 and other BET inhibitors across @DISEASE$ cell lines and xenograft tumors but not in blood and skin.	0
Significant downregulation of @GENE$, a well-publicized target of central nervous system development inhibitors, was largely restricted to hematologic @DISEASE$ cell lines.	1
Significant downregulation of negative regulation of transcription by RNA polymerase II, a well-publicized target of @GENE$ inhibitors, was largely restricted to hematologic @DISEASE$ cell lines.	0
Until recently, four loci (@GENE$, DFN3, DFN4, and striated muscle contraction) had been implicated in nonsyndromic X-linked @DISEASE$; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.	1
Until recently, four loci (purine nucleobase metabolic process, DFN3, DFN4, and @GENE$) had been implicated in nonsyndromic X-linked @DISEASE$; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.	1
In addition to the @GENE$ gene, which was the first gene identified as causing nonsyndromic X-linked @DISEASE$, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of purine nucleobase metabolic process (purine nucleobase metabolic process).	1
In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked @DISEASE$, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of purine nucleobase metabolic process (@GENE$).	1
In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked @DISEASE$, a second gene, @GENE$, has recently been identified to be the causative gene of purine nucleobase metabolic process (purine nucleobase metabolic process).	1
In addition to the cochlea morphogenesis gene, which was the first gene identified as causing nonsyndromic X-linked @DISEASE$, a second gene, purine nucleobase metabolic process, has recently been identified to be the causative gene of @GENE$ (purine nucleobase metabolic process).	1
Bone morphogenetic protein 7 (@GENE$), a member of the BMP family of signaling molecules, has been implicated in various types of @DISEASE$, particularly prostate cancer and breast cancer.	0
80.5 % of luminal-type @DISEASE$ developed bone metastasis as opposed to 41.7 % of basal and 55.6 % of @GENE$-like tumours.	1
The expression levels of the up-regulated genes (@GENE$, retina homeostasis and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the @DISEASE$.	0
The expression levels of the up-regulated genes (regulation of translational initiation, @GENE$ and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the @DISEASE$.	0
@GENE$ was identified as a genetic modifier of @DISEASE$ in mice and humans.	0
An in-frame insertion polymorphism in the murine @GENE$ gene associates with partial protection against @DISEASE$.	0
In humans, nonsynonymous single nucleotide polymorphisms in @GENE$ associate with prolonged ambulation in Duchenne @DISEASE$.	0
In order to assess the effects of regulation of proteolysis in @DISEASE$, LTBP4 overexpressing @GENE$ were bred to mdx mice, a model of Duchenne muscular dystrophy.	0
a small fraction of the breast @DISEASE$ burden, mutations in the @GENE$ and mitotic cytokinesis genes are known to confer a high	1
a small fraction of the breast @DISEASE$ burden, mutations in the double-strand break repair via homologous recombination and @GENE$ genes are known to confer a high	1
studies have shown that mutations in the @GENE$ gene are involved in breast @DISEASE$ susceptibility due to its impact	1
germline mutations in @GENE$ gene (c.1100delC, R145W and I157T) in breast @DISEASE$s in Rwanda.	1
Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed @GENE$ rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), transcription-coupled nucleotide-excision repair rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	0
Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed mitochondrial translational elongation rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), @GENE$ rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	1
We found that rs1042752-located in the 3'-UTR of POU2AF1, which plays a vital role in @DISEASE$genesis-@GENE$ significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.	1
Cystinuria is a @DISEASE$, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and @GENE$.	0
We report 83 patients affected by @DISEASE$: 44 presented prenatally with a @GENE$ (HEC group) and 39 with a classical postnatal form (CC group).	0
This study shows a relationship between genotype and the clinical form of @DISEASE$, suggesting that only the patients with the most severe mutations presented with an @GENE$.	0
PM were loaded with a siRNA against @GENE$, an important oncogene involved in breast cancer @DISEASE$igenesis, with a special role in CSC malignancy.	0
Efficacy of si@GENE$-PM was validated in CSC isolated from two breast @DISEASE$ cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer.	0
These results prompt @GENE$ inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related @DISEASE$ recurrence	0
We conducted further optimization of dual enzymatic inhibitions towards FGFR1 and @GENE$, two important kinases in lung @DISEASE$.	0
Hereby, we describe a 18 months old girl presenting with @DISEASE$ and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without @GENE$ amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	0
Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including @DISEASE$, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without @GENE$ amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	0
Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, @DISEASE$, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without @GENE$ amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	1
Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 @DISEASE$ without @GENE$ amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	0
Human-induced neuronal progenitor cells (iNPCs) carrying dominant and recessive @GENE$ mutations showed alterations of mitochondrial proteins, which were more prominent in iNPCs with dominant, @DISEASE$-causing mutations.	1
Our data suggest that altered mitochondria-associated endoplasmic reticulum (ER) membranes (@GENE$) may be important disease mechanisms leading to @DISEASE$ in this condition	0
Mucopolysaccharidosis @GENE$ IIIA (MPSIIIA), also known as Sanfilippo A syndrome, is an inherited @DISEASE$ caused by mutations in the lysosomal enzyme, N-sulfoglucosamine sulfohydrolase (glycosaminoglycan catabolic process), also known as sulfamidase.	0
Mucopolysaccharidosis muscle organ development IIIA (MPSIIIA), also known as Sanfilippo A syndrome, is an inherited @DISEASE$ caused by mutations in the lysosomal enzyme, N-sulfoglucosamine sulfohydrolase (@GENE$), also known as sulfamidase.	0
Mutations in human @GENE$, encoding an ADAMTS-like protein which has been implicated in fibrillin microfibril biogenesis, cause @DISEASE$ (EL) and EL et pupillae.	1
@GENE$-induced skin @DISEASE$ were subjected to mutation screening, which identified genetic changes in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (7/40, 17.5%) and Tp53 (2/40, 5%), but not in protein polyubiquitination, a commonly mutated gene in PhIP-induced colon tumors.	0
positive regulation of transcription by RNA polymerase II-induced skin @DISEASE$ were subjected to mutation screening, which identified genetic changes in @GENE$ (7/40, 17.5%) and Tp53 (2/40, 5%), but not in protein polyubiquitination, a commonly mutated gene in PhIP-induced colon tumors.	1
positive regulation of transcription by RNA polymerase II-induced skin @DISEASE$ were subjected to mutation screening, which identified genetic changes in regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (7/40, 17.5%) and Tp53 (2/40, 5%), but not in @GENE$, a commonly mutated gene in PhIP-induced colon tumors.	1
Despite the absence of @GENE$ mutations, β-catenin was overexpressed in nuclear and plasma membrane fractions from positive regulation of transcription by RNA polymerase II-induced skin @DISEASE$, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.	1
Despite the absence of protein polyubiquitination mutations, β-catenin was overexpressed in nuclear and plasma membrane fractions from @GENE$-induced skin @DISEASE$, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.	0
Real-time RT-PCR revealed that p120-catenin isoforms 1 and 4 were upregulated in @GENE$-induced skin @DISEASE$, whereas p120-catenin isoform 3 was expressed uniformly, compared with adjacent normal-looking tissue.	0
Co-immunoprecipitation experiments identified associations of β-catenin with p120-catenin isoforms in @GENE$-induced skin @DISEASE$ and human cancer cell lines.	0
Co-immunoprecipitation experiments identified associations of β-catenin with p120-catenin isoforms in @GENE$-induced skin tumors and human @DISEASE$ cell lines.	0
In severe bilateral cases (@DISEASE$ or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or @GENE$ being the most common.	1
In severe bilateral cases (anophthalmia or severe @DISEASE$) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or @GENE$ being the most common.	1
After its downregulation in @DISEASE$ cells and in brains of @GENE$-deficient epidermis development, membrane protein ectodomain proteolysis and regulation of presynapse assembly levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.	0
After its downregulation in @DISEASE$ cells and in brains of biological_process-deficient @GENE$, membrane protein ectodomain proteolysis and regulation of presynapse assembly levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.	0
Deregulated monoubiquitination of histone H2B (H2Bub1), mainly catalyzed by E3 ubiquitin-protein ligase @GENE$/RNF40 complex, may play an important role in @DISEASE$.	0
Concurrently, global transcriptional profiling analysis reveals that multiple @DISEASE$-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, @GENE$ modifying factor (negative regulation of autophagy), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	1
Concurrently, global transcriptional profiling analysis reveals that multiple @DISEASE$-associated genes such as positive regulation of protein phosphorylation, E2F1/2, HOXA1, protein polyubiquitination modifying factor (@GENE$), Met, and negative regulation of transcription by RNA polymerase II; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, integrin-mediated signaling pathway, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	0
Moreover, @GENE$ knockdown dramatically suppresses terminal squamous differentiation of cultured bronchial epithelial cells, and significantly enhances proliferation, migration, invasion, and cisplatin resistance of lung @DISEASE$ cells.	0
Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, epidermis development with a targeted deletion of @GENE$ displayed multiple skeletal defects, including @DISEASE$, deficient calvarial mineralization, and reduced bone mass.	0
Very recently, @GENE$ mutations were reported to cause @DISEASE$ with growth retardation.	0
We describe two families in which two different homozygous @GENE$ mutations (missense and frameshift deletion) segregate with a phenotype comprising @DISEASE$ and progressive microcephaly.	0
An array of @DISEASE$ syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (@GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of @DISEASE$ syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, @GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of @DISEASE$ syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (@GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary @DISEASE$-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (@GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-@DISEASE$, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, @GENE$, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-@DISEASE$, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, @GENE$, tricarboxylic acid cycle, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of @DISEASE$, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary @DISEASE$-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-@DISEASE$, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of @DISEASE$, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
We identified 30 new blood pressure- or @DISEASE$-associated genetic regions in the general population, including 3 rare missense variants in hematopoietic progenitor cell differentiation, biological_process and @GENE$ with larger effects (&gt;1.5 mm Hg/allele) than common variants.	0
Our data extend the spectrum of allelic variation underlying blood pressure @GENE$ and @DISEASE$, provide new insights into the pathophysiology of hypertension and indicate new targets for clinical intervention	0
Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 @GENE$ gene variant, and the 71098693 epithelial cell development gene variant were found to be significantly associated with @DISEASE$ ASD (P&lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&lt;5×10^-4).	0
Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 regulation of the force of heart contraction gene variant, and the 71098693 @GENE$ gene variant were found to be significantly associated with @DISEASE$ ASD (P&lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&lt;5×10^-4).	0
CONCLUSIONS This was the first study that demonstrated variants in negative regulation of transcription, DNA-templated and @GENE$ associated with @DISEASE$ ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations	0
We suspected PVOD from CT characteristics and @DISEASE$ after @GENE$-targeted vasodilator therapy, and then started oral imatinib treatment.	0
The current study aims to investigate the biological roles and clinical significance of @GENE$ in human gastric @DISEASE$.	0
@GENE$ downregulation was found in 57 of 137 human gastric @DISEASE$ samples and correlated with advanced regulation of transcription by RNA polymerase III stage, positive positive regulation of cysteine-type endopeptidase activity involved in apoptotic process status, and relapse.	0
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway downregulation was found in 57 of 137 human gastric @DISEASE$ samples and correlated with advanced regulation of transcription by RNA polymerase III stage, positive @GENE$ status, and relapse.	1
In conclusion, our results suggest that @GENE$ downregulation might serve as an indicator for poor prognosis in gastric @DISEASE$ patients.	0
To better understand the molecular changes in the AH content under such conditions, we analyzed the @GENE$NA profiles of AH samples from patients with POAG and XFG compared to non-@DISEASE$ controls.	0
While none of these @GENE$NAs have been previously linked to @DISEASE$, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-ß1.	0
Pathway analysis revealed that these @GENE$NAs are involved in potential @DISEASE$ pathways, including focal adhesion, tight junctions, and TGF-ß signaling.	0
Trichothiodystrophy (@GENE$), also known as sulfur-deficient @DISEASE$ syndrome, is a rare autosomal recessive multisystem disorder, which manifests with brittle hair, mental retardation, ichthyosis and decreased fertility.	1
